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ATR is Required for a Mitotic Entry Checkpoint that Prevents Premature Chromatin
Condensation after UV Exposure
P. Nghiem, P. Park, Y. Kim, C. Vaziri,² and S. Schreiber
Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts; *Cutaneous Oncology,
Dana-Farber Cancer Institute, Boston, Massachusetts; ²Cancer Research Center, Boston University, Boston,
Massachusetts
ATR (Ataxia Telangiectasia and Rad3-related) is homologous to yeast protein kinases required for
survival after UV. In a separate abstract we describe the generation of stable human cell lines
inducible for wild type or a dominant negative (kinase dead) isoform of ATR. Expression of the
kinase dead isoform (ATR- kDa) markedly sensitized cells to multiple types of DNA damage but
did not affect p53 function or G1 arrest after damage. Without damage, ATR- kDa had no effect
even when expressed for two weeks. In the presence of low dose damage (UV, ionizing radiation
or hydroxyurea), ATR- kDa expressing cells underwent profound chromosomal fragmentation as
revealed by mitotic spreads. This fragmentation was analogous to that described as ``premature
chromatin condensation'' (PCC) induced by caffeine and DNA damage (Schlegel & Pardee,
Science, 1986). Caffeine has recently been shown to inhibit ATR protein kinase activity in vitro.
Indeed, we ®nd in vivo that ATR- kDa promoted caffeine's ability to sensitize to DNA damage,
while ATR-wt rescued cells from this radiosensitizing effect of caffeine. Cell synchronization
experiments showed that ATR is most important in mid-S phase to prevent PCC and apoptosis.
Consistent with a presumed role downstream of ATR, adenoviral expression of the kinases Chk-1
or Chk-2 rescued PCC caused by ATR- kDa, while expression of the dominant negative isoforms
of these kinases promoted PCC. Because they often lack a DNA damage-responsive G1
checkpoint, cancer cells are often more sensitive to the loss of later cell cycle checkpoints than
normal cells. We mimicked the loss of the G1 checkpoint by adenoviral expression of G1/S cyclins
(cyclin E or CDK2). Indeed, expression of these cyclins synergized with ATR inhibition to cause
increased sensitivity to damage. This result coupled with the sensitivity of S phase cells to ATR
inhibition suggests ATR as a possible target for a radiosensitizing agent. We conclude that ATR
plays an essential role in a checkpoint which prevents lethal premature mitosis in cells which have
received low dose DNA damage.
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The C-Kit Signaling Pathways in Normal and Mastocytosis Mast Cells
I. Chan, K. Kayashima, Y. Ma,* B. Longley,* and M. Tharp
Dermatology, Rush-Presbyterian-St-Luke's Medical Center, Chicago, Illinois; *Dermatology, College of
Physicians & Surgeons of Columbia University, New York, New York
The C-kit receptor is a tyrosine kinase vital in the development and survival of mast cells (MCs).
Mutated c-kit autoactivation is associated with the development of adult mastocytosis. Mitogen
activated kinases (MEKs) and Janus kinases (JAKs) are pivotal enzymes in c-kit signaling pathways.
We examined the roles of JAK-3 and MEKs on the proliferation of mastocytosis cell lines HMC-1
and RMT, which express autoactivated c-kit. When added to these cells for 3 days, the JAK-3
inhibitor WHI-P131 (5 and 20 mM) decreased the number of HMC-1 by 53 6 14% and 61 6 19%
and RMT by 46 6 8% and 58% 6 19%, when compared to controls. The MEKs inhibitor UO126
(5 and 20 mM) also reduced the growth of HMC-1 (47 6 7% and 54 6 11%) and RMT (23 6 9%
and 33 6 10%). When stem cell factor (SCF, 30 ng per ml) was added to these cultures, it did not
signi®cantly reverse the growth inhibiting effects of both WHI-P131 and UO126. Neither
inhibitor induced signi®cant cell death in these cultures. We also investigated the role of c-kit on
normal skin MCs using in vitro MC maturation model. When added to neonatal foreskin cell
cultures that containing MC precursors for 7 days, SCF (30 ng per ml) enhanced the number of
mature MCs to 34 6 15% above controls. The JAK-3 inhibitor did not alter this SCF maturation
effect. These results demonstrate that JAK-3 and MEKs are important enzymes in the signaling
pathways of auto-activated c-kit. Since their inhibition results in decreased mastocytosis MC
proliferation, the primary role of these kinases appears to be in cell division. In contrast, JAK-3
appears play little role in normal skin MC maturation because inhibition of the enzyme did not
reduce the number of mature MCs in culture. We conclude that c-kit play an important role in
MC proliferation and maturation, but the c-kit signaling pathways for MC proliferation and
maturation differ.
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Differences in Proliferation and Maturation Between Normal and Mastocytosis Mast
Cells
K. Kayashima, I. Chan, and M. Tharp
Dermatology, Rush-Presbyterian-St-Luke's Medical Center, Chicago, Illinois
We have examined the development of mast cells (MCs) in normal skin and mastocytosis lesions by
analyzing the expression of proliferative cell nuclear antigen (PCNA) and the BCL-2 oncoprotein
with speci®c mAbs. MCs were identi®ed with conjugated avidin and mAbs for chymase and
tryptase. In normal skin, less than 2% of MCs expressed PCNA and all cells were BCL-2-negative,
whereas 30±95% of mastocytosis lesional skin MCs expressed PCNA and 10±45% of these MCs
were BCL-2 positive. To con®rm these observations in vitro, normal skin MCs in culture and the
mastocytosis cell lines (HMC-1 and RMT) with activating c-kit mutations were also examined.
Normal skin MCs cultured in medium alone had less than 2% PCNA-expression and all of these
cells were BCL-2-negative. With the addition of stem cell factor (SCF, 30 ng per ml) to these cells
for 7 days, 25% of normal MCs expressed PCNA, but none dividing MCs were observed and the
total number of MCs decreased by 8% when compared to the added number of cells at day 0. All
these cells remained BCL-2-negative. In contrast, more than 95% of the mastocytosis cell lines
expressed both PCNA and BCL-2. The results of this study indicate that mastocytosis MCs with c-
kit auto-activation in tumor and culture are highly proliferative and these cells may avoid apoptosis
by expressing BCL-2 oncoprotein. In contrast, normal skin MCs in tissue and culture appear to
have very low proliferation activity and do not express BCL-2. These latter observations have led
us to propose that SCF activation of c-kit in normal skin MCs leads primary to maturation rather
than proliferation.
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Folliculotropic Mycosis Fungoides with Central Nervous System Involvement
M. Ke, N. Kamath, M. Nihal,³ D. Mikkola,³ O. Koc,² S. Stevens, A. Gilliam, K. Cooper, and G.
Wood
Dermatology Case Western Reserve University, Cleveland, Ohio; *Pathology, Case Western Reserve
University, Cleveland, Ohio; ²Medicine, Case Western Reserve University, Cleveland, Ohio;
³Dermatology, Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, Ohio;
§Dermatology, Department of Veterans Affairs Medical Center, Madison, Wisconsin; ¶Dermatology,
University of Wisconsin, Madison, Wisconsin
Folliculotropic mycosis fungoides is a rare variant of cutaneous T-cell lymphoma, mycosis
fungoides (MF) type characterized by atypical lymphocytes preferentially in®ltrating the hair
follicle epithelium relative to the epidermis. We describe the ®rst case in which laser capture
microdissection was used to show that the atypical lymphocytes within the hair follicle epithelium
were part of the same tumor clone as those in the epidermis and the patient's blood. This is also the
®rst case of folliculotropic mycosis fungoides with involvement of the central nervous system. The
successful procurement and analysis of atypical lymphocytes from hair follicle epithelium by laser
capture microscopy ushers in a new era in molecular diagnostics. In reviewing the literature
describing atypical lymphocytes in®ltrating hair follicle epithelium relative to the epidermis, we
encourage the use of the term ``folliculotropic MF.'' Our case also supports previous ®ndings in
classic MF patients that CNS involvement can occur in advanced disease.
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Up-Regulated L-Selectin and Diminished Integrin Expression in SeÂzary Cells:
Functional Consequences Under Physiologic Shear Stress Conditions
S. Hwang and D. Fitzhugh
Dermatology Branch, National Cancer Institute, Bethesda, Maryland
Although aberrations in adhesion molecule expression by lymphoma cells have been reported, the
functional consequences of these changes are unclear. Herein, we report a patient with SeÂzary
syndrome whose peripheral blood T cells (90%) consisted of a TCRVb17+ malignant clone as
detected by TCRVb-speci®c mAb. Thin plaques which showed a dense in®ltrate of TCRVb17+
cells were present on 70% of the patient's body surface. By ¯ow cytometry, peripheral blood
malignant T cell adhesion molecule abnormalities included an 80% down-regulation of LFA-1
compared to normal controls and no detectable expression of a4 integrin. Under shear stress
conditions (1.5 dynes per cm2) in a parallel plate ¯ow chamber, malignant T cells failed to arrest on
recombinant ICAM-1 in the presence of several chemokines and displayed an 80% decrease in the
ability to arrest on TNF-a activated dermal microvascular endothelial cells compared to normal
CD4+ memory T cells (mTC). Cutaneous lymphocyte-associated antigen (CLA) expression was
detected in ~25% of malignant T cells in the peripheral blood, but was expressed in < 10% of
TCRVb17+ T cells in the dermis. By contrast, 95% of malignant T cells in peripheral blood
expressed L-selectin (CD62L), and (as others have reported with CTCL) L-selectin ligand was
detected in dermal blood vessels at affected skin sites by MECA79 mAb. Compared to normal
CD4+ mTC, malignant T cells expressed 2-fold more L-selectin and rolled in 6-fold greater
numbers/unit area on L-selectin ligand (n = 5, p < 0.0001). Thus, aberrant expression of integrins
led to striking defects in SeÂzary cell arrest on activated endothelial cells in vitro. Malignant T cells in
this patient, however, entered skin and produced signi®cant clinical disease. We propose that up-
regulated expression of L-selectin may be a novel mechanism by which malignant T cells may
target skin in greater numbers and compensate for diminished integrin expression.
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Borrelia Burgdorferi is Absent in Cutaneous B-Cell Lymphomas within the United
States
N. Kamath, G. Wood,² J. Guitart,§ B. Smoller,¶ S. Kohler, P. Heald, and L. Cerroni
Dermatology, Case Western Reserve University, Cleveland, Ohio; *Dermatology, Louis Stokes Veterans
Affairs Medical Center, Cleveland, Ohio; ²Dermatology, University of Wisconsin, Madison, Wisconsin;
³Dermatology, Veterans Affairs Medical Center, Madison, Wisconsin; §Dermatology, North-western
University, Chicago, Illinois; ¶Dermatology, University of Arkansas, Little Rock, Arkansas;
**Dermatology, Stanford University, Stanford, California; ²²Dermatology, Yale University, New Haven,
Conneticut; ³³Dermatology, University of Graz, Graz, Austria
An association between Borrelia burgdorferi and cutaneous B-cell lymphoma (CBCL) has been
made in several European countries. The evidence in favor of such an association has recently been
based on more de®nitive tests for the pathogenetic role of Borrelia burgdorferi in CBCL, including
positive cultures or PCR ampli®cation of borrelial DNA from lesional skin. However, there has
been only one negative report of Borrelia burgdorferi in ®ve North American cases of CBCL.
Therefore, we retrieved 38 cases of primary and secondary CBCL from different geographic
locations of the United States. Two separate techniques were used to detect borrelial DNA by
PCR, a nested PCR method to amplify a Borrelia burgdorferi-speci®c gene as well as a borrelial
chromosomal Ly-1 clone ampli®cation method. Southern blot hybridization was used for
con®rmation of the PCR results. No Borrelia burgdorferi-speci®c DNA was detected in any of the
38 CBCL cases, whereas detectable PCR products were obtained with our positive controls. Our
®ndings suggest that Borrelia burgdorferi plays no role in the development or pathogenesis of
CBCL in the United States. The ®ndings also suggest that the geographic variation of the clinical
manifestations of Borrelia burgdorferi is indeed real and may be secondary to the genetic and
phenotypic differences between species present in Europe and North America.
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Fas/Fas Ligand-Mediated Elimination of Cytotoxic CD8+ Lymphocyte in Mycosis
Fungoides: A Potential Mechanism of Tumor Immune Escape?
X. Ni, P. Hazarika, C. Zhang, and M. Duvic
Department of Dermatology, UT-M.D.Anderson Cancer Center, Houston, Texas
Mycosis fungoides (MF) is an indolent cutaneous T-cell lymphoma (CTCL) of skin homing,
CD4+/CD45RO+ (helper/memory) T-lymphocytes. Loss of CD8+ cytotoxic T cells in MF
lesions is associated with poor prognosis. T-cell apoptosis controlled by Fas/Fas ligand (FasL)
system allows FasL+ tumors escape immune surveillance, triggering apoptosis of tumor in®ltrating
T-lymphocytes. To evaluate the potential role of Fas/FasL-mediated apoptosis, immunochemical
staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)
were used to study FasL expression and apoptosis in MF lesions and paired, uninvolved skin
specimens taken from 21 patients.Western Blotting showed FasL expression in CTCL cell lines
(MJ, Hut78 and HH). FasL staining was positive (1±3+) in epidermal keratinocytes (17/21) and
in®ltrating lymphocytes (13/21) in MF lesions and higher in stage IV (5/6). FasL staining was more
intense in MF dermal in®ltrates than in paired, uninvolved MF skin (10/15, sign test,p < 0.01).
Strongest FasL expression was seen colocalizing with CD45RO + cells with cerebriform nuclei.
The number of CD8+ cytotoxic T lymphocytes in FasL+ areas (2.01 6 0.86%) was signi®cantly
less than in FasL± areas (13.53 6 3.54%, Wilcoxon signed ranks test, p < 0.02). Increased TUNEL-
positive epidermal keratinocytes (13/15) and dermal lymphocytes (13/15) were present in MF
lesions and paired uninvolved skin. By CD8/TUNEL doublestaining, the majority of CD8+
cytotoxic T lymphocytes were TUNEL-positive. These data suggest that FasL expression by MF
tumor cells may lead to apoptosis of CD8+ cytotoxic T lymphocytes by the Fas/FasL pathway.
Fas/FasL mediated elimination of CD8+ cytotoxic T lymphocytes may thus be a potential
mechanism of tumor immune escape in mycosis fungoides.
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Three Pediatric Cases of CD30+ Cutaneous Anaplastic Large Cell Lymphomas (ALCLs)
Bearing the t(2;5)(p23;q35) Translocation
A. Trowers, E. Kodish,* S. Kuerbitz,² and G. Wood³
Dermatology, University Hospitals of Cleveland/Case Western Reserve University, Cleveland, Ohio;
*Department of Pediatrics, Rainbow Babies' and Children's Hospital of University Hospitals of Cleveland,
Cleveland, Ohio; ² Department of Pediatrics, Medical College of Ohio, Toledo, Ohio; ³ Department of
Medicine (Dermatology), University of Wisconsin and the Middleton VAMC, Madison, Wisconsin
The t(2;5)(p23;q35) translocation may be more strongly associated with younger patient age, rather
than nodal vs. cutaneous site of presentation. Review of the available literature, in conjunction
with our analysis of three pediatric cases of cutaneous CD30+ ALCLs with the translocation,
support this conclusion. Our three cases of pediatric cutaneous ALCL all contained the
t(2;5)(p23;q35) translocation as determined by PCR analysis of genomic DNA. Each case
exhibited a unique breakpoint as evidenced by different sizes of the PCR products. All three cases
had an excellent outcome. Two were stage IEA. One was stage IIIEA. Since its discovery in
CD30+ ALCLs the t(2;5)(p23;q35) translocation has shown a high degree of association with nodal
disease, younger patient age and a better prognosis. The translocation results in the fusion of the
NPM nucleolar phosphoprotein housekeeping gene on chromosome 5q35 to the protein
tyrosinase kinase gene, anaplastic lymphoma kinase, on chromosome 2p23. As a result, anaplastic
lymphoma kinase which is normally silent, is constitutively expressed. Most prior studies of the
t(2;5) translocation in primary cutaneous ALCLs were restricted almost exclusively to adults.
Therefore it is not suprising that the t(2;5) translocation has been rarely associated with pediatric
cutaneous presentations. We conclude that the t(2;5) translocation is associated with younger
patient age and better survival, but is not a marker for nodal disease.
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Cutaneous Lymphomatoid Granulomatosis: A Clinical, Microscopic and Molecular
Study
M. Beaty, J. Toro, L. Sobara, J. Stern, W. Wilson, and E. Jaffe
National Cancer Institute, Bethesda, Maryland
Lymphomatoid granulomatosis (LYG) is a rare and unique angiocentric and angiodestructive
Epstein-Barr virus associated B-cell lymphoproliferative disorder (EBV-BLPD), varying widely
from an indolent process to an aggressive large cell lymphoma. The skin is the extrapulmonary
organ most commonly involved in LYG. We studied 31 skin lesions from 20 patients with known
pulmonary LYG, using immunohistochemistry, in situ hybridization for Epstein-Bar virus (EBV),
and PCR for the presence of antigen receptor gene rearrangements (IgH and TCR), to better
de®ne both the clinicopathologic spectrum and pathogenesis of the cutaneous lesions. We
identi®ed 2 distinct patterns of cutaneous involvement. Multiple erythematous dermal papules
and/or subcutaneous nodules, with or without ulceration, were present in 17 patients (85%). These
lesions demonstrate a marked angiocentric lymphohistiocytic in®ltrate, composed predominantly
of CD4-positive T-cells, with a high propensity for involving the subcutaneous tissues, and
exhibiting angiodestruction, necrosis, and cytologic atypia. EBV-positive B-cells were detected in
the nodules from 5 patients; clonal immunoglobulin heavy chain gene (IgH) rearrangements were
detected by PCR in 2 patients. Multiple indurated, erythematous to white plaques were present in
3 patients (15%). The plaque lesions uniformly lacked EBV and clonal IgH gene rearrangements.
The clinical course of overall disease was variable, ranging from spontaneous regression without
treatment (1/13; 7%), resolution with chemo/immunomodulatory therapy (8/13; 62%), and
progression (4/13; 31%). The clinical and histopathologic features of cutaneous LYG are extremely
diverse. However, the majority (85%) of the cutaneous lesions mirrors to some extent LYG in the
lung, although EBV + cells are less frequently identi®ed. This subset of cases shows the
histopathologic triad of angiodestruction with associated necrosis, panniculitis, and in some cases
atypical lymphoid cells. A small percentage of the lesions (15%) contain only sparse lymphoid cells,
are EBV-negative, and presented as indurated and atrophic plaques. The pathophysiological basis of
these two types of lesions appears to differ. While some cases of LYG regress spontaneously, most
require therapy.
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Loss of PTEN Tumor Suppressor Gene Expression in the Pathogenesis of
Trichilemmomas
J. Ditelberg, S. Granter,* M. Zimarowski,² and G. Mutter*
Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; *Pathology, Brigham and
Women's Hospital, Boston, Massachusetts; ²Pathology Services, Inc., Cambridge, Massachusetts
Cowden syndrome (CS) is a genetic disorder characterized by multiple hamartomas and a higher
risk of benign and malignant neoplasms of the thyroid, breast, endometrium, and skin. The most
frequently occurring skin lesion in patients with CS is the trichilemmoma, a benign tumor with
follicular infundibular differentiation. Patients with CS have recently been shown to have germline
mutations of the PTEN tumor suppressor gene, which encodes a dual-speci®city phosphatase at
10q23.3. We hypothesized that both CS and non-CS (sporadic) trichilemmomas may have a high
frequency of PTEN mutation and subsequent loss of expression. Using immunohistochemistry, we
examined PTEN expression in 16 trichilemmomas from 11 patients (2 CS, 14 sporadic). In all
specimens, there was strong PTEN staining of melanocytes, Langerhans cells, and endothelial cells.
Weaker staining was observed in the inner root sheath, outer root sheath, and infundibulum of the
hair follicle, as well as in the keratinocytes and eccrine glands. In PTEN positive cells, staining was
seen in both the cytoplasm and nucleus (or nuclear membrane). Both of the trichilemmomas
associated with CS (from 2 patients) showed loss of PTEN expression. Eight of 14 non-CS,
sporadic trichilemmomas (from 5 patients) also showed loss of PTEN expression. Of the 10 PTEN
negative trichilemmomas, the loss of cellular PTEN expression was uniform in 8 tumors. In the
remaining 2 trichilemmomas (from the same non-CS patient), both PTEN positive and PTEN
negative cells were observed (heterogeneous expression). Loss of PTEN expression is seen in both
CS-associated and sporadic trichilemmomas, which may imply a similar step in their pathogenesis.
However, the fact that not all sporadic trichilemmomas were PTEN negative may suggest that loss
of PTEN expression is associated with, but not causative of, some trichilemmomas. Alternatively,
loss of PTEN expression may be an early, but not necessary, event that predisposes neoplastic
transformation through other genetic pathways. The uniform loss of PTEN expression in 8 of the
10 PTEN negative tumors studied implies that this loss is an early event, which is propagated
among all neoplastic cells. However, occasional tumors with heterogeneous PTEN expression are
consistent with mutation occurring after initial neoplastic transformation.
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Expression and Distribution Patterns for the ErbB2 Receptor During Wound Repair
L. Nanney, N. Cardwell, S. Register, and M. Davidson
Plastic Surgery, Vanderbilt School of Medicine, Nashville, Tennessee
Although 4 isoforms of the EGF receptor family have been identi®ed in human cells, the purpose
of our study was to characterize the possible involvement of the receptor member known as ErbB2
(neu or HER-2) during wound repair. While this orphan receptor binds no known ligand, its
expression has proven to be a poor prognostic indicator for many tumor types. To investigate the
potential role of the ErbB2 receptor during wound healing, we selected a porcine wound model
since we ultimately planned in future studies to modulate receptor expression using in vivo porcine
studies. Since porcine sequences for EGF receptor isoforms were unknown, we began by cloning
the porcine ErbB2 out of a cDNA library constructed from a day 7 partial-thickness excisional
wound. At present we have sequenced the majority of the porcine ErbB2 gene. Expression of
porcine ErbB2 was veri®ed by Northern blotting using excisional wounds collected at days 4 and 7
after excisional injury. In our next experimental series, a speci®c ErbB2 antisera was used in
immunohistochemical staining studies to evaluate the temporal and spatial distribution of this EGF
receptor isoform. Porcine excisional injuries were examined ®rst. Human burn wounds (N = 15)
were also examined to con®rm that ErbB2 is relevant to the human wound environment. In
nonwounded skin controls, ErbB2 protein was identi®ed throughout the normal epidermal layers
with a prominent plasma membrane distribution in the stratum granulosum. In wound margins or
upwardly growing dermal sweat ducts or hair follicles, weak, patchy or absent ErbB2
immunoreactivity was observed whereas more differentiated keratinocytes in the stratum spinosum
or granulosum, inner root sheaths or secretory segments of sweat glands showed increasingly
stronger accumulations of immunoreactive ErbB2 protein. The ErbB2 receptor also appears to
accumulate in endothelial cells lining all segments of the vasculature and is present in select dermal
populations with a ®broblastic phenotype. While our earlier studies have shown that the ErbB1
receptor form plays a prominent role in wound healing, the present studies suggest that the ErbB2
receptor form is likewise up-regulated during normal wound healing. Our experiments show that
ErbB2 expression is not exclusively associated with neoplastic proliferation and is not a
constituitively expressed gene in keratinocytes. These data raise the possibility that the ErbB2
receptor form is available to form heterodimers with other ErbB receptor isoforms in at least 3 of
the cell types that are critical to wound repair.
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Distinct Roles of Extracellular Signal-Regulated Kinase, Jun N-Terminal Kinase, and
p38 Signaling Pathways in Enhancement of Matrix Metalloproteinase-1, ±3, and ±19
Expression in Dermal Fibroblasts
N. Reunanen, M. Foschi,* J. Han,² C. LoÂpez-OtõÂn,³ and V. KaÈhaÈri
University of Turku, Turku, Finland; *University of Florence, Florence, Italy; ²Scripps Research Institute,
La Jolla, California; ³University of Oviedo, Oviedo, Spain
Matrix metalloproteinase-19 (MMP-19) is a novel MMP previously found in endothelial and
synovial cells. We have examined the roles of mitogen-activated protein kinase (MAPK) signaling
pathways in the regulation of MMP-19 expression in normal human skin ®broblasts. Tumor
necrosis factor-a (TNF-a) activates extracellular signal-regulated kinase (ERK)1,2, Jun ± N-
terminal kinase (JNK) and p38 MAPK in dermal ®broblasts. TNF-a-elicited induction of MMP-
19 mRNA (4.7-fold) was inhibited in part (by 46%) by MEK1,2 inhibitor PD98059, that blocks
the ERK1,2 pathway (Raf/MEK1,2/ERK1,2), and by a speci®c p38 MAPK inhibitor SB203580
(by 49%). In contrast, induction of collagenase-1 (MMP-1) and stromelysin-1 (MMP-3) mRNA
levels by TNF-a was potently reduced by SB203580 (by 76 and 90%, respectively), but not by
PD98059. Infection of the cells with recombinant adenovirus for constitutively active MEK1
resulted in activation of ERK1,2, and markedly enhanced the mRNA levels and production of
MMP-19, MMP-1, and MMP-3. Infecting cells with an adenovirus for constitutively active
MKK3b or MKK6b (p38 kinase) speci®cally activated p38 MAPK and slightly enhanced the
production of MMP-19. Co-infection of cells with constutively active MEK1 in combination with
active mutants of MKK7 (JNK kinase), MKK3b, or MKK6b potently enhanced the MMP-19,
MMP-1, and MMP-3 expression as compared to infection with constitutively active MEK1,
MKK3b, or MKK6b alone. The activation of ERK1,2 resulted in induction of c-jun, junB, and c-
fos expression, whereas activation of p38 alone had no effect on their expression. These results
identify two distinct mechanisms for inducing MMP-1, MMP-3, and MMP-19 expression in
®broblasts: AP-1-dependent activation via ERK1,2 pathway, and AP-1-independent activation via
p38 pathway, both of which apparently control the proteolytic activity of normal ®broblasts, e.g. in
wound repair and tumor invasion.
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Interstitial Collagenase (MMP-1) is Induced in Dermal Fibroblasts through Interleukin-1
Secreted by Epidermal Keratinocytes
S. Moon, M. Dame, D. Remick, and J. Varani
Pathology, University of Michigan, Ann Arbor, Michigan
When human skin is maintained in organ culture under growth factor-free conditions, normal
architecture is preserved for several days. When exogenous growth factors such as epidermal
growth factors (EGF) or hepatocyte growth factor (HGF) are included in the culture medium,
invasion of the underlying stroma by epithelial cells occurs. Invasion is dependent on MMP-1
(interstitial collagenase) elaboration by dermal ®broblasts. In the present study, we have
investigated how MMP-1 production is regulated during invasion. Human foreskin ®broblasts
were exposed to culture ¯uid from epidermal keratinocytes. After 48 h incubation, ®broblast
culture ¯uids were assessed for MMP-1 using casein zymography. Fibroblasts elaborated low levels
of MMP-1 under control conditions, and increased amounts following stimulation with
keratinocyte culture ¯uid. Concomitant treatment of ®broblasts with two different EGF receptor
antagonists had little effect on keratinocyte induction of MMP-1 synthesis. In contrast,
concomitant treatment with recombinant interleukin-1 (IL-1) receptor antagonist suppressed the
majority of the stimulating activity in keratinocyte culture ¯uid. Inhibition was dose-responsive. In
additional studies, ®broblasts were treated with HGF or with culture ¯uid from HGF-treated
keratinocytes. HGF by itself did not induce signi®cant MMP-1 production, but culture ¯uid from
HGF-treated keratinocytes was more potent that control keratinocyte culture ¯uid in stimulating
®broblasts to produce MMP-1. Taken together, these data indicate that the elaboration of MMP-1
in organ-cultured human skin involves interaction between the epidermis and dermis. IL-1
produced in the epidermis may play a role in dermal MMP-1 induction.
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Collaboration Between MAP Kinase Activation and p16 Deletion in a Tuberous
Sclerosis-Related Sarcoma
B. Govindarajan, M. Miller,* D. Kwiatkowski,³ H. Onda,³ M. Nunnelly, L. Brown, and J.
Arbiser
Dermatology and Emory Skin Disease Research Center, Emory University School of Medicine, Atlanta,
Georgia; *Cancer Biology, Wake Forest University School of Medicine, Atlanta, Georgia; ²Hematology/
Oncology, Brigham and Womens Hospital, Winston-Salem, North Carolina; ³Pathology, Beth Israel
Deaconness Hospital, Harvard Medical School, Boston, Massachusetts
Tuberous sclerosis is a common autosomal disorder due to inactivation of the tumor suppressors
tuberin and hamartin. Cutaneous sarcomas arise in 10% of mice heterozygous for tuberin, and
represent the second most common malignancy in these mice after renal cell carcinoma. We
established a cell line (Tsc2Ang1) from a cutnaeous sarcoma and analyzed signal transduction and
tumor suppressor gene pro®les. Tsc2Ang1 cells demonstrate tumorigenesis in vivo and high level
expression of activated MAP kinase in vitro. Introduction of a dominant negative MAP kinase
kinase leads to abrogation of tumor growth in vivo and tumor dormancy. Genomic analysis shows
loss of heterozygosity (LOH) of the tumor suppressor p16, and no alteration of p53. Surprisingly,
LOH of tuberin was not observed. The potent angiogenic factor vascular endothelial growth factor
(VEGF) is expressed in vivo as determined by in situ hybridization. Cutaneous sarcomas may
represent the murine homolog of cutaneous angio®bromas. Inhibition of MAP kinase may be a
therapeutic target in the treatment of tuberous sclerosis related tumors. Heterozygosity for tuberin
may predispose to deletion of tumor suppressor genes. Finally, this model suggests a collaboration
betweeen p16 inactivation and MAP kinase activation, which may be operative in other human
tumors, including cutaneous melanoma.
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PIG7 Gene Mutation and the Overexpression of its Gene Product in Extramammary
Paget's Disease
Y. Matsumura, Y. Matsumura, C. Nishigori, and Y. Miyachi
Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Although extramammary Paget's disease (EMPD) is a grave skin disease and is not so uncommon,
little is known about the genetic disorder of its pathogenesis. c-erb B-2 oncogene has been the only
suspect gene involved in its carcinogenesis (probably in tumor promotion) because its product is
highly expressed in invasive lesions and in metastatic lesions of EMPD. As for the other important
oncogenes or suppressor oncogenes such as ras, p53 or p16, however, no gene mutation or
expression disorder has been reported. In order to search for other candidate gene(s) involved in
EMPD pathogenesis, we compared the mRNA expression level of representative tumor-related
genes between EMPD lesional skin and intact skin of the same patient using DNA array technique.
We extracted total mRNA from 4 EMPD surgical specimens and their normal counterparts (either
the surplus of skin graft or the surgical margin), obtained cDNA by RT-PCR, and performed
DNA array analysis (Clontech, CA). Several genes were two-fold or more highly expressed in
multiple EMPD lesions compared with normal epidermis. Among them, PIG7 mRNA was
overexpressed in 3 among 4 EMPD lesions. PIG7 transcription is induced by p53 expression and is
implied to be involved in the p53-induced apoptotic pathway. Since p53 mRNA expression level
is not high in any of those 3 EMPD samples compared with the intact skin specimens, we analyzed
PIG7 cDNA mutations among 12 EMPD samples, including the former 4 samples, using PCR-
SSCP technique. Brie¯y, we ampli®ed the translation sequence of PIG7 gene as 53 overlapping
fragments (206±216 base pairs), performed SSCP analysis followed by direct sequencing of DNA
fragments derived from the shifted bands. As a result, 5 EMPD samples had shifted bands (two of
them had point mutations which lead to amino acid substitutions, one had a silent mutation and
the other two samples are under investigation). One sample with amino acid substitution
overexpressed PIG7 mRNA in the former DNA array analysis. These results indicate that the
overexpression of (mutated?) PIG7 expression would be related to EMPD carcinogenesis, and that
genetic mutations underlie its overexpression.
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Genetic and Immunohistochemical Studies of Angio®bromas and Collagenomas in
Multiple Endocrine Neoplasia Type 1
J. Nguyen, J. Wang, A. Vortmeyer,* M. Turner,² S. Marx,³ Z. Zhuang, and T. Darling
Department of Dermatology, Uniformed Services University, Bethesda, Maryland; *NINDS, National
Institutes of Health, Bethesda, Maryland; ²North CarolinaI, NIH, Bethesda, Maryland; ³NIDDK, NIH,
Bethesda, Maryland
Multiple facial angio®bromas and collagenomas commonly occur in adults with multiple endocrine
neoplasia type 1 (MEN1), a familial tumor syndrome caused by mutations in the MEN1 gene. We
have previously shown that MEN1 angio®bromas show loss of heterozygosity (LOH) at the
MEN1 locus and that the neoplastic cells in these tumors are located in perivascular clusters. Here,
we examined collagenomas for 11q13 LOH and further characterized the cells within
angio®bromas and collagenomas using immunohistochemistry. In preliminary LOH studies of
skin lesions from 2 MEN1 patients, clusters of potentially neoplastic cells were microdissected from
2 collagenomas and 1 biopsy of normal appearing skin. Four microsatellite markers at the MEN1
locus (D11S449, D11S480, PYGM, INT-2) showed LOH occasionally in perifollicular stromal
cells of collagenomas but not in epidermal cells or normal appearing skin. These studies extend our
report that, instead of being hamartomatous, MEN1 angio®bromas and collagenomas contain
mono- or oligoclonal neoplastic proliferations of cells. To clarify the anatomic zone of this
clonogenic process, 3 angio®bromas and 9 collagenomas from 5 patients with MEN1 were stained
for vimentin (mesenchymal cells), factor XIIIa (dermal dendritic cells), CD34 (endothelial cells,
stromal cells), CD68 (macrophages, mast cells), S-100 (melanocytes, neuronal cells, Langerhans
cells), HMB-45 (melanocytes), and smooth-muscle actin (myo®broblasts, pericytes). Although no
clear demarcation of markers was observed with regard to the distribution of LOH, perivascular
and perifollicular stromal cells stained positively for vimentin, negatively for smooth-muscle actin,
mostly positive for factor XIIIa and occasionally positive for CD34. Compared to normal
appearing skin, angio®bromas and collagenomas showed strongly increased dermal staining for
vimentin, factor XIIIa, and CD34, and modest increases in CD68 and S-100. In conclusion,
genetic and immunohistochemical analyses suggest that MEN1 angio®bromas and collagenomas
are neoplastic proliferations of mesenchymal cells showing 11q13 LOH.
611
Calcitonin Gene-Related Peptide (CGRP) has a Dual Regulatory Function in Human
Dermal Microvascular Endothelial Cell (HDMEC) Nuclear Factor kB (NF-kB)
Activation
T. Scholzen, T. Brzoska, M. Fastrich, D. Kalden,* M. Steinhoff, C. Armstrong, J. Ansel, and T.
Luger
Ludwig Boltzmann Institute for Cell- and Immunobiology of the Skin, University of MuÈnster, MuÈnster,
Germany; *Department of Dermatology, Emory University, Atlanta, Georgia
The cutaneous sensory neuron-derived neuropeptide calcitonin gene-related peptide is capable of
modulating numerous biological functions of epidermal and dermal cells via the interaction with
speci®c cell surface receptors. Less is known about CGRP effects on HDMEC activities. To
address the hypothesis that endothelial cell NF-kB activation in CGRP receptor-expressing
HDMEC is directly modulated by CGRP, HDMEC isolated from human foreskins or cells of the
endothelial cell line HMEC-1 were stimulated with CGRP (1±1000 nM) alone or in combination
with TNFa or IL-1b. The activation of NF-kB was examined by electrophoretic mobility shift
assay (EMSA), Western blotting and NF-kB-luciferase reporter gene assays. After 15 min, CGRP
dose-dependently stimulated NF-kB activation and nuclear translocation. Speci®city and
composition of DNA-protein complexes was demonstrated by supershift analysis using antibodies
against the NF?B subunits p50, p65/RelA, cRel or RelB. The speci®c CGRP receptor antagonist
GCRP8-37 was capable of antagonizing this CGRP induced NF-kB activation. In addition, CGRP
dose-dependently induced luciferase activity in NF-kB-luciferase transfected HDMEC. However,
when cells were costimulated with IL-1b or TNFa and CGRP or protein kinase A activators
(forskolin), CGRP (100/10 nM) as well as forskolin antagonized the TNFa or IL-1b induced
formation of the NF-kB p50/p65 transactivator complex which is presumably mediated by
cytosolic stabilization of IkBa and IkBb. Likewise, the TNF-induced activation of HDMEC
ICAM-1, VCAM-1 or E-selectin mRNA expression was antagonized by CGRP in similar
concentrations. Thus, these novel data suggest that perivascular sensory nerve-derived CGRP by
activating high-af®nity receptors is capable of differentially regulating NF-kB controlled
endothelial cell gene expression which may be of importance for both initiation and termination
of an in¯ammatory response during cutaneous neurogenic in¯ammation.
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Basic Fibroblast Growth Factor Stimulates Lef/Tcf-Dependent Transcription in Human
Umbilical Vein Endothelial Cells
W. Holnthoner, M. Groeger, M. Pillinger, K. Wolff, and P. Petzelbauer
Department of General Dermatology, University of Vienna Medical School, Vienna, Austria
Lef/Tcf proteins belong to a family of architectural transcription factors, which control many
developmental processes and also play an important role in oncogenesis. Classical activators of Lef/
Tcf-dependent transcription belong to the Wnt family of proteins, which translocate b-catenin
into the nucleus and allow the formation of transactivation-competent Lef/Tcf/b-catenin
complexes. Here we show that in human endothelial cells, also FGF induces nuclear translocation
of b-catenin, which enhances transcription of a Lef/Tcf reporter construct by two fold. Performing
semiquantitative RT-PCR analysis of Wnt mRNAs we show that this FGF effect is not mediated
by induced Wnt expression. Since down-regulation of the glycogen synthase kinase-3 (GSK-3)
activity is the prerequisite of b-catenin translocation into the nucleus we performed kinase assays.
Like Wnt proteins, FGF induced a rapid reduction of GSK-3 activity. This was completely blocked
by the MEK kinase inhibitor UO126 (1 mM) back to baseline, indicating that FGF acts on GSK-3
via the MAP kinase pathway. Employing gel shift assays we show that FGF enhances the binding of
a Lef/Tcf/b-catenin complex to a Lef/Tcf binding site within the promoter of the urokinase
receptor. In summary, we describe a novel modulatory mechanism of b-catenin-mediated
transcription in endothelial cells controlled by FGF, which is independent from Wnt proteins.
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Overexpression of Bcl-2 in an In Vivo Model of Low Grade Angiosarcoma
J. Schechner, J. Pober, A. Bothwell, F. Wang, and J. Arbiser*
Dermatology, Yale University, New Haven, Conneticut; *Dermatology, Emory University, Atlanta,
Georgia
Bcl-2 expression in normal vascular endothelial cells (EC) promotes vascular maturation without
overt tumor formation. An in vivo model of low-grade angiosarcoma was developed, and utilized
to evaluate the effects Bcl-2 in combination with a transforming gene. The SV40 transformed
murine endothelial cell line MS-1 was suspended in a collagen/®bronectin matrix. This resulted in
the in vitro formation of vascular cords. When implanted subcutaneously into SCID-beige mice,
tumors composed of dense networks of perfused vascular structures, containing EC with
hyperchromatic nuclei, and intravascular endothelial hyperplasia, were observed. Retroviral
transduction was utilized to overexpress a caspase resistant form of Bcl-2, or the control transgene
EGFP, in the EC incorporated into these constructs prior to implantation in mice (n = 9). Thirty
days after implantation 5 mice in each group were harvested. The morphology of the resultant
vascular networks in both groups was similar to those which had not been transduced. Although
the mean Bcl-2 transduced tumor volume (71.9 6 19.7 mm3) was greater than those transduced
with EGFP (34.0 6 26.5 mm3) at 30 days, 60 days after implantation, there was no signi®cant
volume difference between the Bcl-2-transduced (60.2 6 23.3 mm3 and the EGFP-transduced
(77.5 6 19.65 mm3) tumors (p = 0.78, n = 4). No gross or microscopic metastases were detected in
either group. Local invasion was minimal, although slightly greater extension of the atypical
vascular structures into the abdominal wall musculature was observed in the Bcl-2 transduced
tumors. In summary, suspension of MS-1 cells in a tissue like matrix resulted in the in vivo
formation of tumors resembling low grade angiosarcomas, but concomitant overexpression of Bcl-
2 did not signi®cantly increase the tumorogenicity of these cells. These ®ndings suggest that
overexpression of Bcl-2 in normal EC may be a safe modi®cation when applied to tissue
engineering.
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The Kaposi's Sarcoma Associated Herpesvirus G Protein-Coupled Receptor Up-
Regulates VEGF and Promotes Endothelial Cell Survival
A. Sodhi, S. Montaner, and J. Gutkind
Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, Bethesda,
Maryland
The Kaposi's Sarcoma Associated Herpes Virus (KSHV) is the infectious etiologic agent of Kaposi's
Sarcoma (KS), a multifocal neovascular neoplasm frequently associated with AIDS. One of the viral
genes, the KSHV G protein-coupled receptor (KSHV-GPCR), is a key molecule in the
pathogenesis of KS, playing a central role in the promotion of VEGF-driven angiogenesis and
spindle cell proliferation. We have studied the signal transduction pathways controlling VEGF
expression and endothelial cell survival induced by the KSHV-GPCR. We found that this viral
receptor enhances the expression of VEGF by stimulating the activity of HIF-1a, which activates
transcription from a hypoxia response element within the VEGF promoter. Stimulation of HIF-1a
by the KSHV-GPCR involves the phosphorylation of the regulatory/inhibitory domain of the
protein by the p38 and MAPK signaling pathways, enhancing HIF-1a transcriptional activity.
Moreover, speci®c inhibitors of the p38 (SKF86002) or MAPK (PD98059) pathways were able to
inhibit the transactivating activity of HIF-1a, as well as VEGF expression and secretion in cells
overexpressing this receptor. We further found that the KSHV-GPCR is able to promote
endothelial cell survival and that this ability is not dependent on the receptor's induction of VEGF
secretion. When expressed in human primary endothelial cells, the KSHV-GPCR is able to rescue
cells from apoptosis induced by serum deprivation. Interestingly, expression of the KSHV-GPCR
also potently induced the kinase activity of Akt/PKB, a critical molecule involved in the control of
cell survival and in tumor development. Indeed, we found that the PI3K-Akt pathway is required
for the prevention of cell death induced by the KSHV-GPCR, as both treatment with wortmannin
and expression of a dominant negative interfering mutant of Akt are suf®cient to abolish the
inhibition of apoptosis in response to the expression of the KSHV-GPCR. These results suggest
that the KSHV-GPCR could promote the survival and uncontrolled cell proliferation of the viral-
infected cells and may help to explain the molecular mechanism(s) whereby viral and cellular
oncogenes govern the acquisition of the angiogenic phenotype and drive tumor-induced
neovascularization.
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Heterogeneity of the g-T-Cell Receptor (gTCR) is Accompanied by a Heteregeneous
Pro®le of the Lymphoid In®ltrate in Vulvar Lichen Sclerosus (LS) and Associated
Squamous Cell Carcinomas (SCC)
S. Regauer, O. Reich,* and C. Beham-Schmid
Pathology, University of Graz, A8036 GRAZ, Austria; *Gynecology, University of Graz, A8036
GRAZ, Austria
The lymphoid in®ltrate in LS has been shown to be of a T-cell phenotype with a high percentage
of gTCR rearrangement. We evaluated the differences of the immunohistochemical (IHC)
phenotype between gTCR-positive and gTCR-negative LS cases and tested if gTCR-
rearrangement would be a prerequisite for the development of a SCC in LS. We analyzed 15
SCC arising in LS, 15 SCC without LS, and 15 LS by PCR for gTCR and compared the IHC
pro®le of the lymphoid in®ltrate (CD2, CD3, CD4, CD8, CD20, CD57, fascin, and granule-
associated cytotoxic proteins granzyme, TIA and perforin). Clonally rearranged gTCR was
identi®ed in 5/15 LS, 6/15 SCC with LS and in 0/15 SCC without LS. Analysis of multiple
concomittant biopsies of a single lesion of LS and various regions of the SCC, however,
demonstrated a heterogeneity of the gTCR within a single lesion. All LS covered by intact
mucosa/epidermis showed a predominant CD8-positive dermal and epidermal lymphoid in®ltrate
with TIA positive dermal lymphocytes. In ulcerated LS, CD4-positive T-cells predominated.
Differences between gTCR-positive and gTCR-negative biopsies were observed within
submucosal and perivascular lymphocytic cell aggregates (LA), which were predominantely
positive for CD20 and TIA in gTCR-positive with numerous fascin-positive cells in the B-cell
fraction, and individual CD8, CD57, granzyme and perforin-positive cells in the peripheral zones
of the LA. LA in gTCR-negative biopsies demonstrated only single peripherally located CD20 and
fascin-positive lymphocytes, but a diffuse CD57 and granzyme staining in the absence of perforin
staining. We postulate that development of T-cell clones in lesional skin of vulvar LS is a focal
event, which is not required for the development of a SCC. The presence of B-cells, fascin and
perforin-positive cells in gTCR-positive biospies of LS has not been previously described and may
represent an immunologic mechanism to exert a cellular cytotoxicity to the proliferating T-cell
clones.
616
Cumulative and Conditional Probabilities for Death from Squamous Cell Carcinoma
(SCC) in Recessive Dystrophic EB (RDEB): Experience of the National EB Registry
(NEBR), 1986±2000
L. Johnson, J. Fine, M. Weiner, A. Stein, and C. Suchindran
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
SCCs are a common occurrence in RDEB, especially in those patients with the Hallopeau-
Siemens subtype. It is also known that metastases and death do occur in some of these patients,
despite early diagnosis and aggressive surgical treatment of these tumors. We have attempted to
quantitate the cumulative and conditional risks for death from SCC in RDEB, using lifetable
analysis of 14 years' data, collected through 12/31/00, on all RDEB patients who have been
enrolled in the NEBR. We have shown that the cumulative risk of developing a ®rst SCC in
RDEB-HS is nearly 6% by age 20, rising rapidly to nearly 81% by age 40. Using the same study
population, the cumulative risk of death from any SCC was found to be 4.2%, 8.6%, 21.4%, 29.9%,
57.9%, and 70.0% by age 20, 25, 30, 35, 40, and 45, respectively, with the highest conditional risk
(40.0%) occurring between ages 35±40. In contrast, a much lower cumulative risk was found in
patients with the non-Hallopeau-Siemens subtype (RDEB-nHS), beginning at 2.2% by age 25,
and progressing to 5.4%, 8.4%, and 15.4% by ages 25, 45, and 55, respectively. These latter ®ndings
are consistent with the overall lower cumulative risk of SCC in RDEB-nHS (only 17.4% and
43.1% by ages 40 and 55), compared to RDEB-HS. Based on these data, it can be concluded that
the risk of fatality from SCC is very high in patients with RDEB-HS, and that this usually occurs
within about 5 years of the diagnosis of the ®rst SCC in these patients. A much lower but still
signi®cant risk of death from SCC occurs in patients with RDEB-nHS, with a much longer period
of time from ®rst diagnosis to subsequent death. Based on these ®ndings, we recommend biopsy of
any suspicious lesions in RDEB that arise on or after about age 10.
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Loss of Heterozygosity (LOH) is a Quantitative Trait in Aquired Melanocytic Nevi and
can Help to Discriminate Between Benign and Dysplastic Lesions
A. RuÈbben, C. Pasing, I. Bogdan,* and R. BoÈni*
Dermatology, University Hospital RWTH Aachen, Aachen, Germany; *Dermatology, University Hospital
ZuÈrich, ZuÈrich, Switzerland
Loss of heterozygosity (LOH) is frequently found in aquired melanocytic nevi and malignant
melanomas. Its role in melanoma development thus remains unclear although LOH is a sign of
genetic instability and should therefore facilitate malignant progression. To assess the role of LOH
as well as microsatellite instability (MSI) in nevi and melanomas we used a quantitative approach by
analysing multiple microdissected tumor areas arrayed linearly within a histological tissue section.
Six benign nevi, 6 dysplastic nevi and 5 malignant melanomas were analyzed at microsatellite
markers D9S162 and D14S53. Each microdissected region contained about 500 cells and the mean
number of microdissected areas per tumor was 9. LOH and MSI were demonstrated by
electropherogram analysis using an automated sequencer (ABI Prism 373). For LOH and MSI, the
frequency of mutants (FM) as well as the frequency of distinguishable tumor cell clones (FC) were
then used to calculate a mutation index (MI): MI = (FMxFC)0.5. For LOH, MI was signi®cantly
higher in dysplastic nevi then in benign aquired nevi at both markers (D9S162: 0.48 vs. 0.17,
p = 0004; D14S53: 0.43 vs. 0.19, p = 0,05). A similar but statistically not signi®cant trend was
observed for MSI. Melanomas did not differ from dysplastic nevi with regards to MI. Our data
suggest that quantitative LOH analysis may be useful to discriminate on a molecular basis between
benign and dysplastic aquired nevi.
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Frequency and Cumulative Risk of Cutaneous Squamous Cell Carcinomas in Inherited
Epidermolysis Bullosa within the United States: Experience of the National EB Registry
(NEBR), 1986±2000
J. Fine, L. Johnson, M. Weiner, A. Stein, and C. Suchindran
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Although it has been known that squamous cell carcinomas (SCCs) may arise in some types of EB,
the magnitude of this risk was ®rst demonstrated in 1995 by analysis of data collected by the
NEBR, a nationally based, cross-sectional and longitudinal epidemiologic project, based on 9
years' data on its ®rst 1900 patients. At that time, the cumulative risk of developing at least 1 SCC
in Hallopeau-Siemens RDEB (RDEB-HS) by age 40 was estimated by lifetable technique to be
53%. We now report on our experience, through 12/1/00, on 2629 consecutively enrolled
patients. Within this cohort, 0.36%, 0.90%, 1.08%, and 13.11% of all NEBR enrollees with EB
simplex (EBS), junctional EB (JEB), dominant dystrophic EB (DDEB), and RDEB had developed
at least 1 SCC. Signi®cant differences were further noted when these data were strati®ed by major
EB subtype. Lifetable analyses con®rmed that SCCs were primarily the concern, during at least
mid-adulthood, of patients with RDEB, although rare cases were also found in JEB. By age 40, the
cumulative risk of at least 1 SCC was 0.39%, 18.18%, 0.00%, 0.00%, 80.80%, and 17.41% in EBS,
JEB-H, JEB-nH, DDEB, RDEB-HS, and RDEB-nHS, respectively. By age 50, these cumulative
risks had risen to 0.64%, 18.18%, 4.76%, 1.83%, 86.29%, and 38.17%, respectively. When the
ratios of these cumlative risks were compared, patients with RDEB-HS, RDEB-nHS, and JEB
were found to be 207.2, 44.6, and 5.1 times, respectively, more likely to have developed at least
one SCC than patients with EBS by age 40. These strikingly higher risks for development of SCC
suggest the near universal risk of SCC by age 50 in RDEB-HS, as well as clinically substantial risks
for patients with RDEB-nHS and both subtypes of JEB.
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Basal Cell Carcinomas and Malignant Melanomas in Inherited Epidermolysis Bullosa
(EB) within the United States: Experience of the National EB Registry (NEBR), 1986±
2000
C. Suchindran, J. Fine, L. Johnson, M. Weiner, and A. Stein
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
We report on the occurrence of basal cell carcinomas (BCCs) and malignant melanomas (MMs),
through 12/1/00, on 2629 patients who have been followed by the NEBR, a nationally based,
cross-sectional and longitudinal project. Differences between current data and those by the NEBR
in 1995 re¯ect increased numbers of subjects, longer follow-up, and, in the case of RDEB, more
precise clinical and molecular subtyping. Within the latest cohort, only 1.76%, 0.00%, 1.08%, and
0.52% of all enrollees with simplex (EBS), junctional (JEB), dominant dystrophic (DDEB), and
recessive dystrophic (RDEB) EB had developed one or more BCC. Similar frequencies of BCCs
(1.51±1.90%) were seen within the two major EBS subtypes. Within the RDEB subjects, BCCs
occurred exclusively within those with non-Hallopeau-Siemens (RDEB-nHS) disease. Lifetable
analysis demonstrated that the onset of BCC in EBS-nWC began between ages 30±35, with
cumulative risks of 0.58%, 2.08%, 4.44%, 8.09%, and 17.28% by ages 35, 40, 50, 60, and 70,
respectively. A similar pattern was noted in EBS-WC, although the earliest onset was by age 45±
50, with a cumulative risk of 2.19% by age 50, reaching 14.93% by age 70. Only 2 of 252 RDEB-
nHS patients developed BCCs (and only in late adulthood), and by age 60 the risk of BCC in
DDEB was only 0.67%. The cumulative risk of MM by age 50 was low in EBS (0.57%) and DDEB
(1.36%) and absent in JEB. The risk of MM in RDEB, at least through age 65, was con®ned to
RDEB-HS, with cumulative risks of 0.82%, 1.71%, and 2.76% by ages 4, 7, and 12. These data
demonstrate that BCC is not a clinically signi®cant concern in any type of EB until at least mid-
adulthood, whereas MM, although a rare event, is a real risk in children with RDEB-HS. The
latter strongly suggests the need for careful surveillance for pigmented lesions in patients with
RDEB, beginning in early childhood.
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A Mouse Model for UV-Induced Junctional Melanoma
F. Noonan, J. Recio,* M. Anvers,² E. De Fabo, and G. Merlino*
Immunology and Dermatology, George Washington University Medical Ctr, Wash., DC; *Laboratory of
Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland; ²Pathology/Histotechnology
Laboratory, SAIC, North CarolinaI-FCRDC, Frederick, Maryland
Investigations of malignant melanoma have been hampered by lack of an animal model with
histology and pathogenesis similar to human disease. We used melanoma-prone transgenic mice
ectopically expressing hepatocyte growth factor/scatter factor (HGF/SF) as an experimental model
system to ascertain the effects of UV radiation on melanomagenesis. HGF/SF stimulates growth,
motility and morphogenetic transformation in cells, including melanocytes, expressing its tyrosine
kinase receptor, c-Met. HGF/SF transgenic mice have ectopic extra-follicular localization and
accumulation of melanocytes in the dermis, epidermis and junction and, if untreated, developed
cutaneous melanomas of dermal pathology with a mean onset age of 21 months. Transgenic mice
and wild type littermates given UV radiation (FS40 sunlamps, UV doses 2.25±6.0 kJ per m2) 3
times weekly developed cutaneous tumors with a mean onset of 26 and 37 weeks, respectively
(p < 0.001). All tumors were sarcomas or carcinomas. The conspicuous absence of melanocytic
tumors occurred despite immunohistochemical detection of UV-induced stimulation (p < 0.001)
of melanocyte proliferation and a 2.6- and 4.6-fold increase in melanocyte numbers in the dermis
and epidermis, respectively. In contrast, neonatal transgenic and wild type littermates given a single
dose of UV radiation (FS40, 9 kJ per m2), had a high incidence of premalignant nevus-like lesions,
progressing to malignant melanoma and metastasis with an estimated cumulative tumor rate of 70%
and a median tumor time of 9 months. An additional UV dose (18 kJ per m2) at 6 week of age did
not accelerate melanoma formation but increased the number of melanocytic lesions/animal
(p < 0.03). Remarkably, 75% of UV-induced melanocytic lesions developed in apposition to
epidermal elements and had a junctional morphology. Melanomas were reminiscent of human
radial and vertical growth phase and Pagetoid melanomas. Molecular studies showed expression of
HGF/SF in melanocytes followed by induction of c-met RNA in nevoid lesions, suggesting an
autocrine HGF/SF-c-Met loop as an early step in melanoma formation. Mutational studies are
underway. This novel model of UV-induced melanoma provides a much-needed experimental
tool to facilitate analysis of the photobiology and genetics of melanoma and the development of
effective prevention and treatment strategies.
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DNA Homologous to the 3¢ Telomere Overhang Mimics UV Induced Cytokine
Responses in Keratinocytic Cells
D. Luo, M. Yaar, and B. Gilchrest
Department of Dermatology, Boston University, Boston, Massachusetts
Single-stranded DNA fragments partially (or totally) homologous to the telomere sequence
TTAGGG induce cellular DNA damage responses, such as melanogenesis and apoptosis,
suggesting that exposure of the 3¢ telomere overhang during DNA damage and/or repair is a
physiologic stimulus for such responses. UV irradiation is a DNA-damaging agent that induces
cytokine synthesis and secretion in keratinocytes (Kc), and we have shown that tumor necrosis
factor and IL-10 are induced by thymidine dinucleotide. To determine if IL-1 is similarly
regulated, well-differentiated squamous carcinoma cells (SCC12F) were stimulated with an 11-base
oligonucleotide (11mer-1) homologous to the telomere overhang. Controls were treated with
diluent alone or with the complementary sequence (11mer-2). Duplicate cultures were exposed to
30 mJ per cm2 solar simulated light or were sham irradiated (CTL). Within 2 h there was 1300%
increase of IL-1 mRNA in UV compared to CTL cells. The induction was sustained through 48 h
when the experiment was terminated. Western blot revealed that IL-1 protein level was ~300%
that of CTL cells at least through 96 h. Moreover, within 6 h, IL-1 protein level in medium
conditioned by UV irradiated cells was 38 6 2 pg per ml vs. = 1 pg per ml in sham irradiated
conditioned medium (p < 0.03, non-paired t test). These data demonstrate that a DNA oligomer
homologous to the 3¢ telomere overhang induces IL-1 similar to physiologic UV irradiation. The
data suggest that exposure of telomeric DNA during UV-induced damage and/or repair is a potent
stimulus for the immunomodulatory response following UV irradiation of skin. Homologous
oligomers may prove therapeutic for UV-responsive dermatoses.
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Induction of Melanogenesis In Vivo by UV Light and Oligonucleotides is Mediated by
p53
M. Kosmadaki, I. Hadshiew, L. Wang, M. Eller, M. Yaar, S. Gonzales, and B. Gilchrest
Departments of Dermatology, Boston University/Harvard University, Boston, Massachusetts
DNA oligonucleotides that share sequence homology with the telomere 3¢ overhang sequence,
TTAGGG, induce DNA damage responses when added to mammalian cells. Speci®cally, we have
shown that thymidine dinucleotide (pTT), a partial telomere homology, as well as ultraviolet light
enhances tyrosinase expression and melanin content in p53 pro®cient cells while after pTT or UV
melanoma cells with dominant negative p53 show no up-regulation of tyrosinase, the rate-limiting
enzyme for pigmentation. To determine the role of p53 in these tanning responses, we designed
two 11 base oligonucleotides, one homologous to the telomere overhang sequence (11mer-1) and
an unrelated control (11mer-2). In p53 pro®cient and p53 knock-out C57/B16 mice we treated
ears topically with 100 mM pTT or 40 mM llmer-1 or ±2 or diluent alone ®ve days a week or UV-
irradiated three times a week, for three weeks. Three days after the last treatment, the ears were
removed, sectioned and stained with Fontana Masson to assess melanin content by image analysis.
Compared to controls, there were increases in UV-irradiated ears of both p53+/+ and p53±/±
mice (p = 0.001) but the increases were greater in p53+/+ than in p53±/± mice (p = 0.003): (625%
vs. 260%). Compared to diluent controls, in p53+/+ mice, both oligomers increased melanin
content (p = 0.001), but 120% for pTT and 630% for 11mer-1; but there was no increase in
p53±/± mice treated with either oligomer. The control 11mer-2 had no signi®cant effect in either
animal group. The data demonstrate that pigmentation induction by oligonucleotides that share
sequence homology with the telomere 3¢ end is totally dependent on p53 and that pigmentation
induced by UV is substantially p53 dependent. The data suggest that tanning is largely a direct
DNA damage response and can be mediated by exposure of telomere 3¢ overhang DNA.
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Genomic Analysis Reveals a Coordinate Transcriptional Program Underlying
Responses of Human Keratinocytes to UVB Radiation
J. Takao, I. Dougherty, K. Ariizumi, and P. Cruz
Department of Dermatology, The University of Texas South-western Medical Center, Dallas, Texas
UVB radiation is an important inducer of many biological changes in skin, of which keratinocytes
are a key target. To gain better insight into changes in gene expression generated in the early phase
after UVB exposure, we took advantage of complementary RNA (cRNA) microarray
hybridization to analyze mRNA expression in cultured keratinocytes isolated from freshly excised
neonatal human foreskin by comparing differences in UVB-irradiated (single dose of 100 J per m2)
vs. sham-irradiated cells. Six hours after UVB- or sham-irradiation, total RNA was isolated from
keratinocytes, and then cRNA was synthesized and hybridized to a GeneChip expression array
(Affymetrix) consisting of 6800 genes. Based on a threshold of 2-fold change, 187 genes (2.8%)
were designated to be UVB-responsive. Surprisingly, none of these genes were shown previously
to be modulated by UVB. And conversely, several genes represented in the microarray that had
been reported previously to be UVB-responsive showed little (< 2-fold) to no change. Clustering
based on known functions indicated that among 88 up-regulated genes, 9 encode for cytochrome c
subunits, 6 for ribosomal proteins, and 2 for regulators of apoptosis. By contrast, many of the 99
down-regulated genes are involved in cell differentiation and transport. Finally, Northern blotting
was used to validate results. For UVB-responsive genes examined to date, there has been
concordance with respect to the direction of UVB regulation (up or down). We conclude that
human keratinocytes respond to UVB radiation (6 h after a single low dose) through a coordinate
transcriptional program, enhancing several translation systems while also suppressing differentiation
and transport. These ®ndings af®rm the utility of genome-wide analyses for studying effects of UV
radiation on skin cells.
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DNA Oligonucleotides Modulate DNA Repair, Cell Cycle and Apoptosis: Therapeutic
Implications
D. Goukassian, S. Bagheri, F. Gasparro, and B. Gilchrest
Derm, Boston University, Boston, Massachusetts
Ultraviolet (UV) irradiation produces DNA photoproducts and if not repaired, can cause
mutations. UV-induced DNA damage delays cells for entering into the S phase, hence, increases
repair time; in case of severe damage they undergo apoptosis. We have shown that DNA oligomers
mimic many effects of UV irradiation, based on their homology to the telomeric sequence
TTAGGG. We therefore examined the effect of thymidine dinucleotide, pTpT, and 5¢
phosphorylated oligonucleotide (p9mer) on the cell cycle, and baseline as well as UV-induced
expression of DNA repair and apoptosis proteins in human ®broblasts (fb). To determine if
pretreatment with oligomers alters these cellular responses, we pretreated fb with 100 mM pTpT or
40 mM p9mer or diluent (DME) for 48 h, then UV irradiated (30 mJ per cm2). Treatment with
oligomers up-regulated baseline levels of DNA repair proteins PCNA 400±600%, ERCC1200±
1000%, RPA 300±1000%; XPA 1500±2200%; p53 400±600%, p21 150±600, MDM2230±350%;
Bax 130±150% proteins. Compared to diluent oligomers treated cells revealed signi®cant reduction
150±400% in cell counts at 24 and up 72 h 300±400%. FACS analysis showed fb treated with
oligomers remained in Go/G1 phase up to 24 h (p9mer) or 48 h (pTpT), whereas diluents treated
cells grew exponentially. A greater number of p9mer treated cells showed annexin V and activated
caspase-3 positivity (35±42%) compared to pTpT (16±23%) or diluent (11±19%) treated cells at 48
and 72 h. Furthermore, the rate of removal of thymine dimers showed that cells pretreated with
oligomers and then UV irradiated removed photoproducts 40±60% more ef®ciently at 16 and 24 h,
respectively. These data con®rm the ability of oligomers to evoke DNA damage responses in
human cells, with potency dependent on degree of telomere homology. Such oligomers might be
employed to endogenous DNA repair capacity and to reduce the carcinogenic risk from UV
irradiation, as well as for ``sunless phototherapy'' of various dermatoses.
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UVB Sitmulates the COL7A1 Promoter via the NIK-IKK-NF-kB Pathway Independent
of the TNF-a Receptor
K. Korang, F. Gasparro,* J. Uitto,* and A. Mauviel
Skin Research Institute, INSERM U532, Paris, France; *Dermatology and Cutaneous Biology, Thomas
Jefferson University, Philadelphia, Pennsylvania
Type VII collagen is the major if not the only component of the anchoring ®brils which connect
the basal membrane zone with the underlying dermis. UVB has been attributed not only with an
enhanced skin cancer rate, but also to be a strong inducer of solar elastosis and causing
accumulation of extracellular matrix proteins in the skin. Recently, Chen and collegues described
an strong enhancement of Type VII Collagen mRNA after UV irradiation. We therefore wanted
to elucidate the mechanism of UV induced COL7A1 activity by the usage of a series of 5¢ deletions
of the human Type VII collagen gene promoter in transient cell transfections. An up to 9-fold
increase after UVB irradiation of 772 basepairs of the promoter linked to a cat reporter gene could
be observed. To further ®nemap the region in the promoter responsible for mediating this effect,
we used created 5¢ deletions and could identify a region beeween ±252 and ±230 as response
element. This 22 basepair element contains a functional NF-kB binding site. Introduced mutations
in this site caused a strongly diminished response to UVB irradiation. The role of NF-kB was
further supported by electrophoretic mobility shift assays in which binding of nuclear proteins from
UVB-irradiated ®broblast cultures to the response region of the promoter is competed by
consensus NF-kB oligonucleotide, but not by AP-2 or Sp-1 oligonucleotides. Key components of
the intracellular signal transducting pathway which regulates NF-kB activation are NIK and the
Ik-B kinases. Therefore their role in the NF-kB-mediated stimulation of COL7A1 was
investigated. Cotransfection of a dominant negative NIK expression vector with ±252 COL7A1
prevented activation of the type VII collagen gene promoter by UVB. Similar results were
obtained when using a dominant negative IKK expression vector, indicating that intact NIK and
IKK cascade are required for the intracellular signaling and resulting UVB induced NF-kB
mediated activation of COL7A1. In contrast,overexpresion of a dominant negative TNF-a
receptor did not interfere with UVB-driven activation of the COL7A1 promoter. In conclusion,
this is the ®rst study which demonstrates an involvement of the NIK-IKK-NF-kB pathway in
UVB mediated activation of the human type VII collagen gene promoter independent of the
TNF-a receptor in dermal ®broblasts.
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UVB-Irradiated Dendritic Cells (DC) Induce Nonproliferating, Regulatory Type T Cells
(TC)
H. Hara, R. Denfeld, S. Martin, and J. Simon
Dermatology, Clinical Research Group, University of Freiburg, Freiburg, Germany
It is well established that low-dose UVB-radiation (UVBR) inhibits the APC function of murine
Langerhans cells in vivo and coverts them from immunogenic to tolerogenic APC. Recently, we
have shown that UVB-irradiated murine bone marrow-derived DC (UVB-DC) suppressed
proliferation of naive and primed TC, but tolerized primed TC only. To examine the underlying
mechanism for these differences, naive OVA323-339-peptide-speci®c, TCR-transgenic TC from
DO11.10 mice were analyzed following coculture with unirradiated DC or UVB-DC. First, we
found UVB-DC to inhibit OVA-speci®c TC-proliferation UVB dose- and antigen dose-
dependently. Analysis of TC cocultured with both, unirradiated DC and UVB-DC, revealed an
activated TC-phenotype with increased expression of CD25 and CD69 by FACS. Supernatants
harvested from cocultures with UVB-DC showed reduced levels of IFN-g, IL-2, and IL-4, but not
TGF-b, compared to unirradiated DC as determined by ELISA. Furthermore, these TC did not
proliferate upon restimulation. Interestingly, addition of these nonproliferating TC to cocultures of
naive TC and freshly prepared unirradiated DC inhibited TC-proliferation depending on the
number of added nonproliferating TC. Also, in supernatants increased levels of TGF-b were
found. Therefore, our data indicate that UVB-DC propagate TC with a regulatory function. Since
regulatory TC are characterized by enhanced TGF-b-secretion and increased CTLA-4-expression,
we currently investigate the role of CTLA-4 phenotypically and functionally. In conclusion, we
have shown UVB-DC to inhibit proliferation of naive OVA-speci®c TC. These TC, exhibiting an
activated phenotype and increased TGF-b-production, suppress proliferation of naive TC
cocultered with unirradiated DC. These results suggest that UVB-DC induce nonproliferating,
regulatory type TC.
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IL-12 Protects from UV-Induced Apoptosis by Enhancing DNA Repair
A. Schwarz, S. StaÈnder, M. Berneburg,* K. Grobe-Heitmeyer, J. Krutmann,* and T. Schwarz
Department of Dermatology, University MuÈnster, MuÈnster, Germany; *Department of Dermatology,
University DuÈsseldorf, DuÈsseldorf, Germany
Induction of apoptosis of keratinocytes by ultraviolet radiation (UV) is a protective phenomenon
relevant in limiting survival of cells with irreparable DNA damage. Hence, alterations of UV-
induced apoptosis may have signi®cant impacts on photocarcinogenesis. Based on the previous
observation that the pro-in¯ammatory cytokine interleukin (IL)-1 enhances UV-induced
apoptosis, we screened several other mediators for their effects on UV-induced apoptosis.
Pretreatment of the keratinocyte cell lines HaCaT and KB with the immunomodulatory cytokine
IL-12 led to a signi®cant reduction in cell death following UV exposure, as shown by the use of a
DNA fragmentation ELISA and annexin-V staining. Surprisingly, IL-12 treatment caused a
remarkable reduction in UV-speci®c DNA lesions, as determined by South-western dot blot
analysis using antibodies directed against UV-speci®c pyrimidine dimers. Spectrophotometric
analysis excluded a ®ltering effect of IL-12. Comet assays revealed longer comets in UV-exposed
cells which were treated with IL-12. This ®nding suggests that IL-12 may enhance DNA repair.
RNase protection assays revealed that the expression of 3 components of the nucleotide excision
repair complex (RPA, DBB1, DBB2) was induced by IL-12. To determine the in vivo signi®cance
of these ®ndings, IL-12 was injected i.c. into skin areas of BALB/c mice which were subsequently
exposed to UV. Immunohistochemical analysis revealed remarkably fewer UV-speci®c DNA
lesions in the epidermis of mice which had been subjected to IL-12 treatment. Accordingly, the
number of sunburn cells was signi®cantly reduced upon IL-12 treatment. Taken together, this is
the ®rst demonstration of a cytokine being able to protect cells from apoptosis induced by a DNA
damaging agent via modulation of DNA repair.
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Spatially Speci®c and Gene-Speci®c Targeting of Photodynamic DNA Damage
D. Oh, B. King,* S. Boxer,* and P. Hanawalt²
Department of Dermatology, University of California, San Francisco, San Francisco, California;
*Department of Chemistry, Stanford University, Stanford, California; ²Department of Biological Sciences,
Stanford University, Stanford, California
Most methods for studying and treating intact skin do not readily discriminate among the
structurally and functionally distinct distribution of cutaneous tissue layers and cells. We have
previously used triple helix-forming oligonucleotides linked to psoralen (psoTFOs) to damage
speci®c nucleotide sequences of the human collagenase gene. This method has now been
combined with laser-induced two-photon excitation (TPE) to damage a speci®c nucleotide
sequence of DNA residing in a speci®c location in three-dimensional space. First, to demonstrate
TPE-induced photoadducts, collagenase DNA target sequences were incubated with psoTFOs and
then irradiated in liquid solution with pulsed 765 nm laser light which is half of the quantum
energy needed for conventional one photon excitation used in psoralen + UVA (PUVA) therapy.
The DNA target acquired strand-speci®c psoralen monoadducts in a light dose-dependent fashion.
Second, to simulate DNA damage in a tissue, the DNA-psoTFO mixture was formed as a cubic
centimeter polyacrylamide gel that was irradiated with a converging laser beam targeting the rear of
the gel. The largest number of photoadducts formed at the rear of the gel while sparing DNA at the
front of the gel, demonstrating spatial localization of sequence-speci®c DNA damage by TPE.
Third, to assess whether TPE treatment could be extended to cells, cultured monolayers of normal
human dermal ®broblasts were incubated with tritium-labeled psoralen, without TFO in order to
maximize detectable damage, and irradiated by laser TPE. DNA from cells treated with psoralen
and irradiated had a four- to seven-fold increase in tritium-activity relative to untreated controls.
Functional survival assays indicated the psoralen-TPE treatment was no more toxic than psoralen
alone. These results are proof of principle that DNA damage can be simultaneously manipulated
both at the nucleotide level and in three-dimensional space. This approach should be useful for
dissecting whole tissue responses to DNA damage as well as for gene-speci®c photodynamic
therapy of skin.
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Array of Sun: UVB-Regulated Genes in Epidermal Keratinocytes
M. Blumenberg, D. Li, T. Turi,* A. Schuck, and I. Freedberg
Dermatology, NYU Sch. of Medical, New York, New York; *Central Research, P®zer, Groton, Conneticut
Epidermis, while nobly protecting the rest of our body, bears the majority of photodamage.
Hypothesizing that the skin has developed elaborate mechanisms to protect itself from the UV
light, we used DNA array technology to follow changes in gene expression in response to UV in
epidermal keratinocytes. Of the 6800 genes represented on Affymetrix chips, UV light regulates
approximately 320 by 2.5 fold or more within the ®rst 24 h after illumination. Three waves of
regulated genes, at 0.5±2, 4±8, and 16±24 h post treatment can be distinguished. Genes regulated in
the ®rst wave include transcription factors and signal-transducing proteins that change cell
phenotype. The early induction of mitochondrial proteins and glycolytic enzymes provide cells
with a burst of energy, while several energy requiring proteins, such as transporters, are suppressed.
The second wave notably includes secreted growth factors, cytokines and chemokines;
keratinocytes, having accomplished the immediate changes in their own physiology, alert the
cells in the surrounding tissues to the damage. The third wave prominently includes the
components of the corni®ed envelope; keratinocytes attempt to enhance the protective covering of
the epidermis and, not coincidentally, terminally differentiate and so die. During the 24±h period,
UV light induces the expression of histones and enzymes that synthesize dNTPs, raw materials for
DNA synthesis. Detoxifying and antioxidant enzymes, RNA processing proteins and translation
facilitators are also induced by UV light. Using a novel skin organ culture model we demonstrated
that the UV-induced changes in gene expression detected in keratinocyte cultures also occur in
human epidermis in vivo. In summary, human epidermal keratinocytes in response to UV
commence DNA repair, alter their assortment of transcription factors and other signal transducing
proteins, procure more energy, alert the surrounding tissue and differentiate.
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OGG1-De®cient Cells are Hypersensitive to UVA, but Not to UVB
K. Kim, G. Li, and T. RuÈnger
Dermatology, Boston University, Boston, Massachusetts
UVA might play an important role in photocarcinogenesis and oxidative DNA base damage has
been suggested to be responsible for its mutagenic and carcinogenic properties. Oxidative DNA
base lesions are processed by base excision repair (BER), in which a DNA-glycosylase with
speci®city for a particular kind of base modi®cation removes the damaged DNA base and leaves an
abasic AP-site for further processing by AP-endonuclease 1, polymerase-b, and DNA ligase.
OGG1 is a DNA-glycosylase/AP-lyase, which excises the mutagenic oxidative lesion 8-
oxoguanine (8-oxoG) from DNA. Recently, we reported that human ®broblasts, in which
BER is blocked by methoxyamine are hypersensitive to UVA and that CHO cells overexpressing
APE-1 are hyposensitive to UVA. We can now report that this altered UV-sensitivity is limited to
the UVA-range, because sensitivity to UVB was found not to be altered. In order to further clarify
the role of oxidative DNA damage and its repair in the biological response to UVA, we studied
UVA1- and UVB-induced cytotoxicity in embryonal ®broblasts from OGG1±/± and OGG1+/+
mice. OGG1±/± cells were shown to have a de®cient global genome repair of 8-oxoG, but an intact
transcription coupled repair. Irradiation of wildtype cells with 5 or 10 J per cm2 UVA1 (340±
420 nm) did not slow their proliferation. In contrast, the OGG1±/± cells exhibited a signi®cant
inhibition of cell proliferation by these UVA1-irradiations, with reduced cell yields (as compared
to the unirradiated controls) ranging from 57 to 29% with 5 J per cm2 UVA1 and 38±16% with 10 J
per cm2 UVA1 at days 1, 2, and 3 after irradiation. The sensitivity of these two cell lines to UVB
(10 or 25 mJ per cm2) was not different. This isolated hypersensitivity of OGG1±/± cells to UVA1,
but not to UVB, demonstrates that unrepaired UVA-induced oxidative DNA damage in
nontranscribed genes decreases cell survival and/or proliferative capacity. Together with our prior
data, this underlines a pivotal role of oxidative DNA damage and BER in the cellular response to
UVA.
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Oxidative Inhibition of Membrane-Associated Protein Tyrosine Phosphatase Activates
EGF-Receptors, which are Critical Mediators of the UV Responses in Human
Keratinocytes
Y. Xu, L. Tan, Y. Wan, S. Kang, J. Voorhees, and G. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan
Ultraviolet (UV) irradiation rapidly activates epidermal growth factor receptors (EGFR) in human
keratinocytes (KC). We have investigated the role of EGFR in cellular responsiveness to UV and
the mechanism of UV activation of EGFR. Treatment of human skin in vivo with genistein, an
EGFR inhibitor, reduced UV-induced EGFR activation by 75%, and blocked subsequent
activation of ERK and JNK MAP kinases by 50%. Genistein also inhibited UV-induction of c-Jun
protein and collagenase mRNA by 50% and 60%, respectively. Treatment of intact KC with the
speci®c EGFR inhibitor PD169540 reduced UV activation of ERK by 80%, JNK by 30%, and
completely blocked induction of both c-Fos and c-Jun mRNA, indicating that all of these cellular
responses are dependent on EGFR. EGFR in isolated KC membranes, unlike intact cells, was not
activated by UV irradiation (10±40 mJ per cm2 UVB source), indicating that UV does not act
directly on EGFR. In contrast, addition of peroxide or protein tyrosine phosphatase (PTP)
inhibitors activated EGFR 10-fold in isolated KC membranes. Coincident with activation of
EGFR, peroxide caused signi®cant inhibition of membrane-associated PTP activity. PTP activity
coimmunoprecipitated with EGFR, and this activity was substantially reduced following UV
irradiation of intact KC. In summary, EGFR mediates many critical UV-induced cellular
responses, including MAP kinase activation, induction of transcription factor AP-1, and gene
expression. Our data indicate that EGFR is constitutively phosphorylated, and maintained in an
inactive, dephosphorylated state by PTP activity. UV activation of EGFR results from oxidative
inhibition of PTP activity.
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Activation of Protein Kinase B/Akt by Singlet Oxygen is Not Dependent on Growth
Factor Receptors
I. Kochevar, and S. Zhuang
Dermatology, Harvard Medical School, Boston, Massachusetts
Reactive oxidizing species (ROS) activate pro- and antiapoptotic signaling pathways. The balance
between these pathways is often determined by the concentration of the ROS. Singlet oxygen is an
ROS that initiates apoptosis in photodynamic therapy and is produced in skin cells in response to
UVA radiation. We have investigated the activation of a cell survival signal protein, protein kinase
B (PKB; also called Akt), by singlet oxygen and the relationship of PKB activation to singlet
oxygen-induced apoptosis. Singlet oxygen was produced by Rose Bengal (RB) photosensitization
in NIH3T3 ®broblasts using 514 nm argon ion laser radiation. Singlet oxygen induced PKB
phosphorylation in a time and light-dose dependent manner. Phosphorylation of PKB, detected by
immunoblotting, was observed at 5 min, maximal at 10 min and detectable until at least 2 h using
300 mJ per cm2. As expected, PKB phosphorylation was dependent on activatoin of PI3-kinase as
shown by the ability of wortmannin and LY 29302 to inhibit this response. Importantly, inhibition
of PI3-kinase also enhanced singlet oxygen-induced cell death, demonstrating the that this survival
pathway is functionally signi®cant. To determine whether activation of growth factor receptors
was involved in activation of PKB, as shown previously for H2O2, inhibitors of receptor tyrosine
kinases (suramin), PDGFR (AG 1295) and EGFR (AG1478) were tested. None of these inhibitors
decreased the singlet oxygen induced PKB phosphorylation even though the same concentrations
inhibited PKB phosphorylation by growth factors. In addition, these inhibitors did not enhance
singlet oxygen-induced cell death. MEK but not p38 kinase also contributes to activation of PKB
kinase since a MEK inhibitor, PD 98059, but not a p38 kinase inhibitor, SB 203580, inhibited
PKB phosphorylation. These results indicate that singlet oxygen-induced apoptosis is modulated
by concurrent activation of PKB kinase survival pathway but, in contrast to H2O2, PKB activation
by singlet oxygen does not involve growth factor receptor phosphorylation.
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Identi®cation of a Role for Mitochondria in Transcription Factor Activation and Gene
Regulation
S. Grether-Beck, I. Felsner, H. Schmitt-Brenden, and J. Krutmann
Dermatology, Clinical & Experimental Photodermatology, Heinrich-Heine University, Duesseldorf,
Germany
Transcriptional expression of genes in normal human epidermal KC by ultraviolet (UV) A
radiation was previously shown to result from the generation of ceramide from cell membrane
sphingomyelin. Ceramide then serves as second messenger to activate transcription factor AP-2
which mediates increased transcriptional expression of UVA radiation-inducible genes such as
ICAM-1. In the present study we analyzed the mechanism by which ceramide activates AP-2. We
were particularly interested in the role of mitochondria in this system because we have observed
that ceramide-induced AP-2 activation and ICAM-1 mRNA expression could be inhibited upon
treatment of KC with inhibitors of the mitochondrial (mt) electron transport chain. Ceramide-
induced apoptosis is known to involve the release of cytochrome C from the mitochondria
through their voltage dependent ion channel (vdac; = permeability transition pore) into the
cytoplasm. We now report that stimulation of KC with C2- or C6-ceramide at concentrations
which did not cause apoptosis but AP-2 activation and ICAM-1 induction, also lead to the release
of mt cytochrome C into the cytoplasm of KC (Western blot analysis). Even more important,
treatment of ceramide-stimulated KC with substances, which prevent opening of the mt vdac (e.g.
Carboxyatractyloside and Bongkretic acid) inhibited (i) the release of mt cytchrome C into the
cytoplasm (ii) AP-2 activation (GEMSA) and (iii) increased ICAM-1 transcription (RT-PCR).
This effect was speci®c because under identical experimental conditions IFN-g-induced ICAM-1
mRNA expression was not prevented. Mitochondrial cytochrome C, after its release into the
cytoplasm of KC, might thus have the capacity to activate transcription factor AP-2 and thereby
induce gene transcription. In order to test this possibility rh AP-2 was coincubated in vitro with
cytochrome C. Photometric analysis revealed that this interaction was associated with a redox
change, i.e. cytochrome C was reduced, whereas AP-2 was oxidized. The latter effect was of
functional relevance, because oxidized AP-2 exhibited a greatly increased binding capacity for AP-
2 consensus sites (GEMSA). These studies indicate a previously unrecognized role of mitochondria
in transcription factor activation and gene regulation in mammalian cells.
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A Novel Costimulatory Molecule, Dectin-2, Selectively Mediates Ultraviolet Radiation-
Induced Tolerance
Y. Aragane, A. Maeda, M. Nakamura, F. Yamazaki, K. Matsushita, M. Asai, T. Yudate, A.
Kawada, T. Tezuka, and K. Ariizumi
Dermatology, Kinki University School of Medicine, Osakasayama-shi, Japan; *Dermatology, South-western
Medical Center, University of Texas, Dallas, Texas
Ultraviolet (UV) light abrogates contact hypersensitivity (CHS) responses and induces hapten-
speci®c tolerance. Although this phenomenon has long been appreciated, molecules speci®cally
involved in this pathway still remains to be shown. We have reported previously that dectin-2
(Dec2) is a dendritic cell-speci®c C-type lectin receptor with costimulatory function. Therefore,
we tested the possibility that Dec2 mediates UV-induced local immunosuppression. C3H/HeN
mice that were exposed to low doses of UV light over 4 days (d) and hapten-sensitized through
radiated-skin area with dinitro¯uorobenzene showed profound inhibition of the CHS response,
which was completely prevented upon intravenous injection of soluble recombinant Dec2 (sol-
Dec2), an antagonist for cognate Dec2, after the last UV exposure. By contrast, injection of sol-
Dec2 did not affect the CHS response in animals that were sensitized and challenged but not UV-
exposed. UV-treated mice resensitized 14 d after the ®rst challenge displayed hapten-speci®c
tolerance, whereas UV-exposed mice injected with sol-Dec2 before the ®rst sensitization exhibited
a vigorous CHS response. Furthermore, mice that were sol-Dec2-injected with no UV exposure
produced the intact CHS response. Adoptive transfer of T cells from regional lymph nodes of UV-
exposed mice treated with sol-Dec2 had no effect on the CHS response in recipient mice, whereas
the transfer of T cells from UV-treated mice inhibited the immune response. These ®ndings
indicate that sol-Dec2 can selectively prevent UV-induced tolerance without affecting effector
routes of the CHS response, thereby demonstrating the Dec2-dependent pathway involved in
generation of immunological tolerance by UV light.
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Ultraviolet-A Irradiation Induces Expansion of Intraepithelial Tumor Cells in a Tissue
Model of Early Cancer Progression
A. Mudgil, N. Segal, Y. Wang, N. Fusenig,* and J. Garlick
Oral Biology & Pathology, SUNew York at Stony Brook, Stony Brook, New York; *German Cancer
Research Center, Heidelberg, Germany
One of the early events in skin cancer associated with ultraviolet-A (UV-A) is thought to occur as
clones of damaged keratinocytes escape apoptosis and undergo clonal expansion at the expense of
adjacent normal cells. However, factors leading to expansion of potentially malignant cells are not
well understood due to a lack of tissue models which mimic these early events. The goal of this
present study was to further characterize the early events in UV-induced skin neoplasia. To
accomplish this, we generated organotypic cultures which mimic premalignant disease by mixing
normal keratinocytes (NHK) with b-galactosidase (b-gal)-marked intraepithelial tumor cells
(HaCat-ras, clone II-4), which bear mutations in both p53 alleles. The fate of intraepithelial tumor
cells was then followed by immunohistochemical staining for b-gal after UV-A irradiation. The
effect of UV-A irradiation on NHK and II-4 cells was characterized by measuring UV-A-induced
cellular damage, as determined by the numbers of sunburn cells and apoptotic nuclei (TUNEL-
positive cells), as well as proliferation (BrdU incorporation into S-phase nuclei). We found that
UV-A (30±60 mJ per cm2) induced a dose-sensitive, apoptotic response and suppressed
proliferation of pure cultures of NHK cells. Neither apoptosis nor proliferation of II-4 cells was
altered. This differential response suggested that II-4 cells were resistant to the effects of UV-A
irradiation. When 12:1 and 4:1 mixtures of NHK:II-4 cells were irradiated, a signi®cant increase in
intraepithelial tumor cell expansion was seen. We concluded that UV-A irradiation caused a dose-
dependent induction of apoptosis in NHK, while II-4 cells escaped apoptosis, maintained
proliferation and subsequently gained a selective growth advantage. This study contributes to our
understanding of how UV-A induces intraepithelial tumor cell expansion, thereby accelerating
progression towards malignancy.
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Stat3 in Keratinocytes Plays a Crucial Role in Preventing Apoptosis Induced by UVB
Irradiation
S. Sano, M. Kira, S. Takagi, M. Tarutani, S. Itami, K. Yoshikawa, and J. Takeda
Dermatology, Osaka University Graduate School of Medicine, Suita, Japan; *Social and Environmental
Medicine, Osaka University Graduate School of Medicine, Suita, Japan
Response of mammalian cells to UV irradiation results in induction of a variety of intracellular
signalings, which dictate cell apoptosis or survival. We found that Stat3 in mouse keratinocytes was
down-regulated by UVB irradiation. Down-regulation of Stat3 mRNA occurred faster than the
decline of the protein expression, suggesting that UVB irradiation affects the Stat3 transcription.
Furethermore, we found that keratinocyte-speci®c Stat3-disrupted mice exhibited an increased
number of sunburn cells upon UVB irradiation in vivo. Also, their keratinocytes showed an
increased susceptibility to apoptosis by UVB in vitro. Topical application of the naked Stat3 gene
onto the skin not only reversed the UVB sensitivity of Stat3-disrupted mice, but also attenuated
apoptosis in wild-type mice. These results indicate that Stat3 plays an important role in preventing
apoptosis in keratinocytes induced by UVB irradiation.
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Ultraviolet Irradiation Reduces NF-kB Inhibitor IkB-a Protein Levels Thereby
Activating NF-kB and Up-Regulating NF-kB-Regulated Pro-In¯ammatory Cytokines
in Human Skin In Vivo
G. Xu, Z. Wang, Y. Shao, S. Kang, G. Fisher, and J. Voorhees
Dermatology, University of Michigan, Ann Arbor, Michigan
Transcription factor NF-?B is a key mediator of in¯ammation. We have investigated expression
and mechanism of activation of NF-kB by UV irradiation in human skin in vivo. Non-irradiated
human skin expressed transcripts and proteins for all ®ve members of NF-kB family (p65, p50,
p52, RelB and C-Rel), and the NF-kB inhibitors IkB-a, IkB-b, and IkB-e. Levels of NF-kB
proteins did not change 30 min-8 h post UV (2MED UVB source). In contrast, IkB-a protein was
reduced 25% and 33% at 4 and 8 h post UV, respectively (p < 0.05, n = 6). Increased DNA binding
of p65/p50, but not p52, RelB or C-Rel, was detected at 4 h post UV and maximally increased
(2.5 fold) at 8 h (n = 6), as determined by electrophoretic mobility shift assay (EMSA). Increased
nuclear staining of p50 and p65 was detected at 4, 6, and 8 h by immuno¯uoresence, consistent
with activation of NF-kB. IkB-a gene expression, which is speci®cally induced by NF-kB, was
signi®cantly increased at 5 h post UV (p < 0.05, 2-fold, n = 6), as determined by Real-time RT/
PCR. NF-kB-regulated pro-in¯ammatory cytokines TNF-a, IL-1 and IL-6, were also up-
regulated at 4 h post UV (p < 0.05, n = 8±17). The glucocorticoid clobetasol (0.05%) inhibited UV
activation of both NF-kB (77%) and AP-1 (78%), while all-trans retinoic acid (RA, 0.1%) inhibited
AP-1 (74%), but not NF-kB, as demonstrated by EMSA. Clobetasol reduced UV-induced nuclear
localization of NF-kB (p50/p65). Pretreatment with clobetasol, but not RA, inhibited UV up-
regulation of TNF-a (66%), IL-1 (65%) and IL-6 (47%). In summary, (1) UV induces NF-kB
activation by reducing protein levels of the NF-kB inhibitor IkB-a (2) NF-kB is a critical
participant in UV-induced expression of pro-in¯ammatory cytokines, and (3) the modest anti-
in¯ammatory action of RA is consistent with its inability to inhibit NF-kB-mediated cytokine
induction in human skin in vivo.
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Activation of PI-3-Kinase/Akt Pathway Protects Human Keratinocytes from Ultraviolet
Irradiation-Induced Apoptosis
H. Wang, Y. Wan, J. Voorhees, and G. Fisher
Dermatology, University of Michigan, Ann Arbor, Michigan
PI-3-kinase (PI3K) catalyzes formation of 3-phosphorylated phosphatidylinositols, which in turn
activate the serine/threonine kinase AKT. AKT functions to promote cell survival in a variety of
cell types. We have investigated the role of the PI3K/AKT pathway in protecting human
keratinocytes (KC) from ultraviolet (UV) irradiation-induced apoptosis. UV (2MED from UVB
source) increased PI3K activity (2.5 fold, n = 3) and activated AKT (5-fold, n = 11) within 30 min
in human skin in vivo and cultured human KC. Pretreatment of KC with the PI3K inhibitors LY
294002 and wortmannin abolished UV-induced AKT activation (n = 3), and increased UV-
induced apoptosis by 4-fold (n = 4), as measured by ¯ow cytometry analysis and DNA
fragmentation. UV may induce KC apoptosis by mitochondrial-mediated activation of caspases
9 and 3 and/or FAS-mediated activation of caspase 8. AKT inhibition increased UV-induced
release of mitochondrial cytochrome c 5-fold (n = 3), and caused appearance of active forms of
caspase-9 and caspase-3, 5-fold (n = 3). Inhibition of AKT also elevated UV-induced activation of
caspase 8 activity 3-fold (n = 3). Together these data demonstrate that UV induces apoptosis in
human keratinocytes by stimulating mitochondrial release of cytochrome c and with subsequent
activation of caspases 9 and 3, and by FAS-mediated activation of caspase-8. UV activation of AKT
inhibits cytochrome c release and activation of caspases 3, 8, and 9, thereby protecting KC from
UV-induced apoptosis. Selective therapeutic inhibition of AKT in premalignant and transformed
KC may be of bene®t in the treatment of skin cancer.
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Ultraviolet B Radiation Generates Platelet-Activating Factor and Novel Oxidatively
Modi®ed Glycerophosphocholines Which act as Platelet-Activating Factor Receptor
Agonists in Human Epidermal Cells
J. Travers, M. Southall, C. Johnson,* R. Murphy,* T. McIntyre,² and G. Marathe
Dermatology, Indiana University School of Medicine, Indianapolis, Indiana; *Pediatrics, National Jewish
Center, Denver, Colorado; ²Genetics, University of Utah, Salt Lake City, Utah
Ultraviolet B radiation (UVB) has been shown to generate cutaneous in¯ammation in part through
inducing oxidative stress and cytokine production in human keratinocytes. Though the lipid
mediator platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is synthesized in
response to oxidative stress, and keratinocytes express PAF receptors (PAF-R) linked to cytokine
biosynthesis, it is not known whether the PAF system is involved in UVB-induced signaling and
in¯ammation. Using select-ion monitoring mass spectrometry, these studies examined whether
UVB can generate PAF in epidermal cells. Lipid extracts from UVB treated KB cells contained
PAF-R agonistic activity as shown by calcium mobilization assays in both PAF-R-expressing
neutrophils and PAF-R-negative KB cells transduced with the PAF-R. Mass spectrometry studies
of these lipid fractions revealed that PAF was the major species responsible for the biological
activity, but 1-alkyl glycerophosphocholine lipids which contained an sn-2 short-chained 4 carbon
modi®ed fatty acid were also detected. Pretreatment with antioxidants inhibited both the biological
activity and PAF species generated by UVB. Consistent with the ability of UVB to generate PAF-
R agonists, UVB treatment of KB cells expressing the PAF-R resulted in an enhanced epidermal
growth factor receptor phosphosphorylation over control transduced KB cells, which could also be
inhibited by antioxidants. These studies indicate that the epidermal PAF-R is a pharmacologic
target for UVB through the generation of PAF and novel PAF-like species via oxidative stress.
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Apoptosis Induced by Disruption of the Actin Cytoskeleton is Mediated Via Activation
of CD95
D. Kulms, H. DuÈssmann,* B. PoÈppelmann, S. StaÈnder, and T. Schwarz
Department of Dermatology, University MuÈnster, MuÈnster, Germany; *Interdisciplinary Center for Clinical
Research, University MuÈnster, MuÈnster, Germany
Activation of the death receptor CD95 (Fas/APO-1) either by its ligand or by ultraviolet radiation
(UV) is associated with receptor clustering. The mechanism underlying receptor clustering is
mostly unclear. There are recent indications that interactions between the cell membrane and the
cytoskeleton may play a role in apoptosis. Therefore, we were interested which impact disruption
of the cytoskeleton might have on receptor clustering and apoptosis induced by UV. Disruption of
the actin cytoskeleton by cytochalasin B (CyB) induced moderate apoptosis, but enhanced UV-
induced apoptosis in HeLa cells. CyB exerted its effect on UV-induced apoptosis independently of
UV-mediated DNA damage, since induction of DNA repair by addition of exogenous repair
enzymes did not alter the effect of CyB. Inhibition of caspase-8, the upstream caspase in CD95
signaling, blocked the apoptotic effect of CyB and its enhancing effect on UV-induced apoptosis.
Confocal laser scanning microscopy revealed that (i) CyB induces CD95 clustering, (ii) enhances
UV-induced CD95 clustering, and (iii) CD95 clusters colocalize with disrupted actin ®laments,
suggesting a link between receptor clustering and actin rearrangement. Disruption of CD95
signaling with a dominant negative mutant of the CD95 signaling protein FADD protected HeLa
cells from CyB-induced apoptosis and prevented the enhancing effect on UV-induced cell death.
The data indicate that disruption of the cytoskeleton causes apoptosis via activation of CD95,
demonstrating that death receptors can also be triggered from inside of the cell. Furthermore,
cytoskeleton disruption enhances UV-induced apoptosis, possibly via aiding receptor clustering.
Together, these data suggest a link between death receptors and the cytoskeleton and that death
receptor clustering may be related to cytoskeleton rearrangement.
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Xeroderma Pigmentosum Variant Heterozygotes Show Reduced Levels of Recovery of
Replicative DNA Synthesis in the Presence of Caffeine after Ultraviolet Irradiation
T. Itoh, R. Kamide,² H. Tokushige,³ M. Yamaizumi,* and S. Linn
Molecular and Cell Biology, University of California, Berkeley, Berkeley, California; *Cell Genetics,
Kumamoto University, Kumamoto, Japan; ²Dermatology, Jikei University School of Medicine, Tokyo,
Japan; ³Plastic and Reconstructive Surgery, Showa University School of Medicine, Tokyo, Japan
Patients with xeroderma pigmentosum variant (XPV) show clinical photosensitivity, skin
neoplasias induced by ultraviolet (UV) light, and defective postreplication repair, but normal
excision repair. We recently reported an alternative, simple method for the diagnosis of XPV that
measures by autoradiography three cellular markers for DNA repair after UV irradiaiton:
unscheduled DNA synthesis (UDS), recovery of RNA synthesis (RRS), and recovery of
replicative DNA synthesis (RDS) (Itoh et al, J Invest Dermatol 107:349±353, 1996). Among
hereditary photosensitive disorders, including other XP, Cockayne syndrome, and UV±sensitive
syndrome, only XPV cells exhibited normal UDS, normal RRS, but reduced RDS. This
reduction of RDS was enhanced in the presence of a nontoxic level of caffeine. In this study we
assess the cellular markders in two independent families that included two photosensitive patients
that were identi®ed as XPV. Cells from heterozygotic parents showed normal levels of UDS,
RRS, and RDS but reduced rates of RDS in the presence of 1 mM caffeine. Furthermore, with a
colony-forming assay, the cells showed normal survival by UV without caffeine, but slightly
reduced survival by UV with 1 mM caffeine present. In one family, we con®rmed inheritance of
two heterozygous missense mutations. One mutation is an A to G transition at nucleotide 1840
that generates a K535E missense mutation. Another mutations is an A to C transversion at
nucleotide 2003 that generates a K589T missense mutation. These results suggest that XPV
heterozygotes can be identi®ed by their sensitivity to UV in the presence of nontoxic levels of
caffeine. + Asc-
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Nucleotide Excision Repair Genes are Up-Regulated by Low Dose UVB: Evidence of a
Photoprotective SOS Response?
V. Tron, T. Maeda, P. Chua, M. Chong, A. Sim, and O. Nikaido*
Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; *Radiation Biology,
Kanazawa University, Kanazawa, Japan
Nucleotide excision repair (NER) is a major mechanism of defense against the carcinogenic effects
of ultraviolet light. Ultraviolet B (UVB) causes sunburn and DNA damage in human skin. NER
has been studied extensively and described in detail at the molecular level including identi®cation
of many NER-speci®c proteins and the genes encoding NER proteins. In this study, normal
human keratinocytes were exposed to increasing, physiologically relevant doses of UVB, and the
effect of this exposure on expression of NER genes was examined. An RNA protection assay was
performed to quantify transcripts from NER genes, and a slot blot DNA repair activity assay was
used to assess induction of the NER pathway. The activity assay demonstrated that cyclobutane
pyrimidine dimers were removed ef®ciently after exposure to low doses of UVB, but this activity
was delayed signi®cantly at higher doses. All NER genes examined, including XPG, DDB1, XPC,
XPF, RPAp70, DDB2, hHR23B, XPA, RPAp32, RPAp14, CSB, XPB, TFIIHp44, CSA,
CDK7, CycH, TFIIHp34, ERCC1, and XPD, demonstrated a similar trend: UVB induces
expression of NER genes at low doses (100 J per m2), but down-regulates expression at higher
doses (600 J per m2). These data support the notion that NER is induced in cells exposed to low
doses of UVB, which may protect damaged keratinocytes from cell death. However, exposure to
high doses of UVB down-regulates NER genes and is associated with cell death.
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Stress-Free Hsp70 Induction by Artemia Extract Modulates p53 and p21 Expression and
Enhances Human Cells Protection from UVB
N. Domloge, K. Cucumel, C. Dal Farra, and E. Bauza
Dermatology, Seporga Research Laboratories, 06904 Sophia Antipolis, France
Prior data have shown that human epidermal cells exposed to thermal shock, synthesize Hsp70,
which offers UVB-protection a few hours after. They also show that Hsp70 can inhibit apoptosis
and even increase cell survival. Our parallel studies have demonstrated that Artemia extract 3%
induces in a stress-free manner Hsp70 in human cells. Based on the above, we were interested in
investigating, using different UV doses, the protection from UVB insult offered by this stress-free
induction of Hsp70, prior to the stress stimuli, in cultured human ®broblasts and ex vivo skin organ
culture. Our immunoblotting studies showed that at low UVB doses in Artemia-induced Hsp70
cells, p53 and p21 are up-regulated more than in control cells, which suggests an enhancement of
cell cycle arrest and DNA repair pathway. This suggestion was con®rmed by comet assay which, to
the contrary of control cells, showed no UVB-induced DNA degradation in Artemia-induced Hsp
cells. Interestingly, at higher doses of UVB, our results were similar and showed that in Artemia-
induced Hsp cells, both p53 and p21 levels were higher than in control cells, and exhibited a
signi®cant decrease in cell damage and apoptosis, which suggests strongly the action of the repair
pathway rather than the apoptosis pathway, while most of the control cells showed the activation of
p53-dependent apoptosis. In order to con®rm this, Hsp70 was induced similarly in ex vivo skin
prior to UVB exposure. Interestingly, these skin samples exhibited a great conservation of structure
with rare signs of UV damage (rare occurrence of sunburn cells) in contrast to the control skin that
exhibited extended signs of damage. Moreover, Langerhans cells immunostaining showed no sign
of UV-induced immunosuppression in the Artemia-induced Hsp70 skin samples. These results
propose a very interesting and new way of enhancing cell defense against UV stress, using the
stress-free Hsp70 induction by Artemia extract.
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Cytokine Release and Alloantigen Presentation Measured after UV Exposure of Human
Skin
A. Gueniche and A. Fourtanier
Life Sciences-Advanced Research, Loreal/Zviak Center, Clichy, France
A large number of experimental and clinical studies performed in the last two decades have
established that ultraviolet (UV) light has suppressive effects on the immune system. At cellular
level, there are principally alterations of Langerhans cells (LC), production of immunomodulating
cytokines by epidermal cells and in®ltration into the epidermis of CD11+ macrophages known to
have important immunosupressive activities. Moreover, it has been recently demonstrated that the
production of TNF-a and IL-1b by epidermal cells after UV exposure, stimulate the production
by macrophages of a matrix metalloproteinase, MMP-9 (92 kDa gelatinase). In the present study in
human volunteers, we measured IL-10 and MMP-9 release as well as alterations of Langerhans cells
(LC) number and alloantigen presentation after acute UV exposure to solar simulated radiation.
Each of the 10 volunteers received 0, 1, 2 and 3 MED on the unexposed buttock skin. Twelve
hours after exposure, suction blisters were raised. From blister roofs, we determined LC density (by
¯ow cytometry) and function (using the MECLR assay). We also extracted IL-10 and MMP-9 as
described by J. Peguet-Navarro (Br J Dermatol 133:660±661, 1995) and quanti®ed them by ELISA.
Each end-point showed a SSR dose-dependent response with decrease (Pex-vivo'assays used in this
study are much less sensitive than the in vivo methods measuring the UV effect on immune
function. They also evidence that a new sensitive in vitro method must be developed.
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Ceramides Induce Photoaging-Associated Mitochondrial (mt) Mutation
M. Berneburg, S. Wild, V. Kurten, A. Timmer, and J. Krutmann
Clinical & Experimental Photodermatology, Dermatology, University of Duesseldorf, Dusseldorf, Germany
It is well established that mtDNA deletions in human dermis re¯ect photoaging. We have
previously demonstrated that the most frequent deletion of mtDNA, i.e. the common deletion
(CD) can be induced in human ®broblasts and skin. This induction is mediated by reactive oxygen
species and closely associated with a decrease of mt function and induction of matrix
metalloproteinases. The underlying pathways by which repetitive UV-exposure leads to these
effects remain elusive, however. We now report that increase of intracellular ceramides leads to
mtDNA deletions and that ceramide- and UV-effects are directly linked. Normal human
®broblasts were repetitively exposed to sublethal doses of C6-ceramide and N-oleoyl-ethanolamin
(NOE), a known inhibitor of ceramide degrading proteins. To determine intracellular ceramide
levels, lipid extracts were prepared and analysed for ceramide generation by sequential high
performance thin layer chromatography allowing separation and subsequent quanti®cation.
Repetitive exposure of cells to NOE lead to an increase of intracellular ceramides, not inducing
signi®cant cell death or apoptosis. In parallel, exposure of cells to C6-ceramide and NOE lead to
the induction of the CD. To determine whether the ceramide effect is in the same pathway as the
UV-mediated CD-induction, we repetitively irradiated cells with UVA alone or in the presence of
Fumonisin B1, a known ceramide suppressor. Coincubation of cells with Fumonisin B1
signi®cantly delayed the generation of UVA-induced CD, suggesting that UV-mediated and
ceramide effects are indeed in the same pathway. This could be further con®rmed by coincubation
of NOE stimulated cells with singlet oxygen quencher vitamin E which partially abrogated the
induction of the CD similar to UVA. Taken together these results indicate a role of endogenous
ceramides in the induction of mtDNA deletions and ultimately in the process of photoaging.
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Ultraviolet A (UVA) Radiation-Induced Ceramide Generation in Human Keratinocytes
(KC) Involves Nonenzymatic and Enzymatic Mechanisms
J. Krutmann, A. Timmer, S. Grether-Beck, I. Felsner, and H. Schmitt-Brenden
Clinical & Experimental Photodermatology, Dermatology, Heinrich-Heine University, Duesseldorf,
Germany
UVA radiation was previously found to be capable of inducing the release of ceramide in human
KC. Kinetic analysis revealed that UVA radiation-induced ceramide formation follows a biphasic
pattern in these cells with a ®rst and strong (17-fold) maximum 1 h after exposure and a second,
smaller increase (4-fold) between 24 and 48 h. Moreover, the early and strong peak in ceramide
generation was found to be due to nonenzymatic hydrolysis of cell membrane sphingoymelin. In
addition to this nonenzymatic pathway, two additional pathways have been identi®ed for ceramide
accumulation: hydrolysis from sphingomyelin through neutral and acid sphingomyelinases
(Smase's) and de novo synthesis with serine palmitoyl transferase as the rate limiting enzyme. In
the present study the mechanism underlying the second, smaller increase in ceramide formation in
UVA-irradiated KC was assessed. Lipid extracts from UVA-irradiated, longterm-cultured normal
human KC were analyzed for ceramide generation by sequential high performance thin layer
chromatography employing a CAMAG AMD2 device, which allows separation of lipids by
polarity through a solvent gradient and subsequently their quanti®cation. We have found that
inhibitors of neutral Smase such as DCIC as well as inhibitors of acid Smase including chloroquine
and ammonium chloride did neither prevent the ®rst nor the second increase in ceramide
formation in UVA-irradiated KC. These substances were biologically active, because in the same
experiments, IL-1-induced ceramide generation was completely inhibited. Addition of the serine
palmitoyl transferase inhibitor cycloserin and the ceramid synthase inhibitor fumonisin B1,
however, completely inhibited the second, but not the ®rst increase in ceramide formation in
UVA-irradiated cells. These studies indicate that at later time points UVA radiation increases
ceramide formation through de novo synthesis. Accordingly, differential RT-PCR analysis
revealed a signi®cant increase in mRNA expression for serine palmitoyltransferase 16 h after UVA
irradiation, but not for acid or neutral Smase. Solar UVA radiation thus causes ceramide formation
in human KC through both nonenzymatic and enzymatic mechanisms.
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Lutein Inhibits UVB Radiation-Induced Tissue Swelling and Suppression of the
Induction of Contact Hypersensitivity (CHS) in the Mouse
R. Granstein, D. Faulhaber, and W. Ding
Department of Dermatology, Weill Medical College of Cornell University, New York, New York
Studies have suggested that carotenoids have bene®cial effects on human health including
protection against cancer, macular degeneration and cardiovascular disease. Also, there is evidence
that at least some of the immunosuppressive effects of UVB radiation are mediated by radical
oxygen species. Lutein is a plant pigment and antioxidant found in marigolds and other plants,
including some foods. This study examined whether lutein could inhibit some of the deleterious
effects of UVB radiation. C3H/HeJ mice were fed a standard laboratory diet or the diet
supplemented with 0.04% or 0.4% lutein. Two weeks after beginning the lutein diet, the ears of 10
mice in each group were exposed to 2000 J per m2 of UVB radiation (FS40 sunlamps). The
thickness of each ear was measured before and 24 h after exposure with a spring-loaded
micrometer. Ear swelling in response to the UVB radiation was signi®cantly inhibited (p = 0.025)
in the 0.4% lutein diet group [6.4 (x 0.01 mm) 6 0.7 (SEM) for control diet, 4.8 6 0.5 for 0.04%
lutein, 4.3 6 0.4 for 0.4% lutein]. In another experiment, 20 mice were fed each diet for 2 weeks.
Then, the shaved dorsum of each of 10 mice in each group was exposed to 1000 J per m2 UVB
radiation daily for 4 consecutive days. One h after the last exposure, 5 irradiated and 5
nonirradiated mice in each of the diet groups were immunized by topical application of
dinitro¯uorobenzene (DNFB) to the irradiated site. Seven days later each mouse, along with 5
control irradiated, nonimmunized mice and 5 control nonirradiated, nonimmunized mice, was
challenged by application of DNFB to the ears and 24 h ear swelling was assessed. As expected,
control diet mice exposed to UVB radiation exhibited a signi®cantly (p = 0.015) decreased CHS
response. However, mice fed the 0.04% or 0.4% lutein diet failed to exhibit signi®cant suppression
[6.3 (x 0.01 mm) 6 0.5 (SEM) for control diet, 3.4 6 0.4 for UVB/control diet, 8.6 6 1.1 for
UVB/0.04% lutein, 6.3 6 0.3 for UVB/0.4% lutein, 0.6 6 0.4 for the nonimmune control group,
0.9 6 0.4 for the UVB/nonimmune control group]. These data demonstrate that dietary
supplementation with lutein inhibits the cutaneous in¯ammatory response and the local
immunosuppressive response to UVB radiation.
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UVA-Filtering Sunscreen Results in Immune Protection that Exceeds Erythema
Protection
E. Baron, A. Fourtanier,* D. Compan,* and S. Stevens
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio; *Loreal Recherche, Clichy, France
Immune suppression is a harmful effect of UV radiation in humans. Earlier studies focused on
UVB-induced suppression, but there is also evidence that UVA contributes to this event.
Sunscreens have been reported to prevent this phenomenon to varying degrees but differences in
the methodologies prevent accurate comparisons. Regardless, immune protection was universally
less than erythema protection (SPF). The purpose of this study is to determine the ef®cacy of a
UVA-®ltering sunscreen in preventing UV-induced CH suppression, relative to its SPF. 88 human
subjects were randomized into 12 groups. 4 had solar-simulated radiation (SSR) at 0, 0.25, 0.5, and
0.75 MED. 7 had sunscreen-protected SSR at 0, 0.25, 0.5, 0.75, 1.0, 1.5 and 2.0 MED multiplied
by the individual SPF's, before DNCB sensitization. CH response was measured by the millimeter
increase in skin fold thickness (SFT) over 5 graded DNCB challenge sites on the arm, 2 weeks after
sensitization. SSR dose±response curves were generated and the immune protection factor (IPF)
was calculated using linear regression, Weibull and logistic models. Results demonstrate a
nonlinear dose±response relationship between UV dose delivered and mm increase in SFT. The
CH response was signi®cantly higher in the sunscreen-treated than in the nontreated groups.
Signi®cant suppression was observed at 0.5 MED in the untreated groups, vs. 1.0 MEDxSPF in the
sunscreen groups. Regardless of the statistical model used, the calculated IPF (range = 32±
54)consistently exceeded the SPF (15.97). Because the data follow a sigmoidal distribution, the
Weibull model was chosen which yielded an IPF of 55. This UVA-®ltering sunscreen was effective
in preventing UV-induced CH suppression at suberythemogenic UV doses. Although calculated
IPF's varied with the statistical model used, these results provide the ®rst data demonstrating a
sunscreen with an IPF greater than its SPF.
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Aging and Photoaging Dependent Changes of Enzymic and Nonenzymic Antioxidants
in the Epidermis and Dermis of Human Skin In Vivo
G. Rhie, M. Shin, J. Seo, W. Choi, K. Kim, K. Cho, K. Park, H. Eun, and J. Chung
Dermatology, Seoul National University College of Medicine, Seoul, South Korea
This is the ®rst comprehensive study of the changes in major antioxidant enzymes and antioxidant
molecules during intrinsic aging and photoaging processes in the epidermis and dermis of human
skin in vivo. We show that the activities of superoxide dismutase and glutathione peroxidase are not
changed during these processes in human skin in vivo. Interestingly, the activity of catalase was
signi®cantly increased in the epidermis of photoaged (163%) and naturally aged (118%) skin (n = 9),
but it was signi®cantly lower in the dermis of photoaged (67% of the young skin level) and
naturally aged (55%) skin, compared with young (n = 7) skin. The activity of glutathione reductase
was signi®cantly higher (121%) in naturally aged epidermis. The concentration of a-tocopherol
was signi®cantly lower in the epidermis of photoaged (56% of young skin level) and aged (61%)
skin, but this was not found to be the case in the dermis. Ascorbic acid levels were lower in both
epidermis (69% and 61%) and dermis (63% and 70%) of photoaged and naturally aged skin,
respectively. Glutathione concentrations were also lower. Uric acid did not show any signi®cant
changes. Our results suggest that the components of the antioxidant defense system in human skin
are probably regulated in a complex manner during the intrinsic aging and photoaging processes.
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DNA Damage and Melanin Production Induced by Ultraviolet Radiation in Human
Skin within Various Racial/Ethnic Groups
T. Tadokoro, N. Kobayashi, J. Beer,* B. Zmudzka,* V. Hearing, K. Korossy, S. Ito, and K.
Wakamatsu
North CarolinaI, NIH, Bethesda, Maryland; *CDRH, FDA, Rockville, Maryland
The role of racial/ethnic origin in individual UV sensitivity remains unclear. We are evaluating the
usefulness of various biomarker methods to measure UV responses in human skin and to investigate
the relationships between DNA damage/repair and melanin formation induced by UV exposure in
different racial/ethnic groups and phototypes. This study will involve 110 subjects representing
different UV sensitivities within 6 racial/ethnic groups. The MED of each individual was
determined to assess their sensitivity to UV 1 day before the experimental protocol. Shave biopsies
were taken before exposure, immediately after exposure to 1 MED of UV, and then 1 day and 7
days later. Induction of DNA damage (CPD) is detected in frozen sections by indirect
immuno¯uorescence using a monoclonal antibody speci®c for CPD and with FITC. Nuclear
DNA is counterstained with propidium iodide (PI). DNA damage is expressed as the ratio of the
intensities of the FITC and the PI ¯uorescence. The data show that DNA damage measured by
CPD is signi®cant immediately following exposure to UV and is gradually repaired towards the
background level. While melanin contents measured by Fontana-Masson staining did not change
consistently with UV exposure, melanin production increased when DNA damage was more
severe and this tendency became stronger as time passed after UV irradiation. The relationships
between DNA damage and melanin content showed signi®cant differences among each group of
racial/ethnic origin tested and also among each group of phototypes. Melanin staining showed a
good correlation with eumelanin but not with pheomelanin content. Thus, individual racial/
ethnic origin as well as skin sensitivity affects responses to UV and might predict the risk of human
skin cancer. Future study will evaluate the DNA damage evident, the repair ef®ciency and also the
role of melanin in all other skin types.
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Replenishment of Sun-Depleted Vitamin E in Human Stratum Corneum by a Liquid
Skin Cleansing Product
A. Tavakkol, Z. Nabi, C. Cardona, N. Soliman, and T. Polefka
Personal Care, Colgate-Palmolive, Piscataway, New Jersey
Previous studies have shown that solar simulated radiation (SSR) depletes human stratum corneum
(SC) vitamin E (vit. E). It is not however, known whether exposure to natural sunlight has a similar
effect. Nor is it known if the depleted vit. E can be raised above its normal levels via the use of skin
cleansers containing vit. E during daily bathing/shower routine. To determine this, 14 female
Caucasians ages 18±55, with light to medium skin pigmentation were enrolled into a study. They
underwent 2- week of skin preconditioning with cleansers with no vit. E or vit. E acetate (vit. EA).
Subjects had no dietary restriction but were asked to limit their sun exposure. On the day of the
study, the forearms were exposed for 30 6 1 min to natural sunlight (0.47 and 1.17 mJ per s per
cm2 UV-B and UV-A measured at 310 nm and 360 nm, respectively). Prior to and after sun
exposure, forearm skin was washed for 1-min with a skin cleanser containing vit. E and vit. EA,
and rinsed immediately. The SC vitamins were extracted and analyzed by HPLC. The results
indicated that (1) exposure to sunlight, under conditions that did not induce erythema, reduced
baseline skin vit. E from 31 6 30 to 16 6 17 pmoles per cm2 (mean 6 SD, p = 0.05); (2) a single
wash with the vit. E skin cleanser raised SC vit. E levels from 31 6 30 to 204 6 79 pmoles per cm2;
(3) exposure to sunlight depleted this supplemented vit. E by 45% from 204 6 79 to 112 6 44
pmoles per cm2; and (4) in skin pre-exposed to sun, topical application raised vit. E by
approximately 500% above the unexposed levels (185 6 76 vs. 31 6 30 pmoles per cm2). We
provide the ®rst evidence that a brief exposure of human skin to natural sunlight in the North-east
US seriously depletes skin's natural vit. E. We further show that washing the skin with the vit. E
cleanser before sun exposure compensates for vit. E loss. Moreover, using the skin cleanser after
sun exposure replenishes the depleted vit. E to levels that will remain approximately 500% higher
than natural, pre-exposed levels.
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UVA-340 as an Energy Source, Mimicking Natural Sunlight, Activates the Transcription
Factor AP-1 in Cultured Fibroblasts: Evidence for Involvement of Protein Kinase-C
H. Nakano, F. Gasparro, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Ultraviolet radiation (UVR) is known to affect a variety of cellular functions, including gene
expression, and a number of signaling pathways have been suggested to mediate these effects,
including the participation of AP-1, AP-2, and NF-kB. The divergent results from previous studies
could be explained, at least in part, by the source of UVR with different spectral characteristics, as
well as the type of cells employed as targets. In this study, we have utilized UVA-340, which
closely matches the spectrum of natural sunlight over the range of 295±350 nm, as the source of
energy for irradiation of human ®broblasts or mouse NIH-3T3 cells in culture. Combination of
electrophoretic mobility shift assays and Northern analyses revealed activation of AP-1, but not
NF-kB or AP-2. This effect was dependent on de novo protein synthesis, as judged from
incubation experiments with cycloheximide (10 mg per ml). Inhibition studies with H7 and
HA1004 suggested participation of PKC, but not PKA, and PDO98059, an inhibitor of mitogen
activated protein kinase (MEK-1/2) did not alter the AP-1 activation. Free radical quenchers,
sodium azide and N-acetylcysteine, did not affect the AP-1 binding activity. Finally, UVA-340 was
shown to enhance transcriptional expression of the type VII collagen gene (COL7A1), which is
endogenously expressed in dermal ®broblasts and which contains at least one functional AP-1 ci-
element within its promoter region. Introduction of point mutations into the AP-1 site of the
COL7A1 promoter abolished this activation. Thus, the results indicate a role for AP-1 in
mediating the enhanced gene expression by UVR, and collectively suggest that AP-1 is an
important mediator of UVR action in ®broblasts.
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Increasing Stratum Corneum Vitamin E: A Comparison of Topical vs. Oral
Supplementation
Z. Nabi, A. Tavakkol, S. Cardona, N. Soliman, and T. Polefka
Personal Care, Colgate-Palmolive, Piscataway, New Jersey
The objective of this double-blind study was to assess which mode of delivery, topical or oral,
more effectively increases the vitamin E content of the stratum corneum. After a seven-day
washout period, twenty, adult, Caucasian females were entered into the IRB-reviewed study.
Vitamin E was extracted from blood and stratum with solvents and analyzed by HPLC. The
subjects were randomly divided among two treatment groups. One group ingested oral vitamin E
tablets (400 IU a-d-tocopherol) daily. The volar forearms of the other group were washed with an
experimental body-wash with and without tocopherol and tocopheryl acetate. After nine working
days of treatment, vitamin E in blood and stratum corneum were re-analyzed. Topical treatment
with the vitamin E bodywash increased stratum corneum tocopherol from 5 to 267 pmoles per cm2
and tocopheryl acetate from 1 to 158 pmoles per cm2. In contrast, oral ingestion of 400 IU of
vitamin E (18 3 Recommended Daily Intake, RDI) increased stratum corneum tocopherol levels
to 78 pmoles per cm2 without affecting tocopheryl acetate levels. Of the two treatments, only oral
ingestion signi®cantly (p = 0.05) increased plasma tocopherol levels from 24.3 to 45.3 mmoles per
L. Our results show that stratum corneum tocopherol can be increased by either oral or topical
routes. However, topical delivery is superior (4-fold) to systemic delivery. We believe that the
stratum corneum is a reservoir for the lipophilic vitamin E.
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IL-12 Completely Blocks the Secretion of TNFa from Cultured Skin Cells: Implications
for Photosensitive Conditions
V. Werth* and W. Zhang
Dermatology, University of Pennsylvania, Phil., Pennsylvania; *Phil. V.A. Hospital, Phil., Pennsylvania
IL-12 is considered to act primarily on lymphocytes. One recent study showed that IL-12 blunts
the rise in TNFa levels that occur after UV irradiation of mice (Schmitt et al, Immunol 101:90,
2000). Because serum TNFa comes from both lymphocytic and nonlymphocytic sources, we
hypothesized that IL-12 might be an important inhibitor of TNFa secretion from many cell types.
We now sought to determine if IL-12 could affect the synergistic stimulation of TNFa secretion
by UVB plus IL-1a (Werth et al, J Invest Dermatol 113:196, 1999). Human skin ®broblasts (FBs)
were treated with UVB (30 mJ per cm2) or sham (zero mJ per cm2), 6 IL-1a (5 ng per ml), 6 IL-
12 (10 ng per ml). TNFa secretion was undetectable from sham-irradiated cells; 6.2 6 2.4 pg per ml
after IL-1a; 8.3 6 0.7 pg per ml after UVB; and 34 6 0.1 pg per ml after UVB + IL-1a (mean 6
SEM, n = 3). IL-12 totally blocked TNFa production from these cells, regardless of the presence of
UVB or IL-1a. Similar experiments were performed with keratinocytes (KCs) and also showed
total suppression of TNFa with IL-12. TNFa was undectable from sham-irradiated KCs;
23.2 6 4.4 pg per ml after UVB; but then undetectable after addition of IL-12 to either sham or
UVB-treated cells. Exogenous IL-1a was not added to KCs since previous experiments show
endogenous IL-1a secretion from KCs is suf®cient for UVB-induction of TNFa. To determine
the molecular mechanism of the IL-12 effect, we transiently transfected FBs with a construct
containing the CAT reporter under the control of a 1.2-kb TNFa promoter fragment. 24 h later
the cells were exposed to UVB or sham 6 IL-1a, 6 IL-12. After 24 h, CAT protein (normalized
to b-GAL) was 8.1 6 0.2 from sham-irradiated cells; 25 6 3.7 after IL-1a alone; 21 6 1.1 after
UVB; and 89 6 8.7 after UVB + IL-1a, consistent with the strong synergy between UVB and IL-
1a. IL-12 totally blocked any effect of IL-1a (IL-12 + IL-1a: 7.1 6 0.7; IL-12 + UVB + IL-1a:
19 6 2.1), while having no effect on the action of UVB (IL-12 + UVB: 18 6 1.7). These studies
indicate that TNFa production by nonin¯ammatory skin cells is strongly inhibited by IL-12, and
that the mechanism is mediated in part through inhibition of gene transcription via an element
within the ®rst 1.2 kb of the TNFa promoter. Because TNFa is involved in the pathogenesis of
photosensitive skin diseases (Werth et al, J Invest Derm 115:726, 2000), IL-12 may play important
physiologic and therapeutic roles.
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Protection Against UV-Induced Genotoxicity and Immunosuppression by Mineral-
Containing Sunscreens: In Vivo Evaluation
P. Msika and J. Cesarini*
R & D, Laboratoires Pharmascience, Epernon, France; *Dermatology Department, INSERM, Paris, France
Molecular mechanisms in skin photocarcinogenesis has assigned a key role to the sunscreen on p53.
On an another hand, excessive DNA damages will lead to apoptosis, evidenced by ``sunburn cells''
(SBCs). Impairment of skin immunity through the alteration of Langherans cells (LC) seems also to
be implicated in cutaneous malignancy. Thus, it can be reasonably assumed that the prevention of
both SBCs production, p53 induction and LC alteration will be representative of the quality of the
photoprotection beyond the simple prevention of erythema. We have developped speci®c ultra®ne
containing-mineral sunscreens (SPF25 and 50+) with high absorbance in UVA, speci®cally
designed for children, and presente here their capacity to prevent UV-induced genotoxicity and
immunosuppression. Twelve volonteers were irradiated on the buttocks, using a solar simulator
and skin biopsies were performed 24 h later. Sunscreens were applied either at 2 mg per cm2
(COLIPA, SPF determination) or 1 mg per cm2 (more realistic), and speci®c UV doses (5, 10 and
50 MED) were chosen in order to simulate different behaviours under the sun. SBCs were
characterized by morphological features, altered LC and p53 were revealed by immunohis-
tochemistry. In our experimental conditions, we have shown that the two sunscreens were able to
signi®cantly reduced SBCs production and p53 induction and to inhibit LC alteration even for
high level exposure. When comparing 1 MED-induced cellular damages without sunscreen (UV
dose, 1 MED) vs. 1 MED-induced cellular damages with SPF50+ (UV dose, 50 MED), we
observed a signi®cant decrease of both genotoxicity and immunosuppression with the sunscreen.
These results emphasize the key role of UVA in sunlight damaging effects, and clearly demonstrate
that our SPF50+ sunscreen is not only ef®cient in preventing erythema but also in reducing cellular
damages which may lead to skin carcinogenesis in adulthood.
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Vascular Endothelial Growth Factor Up-Regulation after UV is Modulated by a TNF-a
Antagonistic Peptide
M. Kosmadaki, I. Hadshiew, M. Yaar, and B. Gilchrest
Department of Derm, Boston University, Boston, Massachusetts
Vascular endothelial growth factor (VEGF) is one of the potent keratinocyte (Kc) derived
angiogenic factors that is induced by UV irradiation (UVR). To determine UV induced VEGF
modulations in vivo, the lower back of volunteers was exposed to erythermogenic UVR using a
solar simulator. In nonirradiated areas, or in areas that were covered with SPF15 sun-block, VEGF
was strongly expressed only in the papillary dermis. In contrast, 72 h after UVR, VEGF was
induced in the epidermis. Prior reports suggest that following UVR VEGF mRNA in Kc is
induced by tumor necrosis factor (TNF)-a, a cytokine up-regulated by UVR in Kc. We
investigated whether blocking TNF-a binding to it receptors would inhibit VEGF synthesis and
release. We synthesized a small peptide, KWIIVW (MW 887 Da), that is known to interfere with
TNF-abinding to its p55 receptor. Normal human Kc or the Kc-delivered cell line SCC 12 F were
sham or UV irradiated (30±50 mJ per cm2) in the presence of the peptide (2.7 nM) or diluent alone
as control. Within 48 h, VEGF 4.0 kb transcript was substantially induced in UV irradiated cells. In
addition, within 96 h VEGF levels in medium conditioned by sham vs. UV irradiated cells were
3.2 6 0.1 fg per cell vs. 5.4 6 0.2 fg per cell as measured by ELISA (p < 0.05, non paired t test),
expanding earlier reports. Interestingly, addition of TNF-a blocking peptide decreased VEGF
levels in irradiated conditioned medium by half (49 6 2.5%). Furthermore, cytosolic VEGF levels
in Kc treated with the TNF-a binding peptide were substantially reduced as compared to diluent
treated cells as determined by immunohistochemical analysis and confocal laser microscopy. Our
®ndings show that in human epidermis VEGF is upregulated after UVR. Furthermore, UVR-
induced VEGF synthesis and release from Kc can be inhibited by a peptide that prevents TNF-a
binding to its p55 receptor. TNF-a blocking peptide could be used to treat dermatoses
characterized by neo-angiogenesis.
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Intrinsic Aging vs. Photoaging: a Comparative Histopathologic, Histometric, and
Immunohistochemical Study
H. Ahmad, S. Attiah, F. Saleh, D. Brown,* F. Gasparro,* J. Uitto, and M. El-Domyati
Dermatology, aL-Minya University, aL-Minya, Egypt; *Dermatology and Cutaneous Biology, Jefferson
Medical College, Philadelphia, Pennsylvania
Aging of the skin is a complex biological phenomenon affecting the different constituents of the
skin. To compare the effect of intrinsic and extrinsic aging processes, 94 biopsies were collected
from sun-protected and sun-exposed skin of healthy volunteers representing decades from the 1st
to the 9th. Routine H&E staining was used to evaluate epidermal changes. Immunoperoxidase
techniques with antibodies against type I and III collagen and elastin were used to evaluate changes
in collagen and elastic ®bers. Quantitative evaluations of staining intensity and epidermal thickness
employed a computer-assisted image analyzer. Epidermal thickness was found to be constant in
both sun-exposed and sun-protected skin in different decades, however, it was signi®cantly greater
in sun-exposed skin (p = 0.0001). In sun-protected skin type I and III collagen were affected only
after the 8th decade while in sun-exposed skin staining intensity decreased from 82.5% and 80.4%
in the 1st decade to 53.2% and 44.1% in the 9th decade, respectively (p = 0.0004 and 0.0008). Both
collagens appeared disorganized after the 4th decade. The intensity of elastin in sun-protected skin
signi®cantly decreased from 49.2% in the 1st decade to 30.4% in the 9th decade (p = 0.05). In sun-
exposed skin the intensity gradually increased from 56.5% in the 1st decade to 75.2% in the 9th
decade (p = 0.001). The accumulated elastin was morphologically abnormal and appeared to
occupy the areas of lost collagen. Therefore the aging process, whether intrinsic or extrinsic, has
quantitative and qualitative effects on both collagen and elastin.
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Percutaneous Drug Delivery Using Er:YAG Laser
R. Tachihara, W. Farinelli, P. Lee, and R. Anderson
Dermatology, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Harvard Medical
School, Boston, Massachusetts
Transcutaneous drug delivery is a potential pathway to avoid the pain associated with needle
injections. Since the stratum corneum has a strong barrier function which prevents the invasion of
molecules and limits the potential of topical drug diffusion, our aim was to achieve better
penetration of these compounds by using an Er:YAG laser to remove the stratum corneum. The
Er:YAG laser at the wavelength of 2.94 mm, is strongly absorbed by water within the tissue, and
can therefore ablate this tissue painlessly with minimal thermal damage. In this study, irradiation
with an Er:YAG laser was performed on the volar side of forearms in our human subjects using
varying ¯uences. To examine the effect of the irradiation, we used in vivo confocal microscopy
(CM), which enables the imaging of the skin, non-invasively. The Er:YAG laser cause immediate
white color change (whitening), indicating partial removal of the stratum corneum without
in¯ammation, which was veri®ed with CM. The lowest ¯uence for whitening varied between
individuals. We examined the effect of EMLA, a topical anesthetic, by a pinprick test and pain
rating scale. Anesthesia onset was much more rapid after Er:YAG exposure compared with
unexposed control sites. We also applied epinephrine at 0.1 mg per ml to demonstrate its
penetration into the dermis, which we could visualize as a color change due to vasoconstriction.
This demonstrated rapid uptake and the horizontal distribution of the drug. This study suggests that
Er:YAG laser is a promising tool for percutaneous drug delivery.
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Human In Vivo Immune Protection Factors of Sunscreens Containing Chemical UV
Filters Measured in UV Dose Response Studies in the Local Contact Hypersensitivity
Model
P. Wolf, C. Hoffmann, S. Grinschgl, F. Quehenberger,* and H. Kerl
Dermatology, University, Graz, Austria; *Medical Informatics and Statistics, University, Graz, Austria
Experimental studies in animals and humans have resulted in a great controversy on the
immunoprotective capacity of sunscreens. Thus, we have performed this randomized study to
obtain human in vivo immune protection factors (IPFs) in the model of UV-induced local
suppression of the induction of contact hypersensitivity (CHS) to 2,4-dinitrochlorobenzene
(DNCB). Brie¯y, 73 male subjects were exposed in a multistage approach study protocol to
multiples of their individual minimal erythema dose (MED) produced by an Oriel 1000 W solar
simulator, left unsensitized or were sensitized 3 days later with 50 mL of 0.0625 DNCB on a
nonirradiated or UV-irradiated ®eld on the buttock that was unprotected or protected by
sunscreen (2 mg per cm2). Three weeks after sensitization the volunteers were challenged with
different concentrations of DNCB on their upper inner arm and the CHS response was determined
at 48 and 72 h by a clinical semiquantitative score, the lesion's diameter, and skin edema
measurement by 20 MHz ultrasound. The statistical study analysis by a 4-parameter logistic model
revealed that the 50% immunosuppressive dose ranged from 0.71 to 0.79 MED, depending on the
endpoint parameter used for quanti®cation of immune response. There was signi®cant
immunoprotection by sunscreens (p = 0.05±0.001). The IPF of a sunscreen (sun protection factor,
SPF 5.2) containing the UVB ®lter methylbenzylidene camphor (Eusolex 6300) ranged from 5.0 to
6.0 and the IPF of a broad spectrum sunscreen (SPF 6.2) containing methylbenzylidene camphor
and the UVA ®lter butylmethoxydibenzoylmethane (Parsol 1789) ranged from 8.5 to 10.1. Taken
together, these results indicate that (1) chemical sunscreens have immunoprotective capacity in
humans (2) there is some correlation of the IPF to SPF, and (3) sunscreens with broad spectrum
UVA + B protection may exhibit higher immunoprotective capacity.
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The In¯uence of UVA and UVB on the Tyrosine Kinase Pro®le of Normal Human
Keratinocytes
R. Knobler, G. Klosner, R. Varecka,* and F. Trautinger
Department of Dermatology, University of Vienna, Vienna, Austria; *Boehringer-Ingelheim Austria Gmbh,
Vienna, Austria
Exposure of human skin to UV induces major changes in the genetic program of the exposed cells
leading to immediate and long-term skin changes. Although it can be assumed that UV-induced
modi®cations of signal transduction involving protein tyrosin kinases (PTKs) regulate these
processes, details as to the speci®c changes in PTK expression after UV exposure are unknown. To
investigate PTK expression in normal human keratinocytes (HNK) we employed a reversed
transcriptase-PCR approach using degenerate primers derived from the conserved catalytic domain
of PTKs. PCR products were cloned and PTKs from randomly picked colonies (up to n = 90 per
screen) were identi®ed by sequence analysis. PTK pro®les of sham-irradiated, UVA (®ltered metal
halide lamp, 60 J per cm2), and UVB (®ltered metal halide lamp, 256 mJ per cm2) treated HNK
were analyzed 7 h after exposure. We identi®ed 14 PTKs including 3 receptor kinases (axl, cak,
fgfr2) and 11 nonreceptor kinases (abl1, abl2, lck, map4k2, fyn, yes, src, cnk, ptk6, mstr1, jak1).
The PTK pro®le of HNK was characterized by a predominance of abl1 and 2. Differential
screening revealed a further induction of abl2 expression by UVA. UVB had no in¯uence on abl2
but predominantly induced the expression of the receptor kinases of the axl-family. Both
treatments lead to a down-regulation of src-family kinases (src, fyn, yes). Overall evaluation
revealed that UVA predominantly stimulates expression of nonreceptor kinases and inhibits
receptor PTKs, while UVB had the opposite effect. The differences reached statistical signi®cance
at p < 0.0001 (c2 test). We conclude that regulation of PTK expression is part of genetic program
that mediates late effects of UVA and UVB. The observed effects are wavelength dependent and
affect PTKs which are involved in the regulation of gene transcription, cell death, and
proliferation.
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The Fluorescence of Human Facial Skin is a Good Marker for Aging and Documents the
Effects of Retinol Treatment
G. Stamatas, R. Estanislao, M. Suero, H. Watanabe, J. Li, and N. Kollias
Methods & Models, Johnson & Johnson, Skillman, New Jersey
It has been shown that the ¯uorescence of skin is a good marker for aging in mice and in humans.
Speci®cally, the ratio of the ¯uorescence of tryptophan moieties to that of pepsin digestible
collagen cross-links for the hairless mouse model and the ratio of tryptophan moieties to that of
elastin cross-links for human forearm skin decrease monotonically with age. The goal of the
present study was to assess the changes in the ¯uorescence of facial human skin with aging and the
reversal of aging changes with application of topical retinoids. The ¯uorescence of human subjects
in the range of 14±75 years of age, in winter and summer was measured on the cheek of 522
volunteers in 5 different geographical areas. The ¯uorescence intensity was measured with a ®ber
based ¯uorescence spectrophotometer equipped with double monochromators (Model: Skinskan,
Spex Ind., Horiba Group, Edison, Nj). In a second study 20 individuals with ages 51±70 years were
treated with retinol for six months twice a day in a double blind placebo control protocol. All
volunteers used a broad spectrum Spf 15 sunscreen for the duration of the study. The ¯uorescence
of the facial skin was measured at baseline, at three months and at the end of the study. In the ®rst
study the ¯uorescence ratio of the tryptophan moieties to elastin cross-links was found to decrease
monotonically with age in all the groups and independently of the season. In the second study the
¯uorescence ratio of tryptophan moieties to elastin cross links was found to decrease for the
placebo treated group and remained constant for the retinol treated group. Thus the ratio of the
¯uorescence intensity of tryptophan moieties to the ¯uorescence intensity of elastin cross-links is a
marker of aging for human facial skin. Furthermore the ``slowing-down'' of aging changes induced
by retinol (or reversal) can be monitored and documented by the ¯uorescence ratio of tryptophan
to elastin cross-links.
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Both Direct Photodeactivation and Oxidative Damage can Contribute to the Seasonal
Loss of Catalase Activity in Human Stratum Corneum
L. Declercq, L. Hellemans, H. Corstjens, E. Pelle,* T. Mammone,* K. Marenus, and D. Maes
EsteÂe Lauder Coordination Center, Oevel, Belgium; *EsteÂe Lauder Companies, Melville, New York
The enzymes superoxide dismutase (SOD) and catalase contribute to the antioxidant defense
mechanisms of the skin by working in concordance to neutralize superoxide via hydrogen
peroxide into water. In human skin, a disturbance in the equilibrium between SOD and catalase
would result in a local overproduction of hydrogen peroxide, potentially leading to the formation
of the extremely reactive hydroxyl radical through reaction with transition metals. Using a sensitive
noninvasive method to measure catalase-like activity on tape strippings from the stratum corneum,
we have previously shown that chronic sun exposure leads to a progressive loss of this activity in
the skin. The loss of enzymatic activity can be induced by ultraviolet A (UVA) in a dose-dependent
fashion, whereas exposure to a dose of UVB that causes visual erythema (1 MED) does not affect
catalase activity in the stratum corneum. Deactivation of catalase with UVA can be reproduced on
an enzyme solution in vitro, suggesting that the loss of activity may partly result from direct
absorption by the heme group. SOD on the other hand remains fully active in conditions where
catalase is completely inactivated. Exposure of the human skin to 0.5 p.p.m. of the environmental
pollutant ozone induces a loss of catalase activity, indicating that oxidative damage by itself can
reduce catalase activity. We conclude that chronic sun exposure may induce a seasonal variation in
the equilibrium between different antioxidant enzymes in the stratum corneum, by a combination
of direct photodeactivation and oxidative damage to catalase. This could lead to a gradual
accumulation of damage, especially when the skin is additionally exposed to other oxidizing
substances like smoke or pollution. It is therefore important to provide long-term protection for
this internal defense mechanism.
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Keratinocytes Repair UVB- and UVA-Induced DNA Damage More Ef®ciently Than
Fibroblasts or Melanocytes
T. RuÈnger, G. Li, and B. Gilchrest
Dermatology, Boston University, Boston, Massachusetts
All somatic cells are equipped with DNA repair pathways, which allow them to cope with DNA
damage due to endogenous or exogenous agents. In skin, UV-induced DNA damage is of
particular importance. In order to compare the ef®ciency of DNA repair processes in skin-derived
cells, we measured the ef®ciency of nucleotide excision repair (which processes DNA
photoproducts) and base excision repair (which processes UVA-typical oxidative base
modi®cations) in primary cultures of neonatal skin ®broblasts (n = 13), keratinocytes (n = 4), and
melanocytes (n = 5), using a host cell reactivation assay. In this assay, the plasmid pCMVluc is
damaged in-vitro, either with UVB/UVC to produce pyrimidine dimers, or with singlet oxygen
to produce oxidative guanine base modi®cation, and is then transfected into the host cells for
damage processing. Expression of plasmid-encoded luciferase after 48 h depends on the host cells'
DNA repair capacity. With various amounts of DNA damage in the plasmid, keratinocytes
exhibited a higher ef®ciency (p < 0.01) of DNA photoproduct repair than ®broblasts (2.3±4.5-fold)
or melanocytes (2.3±6.3-fold). Keratinocytes also repaired oxidative DNA damage more ef®ciently
(p < 0.01) than ®broblasts (2.4±5.1-fold) or melanocytes (2.0±3.7-fold). Donor variability was not
responsible, because similar differences (p < 0.01) were observed upon comparing repair ef®ciency
among the three cell types from a single donor. This difference in repair ef®ciency did not translate
into a reduced acute UVB- or UVA-sensitivity of keratinocytes, as shown by cell proliferation and
cell cycle FACS analysis. Our data indicate that keratinocytes, which are located at the ``forefront''
of the ultraviolet mutagenic attack, are equipped with the most ef®cient repair of UV-induced
DNA damage. The data demonstrate a marked difference in DNA repair capacity among cell types
and suggest cells most vulnerable to environmental mutagens may have evolved with enhanced
repair capacity.
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Ultraviolet Radiation-Induced Suppression of Hapten-Speci®c Chronic Contact
Hypersensitivity is Not Restricted to the tnf Gene Locus
T. Tezuka, A. Maeda, Y. Aragane, and A. Kawada
Dermatology, Kinki University School of Medicine, Osakasayama-shi, Japan
Ultraviolet (UV) radiation is known to induce local immunosuppression in conventional, acute
contact hypersensitivity (CHS) in some, but not all strains of mice. It was previously reported that
haplotypes of the tumor necrosis factor (tnf) gene locus may determine the fate of UV-
responsiveness. Indeed, mice possessing tnf(d) are uniformly UV-resistant, whereas those possessing
tnf(k, b, s, q, j, p) are UV-susceptible. Recently, it was reported that repeated application of hapten
induces site-directed shift to the immediate onset of antigen-speci®c CHS, also called chronic
CHS. Therefore, we were interested whether UV has any modulatory impact on chronic CHS
and, if so, whether UV-susceptibility in chronic CHS is similarly restricted to the tnf gene locus.
Mouse strains previously reported to be UV-susceptible (C3H/HeN, C57BL/6, C57BL/10) or
UV-resistant (C3H/HeJ, Balb/c, DBA/2) were ®rst UV-exposed over 4 days (d), sensitized with
dinitro¯uorobenzene (DNFB) through shaved abdomen. 5 d later, the right earlobes were
challenged with DNFB, followed by repeated DNFB application at every third days, totally 12
times. As control experiments, the CHS response was monitored after the 1st challenge,
con®rming the previous observation that UV-induced suppression of acute CHS was only
observed in mice previously known to be UV-susceptible. As a consequence of the repeated
challenge, the immediate ear swelling response was observed in all non-UV-exposed mice at the
repeatedly challenged right earlobes. However, suppression of the response by UV was various.
Signi®cant suppression of chronic CHS was observed in C3H/HeJ and DBA/2, while no
detectable suppression was appreciated in C3H/HeN, C57/BL6 and C57BL/10. In addition, the
suppression was only marginal in Balb/c. Together, the present study demonstrates that UV may
suppress hapten-speci®c chronic CHS, which is not necessarily restricted to haplotypes of the tnf
gene locus.
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Ultraviolet Radiation Suppresses Hapten-Speci®c Chronic Contact Hypersensitivity
A. Maeda, Y. Aragane, A. Kawada, and T. Tezuka
Dermatology, Kinki University School of Medicine, Osakasayama-shi, Japan
Repeated application of hapten induces site-directed shift to the immediate onset of antigen-
speci®c contact hypersensitivity (CHS), also called chronic CHS. Ultraviolet (UV) light is known
to exhibit the capacity to impair the induction of conventional, acute CHS, however, it still
remains unclear whether UV has any modulatory impact on chronic CHS. To clarify this issue,
C3H/HeJ mice, previously referred to as UV-resistant strain, that were ®rst UV-exposed or left
untreated, were sensitized with dinitro¯uorobenzene (DNFB). 5 days later, mice were challenged
with the right earlobes, followed by repeated DNFB application at every third day, totally 12 times.
Subsequently, the immediate ear swelling response was observed in non-UV-exposed mice upon
challenge, which was signi®cantly prevented with prior UV exposure, indicating that UV
suppresses chronic CHS. Interestingly, similar suppression of chronic CHS upon UV was not
observed in C3H/HeN that were previously referred to as UV-susceptible. Application of an
irrelevant hapten, oxazolon, successfully sensitized animals unresponsive to DNFB-speci®c chronic
CHS, indicating the hapten speci®city. There is recent evidence that induction of chronic CHS
may be mediated by preferential expression of Th2-type cytokines in repeatedly challenged-ears.
To examine if UV alters cytokine pro®les in local milieu, semiquantitative RT-PCR analysis was
performed, demonstrating that similar expression patterns of cytokine mRNA tested. Furthermore,
adoptive transfer of immune lymphoid cells from UV-exposed, repeatedly challenged animals
revealed successful transfer of the immunosuppressive phenotype, strongly suggesting that UV-
mediated suppression of chronic CHS is, at least in part, mediated by induction of suppressor cells.
Together, our present study demonstrates for the ®rst time that UV suppresses hapten-speci®c
chronic CHS. This represent a novel immunosuppressive properties, by which UV impairs
immune responses.
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Investigation of p53 Mutation Through the Analysis of Exons 2±11 in Squamous Cell
Carcinoma from PUVA-treated Skin
D. Suh, A. Peritz,* D. Brown, J. Uitto, and F. Gasparro
Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania; *Biochemistry, Thomas Jefferson
University, Philadelphia, Pennsylvania
Although PUVA-treated patients are at an increased risk for developing skin cancer, the etiology of
and molecular basis for the increased incidence of squamous cell carcinoma (SCC) in PUVA-
treated patients are unknown. One of the plausible explanations involves mutations in p53 due to
its role in DNA repair and apoptosis. P53 tumor suppressor gene is a major target for carcinogen-
speci®c mutations as revealed in many cancers, and as such, it may be possible to use this gene as a
molecular marker to identify the etiology of skin cancers in PUVA-treated patients. The p53 gene
consists of 11 exons, among which exons 2±11 code for the protein of 393 amino acids. Early
studies noted that most p53 mutations occurred in the regions of the gene which are highly
conserved through evolution and presumably of functional importance, primarily in exons 5±8.
Thus, most investigators have con®ned their analyses to these exons. Because of this bias in
searching, most of the mutations have been reported in exons 5±8 and their intervening introns.
However, from nonskin cancer studies, there is accumulating evidence of mutations in other
exons. In this study, we sequenced exons 2±11 from the human skin SCC tissues. After p53
immunohistochemical staining of 9 mm paraf®n-embedded sections, tumor cells were micro-
dissected from hematoxylin-eosin-stained sections without contamination of normal cells. We
performed DNA extraction, followed by nested PCR. After the purication of PCR products or the
gel extraction of electrophoresed agarose gel, DNA sequencing processes were done. In addition to
the new mutation of 723C?T in codon 241 of exon 7, 279G?A mutation was found in codon 92 of
exon 4. Both of these were characteristic of solar damage to DNA. This result emphasizes the
importance of the analysis of all exons to avoid the potential underestimating of p53 mutation.
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Avocado Phytosterols Decrease UVB Induced Proin¯ammatory Mediators
L. Joseph and K. Koukouras
NATC, Croda Inc, Edison, New Jersey
Exposure of skin to UVB radiation can cause the production of proin¯ammatory cytokines and
prostanoids. Changes in the production of these mediators in the skin can decrease or increase the
potentially damaging effects of UVB irradiation. In this series of experiments we investigated the
effects of avocado-derived sterols on the production of pro-in¯ammatory mediators IL-1a, PGE2,
and IL-8 caused by UVB exposure. A thin ®lm of the avocado lotion, or lotion base was applied to
EpiDerm 24H prior to UVB exposure, and remained on the tissue for a maximum of 72H. At 12,
24, and 48H postexposure, cells were sacri®ced to determine viability, cytokine and prostaglandin
production. Prior to UVB exposure treated and nontreated EpiDerm produced over 40 pg per ml
IL-1a. At 12H post UVB exposure there was a complete suppression of IL-1a. By 48H post UVB
exposure, there was a signi®cant difference in the IL-1alevels in EpiDerm pretreated with the
avocado lotion vs. those treated with either the lotion base or UVB alone (5 vs. 13 or 15 pg per ml,
respectively). The production of PGE2was suppressed for both lotions at 12H. At 48H, there was
no signi®cant difference in the production of PGE2 (~250 pg per ml). IL-8 production was not
completely suppressed 12H after UVB exposure. Twenty-four and 48H after exposure, the
avocado lotion had a profound effect on IL-8 production compared to the lotion base or UVB
alone (468 vs. 1242 or 1464 pg per ml, respectively). Interestingly, 48H after UVB exposure, IL-8
production by untreated control tissue and tissue treated with avocado lotion plus UVB was not
signi®cantly different. These data suggest that the addition of avocado-derived sterols to lotions
may have long-term effects on chemokines produced by UVB induced in¯ammation. It is
probable that avocado-derived sterols could be used to combat the severity of chronic
in¯ammatory conditions such as atopic dermatitis and psoriasis by down regulating chemokine
production, speci®cally IL-8, by damaged keratinocytes.
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A Keratinocyte-Speci®c Pathway Activates NFkB in Response to UV Light
M. Adachi, S. Shifteh, I. Freedberg, and M. Blumenberg
Dermatology, NYU School of Medicine, New York, New York
Epidermal keratinocytes are natural target cells for UV irradiation and upon exposure activate
NFkB, a Rel-family transcription factor. NFkB activation serves to initiate cutaneous
in¯ammation as well as to minimize the cell damage in irradiated keratinocytes. NFkB is activated
by phosphorylation of its inhibitor, IkB. While the activation of NFkB by TNFa and other
cytokines proceeds via IKK kinase complex, we have previously reported that the activation of
NFkB by UV light in keratinocytes does not involve IKKs. Evidence from several studies in HeLa
cells suggests that UV can activate NFkB via a Ras-Raf dependent pathway, involving MEK
kinase. In present study we have used a battery of inhibitors of this pathway as well as antisense
oligonucleotide approaches to compare the UV-responsive NFkB activating mechanisms in HeLa
cells and in keratinocytes. Using PD098059 and U0126, we found that in HeLa cells UV light
indeed activates NFkB via MEK, an important kinase on Ras-Raf dependent pathway. However,
in keratinocytes this pathway does not activate NFkB. We con®rmed these results using
oligonucleotides targeted against MEK. Therefore, in keratinocytes neither of the known pathways
responds to UV light to activate NFkB. Thus we conclude that UV light uses a novel pathway,
independent of Ras-Raf and MEK as well as of IKK, to activate NFkB in human epidermal
keratinocytes.
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Topical Retinoic Acid Increases the Proteoglycan Decorin and Elastic Proteins Fibrillin
and Tropoelastin in Photodamaged Human Skin
M. Green, M. Donovan, P. Kealaher, N. Carter, and K. Ottey
Biosciences, Unilever Research Colworth, Sharnbrook, United Kingdom
Retinoic acid (RA) is the current benchmark therapy for the topical noninvasive treatment of
cutaneous photodamage. Topical application RA has been shown to increase the levels of
procollagen I and ®brillin in the dermis of photodamaged skin. (Grif®ths et al, N Engl J Med
329:530, 1993: Watson J et al, Invest Derm 112:782, 1999). We conducted 3, 14 and 28 week
clinical trials in healthy volunteers in order to determine what other extracellular proteins were
induced by topical retinoic acid. 0.05% retinoic acid was applied daily, for 14 and 28 weeks, to the
photodamaged volar forearm of otherwise healthy volunteers. Immunohistochemical analysis of
skin biopsies showed that compared to the placebo, 0.05% retinoic acid consistently increased the
extracellular proteins decorin, ®brillin and tropoelastin; at 14 weeks the levels of decorin increased
in the dermis in 12/15 of the subjects and at 28 weeks in 15/15 subjects. Fibrillin expression
increased in 10/16 subjects at 14 weeks and in 12/15 at 28 weeks. Tropoelastin expression
increased in 12/16 after 14 weeks of RA treatment and in 13/15 in the 28-week study. The
increase in all three proteins occurred principally in the papillary dermis in a region next to the
epidermal -dermal junction often referred to as the Grentz- or repair -zone. The stimulation of
procollagen I by RA was not as consistent, this protein increased in 9/16 and 10/15 subjects at 14
and 28 weeks, respectively. In a 3-week RA clinical trial following a repeat patch protocol there
was no overall increased in the expression of either decorin, ®brillin or procollagen I. This suggests
that these ECM proteins are late markers of photodamage repair in skin. To our knowledge this is
the ®rst report of enhanced decorin staining in the dermis of retinoic acid treated photodamaged
skin.
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Chronic and Acute Photodamage are Associated with Accumulation of Protein
Oxidation in Human Skin
C. H. Sander, C. Chang, S. Mueller, M. Ekanayake, P. J. Elsner, and Thiele
Department of Dermatology, Friedrich Schiller University, Jena, Germany
Chronic UV-exposure induces solar elastosis as one of the major characteristics of photoaging,
whereas erythema, hyperproliferation and desquamation are observed upon acute UV-irradiation.
While there is increasing evidence for the generation of reactive oxygen species (ROS) in skin
upon UV exposures, little is known about their pathophysiological relevance in human skin in vivo.
We hypothesized, that chronic and acute photodamage is mediated, at least in part, by oxidative
protein modi®cations. Biopsies were taken from patients with histologically con®rmed solar
elastosis (n = 10), and from non-UV-exposed sites of age-matched controls (n = 6) and young
healthy subjects (< 0.05). The epidermis and stratum corneum of all subjects revealed no or weak
staining intensity. Interestingly, in acute UV-exposed skin there was a signi®cantly higher level of
oxidative modi®cation in the epidermis, especially within the stratum corneum. Additionally,
morphological changes were observed including hyperkeratosis and parakeratosis. In conclusion,
the correlation between solar elastosis and protein oxidation was demonstrated for the ®rst time,
which hence may be a relevant pathophysiological factor in photoaging. Furthermore, we present
conclusive evidence for an involvement of oxidative stress in barrier perturbation following acute
UV-exposure.
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UVB Down-Regulates Desmoplakin in Human Keratinocytes In Vitro and In Vivo
J. C. Thiele, H. Mueller, C. Chang, S. Sander, M. Ekanayake, and P. Elsner
Department of Dermatology, Friedrich Schiller University, Jena, Germany
Desmosomes are specialized domains of the plasma membrane that play fundamental role in cell
adhesion, as receptor molecules and are involved in cell movement during embryogenesis and
cancer metastasis. The desmosomal plaque protein desmoplakin (Dsp) is regulated by a variety of
signalling pathways, including protein kinase C. Since protein kinase C can be activated by UVB
and UVA, we hypothesized that the expression of Dsp in human keratinocytes is in¯uenced by
acute UVB and UVA irradiation. To assess this, HaCaT cells were UVB exposed either to single
doses of 5, 15, 30 mJ per cm2 or, on 4 consecutive days, to 5 and 15 mJ per cm2 UVB, respectively.
After 2, 4, 8, and 16 h, cells were immunostained using single and double labeling
immuno¯uorescence and analysed by densitometric image analysis. After both single and repeated
exposures to UVB, a time and dose dependent down-regulation of Dsp was observed, exhibiting
peaks after 4 and 8 h, at doses starting at 15 mJ per cm2 for single exposures and 5 mJ per cm2 for
repeated exposures. In contrast, vinculin expression, used as internal control, remained unchanged.
Next, to verify whether UV-induced down-regulation of Dsp occurs also in human skin in vivo,
frozen sections from repeatedly solar simulated UV irradiated buttock skin (suberythemogenic
doses on 10 consecutive days) and non irradiated contralateral control sites from healthy young
volunteers (n = 8) were immunostained for Dsp. In control skin, Dsp was localized regularly in the
lower stratum granulosum and upper stratum spinosum. In contrast, in irradiated skin sites we
found a signi®cantly weaker expression of Dsp in the overall epidermis. In summary, down-
regulation of Dsp in human keratinocytes is demonstrated in vitro and in vivo. Further studies are
presently undertaken evaluating whether, besides UVB, UVA alone is able to down-regulate Dsp
in keratinocytes and if the responsible signalling pathways involve protein kinase C.
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UVB and H2O2 Induce Expression of PAR, a Marker of DNA Repair, in Human
Keratinocytes by Different Pathways
J. Thiele, H. Chang, C. Sander, C. Mueller, and P. Elsner
Department of Dermatology, Friedrich Schiller University, Jena, Germany
Apoptosis is an active form of cell death and is initiated by a variety of stimuli, including reactive
oxygen species (ROS) such as hydrogen peroxide, hydroxyl radicals, and superoxide anion radicals.
Previously, it has been shown that UVB irradiation of keratinocytes leads to intracellular
production of hydrogen peroxide and that antioxidants can inhibit ROS induced apoptosis.
Poly(ADP-ribose) (PAR), a marker of apoptosis, is formed upon activation of the DNA repair
enzyme poly(ADP-ribose) polymerase (PARP). We hypothesized, that PAR is formed upon UVB
exposure of human keratinocytes in a redox-regulated manner. To asses this, human immortalized
keratinocytes (HaCaT) were UVB irradiated and thereafter PAR formation was measured by
indirect immuno¯uorescence using a monoclonal antibody against PAR. Cells were harvested at 4
h, 8 h, 16 h and 24 h after single exposures to UVB doses of 0, 10, 20 and 30 mJ per cm2. UVB
irradiation induced PAR expression in a dose- and time-dependent manner and clearly preceded
formation of DNA laddering. Similarly, it was demonstrated that hydrogen peroxide induced PAR
formation in a dose-dependent fashion. However, while hydrogen peroxide induced PAR
formation was dose-dependently inhibited by pretreatment with catalase, UVB induced PAR
formation was not signi®cantly reduced by pre or postexposure incubations with catalase. Similarly,
pre or postexposure treatments with other antioxidants, including vitamin E, superoxide dismutase,
and N-acetyl-cysteine did not alter UVB induced formation of PAR. In conclusion, our results
demonstrate that both UVB and hydrogen peroxide are capable of inducing PAR formation at
very low doses. However, while PAR formation was demonstrated to be redox sensitive in the
hydrogen peroxide system, redox regulation does not appear to be responsible for UVB induced
generation of PAR.
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UV-Induced Depletion of Mouse Epidermal Vitamin A is Not Mediated by Oxidative
Stress
O. Sorg, C. Tran, L. Didierjean, P. Carraux, and J. Saurat
Dermatology, University Hospital of Geneva, Geneva, Switzerland
We previously showed that, in hairless mice, epidermal vitamin A (free (retinol) and esteri®ed
(retinyl esters)) from hairless mice was strongly decreased following an acute UVB exposure
(Dermatology 199:302±307, 1999), and that a pretreatment with topical natural retinoids (retinol,
retinal and retinoic acid) prevented a UVB-induced epidermal hypovitaminosis A (Photochem
Photobiol, in press). Here, using the same mouse model, we studied the effects of UVA on
epidermal vitamin A content and lipid peroxidation, as well as the the putative prevention of both
by topical antioxidants. An acute exposure to UVA (Philips Cleo Performance lamps) completely
depleted epidermal vitamin A with EC50s of 0.25 and 0.5 J per cm
2 for retinyl esters and retinol,
respectively; these values were 0.1 J per cm2 for both retinoids with UVB. A single UVA exposure
induced a dose-dependent epidermal lipid peroxidation (EC50 = 3.5 J per cm
2) giving rise to
55.4 6 4.2 nmol LPO per g at 20 J per cm2, while UVB, up to 2 J per cm2, did not increase the
basal concentration of 6.7 6 0.9 nmol LPO per g. A pretreatment with antioxidants (a-tocopherol,
ascorbic acid) did not inhibit UV-induced vitamin A depletion, but inhibited by 96% the increased
lipid peroxidation. Thus acute UVA induced both epidermal vitamin A depletion and lipid
peroxidation, UVB induced only vitamin A depletion, and topical antioxidants prevented only
UV(A)-induced lipid peroxidation. This indicates that the depletion of epidermal vitamin A by UV
does not depend on UV-induced oxidative stress, as assessed by lipid peroxidation, but is more
likely due to a direct interaction between retinoids and UV light.
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Inhibition of PUVA-Induced Photodamage by the Iso¯avone Genistein
E. Shyong, Y. Lu, R. Phelps, M. Lebwohl, and H. Wei
Dermatology, Mount Sinai School of Medicine, New York, New York
Psoralen plus UVA (PUVA) therapy has been widely used in the treatment of many dermatological
disorders. Accumulating evidence shows that long-term PUVA therapy is associated with an
increased risk of squamous cell carcinoma and malignant melanoma. Genistein (5,7,4-
trihydroxyiso¯avone), a major iso¯avone in soybeans and a speci®c inhibitor of protein tyrosine
kinase, has been shown to inhibit ultraviolet B radiation induced skin carcinogenesis in hairless
mice. In this study, the effects of topical genistein on PUVA-induced photodamage on mouse skin
were examined. In two separate experiments, genistein (5, 10, and 20 micromoles) in a dimethyl
sulfoxide/acetone (1:9) solution was applied to SKH-1 female mice one hour post psoralen dosing
(10 mg per kg) and one hour prior to ultraviolet A (UVA) irradiation (25 kJ per m2). Application of
genistein signi®cantly decreased PUVA-induced skin thickening and edema, and greatly
diminished cutaneous erythema and ulceration in a dose-dependent manner. Histological
examination shows that PUVA treatment of mouse skin induced dramatic in¯ammatory changes
as evidenced by epidermal acanthosis, dermal neutrophilic/lymphocytic in®ltration, and prominent
hydropic degeneration with extensive dyskeratotic and atypical keratinocytes throughout the
epidermis. Topical genistein, however, substantially prevented all PUVA-induced histological
changes without noticeable adverse effects. Our study suggests that genistein may work as a
potential preventive agent against PUVA-induced photodamage and carcinogenesis.
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Epidermal Accumulation of Retinyl Esters Inhibits UVB-Induced Biological Effects in
Mouse Skin
C. Tran, O. Sorg, L. Didierjean, and J. Saurat
Dermatology, University Hospital of Geneva, Geneva, Switzerland
Vitamin A (vA) is normally present in the epidermis as retinol (ROL) and retinyl esters (RE).
Besides its many biological effects, vA is photosensitive since both ROL and RE have an
absorption spectrum with a maximum at 325 nm. Accordingly, we and others have previously
shown that UVB exposure depletes both epidermal ROL and RE. The biological implications of
this is not known. In the present work we have explored the possibility that RE may provide a
protective effect towards UVB. Hairless mice were ®rst topically treated with retinaldehyde in
order to increase epidermal RE content, and then exposed to 1 J per cm2 UVB. Topical treatment
promoted an increase of basal epidermal RE from 1.2 6 0.2 to 21.4 6 0.6 nmol per g (n = 4). In
untreated mice, UVB induced, 24 h after irradiation, an increase of epidermal TUNEL positive
cells from 0 to 76 6 30 per mm (n = 8), as well as a 3.7-fold increase of cJun mRNA expression
(n = 8). In mice loaded with high RE levels and then exposed to UVB, epidermal RE levels
returned to 2.4 6 0.4 nmol per g, while UVB-induced apoptotic cells were decreased by 70% and
increase of cJun mRNA expression was abolished. In order to explore the photoprotective effect of
RE, liposomes prepared from RE-enriched phospholipids were loaded with the hydrophilic
¯uorescent marker indo-1. Such liposomes whose membranes contained 15 mM RE inhibited
99% of the ¯uorescence emitted by indo-1 and decreased by 59% the UVB-induced bleaching of
indo-1. Altogether, these observations show that RE were photoprotective in an in vitro model,
and when loading the epidermis with high levels of RE, biological effects induced by UVB such as
apoptosis and induction of cJun mRNA were signi®cantly inhibited. This indicates that RE,
besides their function as vA precursors, have a direct biological action as photoprotectors.
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Liposomes as Cellular Membrane Model for the Prediction of both UV-®lter Capacity
and Photoprotective Effect of Lipophilic Molecules
C. Tran, O. Sorg, L. Didierjean, and J. Saurat
Dermatology, University Hospital of Geneva, Geneva, Switzerland
We developed an in vitro model to assess the UV ®lter capacity of lipophilic molecules. Liposomes
are used as a model of cellular membranes; the molecules of interest are included into liposome
membranes, while the inner aqueous compartment encloses the ¯uorescent marker indo-1. This
model can give 2 types of informations: the UV ®lter capacity of liposome membranes at 330 nm
(excitation of indo-1) can be read out by measuring at 405 nm the ¯uorescence of indo-1 of a
liposome suspension excited (with a low intensity) at 330 nm. The intensity of this ¯uorescence is
decreased by the presence in membranes of a molecule absorbing at the excitation wavelength. The
second information is the photo-protective index of enriched liposome membranes assessed by
measuring the bleaching of indo-1 following exposure to physiological UVB doses (0±50 mJ per
cm2). Indo-1 is extracted from liposomes, and assayed by ¯uorometry. In such a model, the indo-1
¯uorescence of normal liposomes decreased by 99% and 92% in liposomes whose membranes were
loaded with 15 mM retinyl esters (RE) and 15 mM Parsol MCX (a well known UVB ®lter used in
sunscreens), respectively. An exposure of liposomes to 50 mJ per cm2 UVB destroyed 67%, 27%
and 18% of indo-1 in normal liposomes and those enriched with 15 mM RE and 15 mM Parsol,
respectively. Another ¯uorescent marker, 2¢,7¢,-dichloro¯uorescin (DCFH), was used as another
way to assess the photoprotective index of UVB-absorbing molecules. In this case, DCFH, inside
the liposomes, is oxidised by UVB, and the oxidation product, 2¢,7¢,-dichloro¯uorescein (DCF), is
¯uorescent; thus DCF ¯uorescence is maximal in liposomes devoid to UVB absorbing molecules.
In liposomes enriched with 15 mM RE and 15 mM Parsol, DCF production induced by 50 mJ per
cm2 UVB decreased by 78% and 71%, respectively, as compared to normal liposomes. In
conclusion, this model allows to assess the UV ®lter capacity, as well as the photoprotective index,
of lipophilic molecules in a situation simulating that of a biological environment.
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Analysis of Cellular Retinoic Acid Binding Protein II after 1, 3, 14 and 28Weeks Topical
Application of Retinoic Acid to Human Skin
M. Donovan, N. Carter, M. Green, and R. Weinkauf*
Biosciences, Unilever Research Colworth, Sharnbrook, United Kingdom; *Skin Biosciences, Unilever
Research, Edgewater, New Jersey
The topical application of retinoic acid (RA) is the current benchmark therapy for the noninvasive
treatment of cutaneous photodamage. RA selectively induces proteins in skin which are involved
retinoid transport and metabolism. One of these proteins is the cellular retinoic acid binding
protein type II (CRABP II) whose mRNA levels are increased in skin treated topically with RA
and other retinoids. Thus CRABP II has been used as a marker for retinoid bioactivity in cells.
Using a monoclonal antibody, speci®c for CRABP II, we examined the expression of this protein
in the photodamaged skin of healthy human volunteers treated with 0.05% retinoic acid for 14 or
28 weeks. CRABP II expression increased in the epidermis in 12/16 of the volunteers' forearms
treated with RA after 14 weeks compared to those treated with placebo. Quantitative image
analysis showed that this increase was as much as 4 fold. The expression of CRABP II in RA
treated skin formed a gradient across the epidermis with highest expression seen in the granulosum
and with no detectable expression in the keratinocyte basal layers. Furthermore the location of
CRABP II appeared to be polarised on the dermal side of the cytoplasm in those cells expressing
the protein. In a 28-week study 14/15 of the volunteers showed a striking increase of CRABP II in
the epidermis of skin treated with RA compared with the placebo. The gradient of CRABP II in
the epidermis was less evident at 28 weeks and the distribution of the protein in the cytoplasm of
cells was more uniform. There was also evidence of expression of CRABP II in dermal cells.
CRABP II was also used as a marker of retinoid activity in short-term human clinical trials.
Retinoic acid at 0.01, 0.035 and 0.05%, topically applied to photodamaged forearm under a patch
for three weeks, signi®cantly increased the protein levels of CRABP II in the epidermis (p < 0.01,
n = 12) compared to the vehicle. This increase in expression of CRABP II did not correlate with
the erythema score during the study. Retinoic acid (0.05%) and retinol (0.2%) also signi®cantly
induced CRABP II in a one week patch test on photodamaged skin (p < 0.05 n = 16). To our
knowledge this is ®rst reported assessment of the CRABP II protein, as a useful marker of retinoid
activity, in long and short-term human clincial trials on photodamaged skin.
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Ef®cacy of 308 nm Excimer Laser for Treatment of Psoriasis: Results of a Multicenter
Study
T. Salam, S. Feldman, B. Mellen,* R. Fitzpatrick,² R. Geronemus,³ D. Vasily, and W. Morison
Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; *Public Health
Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina; ²Dermatology
Associates, Encinitas, California; ³Laser and Skin Surgery Center of New York, New York, New York;
§Lehigh Valley Dermatology, Bethlehem, Pennsylvania; ¶John Hopkins at Green Spring, Lutherville,
Maryland
Objective: To demonstrate the ef®cacy of the 308 nm excimer laser for treatment of psoriasis.
Design: Multicenter open trial. Setting: Four dermatology practices (one university-based and 3
private practices) Patients: 30 patients per center with stable mild to moderate plaque-type psoriasis
vulgaris. Interventions: Patients received 308 nm UV-B doses to affected areas. The initial dose was
based on multiples of a predetermined minimal erythema dose (MED). Subsequent doses were
based on the response to treatment. Treatments were scheduled twice weekly for a total of 10
treatments. Main Outcome Measure: 75% clearing of target plaque. Time-to-clearing was analyzed
using Kaplan-Meier methods, accounting for truncated observations. Results: 124 patients were
enrolled in the study and 80 completed the entire protocol. The most common reason for exiting
from the study was non-compliance. Of the patients that met the protocol requirements of 10
treatments or clearing, 72% (66/92) achieved at least 75% clearing in an average of 6.2 treatments.
84% of patients (95% con®dence interval, CI=79 to 87%) reached =75% improvement after =10
treatments. 50% of patients (95% CI=35 to 61%) reached =90% improvement after =10
treatments. Common side effects were well tolerated and included erythema, blisters,
hyperpigmentation and erosions. Conclusions: Monochromatic ultraviolet-B (308 nm) photo-
therapy with the excimer laser is an effective and safe treatment for psoriasis. It requires fewer
patient visits than conventional phototherapy, and unlike other phototherapy treatments, the laser
targets only the affected areas of the skin, sparing the surrounding uninvolved skin.
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Evaluation of UVA-Induced Oxidative Stress and Genotoxicity in Human Melanocytes
Z. Abdel-Malek, E. Pereira, H. Shertzer,* M. Scott, R. Kavanagh, A. Kakedaro, H. Kanto, J.
Cornelius, and G. Babcock
Dermatology, University of Cincinnati, Cincinnati, Ohio; *Environmental Health, University of Cincinnati,
Cincinnati, Ohio; ²Surgery, University of Cincinnati & Shriner's Burns Institute, Cincinnati, Ohio
The carcinogenic events that lead to melanoma seem to be distinct from those that result in basal or
squamous cell carcinoma. UVB signature mutations are commonly found in basal and squamous
cell carcinoma but are rare in melanoma tumors. This and the ®ndings that UVA radiation (320±
400 nm) induces melanoma tumors in two animal models suggest that UVA, rather than UVB
(290±320 nm), radiation is mainly involved in the malignant transformation of melanocytes. The
popularity of tanning booths and the increased frequency of melanoma despite the use of
sunscreens that protect from UVB suggest the possible carcinogenic effects of UVA radiation. We
have been investigating the responses of human melanocytes to a single irradiation with doses of
UVA ranging between 22 and 100 J per m2, with peak emission of the UVA source at 350 and
365 nm. Doses = 29 J per m2 consistently produced a signi®cant reduction in proliferation, due to
arrest of melanocytes in G1-S. Human Melanocytes were less sensitive than keratinocytes or
®broblasts to the cytotoxic effects of UVA. Melanocyte death was only observed after exposure to
doses of UVA = 85 J per m2, while extensive cell death was observed in keratinocyte and ®broblast
cultures beginning at a dose of 44 J per m2. This may be partially due to the high constitutive levels
of Bcl2 and/or the presence of melanin in melanocytes. Stimulation of tyrosinase activity and
increased levels of tyrosinase and tyrosinase-related protein 1 in melanocytes were also induced by
doses of UVA = 29 J per m2, indicating stimulation of melanogenesis. This dose of UVA induced
profound phosphorylation of the MAP kinase p38, and irradiation with 38 J per m2 UVA resulted
in a 13-fold increase in hydrogen peroxide generation. These results clearly show that human
melanocytes undergo oxidative stress upon irradiation with relatively mild doses of UVA. The
resistance of melanocytes to killing by UVA might result in increased mutation frequency and in
tumorigenesis.
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Single-Stranded DNA Homologous to the 3¢ Overhang Telomere Sequence Protects
Skin Cells from Oxidative Damage
M. Lee, M. Yaar, M. Eller, T. Ruenger, and B. Gilchrest
Dermatology, Boston University, Boston, Massachusetts
Thymidine dinucleotide (pTT), which is partially homologous to the 3¢ overhang telomere
sequence that is exposed during DNA damage and/or repair, and an 11-base oligonucleotide
(11mer) with full telomere homology (pGTTAGGGTTAG), evoke a variety of cellular responses
like those seen after UV-induced DNA damage. These responses include accelerated removal of
photoproducts, cell cycle arrest and apoptosis. Because UV radiation, especially UVA, produces
oxidative stress in cells, we compared the ability of pTT to 11mer in protecting human ®broblasts
and squamous carcinoma cells (SCC12F) against oxidative damage. In both cell types, optimal
concentrations of pTT (100 mM) and 11mer (40 mM) induced the UV-responsive mitochondrial
superoxide dismutase (SOD2) mRNA levels as compared to cells treated with diluent alone. The
11mer induced SOD2 mRNA by ~100% as early as 8 h, and the induction was sustained through
24 h pTT induction followed a similar time course, but SOD2 was induced only ~30% over
control levels. Cells pretreated for 3 days with pTT were then exposed to UVA (10 J per cm2, 340±
400 nm, Sellas Sunlight) and cell yield was determined up to 72 h after irradiation. pTT
pretreatment signi®cantly enhanced cell survival by ~30% (p < 0.002, paired t-test) at 48 and 72
hours after irradiation. Our data show that DNA oligomers homologous to the 3¢ telomere
overhang enhance cellular defence mechanisms against oxidative damage, at least in part by
upregulating antioxidant enzyme levels. The data suggest that exposure of the 3¢ telomere
overhang during oxidative damage and/or repair results in elevation of antioxidant enzymes,
leading to an adaptive response against further damage. Therefore, oligomers with telomere
homology could be used to decrease cellular oxidative damage that occurs during aging and
cumulative sun damage.
681
Activation of the Human Elastin Promoter by Ultraviolet Radiation can be Decreased
through the Application of Antioxidants
D. Brown, F. Gasparro, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Solar radiation produces reactive oxygen species, which may contribute to the activation of the
elastin promoter, ultimately leading to an increase in elastin deposition. To determine whether
antioxidants reduce the activation of the human elastin promoter (HEP) through screening or free
radical scavenging, UVA340 lamps, simulators of short terrestrial solar wavelengths (295±340 nm)
were used to treat rat aorta smooth muscle cells, containing the HEP/chloramphenicol acetyl
transferase (CAT) gene construct. Cell cultures were incubated with either an antioxidant cocktail
mixture (sodium ascorbate; Trolox, a modi®ed vitamin E derivative; and NAC, n-acetyl l-
cysteine) or a solution of EGCG (major component in green tea). The extent of screening was ®rst
determined by irradiating cell cultures with the antioxidant cocktail either suspended above cell
cultures in quartz dishes or in direct contact with the cells. The suspended antioxidant cocktail
reduced the relative CAT activity ~ 50%; a further 10% reduction was observed when the
antioxidant cocktail was in direct contact with the cell cultures. Incubation of cells with EGCG did
not reveal any signi®cant reduction in relative CAT activity. We further explored the effects of the
antioxidant cocktail through incubation prior to irradiation, throughout the irradiation period, and
after irradiation have been completed. Though pretreatment and direct contact of antioxidant
cocktails throughout the UV irradiation period demonstrated reduced relative CAT activity, 25±
40% reduction in CAT activity occurred when antioxidant cocktails were applied immediately
after UV irradiation. Contrary to commonly accepted views, our ®ndings suggest that antioxidants
perform more as screeners of UVR rather than scavengers of reactive oxygen species.
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Prevention of UVB Light-Induced Leukocytes In®ltration, Oxidative stress, and
Depletion of Class II MHC+ Iak+Cells by Green Tea Constituent (±)-
Epigallocatechin-3-gallate in C3H/HeN Mouse Skin
S. Katiyar and H. Mukhtar
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Exposure of solar ultraviolet (UV) radiation, particularly its UVB (290±320 nm) component, to
mammalian skin induces in®ltration of leukocytes, oxidative stress and depletion of antigen
presenting cells which collectively play an important role in the induction of immunosuppression
and photocarcinogenesis. Earlier, we and others have shown that topical treatment with (±)-
epigallocatechin-3-gallate (EGCG) the major polyphenol present in green tea prevents UV-
induced immunosuppression and photocarcinogenesis in mouse models. To de®ne the
chemopreventive mechanism of EGCG, immunohistochemical detection techniques and analytical
assays were performed. We found that topical treatment of EGCG (1 mg per cm2 skin area) to
C3H/HeN mice before a single UVB (90 mJ per cm2) exposure inhibits UVB-induced in®ltration
of leukocytes, speci®cally CD11b+ cell type which are considered to be the major source of
reactive oxygen species and tolerance-inducing cell types. Treatment with EGCG before UVB
exposure was also found to inhibit UVB-induced myeloperoxidase activity, a marker of tissue
in®ltration of leukocytes, and depletion in the number of antigen presenting cells in the epidermis
when detected as a class II MHC + Iak + cells. Class II MHC + Ia + cells plays an important role in
maintaining immune response in the skin, and suppressed immune responses has been shown to be
associated with UVB-induced skin cancer risk. Pre-treatment of EGCG was also found to decrease
the number of UVB-induced enhancement of H2O2 producing and inducible nitric oxide synthase
expressing cells, and H2O2 and NO production both in epidermis and dermis of UVB irradiated
skin site. Together, these data suggest that prevention of UVB-induced immunosuppression and
photocarcinogenesis by EGCG may be associated with the prevention of UVB-induced in®ltrating
leukocytes, antigen presenting cell depletion and oxidative stress. A detailed study of possible
bene®cial effects of green tea in human skin is warranted.
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Grading of p53 Protein Accumulation in Normal Sun-Exposed and Nonexposed Type
IV Human Skin
N. Galaria, H. Ahmad, J. Uitto, and F. Gasparro
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Sun-exposed human skin is known to have increased expression of the p53 protein when
compared to nonexposed sites and this skin often shows p53 mutations. Using immunohis-
tochemistry, we assessed the quantitative differences in p53 expression in clinically normal, sun
exposed (face) and nonexposed (abdomen) human Type IV skin from the same 40 individuals. The
subjects ranged in age from 6 to 83 years. The pattern of p53 expression was graded using a
previously established technique by two independent observers. Previous studies of Type I and II
skin have demonstrated that when evaluating p53 staining, a dispersed pattern signi®es wild-type
p53 and a compact pattern is a site of p53 mutation., i.e. clonal proliferation of cells. The majority
of our sun-exposed samples 95% (38/40) show a dispersed pattern of p53 staining and an almost
linear correlation between decade (1st to 9th) and p53 expression. In sun-exposed skin from the 1st
decade the average score obtained on histological evaluation was 0%, this increased to 51.7% in the
4th decade and 100% in the 9th decade. We attribute the lack of complete linearity primarily to
variations in the amount of sun-exposure between individuals of the same decade and also the
season when the biopsy was taken. Non sun-exposed skin demonstrated minimal to no staining
despite the age studied and comparison of exposed and protected sites from the same subjects
demonstrated statistically signi®cant (p < 0.05) p53 expression from the 3rd decade on in exposed
skin. In type I-II skin the dispersed pattern is considered to be a temporary response to sun damage
which usually subsides within 15 days. In Type IV skin the dispersed pattern seems to be
cumulative and may represent mutations in p53.
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Glycated Proteins as Photosensitizers of DNA Damage in Skin Photoaging
G. Wondrak, E. Jacobson, and M. Jacobson
Pharmacology and Toxicology, College of Pharmacy, Arizona Cancer Center, University of Arizona and
Niadyne, Inc., Tucson, Arizona
Chronic exposure to sunlight has been implicated in skin aging and carcinogenesis. The molecular
mechanisms of photoaging by UVA, the sunlight's major UV constituent, are poorly understood.
DNA molecules are susceptible to genotoxic damage caused by the light absorption of endogenous
or xenobiotic photosensitizers. Glycation is a process of accumulative protein damage by reducing
sugars and other reactive carbonyl species leading to the intra- and extracellular formation of
complex yellow-brown chromophores called advanced glycation endproducts (AGEs).
Accumulation of AGEs on dermal elastin and collagen occurs during normal skin aging in
humans. Recently, reduced viability of human dermal ®broblasts exposed to UVA irradiation in
the presence of protein modi®ed by AGEs has been attributed to the generation of reactive oxygen
species. Here we describe the photosensitization of DNA damage by AGE-protein and its
inhibition by thiols in vitro. Irradiation of covalently closed circular FX-174 DNA with increasing
doses of solar simulated light in the presence of AGE-BSA was used to detect photosensitized DNA
nicking as a measure of DNA photodamage. The damage was concentration dependent with
respect to AGE-BSA as the photosensitizer. Unmodi®ed BSA displayed no such photosensitizing
activity. Addition of several antioxidants modulated the photosensitization effect. Mannitol (a
hydroxyl radical quencher) and sodium azide (a singlet oxygen quencher) blocked the
photosensitized DNA cleavage, whereas catalase and SOD were not effective, indicating the
involvement of photoactivated oxygen and hydroxyl radicals. D-Penicillamine (an antioxidant
thiol) inhibited the photosensitization effect of AGE-BSA in a dose dependent relationship.
Photosensitized DNA damage in skin is thought to be an important mechanism of UVA
phototoxicity. Our results suggest that glycated skin proteins can function as photosensitizers of
DNA damage and may be important in the genotoxic consequences of skin photoaging.
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In Vivo Regulation of Fas and FasL Expression in Human Skin after UVA and UVB
Exposure
B. Bang, L. Skov, J. Rygaard,* and O. Baadsgaard
Dermatology, Gentofte Hospital, Hellerup, Denmark; *Pathology, Bartholin Institue, Copenhagen,
Denmark
The Fas receptor (CD95/APO-1) can induce apoptosis in human keratinocytes both when
stimulated with the ligand FasL and when stimulated directly with UV radiation. Human
keratinocytes are known to coexpress both Fas and FasL, and in vivo treatment with UVB radiation
increases expression of FasL in psoriatic skin. Since apoptosis of keratinocytes induced by UV
radiation is an important event in photocarcinogenesis, we wanted to investigate the expression of
Fas and FasL in human skin after in vivo UVA and UVB irradiation. Healthy volunteers were
irradiated with 3 MED UVA (n = 5) or 3 MED UVB (n = 6) on previously unexposed buttock
skin. Skin biopsies were taken from unirradiated skin and 12, 24 and 72 h after irradiation.
Expression of Fas and FasL was demonstrated by immunohistochemistry on cryostat sections. In all
subjects both UVA (n = 5) and UVB (n = 6) irradiation resulted in increased membrane expression
of Fas on epidermal cells with maximum expression 12±24 h after irradiation. Expression of FasL
on epidermal cells was also increased after UVA irradiation (n = 5) where the distribution was
heterogeneously with maximum FasL expression in the stratum spinosum. In contrast UVB
irradiation resulted in decreased expression of FasL 12 and 24 h after irradiation, but at 72 h the
expression had returned to basis as in unirradiated skin. The role of the dual expression of both
CD95 and its natural ligand CD95L on keratinocytes has not been established. Our results show
that the expression of both these molecules is in¯uenced by UV radiation. The possible role of this
phenomenon in relation to photocarcinogenesis remains to be elucidated.
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Photobiological and Molecular Mechanisms of UVA-1-Induced Apoptosis in Malignant
T-Cells
A. Morita, R. Yamauchi, T. Tsuji, H. Sies,² and J. Krutmann*
Dermatology, Nagoya City University Medical School, Nagoya, Japan; *Dermatology, University of
Duesseldorf, Duesseldorf, Germany; ²Institute of Physiolological Chemistry I, University of Duesseldorf,
Duesseldorf, Germany
We have previously reported that UVA-1 phototherapy induces apoptosis in skin-in®ltrating T-
cells and can thus be effectively used to treat patients with cutaneous T-cell lymphoma. In
addition, our in-vitro studies have revealed that malignant T-cells exhibit a higher susceptibility to
UVA-1 radiation-induced apoptosis than normal T-cells. In order to better understand this
exquisite sensitivity of malignant T-cells, in the present study the photobiological and molecular
mechanisms underlying UVA-1-induced apoptosis were further analyzed in malignant (Jurkat) vs.
normal T-cells. UVA-1 radiation-induced apoptosis in malignant T-cells did not involve
ceramide-signaling, because addition of exogenous ceramide to malignant cells induced apoptosis
at a rate identical to that observed in normal ones. Treatment of malignant T-cells with FAS
antibody or FASL-transfectant to down-regulate FAS surface expression, however, decreased the
susceptibility of Jurkat cells towards UVA1-induced apoptosis to normal levels, indicating the
involvement of the FAS system. FAS-induced apoptosis is mediated further downstream by
caspase-3. It was therefore of great interest that normal T-cells had signi®cantly lower procaspase-3
levels as compared with malignant T-cells, and that addition of a caspase-3 inhibitor completely
prevented UVA-1-induced apoptosis in malignant cells. Finally, an increased sensitivity towards
apoptosis was also observed in malignant cells in comparison with normals, when T-cells were left
unirradiated but treated with singlet oxygen, which was generated through thermal decomposition
of the endoperoxide of NDPO2. These ®ndings indicate that upon singlet oxygen-induced
activation the Fas signaling pathway determines the susceptibility of a given T cell towards UVA-1
induced apoptosis, possibly at the level of caspase-3 expression.
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Keratinocytes and Fibroblasts Show Differential Regulation of Human Hyaluronan
Synthase-2 Expression During Stimulation with Cytokines and Ultraviolet Irradiation
W. Zhang and V. Werth*
Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania; *Dermatology, Philadelphia V.A.
Hospital, Philadelphia, Pennsylvania
After irradiation, human skin increases its content of hyaluronic acid, a matrix component
produced by the hyaluronan synthase (HAS) enzymes. We reported that the major HAS of human
skin is HAS-2, and that UV and UV-induced cytokines increase HAS-2 message in human
®broblasts (FBs). Because keratinocytes (KCs) also synthesize HA, we now sought to compare
HAS-2 regulation in KCs and FBs. Human skin KCs were irradiated with UVA (5 J per cm2),
UVB (30 mJ per cm2), or sham, and HAS-2 mRNA normalized to 18 s was measured 24 h later.
IL-1a added to sham-irradiated KCs increased HAS-2 mRNA levels by 58%, from 0.03 6 0.01 to
0.05 6 0.01 (mean 6 SEM, n = 3), while FBs exhibited a three-fold increase in HAS-2 expression.
UVA increased HAS-2 message in KCs by 94% (0.07 6 0.02 without added IL-1a; 0.1 6 0.01
with IL-1a), similar to the increase seen with FBs. UVB stimulated HAS-2 message in KCs by
140% (0.08 6 0.01 without IL-1a; 0.09 6 0.01 with IL1a), while FBs exhibited a 4.7-fold increase
with UVB and 13.3-fold increase with UVB + IL-1a. We previously found that IL-1a in
combination with UVB, but not UVA, induces TNFa secretion from ®broblasts (Werth et al, J
Invest Dermatol 113:196±201, 1999), and that addition of anti-TNFa antibodies to FB cells exposed
to IL-1a plus UVB reduced the HAS-2 mRNA level to a value indistinguishable from the effect of
IL-1a alone. We next examined the effect of UV-induced cytokines on HAS-2 expression in KCs.
TNFa increased normalized HAS-2 by 51% over sham (from 0.45 to 0.68), and IL-1a increased
HAS-2 by 30% (from 0.49 to 0.58). This is in contrast to the 8.37-fold increase in HAS-2 in
TNFa-treated FBs and the 3-fold increase in HAS-2 with IL-1a. In summary, HAS-2 mRNA is
stimulated by UVB and UV-induced cytokines in FBs far more briskly than in KCs. These actions
likely contribute to the pattern of increased cutaneous hyaluronan after irradiation in vivo, that is,
more pronounced in the dermis than in the epidermis.
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In Situ Visualization of UV-Induced DNA Damage in Human Fibroblasts Following
Microbeam Irradiation
S. Katsumi, K. Imoto, N. Kobayashi, A. Nakagawa, Y. Yamashina, T. Muramatsu, T. Shirai, S.
Miyagawa, and T. Mori
Department of Dermatology, Nara Medical University, Kashihara, Japan; *Radioisotope Research Center,
Nara Medical University, Kashihara, Japan
In order to examine the interplay of DNA damage and repair proteins in vivo, microbeam UV-
irradiation (100 J per m2) of normal human and xeroderma pigmentosum complementation group
A (XP-A) ®broblasts was performed using an isopore polycarbonate membrane ®lter mask (pore
size 3.0 mm). We then visualized the induction of both cyclobutane pyrimidine dimers (CPD) and
(6±4) photoproducts (6±4PP) using laser scanning confocal microscopy with damage-speci®c
monoclonal antibodies. PCNA, an auxiliary protein for DNA polymerase involved in nucleotide
excision repair (NER), was also visualized using anti-PCNA antibodies. We found that CPD and
6±4PP were produced in subnuclear volumes of normal and XP-A cells as several 3 mm-foci per
nucleus. Normal cells repaired 6±4PP completely within 3 h, and removed half of CPD at 24 h
after irradiation. Detergent-insoluble PCNA was not detected without UV but was induced
30 min after irradiation at the subnuclear sites which superimposed on the sites of DNA damage.
Fluorescence of PCNA foci decreased with increasing repair times, and became very weak at 24 h.
In contrast, XP-A cells could hardly repair both CPD and 6±4PP within 24 h. As expected, almost
no PCNA foci appeared within 3 h. However, they were brightly detected at 9 and 24 h at the sites
which were overlapped with the damage sites. The present results suggest that DNA
photoproducts remain in relatively ®xed subnuclear sites during repair, and NER proteins are
recruited to their sites for repair. Furthermore, the results suggest that there are two types of PCNA
complex formation at the damage sites, stemming from normal NER and from defective NER.
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Inhibitory Effects of Niacin in Ultraviolet Irradiation and Reactive Oxygen Species
Induced Apoptosis
S. Shen,* Y. Chen,² T. Tsai, C. Hu,* Y. Takashi,§ and W. Lee³
Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan; *Departemt of
Dermatology, School of Medicine, Taipei Medical University, Taipei, Taiwan; ²Graduate Institue of
Pharmacognosy, Taipei Medical University, Taipei, Taiwan; ³Graduate Institute of Medical Sciences, Taipei
Medical University, Taipei, Taiwan; §Kobe Technical Center, Procter & Gamble, Kobe, Japan
Niacin (NA), a naturally occurring vitamin and a protease inhibitor, was known well to be
effective in treating some skin diseases. Previous studies showed that NA had therapeutic effects on
several human diseases through inhibiting cell proliferation or inducing cell differentiation.
However, the exact biological function of NA on skin cells is still unknowm. In the present study,
we focused on demonstration of the effects of NA on ultraviolet irradiation (UV) or reactive
oxygen species (ROS) mediated cell injury in ®broblast and keratinocyte cell lines. We found that
ultraviolet irradiation and hydrogen peroxide treatment were able to cause DNA damage and cell
death in ®broblasts and keratinocytes and the cytotoxic effects were associated with elevated
amount of intracellular ROS. Addition of low concentrations of NA followed by UV or H2O2
treatment resulted in signi®cant inhibition of apoptosis in a dose and time-dependent manner,
accompanied by decreasing the amount of 8-OH-dG measured in ®broblasts and keratinocytes.
Nevertheless, the free radical levels were not different statistically between cells with or without
niacin pretreatment. These ®ndings suggest that niacin can, at least partially, prevent UV or H2O2
induced apoptosis through reducing DNA damage and enhancing the DNA repair systems.
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In Vivo Confocal Imaging of Skin Dynamics After 0.5, 1 and 2 MED of UVB Exposure
M. Huzaira, M. Rajadhyaksha,* R. Anderson, and S. Gonzalez
Dermatology, Harvard Medical School, Boston, Massachusetts; *Lucid Inc., Rochester, New York
Introduction: Near infrared re¯ectance confocal microscopy (CM) is a technique that allows skin to
be imaged in vivo with high resolution and contrast. Objective: This study was designed to
investigate in vivo histologic changes after a single exposure to ultraviolet B (UVB) in human skin.
Material and Methods: Inner forearm skin of 16 adult volunteers was exposed to 0.5, 1 and 2 MED
of UVB. Skin sites were imaged from 15 minutes to 3 weeks after UVB exposure by using in vivo
CM. Biopsies were obtained at various time points from 10 subjects. Results: Basal keratinocytes
show increased brightness immediately after exposure to 0.5 MED. After 24 hours, highly refractile
structures that may correspond to sunburn cells are clearly seen in the malphygian compartment. In
the papillary dermis, leukocyte adhesion to the vessel walls and perivascular in®ltrate is clearly seen.
Thickness of stratum corneum peaks at 5-7 days and reduces thereafter. Stratum granulosum shows
focal thinning after 24 hours of 1 and 2 MED and reaches its maximum thickness at 72 hours. It
returns to normal after 3 weeks in 0.5 and 1 MED but remains signi®cantly thickened in 2 MED.
Epidermal thickness starts to increase at 48 hours and peaks at 5 days, being twice the normal. It
continues to reduce thereafter, but does not return to normal even after 3 weeks in any dose of
UVB. All these changes correlate well with histology. Conclusion: Re¯ectance confocal microscopy
allows a better understanding of skin dynamics after UVB radiation.
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Quantitative Photographic Method to Assess Suncare Product Spreading
N. Issachar, G. Payonk, M. Cambon, C. Carpentier, A. Pellegrino, and C. Robert
Skin Care Research Institute, Johnson & Johnson Consumer France, Issy-les Moulineaux, France; *Johnson
& Johnson Consumer, Skillman, New Jersey
Sunscreens are used as protection from the harmful effects of the sun. The sun protection factor
(SPF) is a measure of the effectiveness of a sunscreen to absorb ultraviolet light. The most
important attributes determining SPF ef®cacy are the UV absorber, amount of applied sunscreen
(mg per cm2) and quality of the deposited ®lm. SPF's are determined after applying 2 mg per cm2
of sunscreen; however, people rarely spread such amounts and usually apply 0.5±1 mg per cm2. No
standard measures of the evenness of the applied ®lm are generally accepted. Thus, the objective of
this work was to develop a digital, UV ¯uorescence photographic method to image the applied
sunscreen ®lm and to use new computer software to analyze and quantify its uniformity.
Photography was accomplished using modi®ed strobe units with UV band pass ®lters and a camera
with a visible long pass ®lter. Imaging of untreated human forearm skin yielded images which were
``bright'' in the green channel due to ¯uorescence of cross-linked collagen in the dermis.
Subsequent application of sunscreen led to appearance of dark zones against a bright background as
the sunscreen absorbed the incident UV radiation while it does not attenuate the visible emitted
radiation. The ¯uorescence intensity and homogeneity (gradients) within the applied sunscreen
®lms were studied as a function of applied sunscreen (0.5±2 mg per cm2). The results showed a
diminution in collagen cross-link ¯uorescence that correlated (r = 0.99) with the quantity of
sunscreen applied. In addition, sunscreen spreading was more homogeneous with 2 mg per cm2
than with lower applied amounts. In summary, a simple and rapid ¯uorescence photographic
method has been developed that allows visualization and quanti®cation of sunscreen spreading.
This noninvasive in vivo technique allows comparison between sunscreen formulations for
spreading uniformity, water and sand resistance, and can be combined with human SPF
determinations to assess the in¯uence of spreading on the obtained SPF.
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Mechanism of UVB-Induced Cyclooxigenase-2 Expression
M. Ashida, T. Bito, M. Ueda, and M. Ichihashi
Dermatology, Kobe University school of medicine, Kobe, Japan
Increased production of arachidonic acid and prostaglandin (PG) in the skin are characteristic
responses following UVB exposure. Cyclooxigenase (COX), which convert arachidonic acid to
PG, includes COX-1 and COX-2. In most tissues, COX-1 is constitutively expressed, whereas
COX-2 is highly inducible by a variety of tumor-promoting agents such as TPA and UVB. The
important role of COX-2 in photocarcinogenesis was con®rmed by studies that showed the
reduced photocarcinogenesis in mice by selective COX-2 inhibitor. We studied the mechanisms
of COX-2 induction by UVB in keratinocytes and ®broblasts using RT-PCR. A single exposure
of normal human keratinocytes or HaCaT cells to UVB induced COX-2 mRNA at the peak at 3±
6 h. Increased expression of COX-2 by UVB in HaCaT cells was partially inhibited by tyrosine
kinase inhibitor (Herbimycin A, Genestein), EGF receptor tyrosine kinase inhibitor (AG1478), Src
tyrosine kinase inhibitor (PP2), p38 MAP kinase inhibitor (SB202190), or PKC/PKA inhibitor
(H7). Neutralizing antibodies against TNF RI, IL-1, and EGF did not suppress the COX-2
mRNA activation. Signi®cantly lower doses of UVB induced COX-2 expression in XPA
®broblasts compared with normal ®broblasts. These data indicate that various signaling activated by
UVB and UVB-induced DNA damage are involved in the COX-2 induction in a complex
manner.
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Retinoic Acid Promotes New Capillary Formation through Growth Factors to Replace
the Loss of the Vascular Network in Photodamaged Skin
M. Donovan, M. Green, M. Girard,* W. Parish, M. Lehman,* and D. Meyers
Biosciences, Unilever Research Colworth, Sharnbrook, United Kingdom; *Skin Biosciences, Unilever
Research, Edgewater, New Jersey
We have examined the structure of the capillary network in the papillary dermis in aged
photodamaged skin compared to young protected skin. The capillary loop height and the distance
from the subepidermal plexus to the outermost viable layer of the stratum granulosum were
signi®cantly shorter (p < 0.001) in aged photodamaged skin. In several areas along the epidermal -
dermal junction the capillary bed appeared ¯atter in structure compared to the rich looping
network observed in young skin. Topically applied retinoic acid improves the appearance of
photoaged skin and over time reduces the number of ®ne lines and wrinkles. Previous studies have
reported that these changes are associated with the formation of new dermal blood vessels in
photodamaged skin following the treatment of tretinoin. In order to obtain a better understanding
of the molecular basis for the formation of these new capillaries, we examined the expression of
associated markers in a three month RA clinical trial on photodamaged skin. Histological analysis
of biopsies from the trial revealed the presence of patent capillaries and new capillary formation in
the upper dermis in skin treated with 0.05% RA compared to vehicle controls (n = 10). There was
also clear evidence of perivascular cell proliferation and dissemination of ®broblast like cells into the
dermis. At the molecular level there was increased protein levels of the growth factors VEGF and
bFGF in ®broblasts and endothelial cells. The expression of VEGF was often found in the
migrating buds of new vessels. The expression of the bFGF receptor also increased in both
endothelial and ®broblasts suggesting that the promotion of new capillary formation may be
regulated through an autocrine loop in RA treated photodamaged skin.
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Photoprotective, Antioxidant and Anti-In¯ammatory Properties of A-Lipoic Acid
C. Saliou, P. Lyte, D. Sher, P. Dusman, L. Babiarz, and K. Martin
Skin Research Center, Johnson & Johnson Consumer Products Worldwide, Skillman, New Jersey
a-Lipoic acid (LA) is a cofactor in mitochondrial enzymatic complexes catalyzing the oxidative
decarboxylation of a-keto-acids (e.g. pyruvic acid) to acetyl-coenzyme A. The antioxidant
properties of a-lipoic acid have been extensively demonstrated during the past 15 years. a-Lipoic
acid is a good free radical scavenger and transition metal chelator. Here, a-lipoic acid is shown to
protect human epidermal equivalents against UV-induced MMP-1 and IL-1a expression, and their
loss of viability. In normal human ®broblasts exposed to cigarette smoke, a-lipoic acid is found to
spare cellular thiols. Furthermore, a-lipoic acid blocks nitric oxide production in LPS-stimulated
murine macrophages and inhibits phytohemagglutinin-induced pro-in¯ammatory cytokines in
peripheral blood lymphocytes. The adhesion of Jurkat T-cells to HaCaT keratinocytes was
effectively inhibited by a-lipoic acid in a dose-dependent manner. However, Repeat Insult Patch
Test (RIPT) studies conducted with formulated a-lipoic reveal sensitization reaction. In
conclusion, while a-lipoic acid affords particularly potent photoprotective, antioxidant and anti-
in¯ammatory properties in vitro, its sensitization potential impairs development as a cosmetic
ingredient.
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Protective Effects of Resveratrol Against Short-Term Markers of Photocarcinogenesis in
a Mouse Skin Model
F. Afaq, H. Mukhtar, and N. Ahmad
Department of Derm., University Hosp. Research Institute and Case Western Reserve University, Cleveland,
Ohio
Nonmelanoma skin cancer is the most common cancer among humans and solar ultraviolet (UV)
radiation, particularly its UVB component (290±320 nm), is its major cause. One way to reduce
the occurrence of these cancers is via the use of substances (often antioxidants) termed as
``photochemopreventive agents''. Resveratrol (trans-3,4¢,5,-trihydroxystilbene), a phytoalexin
found in grapes, nuts, fruits and red wine, is a potent antioxidant with strong antiproliferative
properties. Resveratrol has been shown to afford protection against chemically induced skin
carcinogenesis in CD±1 mice. This study was designed to examine if resveratrol possesses a potential
to ameliorate the damages caused by short-term UVB exposure to the skin. The effect of a topical
application of resveratrol (25 micro mole/0.2 ml acetone/mouse), 30 min before UVB (180 mJ per
cm2) exposure to the skin of female SKH-1 hairless mice, was evaluated on bifold-skin thickness,
skin edema, hydrogen peroxide (H2O2) formation, ornithine decarboxylate (ODC) activity and
other short-term markers considered important in photocarcinogenesis. Pre-application of
resveratrol was found to result in signi®cant inhibition of UV-mediated increase in bifold-skin
thickness (52% inhibition) and skin edema (31% inhibition). As evaluated by immunohistochem-
istry, preapplication of resveratrol was found to result in a signi®cant decrease in UVB-mediated
increased generation of H2O2. Further, topical application of resveratrol was also found to result in
signi®cant inhibition (55%) of UVB-mediated induction of ODC enzyme activity, a well-
established marker of tumor promotion. Taken together, our results suggest that resveratrol may
afford protection against the damages caused by UVB exposure, and that these protective effects
may be mediated via its strong antioxidant properties. Because the markers studied here are
regarded as early markers of photocarcinogenesis, our results suggest that resveratrol may be
developed as cancer chemopreventive agent against photocarcinogenesis and other adverse effects
of UVB exposure. Detailed long-term photocarcinogenesis studies to assess the preventive
potential of resveratrol are warranted.
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Costimulation with Ultraviolet B and Polyinosinic -polycytidilic Acid Increase
Interferon-b Production in Human Dermal Fibroblasts
H. Fujisawa, B. Wang,* H. Satomi, T. Mochizuki, and F. Otsuka
Department of Dermatology, University of Tsukuba, Tsukuba, Japan; *Division of Dermatology, University
of Toronto, Toronto, Ontario, Canada
Ultraviolet light, particularly in wavelengths of 290±320 nm (UVB), is known to have synergistic
action on regulation of cytokine productions in the skin. In this study, we sought to determine
whether cotreatment with polyinosinic:polycytidylic acid (poly I:C) which is a synthetic double-
stranded (ds) RNA, a strong interferon (IFN) inducer, and UVB induces IFN-b production from
®broblasts dramatically. Since virus infection triggers IFN production via dsRNA to induce
apoptotic cell death, poly I:C treatment mimics virus infection. Altough UVB irradiation alone did
not induce IFN-b production, combined treatments with poly I:C and UVB induced 2±3 fold
higher levels of IFN-b than with poly I:C treatment alone. This effect was also seen with mRNA
expression. Maximum effect was observed when UVB was irradiated immediately after poly I:C
treatment. Since approximately 10% of incident of UVB penetrates to the level of dermal
®broblasts, our results suggest that the augmented IFN-b production from UVB exposed
®broblasts which are infected with virus may contribute to the increase of IFN-b circulation,
potentially inducing apoptotic cell death in viral infected cells and anti viral state in virus uninfected
cells.
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Ascorbate and a-Tocopherol Decrease in Human Skin During Aging
M. Podda, M. Grundmann-Kollmann, H. Beschmann, J. Fuchs, T. Zollner, and R. Kaufmann
Dermatology, University of Frankfurt, Frankfurt, Germany
Despite increasing evidence that reactive oxygen species play a role in aging, photoaging, and aging
associated skin diseases, data about the antioxidant capacity of skin during the aging process are
very scarce. For human studies this may be partially due to technical dif®culties in measuring low
molecular weight antioxidants in skin. We established a re®ned methodology for the measurement
of low molecular weight antioxidants, which allowed us to look for potential changes in ascorbate,
a-tocopherol and urate skin concentrations during aging. To account for inherent differences in
skin layers which re¯ect predominantly exogenously exposed and nonexposed skin, frozen skin
biopsy punches were horizontally dissected into an upper layer of 1.5 mm and a lower one of
1.5 mm thickness. We found a signi®cant difference between the amount of ascorbate and a-
tocopherol present in the upper 1.5 mm skin (epidermis and upper dermis) compared to the lower
dermal compartment (lower dermis and parts of subcutis). Ascorbate was seven folds higher in the
upper 1.5 mm whereas a-tocopherol had a 6 fold higher concentration in the lower 1.5 mm skin.
Ascorbate showed a signi®cant decrease with increasing age in the upper 1.5 mm (p < 0.05) and a-
tocopherol concentration decreased with increasing age in both compartments (p < 0.01 and p
< 0.05), while urate did not show any correlation with age. A decrease of antioxidants has been
described in other organs in humans. The data reported in this study indicate that there is a
signi®cant decrease of two major small molecular weight antioxidants in human skin during the
aging process. Hence, it seems reasonable to suggest a higher dietary intake of fruits and vegetables
for older people as one possibility to increase ascorbate and a-tocopherol levels.
698
Comparative In Vivo Pharmacokinetic Study of 8-Methoxypsoralen (8-MOP)
Penetration into Human Skin by Microdialysis after Creme, Bath or Oral Delivery
M. Grundmann-Kollmann, I. Tegeder,* R. Ludwig, G. Geiblinger,* R. Kaufmann, and M.
Podda
Dermatology, University of Frankfurt, Frankfurt, Germany; *Pharmacology, University of Frankfurt,
Frankfurt, Germany
Photochemotherapy with oral or topical psoralens combined with long wave ultraviolet light
(PUVA) is a standard treatment regimen for various dermatological disorders. However, until now
clinical treatment schedules are based largely on phototoxicity testing and determination of 8-
MOP serum kinetics while 8-MOP tissue kinetics are still missing. Providing concentration-time
pro®les with a high temporal resolution microdialysis has been shown to be a suitable method for
the characterisation of transdermal drug transport in vivo. We used the microdialysis technique to
compare tissue concentrations in humans after topical (bath and cream) and oral administration of
8-MOP. The microdialysis is based on a diffusion process through a semipermeable membrane
located at the tip of a microdialysis catheter. The catheter is constantly perfused with a physiologic
solution (¯ow rate 0.5±3 mL per min). Substances that enter the catheter through diffusion are
transported to the outlet tube and can be analysed in the dialysate. Hence, microdialysis allows the
sampling and quanti®cation of analytes from the extracellular space of skin. Because proteins can
not pass the membrane, it is pharmacodynamically relevant unbound fraction of a substance that
can be determined by microdialysis. 8-MOP was applied topical and systemical in 8 healthy
volunteers in a cross over study. Dialysate sampling was performed up to 6 h in 20 min intervals.
Plasma samples were taken up to 10 h after 8-MOP application. Plasma and tissue concentrations of
8-MOP were determined by LC with double masspectography. Plasmaconcentrations after oral 8-
MOP administration were signi®cantly higher than after topical 8-MOP application. Tissue
concentrations were signi®cantly higher and showed fewer variance after topical than after oral 8-
MOP. Tissue concentrations decreased fastest after 8-MOP bath. Our data indicate that topical 8-
MOP application may be superior to the oral route as skin concentrations are higher and more
stable. These data con®rm on a pharmacological basis the clinical experience that topical PUVA
therapy requires lower cumulative UV-doses compared to oral application.
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Topical Zinc Sulphate ± An Antioxidant for Skin
S. Pinnell, H. DeBuys, M. Omar,* L. Walker, N. Monteiro-Riviere,² T. Dawson, and M.
Waalkes
Dermatology, Duke University, Durham, North Carolina; *Phytoceuticals, Elmwood Park, New Jersey; ²
Veterinary Medicine, NCSU, Raleigh, North Carolina; ³ NIEHS, RTP, North Carolina
Zinc is a trace mineral required for normal growth, development and function. It is especially
abundant in skin, which contains 20% of the body's total. Zinc is an essential element of over 200
metalloenzymes. It affects conformation, stability and activity of these molecules. In recent years,
studies have revealed that zinc has an important antioxidant role. In cultured skin ®broblasts,
supplemental zinc salts protected cellular DNA and lipids from photodamage induced by UVA and
UVB. Oral zinc supplements protected mice against UV immunosuppression to contact allergens.
Topical zinc salts protected mice against UVB-induced sunburn cell formation. Although the
mechanism of action for the antioxidant effect of zinc salts is unknown, one hypothesis involves
induction of metallothionein synthesis. Metallothionein is a family of low molecular weight
sulfhydryl proteins with a cysteine content of approximately one-third. Metallothionein is a good
antioxidant and indeed is stimulated by UVB radiation, apparently as a protective mechanism
against further free radical attacks. In an attempt to develop a topical zinc formulation for
antioxidant protection of human skin, we have formulated ZnSO4 at levels from 1 to 5% in a
solution containing 15% L-ascorbic acid and bio¯avonoids. Percutaneous absorption of Zn++ at
24 h was tested in Yorkshire pigs. Skin Zn++ levels were maximal at 3% ZnSO4 concentration and
increased from a baseline of 0.115 mg per g skin to 0.902 mg per g. Equimolar ZnCl2 was also
effective, but is know to be more irritating to skin. After 24 h of ZnSO4 induction,
metallothionein-1 increased approximately 3.4-fold, using Northern analysis. These studies reveal
that ZnSO4 can be formulated in a way that permeates skin and induces metallothionein synthesis.
Divalent zinc ion-containing formulations may prove promising for providing antioxidant
protection to skin. It should be noted that zinc oxide is insoluble and is not a source of zinc ions for
skin.
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Enhanced Cyclooxygenase-2 Expression in UVB-Induced Murine and Human Skin
Tumors
K. An, M. Athar, S. Katiyar,² B. Connolly, M. Aszterbaum,* J. Longley, A. Kim, E. Epstein Jr, H.
Mukhtar, and D. Bickers
Dermatology, College of Physicians & Surgeons, Columbia University, New York, New York;
*Dermatology, University of California at San Francisco, San Francisco, California; ²Dermatology, Case
Western Reserve University, Cleveland, Ohio
In¯ammatory stimuli are potent tumor promoters in skin carcinogenesis assays and lead to
cutaneous eicosanoid production. Cyclooxygenase (COX), the rate-limiting enzyme for the
production of prostaglandins from arachidonic acid, exists in at least two isoforms, COX-1 and
COX-2. COX-1 is constitutively expressed in most tissues and plays various physiological roles
whereas, increased COX-2 expression occurs in several types of epithelial neoplasms. Enhanced
prostaglandin synthesis has been shown to be a potential contributing factor in UV-induced
nonmelanoma skin cancers (NMSCs). Increased COX-2 staining is found in murine skin tumors
following chronic exposure to carcinogenic doses of UVB. In this study, using immunohisto-
chemical and Western blot analysis COX-2 expression was assessed longitudinally in a standard
mouse UVB complete carcinogenesis protocol and in human basal cell (BCCs) and squamous cell
carcinomas (SCCs). Exposure of murine and human skin to UVB caused a transient enhancement
of COX-2, which reverted to baseline within hours. Pretreatment with topically applied
antioxidants such as green tea extract (1 mg per cm2) largely abrogated the COX-2 response to
UVB. However with continuing UVB irradiation of mice, COX-2 persistently increased in
hyperplastic skin, benign papillomas and SCCs. Increased COX-2 also occured in human actinic
keratoses and BCCs as well as in murine and human SCCs. The enhanced localization of COX-2
was quite variable occurring in a patchy epidermal distribution in some lesions and limited to the
basal cell layer in others. In general, COX-2 expression was more intense in well-differentiated
murine SCCs than in benign papillomas. In addition, we observed strong cytoplasmic and
perinuclear staining in both murine and human BCCs. Western blot analysis con®rmed that
normal skin had no detectable signal for COX-2 whereas acute UVB exposure resulted in
increased enzyme expression, which continued to increase in developing papillomas and SCCs. In
summary, enhanced COX-2 serves as a marker for epidermal UVB exposure and for murine and
human NMSCs. These results indicate that COX-2 inhibitors could have potent anticarcinogenic
effects in UVB-induced human skin cancer.
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Retinoid Dependent Induction of Apoptosis in UVB-Irradiated Human Squamous Cell
Carcinoma Cell Line SCC-12 Involves Caspase-3, Caspase-6, and bcl-xS
T. Roos, C. Wagner, B. Huppertz, I. RoÈsener, J. Frank, H. Merk, and F. Jugert
Dermatology, University Clinic of the RWTH Aachen, Aachen, Germany
The effects of UVB light and retinoids on the induction of programmed cell death (apoptosis) in
skin cancer are not well understood. In previous studies we found that all-trans-retinoic acid
(atRA) re-induces the UVB-related suppression of apoptosis in the epidermal squamous cell
carcinoma cell line SCC-12 (SCC-12). Here we demonstrate which apoptosis mediators are
involved in these events. Con¯uent SCC-12 were irradiated with UV-B light (0.05±20 mJ per
cm2), consecutively treated with 10±5 M atRA and incubated for 96 h in the dark. Total-DNA and
proteins were extracted, and apoptosis was determined by apoptotic-ladder-PCR, and
immunoblotting of a variety of apoptosis mediators. In addition, apoptosis was determined by
¯uorescence staining of annexin-V and caspase-3. Caspase-3 expression was also determined by
FACS-analysis. UVB irradiation with 20 mJ per cm2 led to a signi®cant decrease of the apoptosis
rate as compared to nonirradiated SCC-12. However, Incubation with atRA after UVB treatment
signi®cantly induced apoptosis as compared to atRA treatment of nonradiated cells, and UV-B
exposed cells without atRA-treatment. Here, Cas-3, Casp-6, Casp-8, and bcl-xs were induced,
while bcl-xl was suppressed. The induction of apoptosis by atRA in SCC-12 after UVB-radiation
suggests that atRA can restore the ability of SCC-12 to induce apoptosis following UVB-damage.
This is unexpected since UVB alone suppresses apoptosis in this cell line, which suggests that SCC-
12 are not able to react adequately to UV-B-stress and related cell damage. Our results further
demonstrate that UVB-induced apoptosis in SCC-12 is regulated different from normal human
epidermal keratinocytes. This nonresponsiveness to UVB of SCC may be one feature in the
pathogenesis of malignant transformation from epidermal keratinocytes to SCC.
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KGF Exerts Protective Effects on Keratinocytes Following UVB-Induced Cell Injury
K. Hamacher, K. Squillace, and M. Pittelkow
Dermatology Research, Mayo Clinic, Rochester, Minnesota
Keratinocyte growth factor (KGF), a member of the ®broblast growth factor family, has been
implicated in wound healing, epidermal proliferation and differentiation. KGF is a paracrine factor
produced by mesenchymal-stromal cells and exerts activity on epithelial cells, including
keratinocytes. KGF protects hair follicles following cytotoxic injury. More recently, KGF has
been shown to act as a mediator of repair in in¯ammatory bowel disease and chemotherapy-or
radiation-induced lung damage. We have previously shown that epidermal growth factor receptor
(EGFR) activation protects keratinocytes from cell death induced by UVB. Here, we investigate
the potential protective effects of KGF on UVB-mediated injury of human keratinocytes in
culture. Treatment with KGF prior to UVB irradiation signi®cantly inhibits loss of clonogenic
potential induced by UVB treatment alone. We also show that KGF maintains proliferative
potential in UVB-treated keratinocytes. Interestingly, treatment with exogenous EGF prior to
UVB irradiation fails to exhibit a protective effect on keratinocyte proliferation or survival. Also,
KGF prevents cell death induced by UVB completely, showing similar cell survival as untreated,
non-UVB exposed cells. This study provides the ®rst evidence that KGF preserves proliferative
potential in human keratinocytes after damage by UVB radiation. KGF also enhances survival of
human keratinocytes in culture following UVB-induced damage. Other known growth factors
(EGF, TGF-b, IL-1b, TNF-a) failed to elicit this response. These ®ndings bear relevance to
clinical dermatology and therapeutics for diseases such as psoriasis, photodermatoses and acute solar
injury. KGF and its receptor may play critical roles in cell survival and hyperproliferation, as
observed in psoriasis. In photodermatoses and acute solar injury, KGF or pharmacomimetic agents
may be of therapeutic bene®t in minimizing keratinocyte injury and death.
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Vitamin C Derivative Ascorbyl Palmitate Promotes UVB-Induced Lipid Peroxidation
and Cytotoxicity in Keratinocytes
A. Meves, S. Stock, A. Beyerle, D. Peus, and M. Pittelkow
Dermatology Research, Mayo Clinic, Rochester, Minnesota
Antioxidant application has been proposed as a preventive and protective strategy against the
harmful effects of ultraviolet radiation to the skin. A potent antioxidant, ascorbic acid has been
shown to protect against sunburn, delay the onset of skin tumors and reduce ultraviolet B (UVB)
radiation-induced skin wrinkling. In this study, we sought to determine the antioxidative
properties of a lipid-soluble derivative of ascorbic acid, ascorbic acid-6-palmitate (AA6P). We
found that AA6P reduced cellular levels of reactive oxygen species following UVB irradiation.
Treatment of keratinocytes with AA6P inhibited UVB-mediated activation of epidermal growth
factor (EGF) receptor, extracellular regulated kinases (ERK) 1/2 and p38 kinase due to its ability to
prevent glutathione depletion and scavenge hydrogen peroxide. However, AA6P strongly
promoted UVB-induced lipid peroxidation (LPO), c-Jun N-terminal Kinase (JNK) activation and
cytotoxicity. End products of lipid peroxidation such as 4-hydroxy-2-nonenal (4-HNE) have been
reported to mediate stress activated protein kinases (SAPKs) activation and cell toxicity in epithelial
cells. The lipid component of AA6P likely contributes to the generation of oxidized lipid
metabolites that are toxic to epidermal cells. Our data suggests that despite its antioxidant
properties, AA6P may intensify skin damage following physiologic doses of ultraviolet radiation.
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Ultraviolet A Exposure Induces Irradiance-Dependent Vascular Injury in Pig Skin
C. Shea, M. Selim, N. Monteiro-Riviere,* and S. Pinnell
Medicine (Dermatology), Duke University Medical Center, Durham, North Carolina; *College of Veterinary
Medicine, North Carolina State University, Raleigh, North Carolina
Most UV photobiologic responses of skin follow the law of reciprocity; that is, within wide limits
the effects are proportional to the sum total of energy delivered (¯uence) but independent of the
intensity of exposure (irradiance). The present investigation tests whether irradiance is an important
variable affecting the responses to UVA (320±400 nm) in a porcine model in vivo. A 1000-W
®ltered xenon arc equipped with a 1-cm-diameter ®ber optic was used to deliver UVA to the skin
surface of anesthetized white Yorkshire pigs, over a ¯uence range of 25±150 J per cm2 and an
irradiance range of 40±120 mW per cm2. UVA photodamage was quanti®ed histopathologically by
a blinded method. UVA exposure caused reproducible alterations that appeared to be primarily
vascular in nature. The gross hallmark of this reaction was purpura. Pathologically, by 2 h after
exposure to threshold ¯uences, the super®cial dermal vessels exhibited congestion and focal
perivascular hemorrhage, with minimal in¯ammation. By 24 h, leukocytoclastic vasculitis and
epidermal apoptosis and/or con¯uent necrosis occurred, in a strongly irradiance-dependent
manner. For example, at 24 h after exposure to 75 J per cm2, the width of full-thickness necrosis
varied more than 103 over a 23 irradiance range. Likewise, at this ¯uence the maximal depth of
vasculitis varied 43 over the same range. Similar irradiance-dependence was also observed at other
¯uences tested, with higher irradiances consistently causing more severe effects at a given ¯uence.
These data indicate that photodamage in this model may not be explained entirely by positing the
accumulation of a stable photoproduct. Rather, UVA exposure at higher irradiances may
dynamically overwhelm the real-time capacity of photoprotective systems such as endogenous
antioxidants, leading to the violations of reciprocity observed.
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A Novel Nitrone-Based Free Radical Trap Blocks UV-Induced Cytokine Production in
Human Fibroblasts and Keratinocytes and Inhibits UV-Induced Erythema in Human
Skin In Vivo
B. Fuller, D. Smith, D. Spaulding, B. Pilcher,* and Z. Draelos²
Biochemistry and Molecular Biology, University of Oklahoma Hlth.Sci.Ctr., Oklahoma City, Oklamhoma;
*Cell Biology and Dermatology, UT South-western Medical Ctr., Dallas, Texas; ²Dermatology Consulting
Services, High Point, North Carolina
Exposure of human skin to ultraviolet radiation results in the induction of an in¯ammatory
response which leads to erythema and skin damage. An early effect of UV radiation is the
production of IL-1 by keratinocytes and an increase in PGE-2 production in both ®broblasts and
keratinocytes. Topical corticosteroids are effective in reducing the production of many of these
in¯ammatory mediators, but long-term use can lead to side-effects, including skin atrophy. Recent
studies have shown that oral administration of a proprietary nitrone-based free radical trap reduces
the production of in¯ammatory mediators in an animal arthritis model. The aim of this research
was to determine if a novel nitrone-based free radical trap molecule, CX-412 can block the UV
induction of in¯ammatory mediators in human keratinocyte and ®broblast cell cultures. We also
assessed the ef®cacy of topical formulations of CX-412 in reducing UV-induced erythema in
humans. For cell culture studies human ®broblast and keratinocyte cultures were irradiated with 50
mJ of UVB. CX-412 completely blocked the UV light induced increase in PGE-2 in ®broblasts
and keratinocytes at concentrations as low as 10 mM. In addition, CX-412 completely prevented
the ®ve-fold induction of PGE-2 in ®broblasts treated with 1 ng per ml of IL-1a. Based on these
®ndings, a 2% formulation of CX-412 was used in a double-blind placebo controlled pilot human
ef®cacy study conducted on 12 patients. Patients were irradiated on each forearm with a 3X MED
dose of UVB, and either a placebo gel vehicle or the 2% CX-412 formulation applied to the
irradiated site. At hourly intervals, patients were evaluated for erythema by both surface
spectrophotometry measurements and digital photography. Over 80% of the patients exhibited a
marked reduction in visible UV-induced erythema at sites treated with CX-412. Further, the mean
difference in erythema between placebo and CX-412 treated sites as determined by surface
spectrophotometric measurements was signi®cant (p = 0.01). These ®ndings demonstrate that
topical formulations of a novel nitrone-based free radical spin trap can signi®cantly inhibit UV-
induced in¯ammation and may protect the skin from sun exposure.
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In Vivo Analysis of Melanocyte Development: Regulation by c-kit and Pax3
J. Gavin and T. Hornyak
Dermatology, Henry Ford Health System, Detroit, Michigan
Murine mutations in the growth factor receptor tyrosine kinase c-kit and the paired homeodomain
transcription factor Pax3 each result in viable adult mice with ventral white spotting when
heterozygous, yet distinct embryonic lethal phenotypes when homozygous. To specify the roles of
c-kit and Pax3 in melanocyte development, an in vivo analysis of melanocyte development was
performed in these mutant backgrounds by intercrossing KitW/+(Dominant spotting) and Pax3Sp±d/
+(Splotch-delayed) heterozygous mice with mice hemizygous for the Dct:lacZ transgene, an in vivo
marker of melanocyte development. Heterozygous crosses were arranged to generate embryonic
litters at E10 ± E14.5 of development, and transgenic embryos genotyped and compared for
differences in melanoblast presence, location, and number. Results of heterozygous crosses showed
that KitW/KitW embryos contain fewer melanoblasts than either +/+ or KitW/+ embryos from E10
onward. Additionally, cephalic melanoblasts in KitW/KitW embryos disappear by E12-12.5. KitW/+
embryos, though always containing cephalic melanoblasts, have consistently fewer than stage-
matched wild-type embryos from E10-14.5. Results of crosses of Pax3Sp±d/+ mice revealed also
that melanoblast number at E12.5 is inversely related to gene dosage of the mutant allele, but, in
contrast to KitW/KitW embryos, Pax3Sp±d/Pax3Sp±d homozygotes feature a limited number of
melanoblasts that survive at E12.5. In fact, at E12.5 cephalic melanoblast number in Pax3Sp±d/
Pax3Sp±d embryos is comparable to that previously described in Pax3Sp/Pax3Sp embryos, despite the
greater effect of the latter allele on other neural crest derivatives. In conclusion, these studies
support a role for the receptor tyrosine kinase c-kit from the earliest stages of melanocyte
development, days prior to the timepoint of epidermal entry, and indicate the importance of the
full complement of receptor for regulating proper proliferation or survival. They also underscore
the importance of proper Pax3 gene dosage, and suggest that melanocyte development may be
unusually sensitive compared to other neural crest derivatives to the full complement and function
of this transcription factor.
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All-trans Retinoic Acid Promotes the Differentiation of Mouse Neural Crest-Derived
Melanocyte Precursors
H. Watabe, M. Ito, Y. Kawa, T. Baba, K. Ohsumi, K. Tsukidate, E. Hosaka, T. Kawakami, Y.
Soma, and M. Mizoguchi
Dermatology, St.Marianna University, School of Medicine, Kawasaki, Japan
Background: Retinoids, a group of chemically related molecules derived from vitamin A, regulate
a large number of biological processes in vertebrate development, cell growth, differentiation, and
homeostasis. Objectives: We studied the effect of all-trans retinoic acid (ATRA) on the
differentiation of melanocyte precursors and the molecular basis of ATRA-induced differentiation.
Methods and Results: We have established melanocyte precursors (NCC-melb4) cloned from
mouse neural crest cells. NCC-melb4 cells were positive for TRP1, TRP2 and KIT, but negative
for tyrosinase and DOPA reaction. They contained stage I melanosomes without those of advanced
stages. After 72 hours of ATRA treatment, many of the cells became tyrosinase- and DOPA-
positive, changed from polygonal to dendritic in shape, and had stage II~IV melanosomes. RT-
PCR analysis showed enhanced expression of tyrosinase mRNA and microphthalmia-associated
transcription factor (MITF) mRNA and PKC ¦¿ mRNA after ATRA treatment. Therefore, it was
con®rmed that ATRA induced the differentiation of NCC-melb4. The proliferation of NCC-
melb4 cells was inhibited by ATRA in a dose-dependent manner. Apoptosis was studied by
electron microscopy, TUNEL method and ¯ow cytometry, and was found to have been induced
in the cells by ATRA treatment. Electron microscopy showed that the apoptotic cells contained
advanced stage melanosomes, suggesting that apoptosis was induced in the differentiated cells.
Conclusions: This is the ®rst report to show that ATRA-induced differentiation of melanocyte
precursors is accompanied by an increase in MITF mRNA. These results suggest that this
transcription factor may be the key molecule in this event.
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Fate of Melanocytes During Hair Follicle Morphogenesis
N. Botchkareva, A. Sharov, V. Botchkarev, and B. Gilchrest
Dermatology, Boston University School of Medicine, Boston, Massachusetts
During hair follicle morphogenesis, melanocyte precursors migrate into developing hair follicles
and give rise to differentiated melanocytes that actively produce and transport pigment into
keratinocytes of the hair shaft. However, patterns of melanocyte proliferation and differentiation
during formation of hair pigmentation unit remain to be elucidated. Using multicolor confocal
microscopy and double immuno¯uorescence of melanogenic proteins [tyrosinase-related proteins
1 and 2 (TRP1/TRP2), tyrosinase] and the proliferative marker Ki67, we show that in C57BL/6
mouse embryonic skin proliferating TRP2 + melanocyte precursors are seen in the hair follicles at
stages 1±2 of morphogenesis. In stage 3±4 hair follicles, the majority of intrafollicular melanocytes
remain TRP2+ and Ki67+, while some located closely to the forming dermal papilla begin to
express TRP1, an early marker of differentiation. First melanin granules appear at stage 5 hair
follicles coincident with tyrosinase expression in nonproliferating TRP2+/TRP1+ melanocytes.
Stage 7±8 hair follicles actively producing hair show nonproliferating TRP2+ melanocytes in the
bulge area, TRP2+/TRP1+ melanocytes in the outer root sheath, and TRP2+/TRP1+/
tyrosinase+ melanocytes above the dermal papilla. Taken together, our data show that during
formation of the hair pigmentation unit, proliferation of TRP2+ melanocyte precursors is reduced
with the onset of expression of differentiation markers TRP1 and tyrosinase, and that
melanogenically active melanocytes located above the dermal papilla do not proliferate and
express all three melanogenic proteins.
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Transcriptional Repression Activity and Induction of RPE Neural Differentiation
Revealed by Expression of Mash-1 Transcription Factor in Pigment Cell Precursors in
Transgenic Mice
T. Hornyak, J. Gavin, Z. Jiao, J. Gawel, and E. Ziff*
Dermatology, Henry Ford Health System, Detroit, Michigan; *Biochemistry and HHMI, NYU Medical
Center, New York, New York
To understand further the transcriptional determinants of neural crest cell development, the
neurogenic transcription factor gene Mash1 was expressed in transgenic mice using the promoter
for the melanogenic gene dopachrome tautomerase (Dct), expressed early in pigment cell
development. Dct:Mash1 transgenic mice feature coat color dilution and microphthalmia. To
analyze neural crest-derived melanoblast development, Dct:Mash1 transgenic mice were
intercrossed with Dct:lacZ transgenic mice which permit the in vivo assessment of melanocyte
development. Results of intercrosses revealed that melanoblasts are reduced in number in E15.5
and E17.5 transgenic embryos, but nonetheless exhibit normal follicular localization. To account
for temporal differences in chromogenic substrate reactivity and for the presence of coat color
dilution between wild-type and Dct:Mash1 transgenic mice, co-transfection experiments were
performed demonstrating that Mash1 negatively regulates Dct promoter activity and activity from a
generic M-box promoter containing nucleotide consensus sequences conserved in the proximal
regions of melanogenic gene promoters. In contrast to results with neural crest-derived
melanocytes, Dct:Mash1 transgenic embryos exhibited hyperproliferation of retinal pigment
epithelium (RPE) precursors, with induction of expression of neuronal and neuroretinal markers,
such as a neuron-speci®c form of class III b-tubulin and Chx10, that are not normally expressed in
developing RPE. In summary, expression of Mash1 in pigment cell precursors results in fewer
neural crest-derived melanoblasts that nonetheless retain cell identity, localize to the follicle, and
produce an altered form of melanin that likely re¯ects direct transcriptional repression activity of
Mash1 upon melanogenic genes, but induces hyperproliferation and transdifferentiation of non-
neural crest-derived RPE precursors, thus further highlighting differences between these two
classes of pigment cells.
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Involvement of MITF and the PKA Signal Pathway in Regulation of Melanoblast
Differentiation Induced by 8-Methoxypsoralen
T. Lei, V. Virador, W. Vieira, K. Toyofuku, and V. Hearing
Laboratory of Cell Biology, National Institutes of Health, Bethesda, Maryland
We used melb-a cells, an immortal line of melanoblasts isolated from neonatal mouse epidermis, as
a model to study the regulatory mechanisms involved in their differentiation to melanocytes
following exposure to 8-methoxypsoralen (8MOP). Tyrosinase activity increased 7-fold and
melanin content increased 3-fold in melb-a cells treated with 10 mM 8MOP for 6 d compared with
untreated controls. Forskolin, a PKA activator, enhanced the 8MOP stimulation of tyrosinase
activity, which was higher in melb-a cells exposed concomitantly to forskolin (10 mM) and 8MOP
(100 mM) for 6 d than in cells treated with 8MOP alone or forskolin alone (p < 0.01 or p < 0.05),
respectively. A PKC activator, 1-oleoyl-2-acetylglycerol (OAG, at 10 mM), did not induce
differentiation of melanoblasts. Combined with results obtained by Western blot analysis,
melanoblast differentiation is stimulated by 8MOP through activation of the PKA pathway rather
than the PKC pathway. To elucidate what roles might be played by MITF in 8MOP induced
differentiation, we used Western blot and semiquantitative RT-PCR to assess the protein and
mRNA expression levels of MITF and tyrosinase in melb-a cells treated with 8MOP for 6, 24, 72
or 144 h. Incubation for 6 h with 8MOP increased MITF protein and mRNA levels, and that up-
regulation was further stimulated by concomitant treatment with forskolin. After incubation with
8MOP for 72 or 144 h, levels of MITF decreased to the basal level. Tyrosinase protein expression
did not increase following 8MOP treatment until 24 h, after which it was markedly increased.
Maximal stimulation of tyrosinase was obtained at 6 days. These ®ndings indicate therefore, that
8MOP initially increases MITF expression through activation of the PKA pathway. In turn, MITF
binds to the tyrosinase promoter M-box, thereby stimulating tyrosinase expression and inducing
melanoblast differentiation in vitro.
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Desacetyl a-MSH is a Partial Agonist at the Human MC1 and MC5 Receptors
M. Tsatmali, J. Ancans, and A. Thody
Biomedical Sciences, University of Bradford, Bradford, United Kingdom
a-MSH peptides are produced in the skin from the precursor protein proopiomelanocortin
(POMC). While the acetylated form of a-MSH is considered to be the most important agonist at
the MC1-R and other MC receptors the most abundant a-MSH in the skin is des-a-MSH. In this
study we have compared the potential of these peptides as agonists at the MC1-R and MC5-R
which are expressed on melanocytes and sebaceous glands, respectively. Competitive binding assays
were carried out in HEK 293 cells transfected with the human MC1-R. Ac-a-MSH showed high
af®nity for the MC1-R with a Ki value of 0.135 nM. Des-a-MSH showed lower af®nity with a Ki
of 1.31 nM, respectively. ACTH1-17, which is also found in the skin and is has also been shown to
act as an agonist at the MC1-R had a Ki of 0.206 nM. All three peptides activated MC1-R
coupling to the cAMP pathway with Ac-a-MSH and ACTH1-17 being equipotent and des-a-
MSH showing relatively weak activity. However, when present with either Ac-a-MSH or
ACTH1-17, des-a-MSH reduced the stimulatory effects of these two peptides. Similar results
were obtained with human melanoma cells. Unlike the a-MSH peptides ACTH1-17 increased the
intracellular concentration of IP3 and this effect was also reduced by des-a-MSH. Experiments
were extended to the MC5-R transfected cells where it was shown that all three peptides increased
cAMP production. Des-a-MSH and ACTH1-17 were equipotent but considerably less active than
Ac-a-MSH. As seen at the MC1-R des-a-MSH reduced the stimulatory effect on cAMP
production. However, it failed to have any effect on the action of ACTH1-17. The present results
con®rm that Ac-a-MSH is a potent agonist at the MC1-R and MC5-R. They also indicate that
des-a-MSH, which is the most abundant a-MSH peptide in the skin is a relatively weak agonist at
these receptors but interestingly acts as a partial agonist to reduce the effects of Ac-a-MSH. If des
a-MSH acts in the same way in vivo then it could be an important regulator of melanocytes and
sebaceous glands function.
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Evidence for the Regulation of Melanogenesis by Tyrosine Hydroxylase Isozyme I and
Tyrosinase in the Human Melanosome
L. Marles, E. Peters, D. Tobin, N. Hibberts, and K. Schallreuter
Clinical and Experimental Dermatology, Department of Biomedical Sciences, University of Bradford,
Bradford, United Kingdom
Both human epidermal melanocytes and keratinocytes have the full capacity for de novo synthesis
of 6(R) L-erythro 5,6,7,8, tetrahydrobiopterin, an essential reducing cofactor for the rate limiting
step in catecholamine synthesis, via tyrosine hydroxylase. Earlier, catecholamine synthesis has been
demonstrated in proliferating keratinocytes of the epidermis in human skin. This investigation
shows, for the ®rst time, the in vitro expression of tyrosine hydroxylase mRNA within the pigment
forming melanocyte. Furthermore, we speci®cally identi®ed tyrosine hydroxylase isoenzyme I
mRNA. The localisation of the protein was demonstrated in melanosomes using immunohis-
tochemistry and immuno¯uorescence double staining with the monoclonal antibody NK1/beteb
directed to (pre)melanosomes as well as with antihuman tyrosine hydroxylase. These observations
were further substantiated with immunogold electron microscopy yielding a melanosomal
membrane association for tyrosine hydroxylase side by side with tyrosinase. Gold conjugate-
labelled tyrosine hydroxylase was also detected in the endoplasmic reticulum and the trans Golgi
network, identifying the same route of origin for this enzyme as for tyrosinase. Both tyrosine
hydroxylase and tyrosinase activities were independently demonstrated in melanosomal
preparations from the melanoma cell line FM94 by measurement of the catalytic release of
tritiated water from 3H-L-tyrosine. The melanosomal membrane location of tyrosine hydroxylase
implies a coupled tyrosinase/tyrosine hydroxylase interaction, because the latter enzyme has the
kinetic potential to provide the preferred substrate and activator, L-Dopa, for tyrosinase to facilitate
melanin biosynthesis. Our results support a direct function for tyrosine hydroxylase in the
melanosome via a concerted action with tyrosinase to promote pigmentation.
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Neutralization of Melanosomal pH in P-Locus Defective Pigment Cells Enhances
Melanogenesis: An Indication for P-Locus Function
J. Ancans and A. Thody
Biomedical Sciences, University of Bradford, Bradford, United Kingdom
The product of P-locus (P protein) is essential for melanogenesis and its absence or mutations lead
to hypopigmentary disorders. Although P-protein has been cloned and characterised as a channel in
the melanosomal membrane, its speci®c function has not yet been identi®ed. The original idea that
it acts as a L-tyrosine transporter has not been con®rmed. More recently it has been suggested that
P-protein could have a role in the determination of melanosomal pH. It has been reported that
melanosomes in P-locus defective melanocytes have aberrant pH implicating an involvement of
the P-protein. In this study we investigated whether neutralization of melanosomal pH would
rescue melanogenesis in the P-locus defective pigment cells. We carried out experiments using the
mouse melanocyte line Melan-p1 (P-locus nonfunctional) as well as the wild-type P locus cell lines
Melan-a and Melan-b. Neutralisation of acidic organelles with ba®lomycin A1 (BafA1) or
concanamycin A (ConA) increased melanin content of Melan-p1 cells to a level comparable to that
in Melan-a cells (wild type) while Melan-a cells showed no changes. Melan-b cells which have
wild type P locus but severely reduced melanogenesis, as a result of mutated b locus, did not
respond to neutralization. Furthermore, we observed that BafA1 and ConA restored melanogenesis
in an amelanotic human melanoma line which failed to express mRNA for P-locus. We tested a
panel of cDNA samples from human melanoma cell lines and found that 5 out of 5 amelanotic lines
showed no expression of P-locus. We would suggest that the P-protein has a role in the
neutralisation of melanosomal pH and that this change facilitates melanogenesis. P-protein is
homologous to the E. coli Na+/H+ antiporter and in the light of our ®ndings it is reasonable to
propose that the P-protein functions as a channel which acts to reduce the proton concentration
inside the melanosome.
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Neutralization of Melanosomal pH by Superoxide can be Involved in the Regulation of
Pigmentation
J. Ancans, D. Tobin, M. Hoogduijn, and A. Thody
Biomedical Sciences, University of Bradford, Bradford, United Kingdom
UVR increases the levels of reactive oxygen species (ROS) in the skin. The ®rst to be formed is
superoxide anion (O2
±) and this serves as a precursor for other ROS. Although O2
± can be
cytotoxic at high concentrations, it may have physiological importance in UV mediated effects.
Thus it has been reported that O2
± stimulates melanogenesis in B16 melanoma cells. We now
propose a possible mechanism as to how O2
± acts to increase melanogenesis. The theoretical basis
for our hypothesis is that as O2
± dismutates to other ROS it scavenges protons. We have reported
previously that neutralization of melanosomal pH induces an immediate increase in melanogenesis
and would propose that O2
± facilitates melanogenesis by neutralizing melanosomal pH. To test this
hypothesis we examined (i) whether noncytotoxic concentrations of O2
± will neutralize acidic
organelle pH; (ii) whether O2
± will enhance melanin production in pigment cells and (iii) whether
these effects are correlated. Xanthine oxidase (XO) was used as a source of O2
±. Non-cytotoxic
concentrations of XO (20±50 mU per ml) induced a rapid and complete neutralization of acidic
organelles. This was followed by increases in tyrosinase activity and melanin production. These
effects were observed in mouse B16 cells, human melanoma cells and normal human melanocytes.
Protein synthesis inhibition by cycloheximide had no effect on these increases. Electron
microscopy revealed an accumulation of melanin and a maturation of melanosomes in response to
pH neutralisation. XO did not potentiate the melanogenic effects of other substances, e.g.
ba®lomycin A1 which neutralised melanosomal pH supporting the idea that O2
± acts by the same
mechanism. In conclusion, O2
± neutralizes acidic organelle pH and this change in melanosomal pH
is responsible for its stimulation of melanogenesis. Thus O2
± may have a physiological role in the
UV induced tanning response. This now needs to be investigated in vivo.
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Melanosome Mapping by Puri®cation of Early Stage Melanosomes
T. Kushimoto, V. Basrur, J. Matsunaga, W. Vieira, J. Muller,* E. Appella, and V. Hearing
North CarolinaI, NIH, Bethesda, Maryland; *CBER, FDA, Rockville, Maryland
This study reports a method for stage I/II melanosome puri®cation and relates their characteristics
and what those results imply for the regulation of melanosome biogenesis and function.
Melanosomes were isolated from human MNT-1 melanoma cells following disruption of the cells
with a tissue homogenizer, and separation by sucrose density gradient centrifugation. The 1.0 M
sucrose fraction was found by EM to be enriched in Stage I/II melanosomes and was then further
puri®ed by free ¯ow electrophoresis (FFE). When distribution of proteins and tyrosinase was
assessed in each fraction, they were found to elute at distinct and discrete parts of the FFE gradient.
The speci®c activity of tyrosinase was about 50 times higher than in the starting material with 40%
recovery. Using EM, we found that the tyrosinase rich FFE fraction consisted of almost all Stage II
melanosomes while the high protein density fraction contained mitochondria and other organelles,
including Stage I melanosomes. Using melanosomal protein speci®c antibodies, western
immunoblotting showed that the Stage II melanosome fraction was rich in tyrosinase, DCT,
GP100 (as recognized by HMB45) and MART1. TYRP1 and GP100 (as detected by aPEP13)
was abundant in the high protein concentration fractions. Since reactivity with antibodies that
recognize GP100 (i.e. aPEP13 and HMB45) localized in distinct fractions, we used immuno-EM
to con®rm the speci®city of epitope recognition by those antibodies. The immuno-reactivity of
aPEP13 was found on the exterior surface of the melanosomal membrane, while in contrast,
reactivity with HMB45 was seen only with the internal matrix of melanosomes following
proteolytic cleavage of GP100. These results suggest that Stage I melanosomes initially contain only
TYRP1 and GP100, and that tyrosinase, DCT and MART1 are detectable only after the
formation of Stage II melanosomes which may depend on the proteolytic processing of GP100.
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Induction of Protein Kinase C-b and Tyrosinase mRNA by cAMP-Dependent Pathway
in Cultured Human Melanocytes
H. Park, M. Murphy-Smith, H. Wu, and B. Gilchrest
Dermatology, Boston University, Boston, Massachusetts
Protein Kinase C-b (PKC-b) and cAMP are known to modulate pigmentation. In cultured human
melanocytes, cAMP has been shown to induce the level of PKC-b protein, increasing tyrosinase
activity. To determine if the cAMP-induced increase in PKC-b protein is due to increased
transcription, paired cultures of human melanocytes were examined after removing bovine
pituitary extract and dibutyryl cAMP, agents routinely added to the medium to support the growth
of melanocytes but which raise cAMP above physiologic levels. Cultures were then treated with
100 mM isobutyl methyl xanthine (IBMX) or vehicle for 72 h, by which time IBMX is known to
increase PKC-b protein. Cells were harvested and PKC-b mRNA was measured using Northern
blot analysis. The level of PKC-b mRNA in IBMX-treated cells was 3 times higher in vehicle-
treated cells. The half-life of PKC-b mRNA in IBMX-treated cells, determined in duplicate
cultures of melanocytes using the transcription inhibitor 5,6-dichloro-1-b-D ribofuranosylbenzi-
midazole (DRB) at 25 mg per ml for 0, 4, 8, and 22 h, was greater than 24 h. In parallel the level
and half-life of tyrosinase mRNA was determined. Tyrosinase mRNA in IBMX-treated cells was
2±3 times higher than in vehicle-treated cells; in vehicle treated cells, the half-life of tyrosinase
mRNA was 6±8 h, as previously reported in murine melanoma cells but, in IBMX treated cells, the
half-life was greater than 22 h, suggesting that cAMP increases tyrosinase mRNA stability. Thus,
the cAMP-dependent pathway increases human pigmentation by up regulating PKC-b and
tyrosinase mRNAs.
717
Keratinocytes Play a Role in Regulating Distribution Patterns of Recipient
Melanosomes
R. Boissy and L. Minwalla
Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio
Melanosomes in keratinocytes of Black skin are larger and distributed individually, whereas those
within keratinocytes of Caucasian skin are smaller and distributed in clusters. This disparity
contributes to differences in skin pigmentation and photoprotection, but the control of these innate
melanosome distribution patterns is poorly understood. To investigate this process, cocultures were
developed so that melanosome transfer from the melanocyte to the keratinocyte occurred. This
transfer process was con®rmed by confocal microscopy using melanocytes labelled with a
¯uorescent and electron microscopy (EM). Co-cultures were established using melanocytes and
keratinocytes derived from different pigmentary backgrounds and examined by EM. Melanosomes
transferred to keratinocytes were categorized as individual or in various clusters. Melanosome size
was also determined for individual and clustered melanosomes. Results indicate that in our model
system, melanosomes in keratinocytes from different pigmentary backgrounds have a combination
of clustered and individual melanosomes. However, when keratinocytes from dark skin were
cocultured with melanocytes from (a) dark or (b) light skin, recipient melanosomes were individual
vs. clustered at (a) 77.6% vs. 22.4% and (b) 63.5% vs. 36.5%, respectively. In contrast, when
keratinocytes from light skin were cocultured with melanocytes from (c) dark or (d) light skin,
recipient melanosomes were individual vs. clustered at (c) 33.5% vs. 66.5% and (d) 38.7% and
61.3%, respectively. These results indicate that recipient melanosomes, regardless of origin, are
predominantly distributed individually by keratinocytes from dark skin; and those from light skin
in membrane-bounded clusters. In contrast, melanosome size did not differ between distributation
patterns. These results suggest that regulatory factor(s) within the keratinocyte determine recipient
melanosome distribution patterns.
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The Role of Extension Gene in Bovine Coat Color Determination. Non-Black
Phenotypes are Associated with Transcripts Spliced in the 3¢UT Region
F. Rouzaud, R. Julien,* H. Leveziel,* P. Gallet,* and A. Oulmouden*
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland;
*Unite de Genetique Moleculaire Animale, INRA/Universite de Limoges, Limoges, France
We established the complete structure of the bovine extension gene encoding the G-protein
coupled melanocortin-1 receptor, a seven transmembrane domain protein that controls the
signaling pathway of melanin synthesis in melanocytes. As in human homologue gene, the active
promoter region seems to be associated to the presence of E-boxes and Sp1 binding sites. The 5¢-
upstream region of the four alleles previously identi®ed (E, ED, E1 and e) doesn't present any
polymorphism that can be related to the various eumelanic and/or phaeomelanic coat color
phenotypes. Interestingly, two types of transcripts are detected in skin samples. A ®rst primary
transcript, which has a nucleotide sequence identical to the corresponding genomic DNA, is
observed among all individuals whatever their coat-color phenotypes. In addition, a spliced
transcript is observed only among the skin of the nonblack individuals and in the noncolored skin
regions of spotted animals. Spliced transcripts have lost an alternative intronic sequence of about
200 bp (193±218) overlapping the typical 3¢ downstream position of RNA regulatory elements that
control mRNA stability. The size of introns and exon-intron junctions are speci®c of each coat-
color selected bovine population. The signi®cance of this post-transcriptional process is discussed
considering the role of RNA binding proteins in translation and turnover of messenger RNA.
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Synchronized Maturation of Tyrosinase by Temperature Shift
A. Kamada, I. Wada,* H. Jin, T. Yamashita, H. Kano,* and K. Jimbow
Dermatology of Sapporo Medical University School of Medicine, Society of Japanese Dermatology, Sapporo,
Japan; *Biochemistry of Sapporo Medical University school of Medicine, Society of Japanese Biochemistry,
Sapporo, Japan
Tyrosinase is localized in lysosomes when expressed in nonmelanosomal cells. To elucidate the
intracellular transport mechanism of tyrosinase, we have developed a novel experimental system
using a temperature-shift technique. When wild type tyrosinase was expressed in SiHa cells at
40°C, tyrosinase accumulation was observed in the reticular network but not in granular structure
of lysosome by indirect immuno¯uorescence. To examine if the transport arrest in the endoplasmic
reticulum (ER) is released by lowering the temperature, we added cycloheximide to inhibit
protein synthesis and analyzed the transport during incubation at 37°C. Upon incubation at 37°C,
exit from the ER was clearly detected, and tyrosinase was concentrated at the jaxtanucllear region
at 30 min after the temperature shift. Additional 2 h incubation at 37°C allowed majority of the
expressed molecules to reach granular lysosomal structures. We next determined the enzyme
activity of the cell extracts to see if the transport arrest at 40°C was caused by misfoldng. Indeed,
little DOPA oxidase activity was detected when incubated at 40°C. However, the oxidase activity
became detectable by incubation of the cells at 37°C, suggesting that the expressed tyrosinase was
reversely arrested in the ER due to aberrant folding at 40°C by the quality control machinery.
Thus, we conclude that maturation of tyrosinase could be synchronized by temperature-shift,
providing a novel approach to analyze intracellular transport mechanism of melanosome-associated
proteins.
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Proper Folding and ER to Golgi Transport of Tyrosinase are Induced by its Substrates,
DOPA and Tyrosine
R. Halaban, E. Cheng, S. Svedine,* R. Aron,* and D. Hebert*
Dermatology, Yale University Sch Medical, New Haven, Conneticut; *Biochemistry & Molecular Biology,
University of Mass, Amherst, Massachusetts
Tyrosinase is essential for pigmentation, and is a source of tumor-derived antigenic peptides and
cellular immune response. Wild type tyrosinase in melanoma cells and loss of function albino
mutants in untransformed melanocytes are misfolded proteins that are retained in the endoplasmic
reticulum (ER), subsequently retranslocation to the cytosol and targeted to proteolytic degradation
by the 26S proteasome. Here we demonstrate that tyrosinase catalytic activation is required for
proper folding and ER exit. The cofactor and substrate DOPA, in the presence of tyrosine,
induced in melanoma cells within hours of exposure a transition in tyrosinase from the misfolded to
the native form, that is resistant to proteolysis, competent to exit the ER, and able to produce
melanin. Since tyrosinase's enzymatic activity is induced by DOPA, we propose that proper
folding of the wild type protein, just like mutant forms, is tightly linked to its catalytic state. Loss of
pigmentation therefore in tyrosinase-positive melanoma cells is a consequence of tumor induced
metabolic changes that suppress tyrosinase activity within these cells. Since solid human tumors,
including melanomas, induce acidi®cation of their extracellular milieu, largely in response to
anaerobic glycolysis and accumulation of lactic acid, we suggest that these metabolic changes affect
tyrosinase activity within the ER.
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Abnormal Tyrosinase Processing and Fate in Melanocytes Lacking the Pink-Eyed
Dilution Gene
K. Chen, P. Manga, and S. Orlow
Cell Biology, NYU school of Medicine, New York, New York
Pink-eyed dilution gene (p) mutations result in Oculocutaneous Albinism Type 2, the most
common form of albinism. The processing of tyrosinase, which catalyzes the rate limiting reaction
in melanin synthesis, was investigated in melan-p1 melanocytes which are null at the p locus.
Electron Microscopy detected a high numbers of 50 nm vesicles which contain active tyrosinase in
Melan-p1 cells, but only a small number are present in wildtype melanocytes. Triton-X114 phase
separation and Endoglycosidase H digestion show that tyrosinase processing is altered in the
absence of p expression. A fraction of tyrosinase is retained in the Endoplasmic Reticulum while
the remainder undergoes further processing and appears to be proteolyzed at an increased rate. The
proteolyzed tyrosinase is no longer membrane bound, but remains enzymatically active and much
of it is secreted into the culture medium of melan-p1 cells. Small gradient fractions enriched for
small vesicles contained predominantly proteolyzed tyrosinase. Our results suggest that an increased
proportion of tyrosinase is misfolded and prematurely proteolyzed in melan-p1 melanocytes. Much
of the proteolyzed tyrosinase is transported in small vesicles and is subsequently secreted rather than
reaching the melanosome. The pink-eyed dilution protein may thus play a role in the ER
processing of tyrosinase.
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Interaction of Tyrosinase Related Protein-1/gp75 with PDZ-domain Protein GIPC:
Relationship to Biosynthesis and Intracellular Sorting
T. Liu, G. Kandala, N. Sangha, and V. Setaluri
Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Interactions of cytosolic proteins with determinants on the cytoplasmic domains of vesicular
membrane proteins play a critical role in intracellular sorting, vesicular targeting and biogenesis of
organelles. Cytoplasmic domains of melanosomal membrane proteins tyrosinase and tyrosinase
related proteins (TRPs) contain signals for melanosome targeting. We employed the yeast two-
hybrid screen and identi®ed a protein that interacts with the cytoplasmic domain of gp75/TRP-1,
the most abundant melanosomal membrane protein. The gp75 interacting protein (GIP) encoded
by a partial 1.4 kb cDNA fragment has a single PDZ domain. Immunoprecipitation of gp75 from
detergent extracts of COS cells transfected with epitope-tagged GIP and gp75 ef®ciently
coprecipitated GIP. Deletion of carboxyl (C) terminal amino acids QSVV of gp75 abolished its
interaction with GIP. Substitution of amino acids residues in the lysosomal/melanosomal sorting
signal of gp75 did not affect this interaction. GIP did not bind tyrosinase tail which lacks C-
terminal QSVV sequence, but tyrosinase tail with two C-terminal residues mutated to valines
bound to GIP ef®ciently. Immuno¯uorescence analysis of COS cells transfectants showed
colocalization of gp75 and GIP in a subset of intracellular vesicles. Cotransfection with mutant
gp75 proteins showed that binding to gp75 determines cellular distribution of GIP. Amino acid
sequence of GIP is identical to the sequence of GIPC, a protein that binds to RGS-GAIP (a
regulator of G protein signaling) localized to clathrin-coated vesicles and to the sequence of
SEMCAP-1, a neural semaphorin binding protein. Thus, speci®c interaction of a multifunctional
PDZ domain protein with gp75 suggests that gp75 and presumably other TRPs play novel
nonenzymatic roles in melanogenesis through interaction of cytosolic proteins with their tails.
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Tyrosinase and Tyrosinase Related Protein-1 (TRP-1) Require rab7 for the Intracellular
Transport from TGN to Melanosomes, Passing Through Early and Late Endosomes
K. Hirosaki, T. Yamashita, I. Wada,* H. Jin, and K. Jimbow
Department of Dermatology, Sapporo Medical University school of medicine, Sapporo, Japan; *Department of
Biochemistry, Sapporo Medical University school of medicine, Sapporo, Japan
Tyrosinase and tyrosinase-related proteins (TRPs) are glycosylated membrane-bound melanogenic
proteins. They are transported from endoplasmic reticulum (ER) to trans Golgi network (TGN)
and ®nally to melanosomes. Previously, we have proposed that late endosomes and rab7 are also
involved for tyrosinase transport between TGN and melanosomes. In order to further investigate
the vesicular transport process of tyrosinase and TRP-1, we expressed these melanogenic proteins,
by using recombinant adenoviruses, in amelanotic SK-MEL-24 human melanoma cells in the
presence or absence of dominant-negative rab7 mutant (rab7 N125I). Tyrosinase and TRP-1
became detectable in 4±5 h within the cytoplasm and, in the case of Ad-HT (tyrosinase) infection,
melanin production was observed from 24 h. To further clarify the intracellular localization and the
involvement of early late endosomes for the transport of tyrosinase and TRP-1 to melanosomes,
SK-MEL-24 cells were infected with Ad-lacZ (¦AÁ -galactosidase), Ad-rab7 wt (wild type rab7) or
Ad-rab7 N125I for 48 h and then with Ad-HT (tyrosinase) or Ad-TRP-1 (TRP-1). Speci®c
intracellular localization was identi®ed by mono- or poly clonal antibody speci®c for detecting
tyrosinase or TRP-1, respectively. They were also processed to double immuno-staining using
early and late endosome markers. We found that (a) melanin synthesis was much lower in Ad-
rab7 N125I mutant than in Ad-rab7 wt infectants (b) the transport of tyrosinase and TRP-1 from
TGN to late endosomes was blocked in the rab7 N125I mutant infectants, and (c) they were
localized in the enlarged granules which also expressed EEA-1, early endosome marker. Our results
strongly indicate that transport of tyrosinase and TRP-1 requires rab7, passing through
compartments of both early and late endosomes before targetted to melanosomes.
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Melanosomes from Human Melanocytes Express the GTP-Binding Protein cdc42 and
cdc42-Effector Molecules PAK-1 and N-WASP: Analysis of the Role of cdc42 in
Melanosome Transfer to Keratinocytes
G. Scott, S. Leopardi, S. Printup, and B. Madden
Department of Dermatology, University of Rochester, Rochester, New York
Melanosomes are specialized melanin-containing organelles that arise from the Golgi apparatus, are
transported on microtubules to the melanocyte (MC) dendrite tip and then are transferred to
keratinocytes (KC). The mechanisms of melanosome transfer to KC are poorly understood. We
present evidence to suggest that melanosome transfer to KC is mediated by the GTP-binding
protein cdc42, a protein involved in actin-based ®lopodia formation in neuronal cells, and by the
cdc42 effector proteins PAK-1 and N-WASP. Human MC-KC cocultures were placed in a heated
chamber perfused with media and viewed under Nimarsky optics on a Nikon Eclipse 800
microscope at 1003. Sequential digital images were obtained with a Spot camera at 8-s intervals.
Images obtained with 10 pixels/micron were further processed using Matlab and converted to
Quick Time Movies. Melanosomes were observed in ®lopodia-like structures arising from the tips
of the dendrites. Filopodia were as long as 16 microns in length, and were dynamically active. Bi-
directional movement of melanosomes along ®lopodia and insertion of ®lopodia into KC was
observed with subsequent transfer of melanosomes to KC. Confocal microscopy of MC dual
labeled for actin and melanosomal proteins (myosin V and/or tyrosinase related protein-2)
con®rmed the presence of melanosomes in ®lopodia as did electron micrographs of MC-KC
cocultures. Because of the well-documented role of cdc42 and its effector proteins N-WASP and
PAK-1 in ®lopodia formation in neuronal cells, we examined the expression of these proteins in
human MC by immuno¯uorescence staining/Confocal microscopy and Western blotting. Cdc42
colocalized with tubulin and b-COP (a Golgi maker), as well as melanosomes. Melanosomes
isolated from human MC by sucrose density ultracentrifugation expressed the cdc42 effector
proteins PAK1 and N-WASP by Western blotting, as well as cdc42. We suggest that melanosomes
act as chaperones to escort N-WASP and PAK1 to the dendrite tip, which, in combination with
cdc42, induce ®lopodia formation and transfer of melanosomes to KC. In combination with our
previous work showing SNARE proteins and rab3a on melanosomes, proteins involved in
membrane fusion and exocytosis, respectively, our observations suggest a novel model for
melanosome transfer to KC.
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Melanocyte Dysfunction in Hermansky±Puklak Syndromes (HPS-1 & 2)
R. Boissy, M. Huizing,* Y. Zhao, R. Sarangarajan, and W. Gahl*
Dermatology, University of Cincinnati College of Medicine, Cincinnati, Ohio; *NICHD, NIH, Bethesda,
Maryland
Hermansky±Pudlak Syndrome Type 1 (HPS-1) results from mutations in the HPS gene that
encodes a 79.3-kDa soluble protein that can form part of a high molecular weight complex of
unknown function. Melanocytes cultured from HPS-1 demonstrate suppressed tyrosinase activity
and altered localization of melanocyte speci®c proteins. Tyrosinase, tyrosinase related protein-1
(TRP-1), and ME-491 were localized to large, membranous complexes throughout the
melanocytes and relatively absent from melanosomes. Recapitulation of the hypomelanosis,
fromation of large membranous complexes, and altered traf®cking of tyrosinase in melanoma cells
transfected with antisense HPS-1 cDNA con®rmed that the HPS-1 protein is required for
successful targeting of melanocyte speci®c proteins to the premelanosome. Localization studies
indicate that HPS-1 may be associated with a cisternal network outside of the Golgi zone in normal
melanocytes. HPS-2 results from mutations in the b-3 A subunit of the heterotetrameric adaptin
complex AP-3. Melanocytes from HPS-2 demonstrated a dramatically reduced expression of b-
3 A. HPS-2 melanocytes exhibited normal distribution of TRP-1, LAMP-1, LAMP-3 and rab27
throughout the cell body and along the dendrites. In contrast, tyrosinase expression was reduced
and predominantly restricted to the perinuclear regions of HPS-2 melanocytes. Tyrosinase
juxtapositioned to and localized in large vesicles resembling late endosomes as demonstrated by
DOPA histochemistry at the EM level. This abnormal localization of tyrosinase could be corrected
with transfection of the AP-3 cDNA into HPS-2 melanocytes. These data suggest that tyrosinase
traf®cking to the melanosome is regulated in part by AP-3, independent of TRP-1.
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Intracellular Distribution and Late Endosomal Effects of the Ocular Albinism 1 Gene
Product: Consequences of Disease-Causing Mutations and Implications for
Melanosome Biogenesis
B. Rosenberg, B. Shen, and S. Orlow
Department of Dermatology, NYU School of Medicine, New York, New York
In order to elucidate the molecular pathogenesis of ocular albinism type 1, we examined the
intracellular distribution and subcellular effects of wild type Oa1 and Oa1 constructs re¯ecting
mutations causing X-linked ocular albinism. To this end. we employed constructs containing
either wild typemurine Oa1, or Oa1 constructs containing missense mutations, fused to green
¯uorescent protein in a COS cell expression system. Comparison with different organelle markers
revealed that wild type Oa1-GFP localized to the late endosomal/lysosomal compartments. Some
Oa1 constructs bearing disease-causing mutations failed to exit the ER (Class I mutants), while
other mutants partially (Class II mutants) or fully (Class III mutants) exited the ER and traf®cked to
endolysosomal compartments. We observed that expression of wild type Oa1-GFP in COS cells
caused an enlargement of late endosomes, and redistribution of the late endosomal markers
mannose-6-phosphate receptor (M6PR) and lysobisphosphatidic acid (LBPA). Only a subset of the
mutants (Class III) examined were capable of causing LE enlargement, and none of the mutants
displayed the full range of effects on M6PR and LBPA exhibited by wild type Oa1. The effects of
Oa1 on LE structure and content are thus likely to re¯ect an important biological property of Oa1.
In its absence, late-endosome derived melanin macroglobules may accumulate at the expense of
normal melanosomes, thus leading to albinism. Our results suggest that the late endosomal
compartment plays a central role in melanosome biogenesis and that OA1 controls a critical step in
the process.
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Identi®cation of a Novel Moab J1 Which Recognizes Luminal Structure of Lysosomes
Common To Melanosomal Compartment in Late Stage of Melanogenesis
K. Shinoda, I. Wada,* H. Jin, and K. Jimbow
Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan; *Department
of Biochemistry, Sapporo medical University School of Medicine, Sapporo, Japan
Melanogenesis cascade may directly/or indirectly link to the dynamics of endosome-lysosome
biogenesis. Our recent gene-transfection studies suggested that tyrosinase and tyrosinase-related
proteins (TRPs) are transported from trans Golgi network (TGN) to late endosomes and
subsequently to melanosomes. However, little is known about how and to what extent the
biogenesis of melanosomes and lysosomes are related. The objective of this study is to further
identify the involvement of endosome-lysosome system in melanosome biogenesis. Speci®cally this
study utilized a new antibody ``J1'', which we identi®ed in the process of developing monoclonal
antibodies (MoAbs) against human melanosomes. MoAb J1 appeared to identify a new luminal
component of lysosomal granules. It was also reactive with not only melanotic and amelanotic
melanoma cells (e.g. MeWo, SK-MEL-23 and SK-MEL-24) but also nonmelanoma cells (e.g.
MRC5 ®broblasts and Hela cells). To identify the J1-positive structures, we sequentially stained
the cells with a series of well-characterized probes incuding Alexa-488 conjugated pepstatin for
lysosomal luminal content and antibodies against lgp85 (lysosomal membranes), syntaxin 8 (late
endosomes), EEA1 (early endosomes), KDEL (ER) as well as tyrosinase (melanosomes). We found
that (1) J1 antigen was expressed in glanular structures which colocalized with lysosomal
luminalprotein in the entire cytoplasm of melanoma and nonmelanoma cells, but more extensively
melanotic melanoma cells (2) J1 also stained most of the tyrosinase-positive granules (3) J1 antigen
was coexpressed with many (c. 30±40%) of lgp85 positive granules, and (4) J1 did not stain
structures which were positive with late/early endosomal or ER markers. Based upon these results,
we concude that J1 possesses a novel antigen epitope that is expressed in the melanogenic cascade
common to a luminal component of both melanosomal and lysosomal compartments, being
speci®cally involved in the late stage of melanosome biogenesis.
728
Expression of Microtubule-Associated Protein 2 in Benign and Malignant Melanocytes:
Implications for Differentiation and Progression of Cutaneous Melanoma
D. Fang, J. Hallman,* N. Sangha, T. Kute,* J. Hammerback,² W. White, and V. Setaluri
Dermatology & Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North
Carolina; *Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina;
²Neurobiology & Anatomy, Wake Forest University School of Medicine, Winston-Salem, North Carolina
Cutaneous melanocytic neoplasms are known to acquire variable characteristics of neural crest
differentiation. Melanocytic nevus cells in the dermis and desmoplastic melanomas often display
characteristics of nerve sheath differentiation. The extent and nature of neuronal differentiation
characteristics displayed by primary and metastatic melanoma cells is not well understood. Here, we
describe induction of a juvenile isoform of microtubule-associated protein 2 (MAP-2c) in cultured
metastatic melanoma cells by the differentiation-inducer hexamethylene bisacetamide (HMBA).
Up-regulation of this MAP-2 isoform, a marker for immature neurons, is accompanied by
extended dendritic morphology and down-regulation of the melanocyte-differentiation marker
tyrosinase-related protein 1 (TYRP1/gp75). In a panel of cell lines that represent melanoma tumor
progression, MAP-2c mRNA and the corresponding ~70 kDa protein could be detected
predominantly in primary melanomas. Immunohistochemical analysis of 61 benign and malignant
melanocytic lesions showed abundant expression of MAP-2 protein in melanocytic nevi and in the
in situ and invasive components of primary melanoma, but only focal heterogeneous expression in a
few metastatic melanomas. In contrast, dermal nevus cells and the invasive cells of primary
melanomas, which stained positive for MAP-2, were TYRP1 negative. This reciprocal staining
pattern in vivo is similar to the in vitro observation that induction of the neuronal marker MAP-2 in
metastatic melanoma cells is accompanied by selective extinction of the melanocytic marker
TYRP1. Our data show that neoplastic melanocytes, particularly at early stages, retain the plasticity
to express the neuron-speci®c marker MAP-2. These observations are consistent with the notion
that both benign and malignant melanocytes in the dermis can express markers of neuronal
differentiation.
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DCoH/PCD (Dimerization Cofactor of Hepatocyte Nuclear Factor 1/pterin-4a-
carbinolamine Dehydratase) is Crucial for Pigmentation in Xenopus and
Overexpressed in Primary Human Malignant Melanoma
U. Hengge, E. Pogge von Strandmann,* and S. Senkel*
Department of Dermatology, Venerology and Allergy, University of Essen, 45122 Esssen, Germany;
*Institute of Cell Biology (Cancer Research), University of Essen, 45122 Essen, Germany
DCoH/PCD is a positive cofactor of theHNF1 homeobox transcription factors as well as an
enzyme catalyzing the regeneration of tetrahydrobiopterin. Dysfunction of DCoH/PCD is
associated with the human disorders hyperphenylalaninemia and vitiligo. In this study loss of
function experiments using DCoH/PCD speci®c antibodies injected into fertilized Xenopus eggs
demonstrated that the protein is absolutely necessary and also suf®cient for pigment formation. In
normal human skin DCoH/PCD protein was weakly expressed in the basal layer of the epidermis,
whereas high protein levels were detectable in several melanoma cell lines and primary malignant
melanoma. The DCoH/PCD overexpression was restricted to and identi®ed all of the melanoma
cells. Comparison with the commonly used melanoma markers S100 and HMB45 demonstrates
that DCoH/PCD had an overlapping but distinct expression pattern. In addition to human colon
cancer, this is the second report about the overexpression of DCoH/PCD in human tumor cells
indicating that the protein may play a role in carcinogenesis.
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An Alternative Approach to Depigmentation by Soybean Extracts via Inhibition of the
PAR-2 Pathway
C. Paine, E. Sharlow, F. Liebel, M. Eisinger, S. Shapiro, and M. Seiberg
Skin Research Center, J & J CPWW, Skillman
The Protease-activated receptor-2 (PAR-2) is expressed on keratinocytes but not on melanocytes.
PAR-2 is involved in the regulation of pigmentation, affecting melanosome phagocytosis by
keratinocytes. Inhibition of PAR-2 activation by serine protease inhibitors results in skin lightening
in vivo, suggesting a new class of depigmenting mechanism and agents. Natural agents that affect the
PAR-2 pathway were tested for their possible modulation of pigmentation. Here we show that
soymilk and the soybean-derived serine protease inhibitors STI and BBI inhibit PAR-2 cleavage,
affect cytoskeletal and cell surface organization and reduce keratinocyte phagocytosis. The
depigmenting activity of these agents and their ability to prevent UV induced pigmentation are
demonstrated both in vitro and in vivo. These results suggest that the inhibition of the PAR-2
pathway by soymilk may be used as a natural alternative to skin lightening.
731
Neural Factors Play a Role in the Pathogenesis of Vitiligo
G. Orecchia, M. Cucchi, P. Frattini, and G. Santagostino
Dermatology, University of Pavia, Pavia, Italy
In order to con®rm a relationship between vitiligo and the activity of mono-aminergic systems, we
measured by high-pressure liquid chromatography and electrochemical detector (HPLC-ED): (1)
plasma levels of some cate-cholamines such as norepinephrine (NE), epinephrine (E) and
dopamine (DA), their precursor 3,4 dihydroxyphenylalanine (DOPA), their metabolites
[normetanephrine (NMN), metanephrine (MN), 3-methoxy-4-hydroxyphenyl-glycol (MHPG),
vanillylmandelic acid (VMA), homo-vanillic acid (HVA)] and 5-hydroxyindolacetic acid (5-
HIAA), as the major metabolite of serotonin; and (2) urinary excretion values of the same
parameters plus vanillylmandelic acid (VMA) in 25 healthy subjects and in 47 patients suffering
from nonsegmental vitiligo at different stages of disease. Plasma and urinary mean values of the
biological markers were higher in vitiliginous subjects, mainly in the subgroup of patients at an
active phase of disease (n = 37/47), than in controls. The difference was signi®cant for all
parameters, except for plasma and urinary HVA. The patients with progressive vitiligo and at its
more recent onset (< 1 years) showed increased levels of all considered parameters than longer-term
sufferers. No signi®cant differences were observed in patients subdivided according to the type of
vitiligo or the age of onset. Signi®cant intercorrelations were noted both in plasma and in urine
among noradrenergic markers as well as between HVA and 5-HIAA. The higher catecholamine
and metabolite levels indicate that the activity of monoaminergic systems is increased in the early
phase of vitiligo, a fact which may probably have a role in the onset of the disease itself.
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Recombined Human/Porcine Skin Methodology for Vitiligo
P. Arenberger, B. Havlickova, and E. Matouskova*
Department of Dermatology, Charles University School of Medicine, Prague 10, Czech Republic; *Molecular
Genetics, Academy of Sciences, Prague 6, Czech Republic
Vitiligo is characterised by the loss of skin pigmentation due to the destruction of melanocytes. The
treatment is usually dif®cult. For stable cases the melanocyte transplantation is the method of
choice. The newly developed treatment with recombined human/porcine skin methodology
permitting easy handling of the graft is described in the present work. In vitiligo patients,
autologous epidermal cells were obtained from pigmented thin skin biopsies. The cells were
cultured on a dried cell-free porcine dermis with the 3T3 feeder layer technique. After 10 days
melanocytes were regularly dispersed in con¯uent keratinocyte cultures. Upside-down delivery of
epidermal cells was used. The epidermal layer was directly applied onto the dermabraded vitiligo
lesion with porcine dermis covering the lesion. The pigmentation started to be visible 4±6 weeks
after grafting. After using of the above described methodology the pigmentation appeared in the
range of 65±80% of the grafted area. Additional UVA irradiation enhanced the treatment success
up to 100%. The surgical vitiligo treatment appears to be a reasonable method of choice in stable
vitiligo cases of a disease duration for at least two years which means for approximately 5% of all
vitiligo patients.
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Treatment of Vitiligo with Broadband Ultraviolet B
A. Hardick, P. Don, A. Iuga, and K. Hardick
Dermatology, New York Medical College, Metropolitan Hospital Campus, New York, New York
While oral PUVA remains the most popular therapeutic modality for vitiligo, recent reports have
shown that narrowband UVB can also induce signi®cant repigmentation. In this study, we
attempted to evaluate the ef®cacy of broadband UVB on actively spreading vitiligo. Nine patients
with actively spreading vitiligo were exposed to broadband UVB two to three times per week at a
starting dose of 20±30 mJ per cm2. Radiation was increased 10 mJ per cm2 per session with
adjustments for symptomatic erythema or missed visits. The response to treatment and side-effects
were assessed at each visit. Broadband UVB halted the progression of vitiligo in all nine patients
and induced early repigmentation after 6±12 treatments (2±4 weeks). After 2±8 months of
treatment, eight out of nine patients achieved good (51±75%) or excellent (76±100%) response.
The percent of repigmentation varied with length of treatment and anatomic site. This study
con®rms the only published report that broadband UVB is effective on actively spreading vitiligo.
Since it is more cost effective than narrowband UVB and has numerous advantages to oral PUVA,
broadband UVB may offer an alternative for future treatment of vitiligo.
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Photoprotective Melanogenesis Induced by Bicyclic Monoterpene Diols
D. Brown, J. Galvin, M. Canning, A. Brown, D. Both, and D. Yarosh
AGI Dermatics, Freeport, New York, New York
The purpose of this study was to investigate agents that induce a natural tan without exposure to
damaging solar radiation. Previous studies have shown that a variety of aliphatic and alicyclic diols
induce melanogenesis in S91 mouse melanoma cells, normal human epidermal melanocytes, and
guinea pig skin (J Invest Dermatol 10:428±437, 1998). The most potent compounds examined
previously were the bicyclic monoterpene (BMT) diols 5-norbornene-2,2-dimethanol and 2,3-cis/
exo-pinanediol. These compounds induced melanogenesis in S91 cells via the nitric oxide/cyclic
guanosine monophosphate/protein kinase G pathway (Pigment Cell Res 12:36±47, 1999). More
recently, novel BMT diols have been synthesized that are 5- to 10-fold more potent than previous
compounds with regards to induction of melanogenesis and nitric oxide. These new compounds
include 2,2-dimethyl-3-(2,3-dihydroxy-propan-3-yl)-norbornane (1S,5S)-(±)-6,6-dimethylbicy-
clo[3,1,1]heptane-2,2-dimethanol, and (1R)-(±)-6,6-dimethylbicyclo [3,3,1]hept-2-ene-2,3-di-
methanol. Pilot studies using 2,3-cis/exo-pinanediol and 2,2-dimethyl-3-(2,3-dihydroxy-propan-
3-yl)-norbornane showed that these induce tanning when encapsulated in liposomes and applied at
20 mM to human skin. Induction of melanogenesis by 250 and 500 mM 2,3-cis/exo-pinanediol in
S91 cells was associated with 20% reductions of cyclopyrimidine dimers produced by subsequent
irradiation with 125 J per m2 UVB. This suggests that tanning induced by BMT diols may be
photoprotective in human skin.
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Nevogenesis and Differential Expression of Matrix Metalloproteinases
E. Gontier, J. Surleve-Bazeille, M. Cario-Andre, and A. Taieb
Laboratoire PMTG, university bordeaux II, Bordeaux, France
Congenital nevi are constituted by pigment cells bearing common features with melanocytes but
showing altered differentiation leading to nesting and dermal location. In a reconstructed epidermis
seeded with a combination of keratinocytes and various sources of pigment cells, we have studied
the formation of nests and the dermal passage of those cells in correlation with the secretion of
matrix metalloproteinases (MMP2 et 9). Dermal nevus cells were shorty cultured, with normal
melanocytes and melanoma cells used as controls. In reconstructs, a positive correlation was
established between the increasing percentage of seeded nevocytes and the pigmentation of
reconstructs as well as the clustering of cells in junctional nests. However, the presence of
nevocytes in the dermis of reconstructs was never detected during the time-span of the
experiments. MMP 9 was never expressed in congenital nevus cells whereas MMP2 was
constitutively expressed by all strains of congenital nevus cells. Previous studies had shown that
melanocytes produced comparable amounts of both MMP2 and MMP9, and that Bowes
melanoma cells secrete a marginal level of MMP2. So, nñvus cells would correspond to an
intermediate status of differentiation between normal melanocytes and melanoma cells. Activation
of MMPs by a cofactor or activation of another pathway seems necessary to provoke the dermal
passage of nevus cells.
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Mutagenesis in Dysplastic (Atypical) Nevus Cells may be Caused by Increased Oxidative
Stress
S. Pavel, F. Van Nieuwpoort, J. Van der Meulen,* N. Smit, A. Mommaas,* and H. Koerten
Dermatology, Leiden University Medical Center, Leiden, Netherlands; *Electron Microscopy, Leiden
University Medical Center, Leiden, Netherlands
There are indications that in dysplastic (atypical) nevi the composition of melanin is abnormal. We
utilized X-ray microanalysis to measure different elements in the melanosomes of histologic
preparations of 12 atypical nevi and compared the results with those obtained from the
melanosomes of normal skin of the same individuals. The atypical nevi originated from
heterogeneous group of patients with solitary or multiple nevi, with or without the history of
familial melanoma. Our results show that the melanosomes of clinical atypical nevi synthesize
signi®cantly more pheomelanin. Since polymer melanin contains many carboxyl groups it can
function as a weak cation exchanger. In many cases of dysplastice nevus cells we found highly
elevated melanosomal concentration of calcium and iron. This is the indication of increased
concentation of these metal ions in the cytoplasm. The elevated concentrations of calcium and iron
can be explained by the existence of chronic oxidative stress in these cells. Using a model situation
we demonstrate that the increased iron concentration can be caused by iron liberation from ferritin
molecules by leaking pheo- and/or eumelanin precursors. Liberated iron ions can bind to
phosphate groups of DNA. Such situation is connected with the increased risk of oxidative DNA
damage and mutagenesis.
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Computerized Digital Image Analysis can Improve the Detection of Potentially
Dangerous Pigmented Skin Lesions
M. Jamora and J. Bystryn
Dermatology, NYU School of Medicine, New York, New York
Melanoma is completely curable if resected early. Unfortunately, early melanoma can lack the
clinical features that are used for diagnosis. Diagnostic accuracy can be improved by dermoscopy,
but this requires experience which is dif®cult to master. Computerized digital analysis instruments
have now been developed to assist in determining whether or not a pigmented lesion is potentially
dangerous and needs to be biopsied. One such instrument is the DermoGenius System
(Rodenstock Precision Optics, Munich, Germany). Lesions are scanned and the digital images
analyzed using an algorithm that assesses asymmetry of color and shape, border qualities, color
variegation and homogeneity, and structural components. A score = 2 suggests an increased chance
of melanoma and warrants a biopsy. To evaluate whether this instrument can improve the
management of pigmented lesions, we biopsied 18 pigmented lesions that appeared clinically
benign to an experienced dermatologist. The lesions were biopsied based on having a computer-
generated score of = 2.0. The lesions were biopsied based on a computer-generated score
suggestive of an increased chance of the lesion being melanoma. The software used to generate the
score was a precursor (beta) version of the ®nal one to be developed. Histologically, 1 lesion was a
dysplastic nevi with cytotoxic atypia that should have been removed. Nine of the lesions were
ordinary dysplastic nevi, and the balance were benign intradermal nevi. These results suggest that
computerized image analysis can improve the evaluation of pigmented skin lesions by
recommending the biopsy of clinically unsuspicious but potentially dangerous lesions that might
have otherwise been neglected.
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Real Time Microscopical Observations of Melanocytes and their Responses to a-MSH
in a Transparent Skin Equivalent
J. Ancans, M. Hoogduijn, M. Tsatmali, S. Britland, and A. Thody
Biomedical Sciences, University of Bradford, Bradford, United Kingdom
It is known that a-MSH stimulates skin pigmentation in humans. While this involves an increase
in melanogenesis in melanocytes, new evidence suggests that the pigmentary response to a-MSH
also involves effects on melanocyte dendricity, motility and interactions with keratinocytes. These
processes have been studied in monolayer cultures but not in 3D models which resemble more
closely in vivo conditions. The aim of this study was to investigate whether transparent skin
equivalents (MelanoDerm(tm)), containing melanocytes, can be used to monitor these parameters
and any effects that a-MSH may have. Initially we carried out immunohistochemical
characterisation of the skin equivalent using mAbs Mel-2, Mel-5, NKI-beteb, NCL-c-kit and
anti-E-Cadherin. The patterns of staining for all ®ve markers was similar to those seen in human
epidermis except for reduced expression of c-kit in the skin equivalent. We went on to measure
tyrosinase activity. Labelled L-tyrosine was added to the skin equivalents and tritiated water
production measured in the presence and absence of 10 nM a-MSH on days 1, 2 and 3. These
experiments showed that skin equivalents, prepared with melanocytes from Asian donors, were
melanogenically active and responsive to a-MSH. Real time observations of melanocytes in the
skin equivalent were carried out at 4003 magni®cation using time lapse photography (8 frames per
hour) over 24 h. Melanocyte motility, dendricity and motility of dendrites was observed.
Preliminary results indicated that a-MSH reduces the motility of the melanocyte cell body but
increases the numbers and pulsatile behaviour of the dendrites. Our results show that melanocytes
in MelanoDerm skin equivalents express melanocyte markers, are melanogenically active, capable
of responding to MSH and suitable for time lapse observations. In conclusion, the transparent skin
equivalent may prove to be a useful experimental model for studying pigmentary responses.
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Restoration of Pigmentation in Cutaneous Wounds by Titration of Melanocytes into
Cultured Skin Substitutes Grafted to Athymic Mice
V. Swope, A. Supp,* G. Warden, and S. Boyce
Department of Surgery, University of Cincinnati, Cincinnati, Ohio; *Research Department, Shriners Burns
Hospital, Cincinnati, Ohio
Hypopigmentation after grafting of cultured skin substitutes (CSS) results in long-term morbidity
to patients. Hypothetically, morbidity from hypopigmentation may be reduced by addition of
suf®cient melanocytes to restore uniform skin color. To address this hypothesis, CSS were
prepared from cultured human keratinocytes and ®broblasts attached to collagen-based substrates.
Cultured human melanocytes from a black donor (melanin content = 90.8 mg per 106 cells) were
added to keratinocytes (1.1 3 106 cells per cm2) of CSS at inoculation densities of 0.0%, 0.01%,
0.10%, and 1.0%, incubated 18 days and grafted to full-thickness skin wounds in athymic mice. On
culture day 14 in vitro, and 12 weeks after grafting, pigmentation was assessed with a Minolta
Chromameter to determine surface darkness. Pigmented areas of healed CSS were determined by
tracing and planimetry at 12 weeks after grafting. Data from each condition were compared using
one-way ANOVA to identify signi®cant differences (p < 0.05 vs. all other groups). Data are
expressed as Chromameter L* values (black = 0; white = 100), and percentage pigmented area.
Chromameter L* values were signi®cantly lower for the 1% group compared to other groups at
14 days in vitro, and signi®cantly greater for either the 0.0% or 0.01% group compared to other
groups at 12 weeks after grafting. Similarly,% pigmented area was signi®cantly lower than all other
groups for CSS with 0.0% or 0.01% melanocytes, was 100% pigmented in CSS with 1% added
melanocytes, and was proportionate to melanocyte density. These results demonstrate that
cutaneous pigmentation can be restored with a melanocyte density of 1% of keratinocytes
(1.1 3 104 cells per cm2) in CSS, and that clinical morbidity from hypopigmentation can be
reduced or eliminated by addition of cultured melanocytes to CSS used for wound repair.
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Improvements to MelanoDermTM, An Epidermal Model Containing Functional
Melanocytes For Skin Lightening Studies
J. Kubilus, M. Klausner, P. Neal, and B. Breyfolgle
R & D, MatTek Corporation, Ashland, Massachusetts
Clinical skin lightening studies often run in excess of 3 months duration and are very costly.
Therefore, there is considerable interest in developing methodology using cultured skin tissues to
perform such studies in vitro. Towards this end, we have produced MelanoDerm, a highly
differentiated, three-dimensional tissue culture model of human epidermis that contains normal
human melanocytes (NHM) and keratinocytes (NHK). Cultures have been produced containing
NHM of varying skin phototypes and pigmentation levels of the tissues follow the expected order,
i.e. BlackAsianCaucasian. One previous limitation in utilizing such tissues has been the gradual
decline in the tissue morphology. Over a 3-week period, tissues maintained in medium containing
b-FGF and a-MSH (LLMM) gradually decrease in the number of viable cell layers (basal to
granular layer, inclusive). Also, melanocytes with tissue maintained in LLMM have a tendency to
clump and lose dendricity over this time period. To address these drawbacks, a new maintenance
medium (NMM) has been developed which omits stimulators of melanogenesis yet maintains
epidermal structure (almost without any decline) over periods of at least 4 weeks. In addition,
melanocytes within the tissue remain distinct and highly dendritic. Quantitative melanin assay
results show that melanin levels in tissues grown in LLMM and NMM are equivalent. These results
demonstrate that MelanoDerm cultured in NMM will be useful for extended studies of
melanogenesis and skin lightening.
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Calgranulin C is Overexpressed in Psoriatic Skin In Vivo
A. Mirmohammadsadegh, E. Tschakarjan, B. Dexling, and U. Hengge
Department of Dermatology, Venerology and Allergy, University of Essen, D-45122 Essen, Germany
The calgranulins are members of the S-100 family of calcium-binding proteins potentially involved
in the pathogenesis of psoriasis. Since the calgranulins A and B have been found up-regulated on
the mRNA and protein level, we determined whether the calgranulin homologue C (Cal C),
which is expressed in cornea and neutrophilic granulocytes, is also detectable in psoriasis lesions.
Therefore, mRNA was analyzed from shave biopsies of lesional and nonlesional psoriasis patients
and healthy volunteers. Northern blot experiments demonstrated the strong expression in lesional,
but not in nonlesional psoriatic skin. Normal keratinocytes cultured in vitro showed constitutive
expression of Cal C and a decrease upon cultivation in the presence of serum (psoriatic and
normal). However, on immunohistology using a rat polyclonal antiserum against Cal C, we were
not able to detect Cal C in keratinocytes on a protein level (1 of 28 biopsies tested). Therefore, we
speculate about the stability of the Cal C mRNA in keratinocytes, which needs to be determined.
In conclusion, Cal C- another calcium-binding protein with potential relevance in the
pathogenesis of psoriasis- is expressed in lesional skin at levels, that are substantially higher than
expected by the presence of neutrophilic granulocytes.
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Identi®cation and Characterisation of Corneodesmosin Single Nucleotide
Polymorphisms
R. Tazi-Ahnini, M. Pearce,* M. Olavesen,* M. Cork, and N. Lench*
Division of Genomic Medicine, University of Shef®eld, Shef®eld, United Kingdom; *In¯ammation Biology,
Oxagen Ltd, Abingdon, United Kingdom
Psoriasis is a chronic in¯ammatory disorder that affects approximately 2% of the population of
European ancestry. Family based studies located a major susceptibility locus (PSORS1) within the
MHC on chromosome 6p21.3. The most signi®cant association has been shown with HLA-Cw6
in psoriatic patients with a strong family history. However, recent attention has been focussed on
non-HLA genes close to HLA-C, in particular the corneosdesmosin (CDSN) gene, located
approximately 160kb telomeric of the HLA-C locus. The CDSN gene contains 2 exons and spans
5.6 kb. Corneodesmosin is expressed during keratinocyte differentiation and has been shown to be
over-expressed in psoriatic lesions compared with normal skin. We have reported signi®cant
association between a polymorphism at position 1243 of the corneodesmosin gene and psoriasis
(Tazi-Ahnini et al 1999). To further de®ne the role of corneodesmosin in the genetic
predisposition to psoraisis, we have exhaustively screened the corneodesmosin gene for single
nucleotide polymorphisms (SNPs). Genomic DNA from a panel of 24 unrelated individuals was
ampli®ed with oligonuleotide primers spanning 350 bp 5¢ UTR, exon1, exon 2 and 910 bp 3¢
UTR. A total of 37 SNPs were identi®ed by direct DNA sequencing. These include 35 SNPs and
2 insertion/deletion polymorphisms. 18 polymorphisms are present within exons 1 and 2; 9 are
neutral polymorphisms, 8 result in nonconservative amino acid substitutions and 1 an amino acid
insertion/deletion polymorphism. Assays have been developed (RFLP and single base extension)
and validated for all polymorphisms, and allele frequencies determined in a panel of 96 unrelated
blood donor controls. These data are being used to de®ne the pattern of linkage disequilibrium
between SNPs within the CDSN gene. This will provide a comprehensive panel of SNPs for the
analysis of haplotype transmission in psoriasis families.
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A Speci®c Multi-SNP Allele of HCR is Strongly Associated with Psoriasis in the Finnish
Population
S. Suomela, K. Asumalahti,* T. Laitinen,* U. Saarialho-Kere, and J. Kere²
Dermatology, Helsinki University Central Hospital, Helsinki, Finland; *Medical Genetics, Haartman
Institute, University of Helsinki, Helsinki, Finland; ²Finnish Genome Center, University of Helsinki,
Helsinki, Finland
The authors present for the Finnish Psoriasis Consortium. In all populations, psoriasis associates
strongly with the HLA-Cw6 allele, and the major role of this genomic region in psoriasis
susceptibility has been con®rmed by genetic linkage studies. However, the functional role of HLA-
Cw6 has been questioned, and the association to it may be caused merely by another nearby gene.
We focused our attention to a new gene called HCR (for alpha helical coiled coil rod protein) and
found that a speci®c coding variant of HCR was strongly associated with psoriasis in a Finnish
subpopulation (Asumalahti et al, Hum Mol Genet 9:1533±1542, 2000). We expanded this study by
recruiting further families (N = 91) from other parts of Finland, representing a more general
population sample. 78% of all the patients had plaque type disease and 101 patients had type I
psoriasis. The median age at onset was 20 years, male:female ratio was 69 : 47, and 34% of probands
had an affected ®rst-degree relative. 18% of patients and 7% of controls carried the HLA-Cw6
allele (p = 0.005). The HCR risk allele consisted of two SNPs encoding for Arg to Trp changes; we
call the risk allele HCR*WW. HCR*WW was present in 27% of patients and in 10% of controls
(p = 0.0001). The suggested corneodesmosin (S gene) risk allele CD*5 was the predominant allele
in control as well as patient chromosomes, providing further evidence against it as the susceptibility
allele. These results were supported by the transmission disequilibrium test. We conclude that
HCR is a strong candidate for the psoriasis susceptibility locus PSORS1.
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Sequence Variation in a Retrovirus-Like Expressed Sequence Tag in the PSORS1
Critical Region of the MHC: Lack of Evidence for a Causative Psoriasis Gene
R. Nair, N. Chia, L. Shahabi, P. Stuart, T. Henseler, S. Jenisch, E. Christophers, J. Voorhees, and
J. Elder
Dermatology, University of Michigan, Ann Arbor, Michigan; *Dermatology and Immunology, University of
Kiel, Kiel, Germany
Several genome-wide searches have shown that an important locus for psoriasis susceptibility
resides in the major histocompatibility complex on chromosome 6p21.3. We mapped this locus
(PSORS1) to a 60-kb interval extending from 25 to 85 kb telomeric of HLA-C by recombinant
ancestral haplotype analysis. In psoriatic individuals, eight microsatellite markers across the 60 kb
region yielded an identical haplotype on all risk chromosomes, which was absent from all nonrisk
chromosomes. This risk haplotype, called RH1, de®nes a genetic interval containing at least 9
expressed sequence tags (ESTs). Five of these ESTs are expressed in skin, as determined by PCR
analysis of normal and psoriatic skin-derived cDNA libraries. We completely sequenced one of the
skin-expressed ESTs (which we designated A119) and found that its entire length (2.6 kb) is
represented in the genomic sequence of RH1 (99% identity). A119 sequences demonstrate
sequence similarity to retroviral integrase and envelope glycoproteins, identifying it as a human
endogenous retrovirus-like element. In an effort to identify disease-speci®c polymorphisms in
A119, we examined its DNA sequence across 5 risk and 7 nonrisk haplotypes. The A119 region
was PCR ampli®ed from genomic DNA, cloned in TOPO XL vector to separate alleles, and
sequenced using primers within and ¯anking A119. We identi®ed 27 polymorphisms in the A119
sequence, including 26 single-nucleotide polymorphisms (SNPs) and one two-base indel. None of
the observed variations were speci®c for RH1. These results indicate that A119 is unlikely to play a
causative role in psoriasis.
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Analysis of HCR Gene Polymorphism in Familial Psoriasis: Evidence Against a Causal
Role
N. Chia, P. Stuart, R. Nair, T. Hensler,* H. Lim,² S. Jenisch, E. Christophers, J. Voorhees, and J.
Elder
Dermatology, University of Michigan, Ann Arbor, Michigan; *Dermatology, University of Kiel, Kiel,
Germany; ²Dermatology, Henry Ford Health System, Detroit, Michigan
A recent report identi®ed 12 coding variations within the HCR (Pg8) gene located in the HLA
class I region (Hum Mol Genet 9:1533±1542). Two of these variations, C®T transitions at
nucleotide positions 251 and 269, form an allele (the ``TT'' allele) that was suggested to associate
with psoriasis. We had previously mapped the PSOSR1 susceptibility locus to a 60-kb segment
telomeric of HLA-C (Am J Hum Genet 66:1833±1844). Using 34 closely spaced microsatellite
markers, we identi®ed 66 relatively homogenous clusters of haplotypes in 478 families and
examined their association with psoriasis by the transmission/disequilibrium test. We found that
cluster numbers 17±25 conferred risk for psoriasis and possessed identical alleles at eight contiguous
markers spanning the 60 kb interval, which we termed risk haplotype 1 (RH1). All risk clusters in
our sample carried RH1, but none of the nonrisk clusters did. Due to the close proximity of RH1
to the HCR gene, we wished to determine whether the RH1-bearing risk haplotypes we
identi®ed carry the ``TT'' allele, and whether the nonrisk clusters do not. We PCR ampli®ed exon
2 of the HCR gene from genomic DNA of 32 individuals representative of the seven most
common risk and ®ve most common nonrisk haplotypes in our sample. The gel-puri®ed PCR
products were directly sequenced for the region containing HCR nucleotides 251 and 269. The
results showed that chromosomes bearing risk haplotypes 17 and 18 carry C at nucleotide 251 and
269, whereas risk clusters 19, 21, 22, 23 and 25 carry T at these positions. Among nonrisk clusters,
cluster 26 carried T at both positions and all other clusters carried C. Since TT alleles are found in
both risk and nonrisk clusters, we conclude that these variations in HCR are not likely to be causal
in psoriasis.
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Differential Relationship of Disease Severity to Age of Onset in Familial vs. Sporadic
Psoriasis
J. Elder, F. Malick, P. Stuart,* H. Lim, R. Nair,* T. Henseler,² S. Jenisch, E. Christophers, and J.
Voorhees
Dermatology, Henry Ford Hospital, Detroit, Michigan; *Dermatology, University of Michigan, Ann Arbor,
Michigan; ²Dermatology, University of Kiel, Kiel, Germany
To evaluate the relationship between psoriasis disease severity, age of onset, and family history, 537
psoriatics were analyzed, most of whom were from Michigan. In 227 individuals there was no
known family history, and in 310 individuals psoriasis was reported or demonstrated in at least one
®rst-degree relative. 98% of probands were ascertained for early onset psoriasis (< 40 year at onset);
therefore, late-onset psoriatics were under-represented. Total body surface area involvement
(TBSA), presence or absence of joint complaints (with or without visible joint changes) and nail
changes (pitting, oil spots, or onycholysis) served as measures of disease severity. Two-way ANOVA
after log transformation revealed highly signi®cant interaction between age at onset and familial
status (p = 0.00001). Two-sample t tests showed that for sporadic psoriatics, TBSA was signi®cantly
less when onset was early (14.3% vs. 28.0%, p = 0.0034), whereas for familial psoriatics, TBSA was
signi®cantly greater when onset was early (15.1% vs. 8.7%, p = 0.00003). Using loglinear analysis,
arthritis and age at onset were not signi®cantly associated after controlling for age at examination,
nor were arthritis and familial status. By the same method, nail abnormalities were also
conditionally independent of familial status, given age at onset. However, psoriatic nail changes
were more frequently encountered in early onset patients. These results suggest that the
relationship between disease severity and age at onset differs in sporadic vs. familial psoriasis. This
®nding may re¯ect the concurrent action of psoriasis-predisposing alleles at multiple loci in
``familial'' cases, whereas environmental factors may play a larger (but not the only) causative role
in ``sporadic'' cases.
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Polymorphis of Vitamin D Receptor Gene in Japanese Patients with Psoriasis Vulgaris
H. Saeki, N. Furuya, H. Mitsui, Y. Tada, H. Torii, M. Komine, A. Asahina, and K. Tamaki
Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
Vitamin D (VD) is known to be effective for psoriasis because it is an antiproliferative factor for
several cell types such as keratinocytes and lymphocytes. There are some polymorphisms in vitamin
D receptor (VDR) gene recognized by restriction enzymes such as FokI, BsmI and ApaI.
Particularly, FokI polymorphism is demonstrated to be associated with the reactivity for VD in
antiproliferative effect. In this study, we analyzed FokI polymorphism in patients with psoriasis
vulgaris. We examined 96 unrelated Japanese patients with psoriasis vulgaris and 67 healthy
Japanese persons were served as control subjects. Genomic DNA was extracted from peripheral
blood leukocytes, and the exon 2 of VDR gene was ampli®ed by PCR. Restriction patterns by
FokI could distinguish F allele from f allele. FokI phenotype frequencies were compared between
patients and controls. We also classi®ed 30 psoriatic patients in terms of response to VD (tacalcitol)
topical treatment into three groups: extremely responsive (n = 6), moderately responsive (n = 15)
and barely responsive patients (n = 9). FokI phenotype frequencies were also compared among
these groups. FF, Ff and ff frequencies are as follows: FF = 31%, Ff = 50%, ff = 19% in patients;
FF = 43%, Ff = 43%, ff = 13% in controls; FF = 66%, Ff = 17%, ff = 17% in extremely responsive
patients; FF = 33%, Ff = 40%, ff = 27% in moderately responsive patients; FF = 0%, Ff = 67%,
ff = 33% in barely responsive patients. FF phenotype tended to be decreased in patients compared
with controls (31% vs. 43%), which was not statistically signi®cant. FF phenotype was signi®cantly
increased in extremely responsive patients compared with barely responsive patients (66% vs. 0%,
p,0.05). Although it is necessary to reanalyze FokI phenotype frequencies among larger number of
psoriatic patients, this result is intriguing because F allele is demonstrated to be more responsive to
VD in vitro compared with f allele.
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The Polymorphism of Vitamin D3 Receptor Gene in Patients with Psoriasis
H. Okita, T. Ohtsuka, A. Yanakage, and S. Yamazaki
Dokkyo University School of Medicine, Mibu, Japan
Vitamin D3 is an effective drug for the treatment of skin eruptions in patients with psoriasis. It has
been reported that vitamin D receptor gene show considerable polymorphism. In 86 normal
subjects and 39 patients with psoriasis, the allelic frequencies of the vitamin D receptor and the
possible association of vitamin D3 receptor gene polymorphism and clinico-laboratory ®ndings
were studied. Using heminested polymerase chain reaction, 3 sites of vitamin D receptor gene
containing the polymorphism in the genome DNA puri®ed from blood were ampli®ed. The
polymorphism was studied using restriction pattern of the polymerase chain reaction products. No
signi®cant difference between normal controls and patients with psoriasis were found for the
frequencies of 3 kinds of alleles. In patients with psoriasis, serum alanine aminotransferase of AA
allele were signi®cantly higher than that of aa allele (p < 0.05). Serum trigyceride in AA allele were
signi®cantly higher than those in Aa allele (p < 0.05) and aa allele (p < 0.02). No other clinico-
laboratory ®ndings showed relation to vitamin D receptor gene polymorphism. These results
showed that polymorphism at intron 8 of vitamin D receptor gene has relation to metabolic
abnormalities including liver dysfunction and hyperlipidemia in patients with psoriasis.
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Compound Heterozygosity for a Recurrent 16.5-kb Alu-Mediated Deletion Mutation
and Single-Base Pair Substitutions in the ABCC6 Gene Results in Pseudoxanthoma
Elasticum
F. Ringpfeil, A. Nakano, J. Uitto, and L. Pulkkinen
Dermatology, Jefferson Medical College, Philadelphia, Pennsylvania
Pseudoxanthoma elasticum (PXE), the prototypic heritable connective tissue disorder affecting the
elastic structures in the body, manifests with cutaneous, ophthalmologic and cardiovascular
®ndings, with considerable morbidity and mortality. Recently, mutations in the ABCC6 gene
encoding MRP6, a putative transmembrane ABC transporter protein of unknown function, have
been disclosed, and most of the genetic lesions delineated thus far consist of single-base pair
substitutions resulting in nonsense, missense or splice-site mutations. In this study, we examined
four multiplex families with PXE inherited in an autosomal recessive pattern. In each family, the
proband was a compound heterozygote for a single-base pair substitution mutation, resulting either
in nonsense or splicing mutations, and a novel, ~16.5-kb deletion mutation spanning the site of the
single-base pair substitution in trans. The deletion mutation was shown to extend from intron 22 to
intron 29, resulting in out-of-frame deletion of 1213 nucleotides from the corresponding mRNA,
and causing a predicted elimination of 505 amino acids from the MRP6 polypeptide. The deletion
breakpoints were precisely the same in all four families. Distinct ethnic backgrounds and haplotype
analysis by 13 microsatellite markers spanning 9 cM of the PXE locus con®rmed that the deletion
had occurred independently. Deletion breakpoints within introns 22 and 29 were embedded in
two highly homologous AluSx repeat sequences, suggesting Alu-mediated homologous
recombination as a mechanism.
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A Spectrum of ABCC6 (MRP6) Mutations are Responsible for Pseudoxanthoma
Elasticum
O. Le Saux, Z. Urban, K. Beck, C. Sachsinger, C. Sylvestri,* A. de Paepe, I. Pasquali-Ronchetti,
F. Pope, S. Terry, and C. Boyd
Paci®c Biomedical Research Center, University of Hawaii, Honolulu; *Department of Biomedical Sciences,
University of Modena, Modena, Italy;²Institute of Medical Genetics, University Hospital of Wales, Cardiff,
United Kingdom; ³PXE International Inc, Sharon, United States; §Center for Medical Genetics, University
Hospital, Universitair Ziekenhuis, Gent, Belgium
Pseudoxanthoma elasticum (PXE) is a heritable disorder characterized by calci®cation of elastic
®bers in skin, arteries and the retina, that results in dermal lesions with associated laxity and loss of
elasticity, arterial insuf®ciency and retinal hemorrhages leading to macular degeneration. PXE is
usually found as a sporadic disorder but examples of both autosomal recessive and dominant forms
of PXE have been observed. Recently, dominant and recessive forms of PXE were mapped to a 5-
cM domain on chromosome 16p13.1. We have re®ned this locus by recombination mapping and
identi®ed six candidate genes. This locus was further reduced to less than 600 kb and ®ve candidate
genes. These candidate genes were screened for mutations using genomic DNA from a cohort of
unrelated patients with autosomal recessive or sporadic PXE. We have found causative mutations
in a gene encoding an ATP-binding cassette (ABC) transporter referred to as ABCC6 (MRP6).
ABCC6 belongs to a subfamily of genes that includes the Cystic Fibrosis Transmembrane
conductance Regulator gene (CFTR). Although most of the variants identi®ed in the ABCC6
gene, thus far, were single-nucleotide substitutions resulting in missense mutations, we have also
observed nonsense, splice site mutations as well as insertions and deletions. The majority of the
mutations appeared to be private. However, a few recurrent mutations were found in unrelated
families of different origins with distinct haplotypes. ABCC6 mutations were primarily located in
the 3¢ end of the gene particularly in domains encoding the C-terminal ATP-binding site where
40% of the variants were clustered. Remarkably, missense mutations affected essentially arginyl
residues suggesting an essential structural or functional role for these residues in ABCC6.
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Characterization of ABCC6 Pseudogenes on Human Chromosome 16p: Implications
for Mutation Detection in Pseudoxanthoma Elasticum
L. Pulkkinen, A. Nakano, F. Ringpfeil, and J. Uitto
Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania
Pseudoxanthoma elasticum (PXE) is a heritable disorder affecting the skin, eyes and the
cardiovascular system, and recently, it has been linked to mutations in the ABCC6 gene on
chromosome 16p13.1. Our original mutation detection strategy, consisting of ampli®cation of each
exon of the ABCC6 gene by the use of primer pairs placed on the ¯anking introns, suggested the
presence of multiple copies of the 5¢-region sequences of the gene. By the use of allele speci®c
PCR, two BAC-clones containing a putative pseudogene of ABCC6, designated as ABCC6P1,
were isolated from the human BAC-library. Sequence analysis of ABCC6P1 revealed several
single-base pair nucleotide changes in regions homologous to coding as well as intronic sequences
of ABCC6. ABCC6P1 was shown to be a truncated copy of ABCC6 containing exons 1±9 and the
upstream region of the gene. Radiation hybrid and marker content mapping placed this
pseudogene 280 kb centromeric from the functional ABCC6 gene. In addition to ABCC6P1,
homology search of the database of Human Genome Working Draft revealed the presence of
another truncated copy of ABCC6, designated as ABCC6P2, which was shown to harbor
upstream sequences and exons 1±4. The BAC-clone containing ABCC6P2 was placed ~1.1 Mb
telomeric from the BAC-clone containing ABCC6. In addition to several nucleotide differences in
¯anking introns, ABCC6P2 contained two nucleotide changes in the sequences homologous to
exons 3 and 4 of ABCC6. Nucleotide differences in ¯anking introns between these two
pseudogenes and ABCC6 allowed us to design allele speci®c primers which eliminate the presence
of both pseudogene sequences in PCR products, providing reliable ampli®cation of the ABCC6-
speci®c sequences only. The use of allele speci®c PCR has revealed thus far one pathogenetic PXE
mutation, 179del9 in exon 2, as well as several polymorphisms within the upstream region and
exons 1±9.
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Two Commonly Occurring Mutations in the Lysyl Hydroxylase 1 Gene Decrease
Enzyme Levels and are a Primary Cause of Ehlers±Danlos Syndrome Type VIA
L. Walker, and H. Yeowell
Dermatology/Medicine, Duke University Medical Center, Durham, North Carolina
Patients with the autosomal recessive type VI variant of the Ehlers±Danlos syndromes (EDS VI: the
kyphoscoliotic type), are clinically characterized by neonatal kyphoscoliosis, generalized joint
laxity, skin fragility and severe muscle hypotonia at birth. Biochemically, EDS VIA is caused by a
de®ciency of lysyl hydroxylase (LH), an important post-translational modifying enzyme in collagen
biosynthesis. This enzyme hydroxylates speci®c lysine residues in the collagen molecule to form
hydroxylysines which have two important functions. The residues serve as attachment sites for
galactose and glucosylgalactose and they also act as precursors for the crosslinking process that gives
collagen its tensile strength. At least 20different mutations have been identi®ed in the LH1 gene
(the originally described form) that contribute to LH de®ciency and the clinical characteristics of
EDS VI. Two of these mutations have been identi®ed in ®ve or more unrelated patients and appear
to be the major cause of the enzyme de®ciency that weakens the extracellular matrix and causes
EDS VI in these patients. In one mutation there is a large duplication of exons 10±16, arising from
a homologous recombination of intronic Alu sequences, and the second mutation is a nonsense
mutation, Y511X, located in exon 14 of the LH1 gene. Each of these mutations appears to have
originated from a single ancestral gene. Alternative processing pathways involving alternate splicing
and mRNA degradation, which reduce the effect of the mutant allele containing the Y511X
mutation, have been identi®ed. This alternative processing has also been associated with other
mutations in the LH1 gene and may represent an attempt to restore partial activity of the enzyme in
these EDS VIA patients.
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In Contrast to Patients with the Type VIA Variant of Ehlers Danlos Syndrome, a
Decrease in One of the Isoforms of Lysyl Hydroxylase Does Not Appear to be a
Common Cause of the Type VIB Variant
H. Yeowell, L. Walker, E. Kitamura,* and M. Yamauchi*
Dermatology/Medicine, Duke University Medical Center, Durham, North Carolina; *Dental Research
Center, University of North Carolina, Chapel Hill, North Carolina
Lysyl hydroxylase 1 (LH1) is an enzyme required for the hydroxylation of speci®c lysine residues in
the collagen molecule. These hydroxylysines are critical in determining the pathways of
intermolecular crosslinks that are essential for the tensile strength of collagen. LH1 is de®cient in
patients with Ehlers Danlos syndrome (EDS) type VIA, an autosomal recessive disorder in which
patients are clinically characterized by kyphoscoliosis, hypermobile joints, and skin that is soft,
fragile and hyperextensible. In a second class of EDS VI, the type B variant, patients have the
clinical phenotype of EDS VI but their levels of LH activity are not signi®cantly decreased. To
examine the biochemical basis for this form of EDS VI, we compared levels of the mRNAs for
LH1 and the two other recently reported isoforms for LH, LH2 and LH3, with the pattern of
crosslinking, and enzyme activity in ®broblasts from 8 patients with EDS VIB. In contrast to EDS
VIA patients, in which levels of LH1 mRNA and corresponding LH activity are < 25% of control,
LH1 mRNA levels in EDS VIB patients ranged between 87 and 150% of control which correlated
with their normal LH activity. However, decreased levels of LH2 mRNA were observed in two
EDS VIB patients (25 and 50% of control, respectively), and in the ®rst patient, the low (25%) level
of LH2 mRNA was accompanied by a similar decrease (18% of control) in the mRNA for LH3.
Another patient also had decreased levels of LH3 mRNA (39% of control). Studies on long-term
cultures of ®broblasts did not show a correlation between levels of the collagen reducible crosslinks,
dehydrodihydroxylysinonorleucine and dehydrohydroxylysinonorleucine, and levels of mRNA
for the LH isoforms. This preliminary study suggests that, unless this group of patients represents a
heterogeneous subset of the type VIB variant of EDS or an unidenti®ed LH isoform is involved,
some alternative pathway other than lysine hydroxylation of collagen is affected in these patients.
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Genetic Analysis of Kindler Syndrome in Panama
D. Siegel, H. Penagos,* C. Wiebe,² H. Feiler,³ K. Wilhelmsen,³ and E. Epstein
Dermatology, UCSF, San Francisco, California; *Dermatology, Chiriqui Regional Hospital, Social Security
Bureau of Panama, David, Panama; ²Oral Biological and Medical Sciences, Faculty of Dentistry, University
of British Columbia, Vancouver, BC, Canada; ³Ernest Gallo Clinic and Research Center, Department of
Neurology, UCSF, Emeryville, California
Kindler Syndrome is a rare genodermatosis characterized by congenital acral bullae, progressive
poikiloderma, photosensitivity, cigarette paper-like wrinkling of the dorsum of the hands and feet,
diffuse cutaneous atrophy, webbing of the digits and easily bleeding buccal mucosa. No more than
several dozen patients have previously been described in the literature. We are searching for the
genetic basis of this rare photosensitivity disorder in an inbred group of twenty±six Kindler
Syndrome patients who are members of the Ngobe Tribe from the province of Bocas del Toro,
Panama. Additional ®ndings included blisters induced by trauma and sun exposure in all patients,
loss of the nailfold angle in eight patients, hypermobility of the ®ngers, knees and elbows in ®ve
patients and clinical features resembling ribbed epidermolytic hyperkeratosis of the lateral ankles in
two patients. Six of the 11 male patients had phimosis. Most patients demonstrated signi®cant
periodontal attachment loss around their teeth. Because Kindler Syndrome has clinical features
overlapping those of Rothmund-Thompson and Bloom Syndromes and these latter are caused by
mutations in genes encoding RecQ helicases, we began by screening our patients for linkage of
disease to regions harboring two other cloned RecQ genes. The results of this initial screen were
negative. We have now proceeded to a genome-wide scan with 811 microsatellite repeat markers.
Initial results show several promising areas.
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A G to A Change at the Splice Donor Site of Intron 2 in the Xeroderma Pigmentosum
Group C (XPC) Gene Alters the Ef®ciency of PremRNA Splicing
T. Ueda, S. Khan, S. Emmert, T. Shahlavi, D. Busch,* T. Schneider, and K. Kraemer
Basic Research Laboratory, National Cancer Institute, Bethesda, Maryland; *Department of Environmental
and Toxicologic Pathology, Armed Forces Institute of Pathology, Washington, District of Colombia;
²Laboratory of Experimental and Computational Biology, National Cancer Institute, Frederick, Maryland
We studied the molecular defects in the XPC gene in a 47 y old woman with XP (XP86BE) with
severe sun sensitivity and multiple cutaneous neoplasms. UV cell killing was 3 times normal in
XP86BE skin ®broblasts. Host cell reactivation of a UV-treated reporter plasmid cotransfected
with a vector expressing wild type XPC message assigned XP86BE to XP complementation group
C. RT-PCR of total RNA revealed two alternatively spliced XPC mRNA isoforms in the exon 2
region: (I) a deletion of 68 bases at the 3¢ end of exon 2 and (II) a 141 base insertion between exons
2 and 3 that retains the 5¢ end of intron 2. These changes resulted in frameshifts with new
termination sites that would encode truncated XPC proteins. Genomic DNA analysis showed a
homozygous G to A mutation at the splice donor site of XPC intron 2. This mutation reduces the
information content of splice donor 2 from 10.2 to ±2.6 bits and results in use of cryptic donor sites
of 8.6 bits (isoform I) and 9.5 bits (isoform II). The mutation inactivates a Bsu36 I site in intron 2
that can be used to diagnose the genomic status of other family members. The splice donor site
mutation identi®ed in XP86BE cells resulted in alternatively spliced XPC mRNA isoforms which
utilize cryptic donors with high information content and are predicted to encode truncated XPC
proteins with defective DNA repair function resulting in clinical disease.
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In¯uence of a Single Nucleotide Polymorphism in an XPC Splice Acceptor Site on
Alternative Splicing
S. Khan, T. Shahlavi, V. Muniz-Medina, C. Baker, T. Schneider,* and K. Kraemer
Basic Research Laboratory, National Cancer Institute, Bethesda, Maryland; *Laboratory of Experimental and
Computational Biology, National Cancer Institute, Frederick, Maryland
Possible variations in DNA repair due to inherited polymorphisms of DNA repair genes are being
investigated in order to determine their association with cancer predisposition. We previously
found a common biallelic poly AT insertion/deletion polymorphism (PAT) in intron 9 of the XPC
gene (Carcinogenesis 21:1821, 2000). Here we report a single nucleotide polymorphism (SNP) in
XPC intron 11 acceptor (±6 A to C) that inactivates a Bcg I site. This SNP was genotyped in 97
normal donors by PCR followed by RFLP. The frequency of the A allele was 42% and the C allele
was 58%. The A to C change increases the information content of the XPC intron 11 splice
acceptor from 5.1 to 7.5 bits. When we analyzed the cDNA from normal individuals either
homozygous (A/A or C/C) or heterozygous (A/C) for this SNP we found two XPC mRNA
isoforms: (I) normal and (II) deletion of exon 12 resulting in a frameshift with termination signal 1
codon downstream. We have developed extremely sensitive, isoform speci®c, real time,
quantitative RT-PCR assays to measure both isoforms. We found that cultured normal ®broblasts
contain measurable levels of both isoforms. We are planning to determine if the level of the
alternatively spliced isoform (II) is correlated with the XPC intron 11 SNP genotype. Interestingly,
we found that the intron 11 SNP A allele is in linkage disequilibrium with PAT + (7.5 kb 5¢) and
another SNP in exon 15 (C2920A, 2.5 kb 3¢). An XPC intron 11 SNP-mediated effect on
alternative splicing of XPC message might be a mechanistic link to cancer predisposition in
association with the PAT + genotype.
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101 Prenatal Diagnoses by the DebRA Molecular Diagnostics Laboratory at Jefferson
E. Pfendner, A. Nakano, K. Nielsen, L. Pulkkinen, A. Christiano,* and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania; *Dermatology,
Columbia University, New York, New York
The DebRA Molecular Diagnostics Laboratory at Jefferson performed 101 prenatal diagnoses
during the period January 1, 1993 to December 31, 2000 in families with a previously affected
child with either the Junctional (JEB) or Dystrophic (DEB) forms of Epidermolysis Bullosa.
Mutation studies were performed using heteroduplex analysis of PCR products spanning all exons
of the appropriate gene for the diagnostic category, followed by direct genomic sequencing.
Linkage studies were performed with intragenic and ¯anking SNP and/or microsatellite markers.
Linked markers were used in conjunction with mutation studies for 7 JEB and 20 DEB cases while
linked markers only were used for 17 DEB cases. In all, 51 JEB and 50 DEB prenatal diagnoses
were performed with outcomes consistent with predicted phenotype in 60 cases, while in 31 cases
outcome was not con®rmed but laboratory error was not reported. Eight pregnancies are ongoing
and there was one miscarriage. In one DEB case, submitted in 1994, where linked markers were
used along with a single mutation, an affected fetus was predicted while normal fetal skin was found
by concurrent EM studies. The cause of this discrepancy was never determined but the DNA result
was con®rmed. Possible explanations include a de novo mutation or germline mosaicism. All tests
were performed for recessive forms of JEB and DEB, and predicted outcomes of 21 homozygous
normal: 51 heterozygous carrier: 24 homozygous affected fetuses were reported for 96 pregnancies.
These values are consistent with the expected corresponding Mendelian ratio of 1 : 2 : 1. There
were 2 known recombinations in DEB linkage studies and 2 pregnancies where linked markers
were inconclusive. Therefore, prenatal diagnosis for JEB and DEB using mutation studies was
found to be 100% accurate and linked markers were found to be 99% accurate with 2
recombinations in 37 DEB cases.
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Paternal Germline Mosaicism in Herlitz Junctional Epidermolysis Bullosa
H. Lam, P. Cserhalmi-Friedman, K. Anyane-Yeboa², and A. Christiano*
Dermatology, Columbia University, New York, New York; *Dermatology and Genetics and Development,
Columbia University, New York, New York; ²Pediatrics, Divsion of Clinical Genetics, Columbia
University, New York, New York
We studied a single patient with the lethal (Herlitz) type of junctional epidermolysis bullosa (H-
JEB) born from unrelated parents. Screening for mutations in the LAMB3 gene in the patient
revealed the previously described hotspot mutation R635X and a novel one basepair deletion in
exon 10 (1094delA). The single basepair deletion could be detected in the clinically unaffected
mother, while the nonsense mutation R635X could not be found in the peripheral blood DNA of
either parent. After excluding nonpaternity by microsatellite analysis using random markers on
chromosomes 3, 8 and 18, we determined that the mutation R635X in the proband was most
likely due to a de novo event or alternatively, germline mosaicism. The parents requested prenatal
diagnosis for a second pregnancy, and while the maternal mutation 1094delA was not detected in
DNA from the fetus, unexpectedly, the mutation R635X was present in the chorionic villus DNA.
These ®ndings were most consistent with paternal germline mosaicism for the recessive mutation
R635X. The results have a signi®cant impact on genetic counseling in this family. To our
knowledge, this study represents the ®rst documented case of germline mosaicism in junctional
epidermolysis bullosa and serves as a reminder that germline mosaicism should be considered in
every case in which a ``new'' mutation is found in the offspring of clinically and/or genetically
unaffected parents.
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Phenotypic Severity of Epidermolysis Bullosa Simplex Caused by a Dominant Missense
Mutation in the keratin 5 is Exacerbated When Combined with a Silent Missense
Mutation in Another Allele
K. Yasukawa, D. Sawamura, J. McMillan, and H. Shimizu
Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Epidermolysis bullosa simplex (EBS) is a group of hereditary skin disorders characterized
intraepidermal cytolytic blister formation after mechanical trauma. Mutations in the either gene
encoding keratin 5 and keratin 14, the primary structural components of the basal epidermal
keratinocytes, lead to three major subtypes of EBS, including Weber-Cockayne, Koebner, and
Dowling-Meara variants. In this study, we have investigated a Japanese EBS family whose members
demonstrated heterogeneous clinical severity. A proband, 22-year-old man presented blisters on
the whole body at childhood, and constantly forms blister by minor friction on the hands and feet
at adulthood, while his father, his paternal uncle and grandmother showed a few blisters on the
soles only after waking for a long time or putting on new shoes. To elucidate the molecular basis of
this apparent clinical heterogeneity, we studied genomic DNA extracted from peripheral blood of
the patient, his mother and paternal uncle, using PCR ampli®cation followed by direct nucleotide
sequencing. A novel missense mutation in the KRT5, E170K, at the conserved 1 A helix initiation
site of the rod domain was found in the proband and his paternal uncle. Interestingly, another
amino acid substitution E418K at the 2B rod domain in keratin 5 was identi®ed in his clinically
unaffected mother as well as in the proband. E418K was not found among the 100 normal Japanese
alleles, thus considered to be silent missense mutation, not polymorphism. As shown in the
proband, these results suggest that mild clinical phenotype of Weber-Cockayne EBS due to E170K
is aggravated when combined with a silent E418K mutation in another allele of KRT5. This is the
®rst example of keratin disorders in which clinical severity caused by a dominant missense mutation
is shown to be exacerbated by the presence of a silent missense mutation in another allele.
760
Maternal Germline Mosaicism in Dominant Dystrophic Epidermolysis Bullosa
A. Christiano, P. Cserhalmi-Friedman, M. Garzon, E. Guzman,² A. Martinez-Mir, and K.
Anyane-Yeboa²
Dermatology, Columbia University, New York, New York; *Dermatology and Genetics and Development,
Columbia University, New York, New York; ²Pediatrics, Division of Clinical Genetics, Columbia
University, New York, New York
We studied a small pedigree in which one child was affected with the mild form of dystrophic
epidermolysis bullosa (DEB). Screening for mutations in the COL7A1 gene in the patient revealed
a single glycine substitution in the triple helical domain of the type VII collagen gene (G2003R),
which has previously been associated with Bart's syndrome, a form of dominantly inherited DEB.
This mutation, however, could not be found in the peripheral blood DNA of the clinically
unaffected parents, thereby suggesting a de novo mutation or alternatively, germline mosaicism. The
parents requested prenatal diagnosis for a third pregnancy, and unexpectedly, the mutation was also
present in the chorionic villus DNA from the fetus, consistent with germline mosaicism.
Microsatellite analysis revealed that all three offspring carried the same maternal chromosome 3
haplotype, while the two offspring carrying the mutation G2003R had inherited different paternal
chromosome 3 haplotypes. These ®ndings were consistent with maternal germline mosaicism for
the COL7A1 mutation G2003R. The results have a signi®cant impact on genetic counseling in
this family. We believe this study represents the ®rst documented case of germline mosaicism in
DDEB. Germline mosaicism should be considered in every case in which a ``de novo'' mutation is
found in the offspring of unaffected parents.
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The Gene for Epidermolysis Bullosa Simplex Super®cialis Maps to Chromosome 3p21
R. O'Shangnessy, A. Martinez-Mir, J. Liu,* M. Weiner,² D. Gordon,³ J. Ott, T. Gilliam, J. Fine,
and A. Christiano
Department of Dermatology and Genetics and Development, Columbia University, New York, New York;
*Columbia Genome Center, Columbia University, New York, New York; ²Department of Dermatology,
University of North Carolina, Chapell Hill, North Carolina; ³Laboratory of Statistical Genetics, Rockefeller
University, New York, New York
Epidermolysis bullosa simplex (EBS) is an inherited blistering disease characterized by
intraepidermal cleavage. In a particular and very rare subset of EBS described by Fine et al
(1989), known as ``EBS super®cialis'', blistering and cleavage occurs just beneath the stratum
corneum. This unique presentation of EBS has been reported in only two unrelated families,
emphasizing the uniqueness of these ®ndings. In order to identify the gene responsible for EBS
super®cialis, we performed a genome-wide screen in one of the families, a dominant pedigree with
25 affected individuals. Using a panel of 324 ¯uorescently labeled microsatellite markers,
distributed at an average of 10-cM intervals, we established linkage (Zmax = 3.72) to a 3.47-cM
region on chromosome 3p21. The type VII collagen gene lies within this linkage interval, and
although an unlikely candidate gene for this type of EB, it was excluded by heteroduplex analysis
and direct sequencing. We are currently undertaking studies to narrow this interval to identify
putative candidate genes. The discovery of the gene underlying EBS super®cialis will provide
further understanding of the mechanisms controlling the ®nal steps in the differentiation of the
epidermis and extend our knowledge of the molecular basis of the different forms of EB.
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A Heterozygous Deletion Mutation of Keratin 5, Resulting in the First Case of a Longish
Mutant Keratin, in an Atypical Epidermolysis Bullosa Simplex Case
L. Gu,* Y. Ichiki, M. Sato, and Y. Kitajima
Department of Dermatology, Gifu University School of Medicine, Gifu, Japan; *Department of Dermatology,
No.1 Hospital of China Medical University, Shenyang, China
Epidermolysis bullosa simplex (EBS) is a dominantly inherited blistering skin disease caused in most
cases by point mutations in keratin (K) 5 and 14 genes. Two deletion mutations of K14 which
resulted in truncated keratins have been previously reported in autosomal recessively EBS with
severe clinical phenotypes, and also a deletion mutation of K14 in a case of the Weber-Cokayne
type EBS has been reported. Here, we have found the ®rst case of deletion mutation of K5, a single
nucleotide heterozygous deletion, resulting in a longish mutant keratin, in a Japanese child with
atypical EBS. The patient had an unusual phenotype as EBS, showing multiple vesicles in an
annular con®guration at the edge of migratory multiple erythema, ranging from coin- to head-size
in diameter, on the trunk and legs. Electron microscopy of skin biopsies showed a marked
reduction in number of keratin intermediate ®laments in the basal cells without tono®lament
clumping. Immuno¯uorescence microscopy showed no or faint staining in basal cells by using
monoclonal antibody C-50 and RCK102 against K5/8. A heterozygous deletion of G from the
second base position of amino acid codon 550 (V2 domain) of K5 was found by sequence analysis
of genomic DNA. This deletion caused a frameshift, which leads to a readthrough mutation,
creating a terminal codon in the end domain of K5. The position of this terminal codon was
located in the furthest downstream among the reported cases suggesting the generation of the ®rst
case of the longish mutant K5. This abnormally longish mutant keratin protein reasonably appears
to exert a dominant negative effect on the keratin intermediate ®lament cytoskeleton in basal cells,
leading to an atypical clinical phenotype as the present case, which has never been reported.
516 ABSTRACTS THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
763
Evidence for Novel Functions of the Keratin Tail Emerging from a Mutation Causing
Ichthyosis Hystrix
E. Sprecher, A. Ishida-Yamamoto,* O. Becker,² L. Marekov,³ K. Neldner,§ P. Steinert, C.
Miller, and G. Richard
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia and Department of
Dermatology, Rambam Medical Center, Haifa, Israel; *Dermatology, Asahikawa Medical College,
Asahikawa, Japan; ²School of Chemistry, Tel Aviv University, Tel Aviv, Israel; ³Laboratory of Skin
Biology, Niams, Bethesda; §Dermatology, Texas Tech University, Lubbock
Unraveling the molecular basis of inherited disorders of epithelial fragility has led to understanding
of the complex structure and function of keratin intermediate ®laments (KIF). Keratins are
organized as a central alpha-helical rod domain ¯anked by nonhelical, variable end domains.
Pathogenic mutations in 19 different keratin genes have been identi®ed in sequences
corresponding to conserved regions at the beginning and end of the rod. These areas have been
recognized as zones of overlap between aligned keratin proteins and are thought to be crucial for
proper assembly of KIF. Consequently, all keratin disorders of skin, hair, nail and mucous
membranes caused by mutations in rod domain sequences are characterized by perinuclear
clumping of fragmented KIF, thus compromising mechanical strength and cell integrity. We report
here the ®rst mutation in a keratin gene (KRT1) that affects the variable tail domain (V2) and
results in a profoundly different abnormality of the cytoskeletal architecture leading to a severe
form of epidermal hyperkeratosis known as ichthyosis hystrix Curth-Macklin. Structural analyses
disclosed a failure in KIF bundling, retraction of the cytoskeleton from the nucleus, and failed
translocation of loricrin to the desmosomal plaques. These data provide the ®rst in vivo evidence for
the crucial role of a keratin tail domain in supramolecular KIF organization and barrier formation.
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A Novel and a Recurrent Mutation in Keratin 10 Causing Bullous Congenital
Ichthyosiform Erythroderma
A. Ishiko, J. Ogawa, M. Akiyama,* Y. Takizawa, and T. Nishikawa
Dermatology, Keio University School of Medicine, Tokyo, Japan; *Dermatology, Teiokyo University School
of Medicine Ichihara Hospital, Ichihara, Japan
Bullous congenital ichthyosiform erythroderma (BCIE) is a congenital, autosomal dominant skin
disease characterized by blister formation in neonates and generalized hyperkeratosis. Point
mutations at the gene encoding keratins 1 (K1) and 10 (K10) have been identi®ed in patients with
BCIE and most of them had amino acid substitution in the highly conserved region of helix
initiation motif of the keratins. Using direct sequencing of genomic DNA ampli®ed by polymerase
chain reaction, we have analyzed two sporadic Japanese patients with BCIE diagnosed clinically,
pathologically, and ultrastructurally. The ®rst case, a newborn male showing typical disease
phenotype was found to have a single base pair substitution (CGC to CTC) at codon 156 of K10,
resulted in an amino acid exchange from arginine to leucine (R156L). The second case, a 22-year-
old male, with mild hyperkeratosis on the whole body revealed to have a novel single base pair
substitution (TAC to TGC) at codon 160 of K10 resulted in an amino acid exchange from tyrosine
to cysteine (Y160C). Both mutations were localized within the highly conserved helix initiation
motif of K10 and excluded in a control population. Our present results were consistent with
previous reports that the codon 156 is a mutation hot spot and that any mutation within the highly
conserved helix initiation motif can lead to the disease. The tyrosine at codon 160 forms a
hydrophobic core during heterodimer formation of keratin ®laments and its substitution to
hydrophilic amino acids (Y160N, Y160D and Y160S) has been reported to be associated with a
very severe disease phenotype, although the severe phenotype was not observed in our case with
Y160C mutation. Further accumulation of the cases should be required for elucidation of the
genotype-phenotype correlation in the missense mutations of the tyrosine at the codon 160.
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Focal Palmoplantar and Gingival Keratosis is Characterized by Epidermolytic
Alterations and Keratin 16 Gene Mutations
G. Kolde, G. Bethke,* and P. Reichart*
Dermatology, Charite, Berlin, Germany; *Oral Surgery, Charite, Berlin, Germany
Focal palmoplantar and gingival keratosis (FPGK), ®rstly by de®ned Gorlin in 1976, is a rare
autosomal dominant palmoplantar keratoderma with oral leukoplakia (MIM *148730) that shows
some clinical overlap to pachyonychia congenita type I. The light and electron microscopical
alterations and keratin mutations of FPGK are currently not known. We recently observed a family
affected by the disease in at least three consecutive generations. The four patients examined
suffered since infancy from circumscribed and sometimes painful hyperkeratosis at the weight-
bearing plantar skin, rather mild palmar hyperkeratosis, and continuous leukoplakic lesions
con®ned to the maxillary and mandibulary attached gingiva. There were no follicular
hyperkeratosis and no nail thickening, the diagnostic hallmark of pachyonychia congenita type
I. Light and electron microscopy revealed epidermolytic alterations in both the suprabasal
epidermis and epithelium, with edematous keratinocytes, abnormal clumping of tono®laments, and
irregularly shaped keratohyaline. These alterations were con®ned to nests of keratinocytes in the
plantar lesions, but were pronounced in the gingival hyperkeratosis. Immunohistochemistry failed
to show regular expression of keratin 16, and linkage analysis of K6 and K16 genes demonstrated
mutations in keratin 16. We conclude that FPGK is a clinically and pathologically distinct
epidermolytic palmoplantar keratoderma caused by keratin 16 mutations. The K16 mutations are
obviously less disruptive than in pachyonychia congenita type I that is characterized by more
pronounced molecular and pathological alterations of the tono®lament organization with
epidermolytic blistering.
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Analysis of ATP2C1 Gene Mutations in 10 Unrelated Japanese Families with Hailey±
Hailey Disease
K. Yokota, K. Yasukawa, K. Kimura, T. Nishikawa,* and H. Shimizu
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; *Dermatology, Keio
University School of Medicine, Tokyo, Japan
Hailey-Hailey disease (HHD) is an autosomal dominant chronic blistering disease caused by a
mutation in the ATP2C1 gene encoding P-type Ca2+-transport ATPase. In this study, we have
examined the ATP2C1 gene in 10 unrelated Japanese families with HHD, and found ®ve
attributable mutations including four novel mutations, which include two missense mutations
(C490F and L584P), one deletion (2460delG), and one splice-site mutation (1259+1 g to a). We
could not detect any ATP2C1 mutations in ®ve out of the 10 HHD families after direct
sequencing of the entire coding region of ATP2C1 genomic DNA, including the exon-intron
boundaries. Patients carrying missense mutations or a nonsense mutation in the 3¢ distal exon have
tendencies of earlier disease onset compared to those with nonsense mutations in the 5¢ proximal
exons. Our data provides a signi®cant addition to the HHD mutation database and will contribute
further to the understanding of HHD genotype/phenotype correlations.
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Novel ATP2A2 Gene Mutations in Two Chinese Pedigrees with Darier's Disease
Y. Yang, X. Zhu, D. Bu, and G. Li
Department of Dermatology, Peking University First Hospital, Beijing, China
Darier's disease (DD; keratosis follicularis) is an autosomal dominant skin disorder characterized by
warty papules with distribution over seborrheic areas. Recently, the cause of DD was identi®ed to
be due to mutations in the ATP2A2 gene on 12q23±24.1, encoding the sarco-endoplasmic
reticulum calcium ATPase type 2(SERCA2), a Ca2+ pump that plays an important role in
intracellular Ca2+ signalling. Here we report two novel point mutations in the ATP2A2 gene in
two Chinese families with DD. Genomic DNA was extracted and each of the 21 exons of the
ATP2A2 gene was ampli®ed by PCR. Ampli®ed DNA fragments were analyzed using SSCP
(single strand conformational polymorphism analysis) to look for abnormal gel migration.
Fragments showing altered migration patterns were sequenced bi-directionally. In Family A, the
extra band in exon 5 was sequenced and revealed a heterozygous point mutation of G to A at
position 445 in exon 5 of the APT2A gene. This mutation is expected to cause replacement of the
normal aspartic acid by asparagine (D149N) in the resultant protein. The proband from family B
was found to have abnormal migration of fragments derived from exon 19. Sequencing of the extra
exon 19 band showed a heterozygous point mutation of C to A at position 2747 in exon19, which
changes codon 916 from serine to tyrosine (S916Y) in the resultant protein. These abnormalities
were not found in any of the unaffected family members or in 50 unrelated healthy individuals.
The missense mutations we describe here, D149N and S916Y, have not been described previously.
They affect regions of the protein that encode IA strand and transmembrane domains, which have
been shown to be highly conserved during evolution, as all known SERCA2 proteins from
different species exhibit 100% identity in these domains. The D149N and S916Y mutations may
alter the function of these important SERCA2 domains and, as a consequence, impair cell adhesion
and differentiation of epidermis.
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Identi®cation of the Locus for a Novel Acantholytic Disease on Chromosome 12
A. Martinez-Mir, J. Liu,* D. Gordon,² T. Gilliam,* J. Ott,² L. Alston, and A. Christiano
Department of Dermatology and Genetics and Development, Columbia University, New York, New York;
*Columbia Genome Center, Columbia University, New York, New York; ²Laboratory of Statistical
Genetics, Rockefeller University, New York, New York; ³Akron General Hospital, Akron, Ohio
We describe a family with a novel acantholytic disease, which although reminiscent of Darier-
White and Hailey-Hailey diseases, appears to be a unique clinical variant. The characteristic rash
does not begin in childhood, but after puberty or in early adult life, and there is a high degree of
variability within the family, ranging from a generalized rash spread over the entire trunk, to a very
limited distribution restricted to the distal extremities. The eruption is in¯uenced by several factors,
including temperature and humidity, and a skin biopsy showed some foci of acantholysis. The
patients belong to a ®ve-generation autosomal dominant pedigree originating from the
Midwestern United States, with at least 20 affected members. Initially, we performed segregation
analysis with markers near both the Darier-White and the Hailey-Hailey disease loci to exclude
these genes. Subsequently, we performed a genome-wide scan with a panel of 324 microsatellite
markers. Age-dependent penetrance was considered for the LOD score calculations. As a result, we
have established linkage (Zmax = 4.3) to chromosome 12, in a region 25 cM proximal to the
Darier-White gene (ATP2A2). Our future work is aimed to the ®ne mapping of the linked region
and the characterization of possible candidate genes, based on the information available for Darier-
White and Hailey-Hailey diseases.
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Increase of Transglutaminase 1 Expression by Interferon-g is Directly Mediated by
STATs in Keratinocytes and Muscle Cells
S. Kim, E. Jeong, P. Steinert, and S. Jang
Laboratory of Skin Biology, NIAMS, Bethesda, Maryland
The physiological signi®cance of transglutaminase 1 (TGase 1) regulation by cytokine molecules is
not determined yet although the increase of TGase 1 expression is responsible for hyperkeratosis in
psoriatic lesions and squamous differentiation in squamous cell carcinomas. Recently, we
discovered that TGase 1 expression is abundantly increased in sporadic inclusion body myositis
(SIBM), a degenerative muscle disease. Increased in¯ammatory cytokines are detected in the lesion
of SIBM since CD8+ T cells were in®ltrated into the lesion. Furthermore, we found that mRNA
of TGase 1 was increased 15 fold within 24 h by 1000 unit per ml INF-g treatment in the cultured
myotubes. The major signal transducer in INF-g mediated gene expression is STAT (signal
transducers and activators of transcription). Therefore we investigated the possible STAT-binding
site (INF-g activation site, GAS) in the human TGase 1 promoter region. The DNA construct
(1.3 kb) including the promoter region (±530), exon 1, and part of intron 1 of human TGase 1 was
cloned into pCAT3 vector since it contains putative GAS. The construct was transfected into
primary human keratinocytes (NHEK) and skeletal muscle cells (SkMC). After transfection and
INF-g treatment, CAT activity showed 15 and 200% increase over the control in NHEK and
SkMC, respectively. Gel shift data showed a speci®c DNA protein complex was formed by the
oligo containing the GAS. In summary, we identi®ed that TGase 1 expression may be directly
modulated through the JAK-STAT signaling pathway in the in¯ammatory diseases.
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Homozygous Novel Deletion Mutation 1349delA in TGM1 Leads to a Classic Phenotype
of Lamellar Icthyosis (LI)
Y. Takizawa, M. Akiyama,* Y. Suzuki, and H. Shimizu²
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan; *Department of
Dermatology, Teikyo University School of Medicine, Ichihara Hospital, Chiba, Japan; ²Department of
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Malformation of the corni®ed cell envelope (CCE) arising from mutations of the transglutaminase
(TGase) 1 gene (TGM1) is the cause of some cases of LI. However, genotype/phenotype
correlation in TGM1 mutations has not been fully clari®ed yet. We report a typical case of LI
caused by novel mutation in TGM1. The patient, a 33-year-old female, showed lamellar scales on
the entire body surface. The patient's parents were distant relatives. Immuno¯uorescence labeling
with anti-TGase1 antibodies was negative in patient's epidermis. In situ TGase activity assay
detected markedly reduced TGase activity in granular layers of the patient's epidermis. Electron
microscopy revealed incomplete thickening of CCE during keratinization in the epidermis.
Sequencing of the entire exons and exon-intron borders of TGM1 revealed that the patient was a
homozygote for a novel deletion mutation, 1349delA in exon 3. This mutation leads to frameshift
resulting in a premature termination 43 bp downstream from the mutation site. According to the
protein modeling of TGase 1, the truncated protein from this mutated allele loses entire catalytic
core domain of TGase 1. Thus, the present homozygous mutation is expected to cause loss of
TGase 1 activity resulting in a classic phenotype of LI in this patient.
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The ichqMouse, a Model for Human Harlequin Ichthyosis: Mapping and Consideration
of Candidate Genes Involved in Epidermal Differentiation
B. Dale, M. Dunnwald,* K. Stephens, A. Zuberi,² J. Sundberg², and P. Fleckman
University of Washington, Seattle, Washington; *University of Iowa, Iowa City, Iowa; ²Jackson Laboratory,
Bar Harbor, Maine
Harlequin ichthyosis (HI) is a rare and usually fatal scaling skin disorder. Because of the severity and
trauma of the disorder, most families are small and genetic studies are dif®cult. The HI mouseichq/
ichqhas many similarities to the human disorder and provides an important model to identify
candidate genes. Here we report improved mapping of the ichq locus and consideration of
candidate genes: Capn1 encoding calpain 1, and Rela and Ikka/Chuk encoding components of the
NF-kB pathway. These candidates were selected because calpain 1 expression is decreased in
human HI, and alteration of the NF-?B pathway via IKKa has profound effects on skin
differentiation. All candidates are close to theichqlocus on mouse chromosome 19, although Ikka is
located more distally on Chr. 19. An intersubspeci®c cross was set up between BALB/cJ+/ichqand
CAST/EiJ, a wild inbred strain. The F1 progeny were then intercrossed and the F2 progeny were
typed for the ichqphenotype. Linkage betweenichqand molecular markers was calculated.
Keratinocytes from skin of individual mice were cultured on collagen IV coated dishes as
previously described, and tail DNA was extracted for genotype identi®cation. Total RNA was
extracted from keratinocytes of each genotype and used for RT-PCR ampli®cation and sequence
analysis for each candidate gene. Capn1 was ampli®ed in three overlapping segments. No
mutations that resulted in a missense or frameshift were detected. Similar analysis of Rela and Ikka/
Chuk also showed no such mutations. Analysis of CAPN1 cDNA from human HI cases revealed
an R433P change, but analysis of 50 normal samples showed that this was a polymorphism, not a
causative mutation. The results eliminate these three genes as the mouseichqlocus. Additional
candidate genes found in the region of interest on mouse Chr. 19 and syntenic region of human
Chr. 11 are being analyzed.
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Consequences of Dominant GJB3 Mutations on Gap Junction Communication in HeLa
Cells
F. Rouan, M. Jost, U. Rodeck, C. Lo, J. Uitto, and G. Richard
Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania; *Biology
Department, University of Pennsylvania, Philadelphia, Pennsylvania
Recently we established the pathogenic role of heterozygous mutations in the connexin-31 (Cx31)
gene (GJB3) in erythrokeratodermia variabilis (EKV), an autosomal dominant disorder of
keratinization. To investigate the pathomechanisms and functional consequences of GJB3
mutations on Cx biogenesis and gap junction intercellular communication, we studied two
missense mutations of different biological relevance in a mammalian expression system. G12R
associated with EKV affects a conserved residue in the cytoplasmic amino terminus of Cx31, while
R32W located in the ®rst transmembrane domain is not disease-causing in a heterozygous state.
Communication-de®cient HeLa cells were stably transfected with wildtype and mutant Cx31.
Using immunostaining, both mutant proteins were detected at the plasma membrane in a punctate
pattern similar to wildtype Cx31, indicating that synthesis, transport and targeting to the cell
surface are not disturbed by G12R and R32W. Subsequently, we assessed the functional properties
of the mutant proteins by studying the transfer of 6-carboxy-¯uorescein between cells. Cells
expressing wildtype or R32W proteins established comparable levels of intercellular communica-
tion. This result provides experimental evidence that R32W is a nonconsequential polymorphism.
In contrast, mutation G12R resulted in impaired intercellular coupling, suggesting that the mutant
protein is not able to form functional gap junction channels. Further studies aim to determine
whether this functional de®ciency might be due to a disturbed oligomerization of hemichannels, or
alternatively, due to changes of the functional properties of Cx31 channels.
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Mutations in the Connexin Gene GJB4 (Cx30.3) Cause Erythrokeratodermia Variabilis
(EKV)
G. Richard, K. Butt, N. Brown, F. Rouan, J. DiGiovanna,* S. Bale, and J. Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania; *Dermatology,
Rhode Island Hospital/Brown University, Providence, Rhode Island
EKV is an autosomal dominant genodermatosis characterized by persistent plaque-like or
generalized hyperkeratosis and transient erythematous patches of variable size, shape and location.
Recently, we demonstrated that EKV is caused by mutations in GJB3 encoding the gap junction
protein connexin-31 (Cx31) on 1p35.1. However, two-thirds of all families had no detectable
mutations in GJB3 or in the colocalized connexin genes GJB5 and GJA4 despite convincing
evidence for locus homogeneity. We report here the identi®cation of 4 distinct mutations in
another connexin gene GJB4 (Cx30.3) at this cluster in 5 EKV families. All heterozygous missense
mutations completely cosegregated with the disease and altered highly conserved residues. One of
them, G12D, lies in the N-terminus and may interfere with the gating polarity of Cx channels.
Other mutations (T85P, F137L, F189Y) affected the transmembrane domains of Cx30.3, thus
potentially hindering regulation of voltage gating and kinetics of channel closure. All GJB4
mutations resulted in localized hyperkeratosis, while some corresponding mutations in GJB3 were
associated with severe, generalized skin involvement. Nevertheless, we observed considerable
intrafamilial variability in 2 multiplex families, suggesting the in¯uence of other genetic and
environmental factors. Sequence analysis further revealed 3 missense substitutions and a common
frameshift deletion within the GJB4 coding region, which might represent either nonconsequential
polymorphisms or recessive mutations, and as such, could contribute to the phenotype. Our results
demonstrate genetic heterogeneity in EKV, and emphasize that intercellular communication
mediated by Cx31 and Cx30.3 is crucial for epidermal differentiation.
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Erythrokeratodermia Variabilis is Heterogeneous ± Mutation in the Novel Connexin
30.3 Gene
D. Hohl, F. Macari, M. Landau,* P. Cousin,² B. Mevorah,* S. Brenner,* R. Panizzon, D.
Schorderet, and M. Huber
Dermatology, CHUV, Lausanne, Switzerland; *Dermatology, Ichilove Hospital, Tel Aviv, Israel; ²Medical
Genetics, Chuv, Lausanne, Switzerland
Erythrokeratodermia variabilis (EKV) is an autosomal dominant keratinization disorder ®rst
described by Mendes da Costa in 1925. It begins in early life and is characterised by migratory
erythematous lesions which sooner or later turn into ®xed keratotic plaques. So far, all EKV
families have been mapped to chromosome 1p34-p35 and mutations in connexin 31 (Cx31) gene
have been reported in some but not all families suggesting that another gene may be involved in
EKV. We studied a large Israeli pedigree of Kurdish origin with annular EKV. After having
mapped the disorder to chromosome 1p34-p35, we found no mutations in Cx31, Cx31.1 and
Cx37 genes. Further investigation revealed a heterozygous T to C transition in the novel human
Cx30.3 gene which colocalises on chromosome 1p34-p35. This nucleotide change cosegregated
with the disease and was not found in 200 normal alleles. The resulting missense mutation (F137L)
concerns a highly conserved phenylalanine in the third transmembrane region of the Cx30.3
molecule. This domain is known to be implicated in the wall formation of the gap junction pore.
RT-PCR analysis revealed expression of human Cx30.3 primarily in keratinocytes in vivo and in
culture, but also in fetal bladder and adult kidney. Our results show that mutations of the novel
Cx30.3 gene are causally involved in EKV and point to genetic heterogeneity of this disorder.
Furthermore, the disease in our pedigree may present a new type of annular EKV similar but not
identical to genodermatose en cocardes of Degos.
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Papillon±LefeÁvre Syndrome: Mutations and Polymorphisms in the Cathepsin C Gene
A. Nakano, K. Nomura,* H. Nakano, Y. Ono,* S. La Forgia, L. Pulkkinen, I. Hashimoto, and J.
Uitto
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania; *Dermatology,
Aomori Prefectural Central Hospital, Aomori, Japan; ²Dermatology, Hirosaki University School of Medicine,
Hirosaki, Japan
The Papillon±LefeÁvre syndrome (PLS), inherited in an autosomal recessive pattern, manifests with
palmoplantar keratoderma and early, destructive periodontitis which may be evident during the
®rst four years of life. Recently, mutations in the gene encoding cathepsin C (CTSC), a lysosomal
cysteine protease, have been disclosed in a limited number of families with PLS. In this study, we
have examined two consanguineous multiplex families with PLS, and evaluated the CTSC gene
for mutations. Family 1 of Puerto Rican origin consisted of 4 affected and 7 unaffected siblings; the
parents were clinically normal. Family 2 from Japan had 2 affected individuals; their parents were
clinically unaffected. The mutation detection strategy consisted of PCR ampli®cation of all 7 exons
and the ¯anking intronic sequences of the CTSC gene, followed by direct nucleotide sequencing
of the PCR products. This strategy identi®ed missense mutations, W39S and G301S, in Families 1
and 2, respectively, affecting amino acid residues which were conserved between human, a number
of vertebrate, and Schistosoma japonicum sequences within the cathepsin C polypeptide. The affected
individuals were homozygotes, while heterozygous carriers (parents) of the mutations were
clinically unaffected, con®rming the recessive nature of the mutations. The W39S mutation resides
within the N-terminal propeptide portion of the CTSC polypeptide which is cleaved off during
post-translational processing. Thus, this mutation may interfere with the transport of the proform
polypeptide from RER to lysosomes or impede the proteolytic processing of the polypeptide. The
G301S mutation renders the enzyme catalytically inactive. In addition to these mutations,
nonpathogenic polymorphisms were detected in the human gene. Addition of novel CTSC
mutations into the expanding PLS mutation database allows further re®nement of genotype/
phenotype correlations towards understanding the molecular basis of this severe, syndromic
genodermatosis.
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Expression Analysis of SLURP-1, the Gene Responsible for Mal de Meleda
F. Macari, M. Huber, J. Fischer,² B. Bouadjar,§ B. Mevorah, R. Heilig, A. Bakija-Konsuo, R.
Panizzon, J. Prud'homme, and D. Hohl
Dermatology, CHUV, Lausanne, Switzerland; *Genoscope, CNS, Evry, France; ²CNG, Evry, France;
³Genethon, Evry, France; §CHU Bab-El-Qued, Algiers, Algeria; ¶General Hospital, Dubrovnik, Croatia
Mal de Meleda (MDM) is a rare autosomal recessive skin disorder characterised by transgressive
palmoplantar keratoderma and keratotic skin lesions. We report here the expression analysis of the
secreted Ly-6/uPAR related protein 1 (= SLURP-1), mutations of which are causing MDM.
SLURP-1 is a member of the Ly-6/uPAR protein superfamily of which most members have been
localised to a cluster on chromosome 8q24.3. The amino acid composition of SLURP-1 is
homologous to that of cytotoxins such as snake venom neurotoxins and cardiotoxins. Members of
the Ly-6/uPAR superfamily have been implicated in transmembrane signal transduction, cell
activation and cell adhesion. Expression of SLURP-1 transcripts was investigated in cultured
keratinocytes and tissue samples from normal and affected individuals. Northern blot analysis
showed strong expression of SLURP-1 mRNA in cultured keratinocytes derived from normal
control plantar skin but none in cultured keratinocytes established from involved plantar skin of
patients. No transcripts were detected in cultured keratinocytes from normal trunk skin or in
biopsies from control trunk epidermis. Using a more sensitive technique, RT-PCR analysis
detected SLURP-1 mRNA in cultured keratinocytes established from skin biopsies of different
body sites in both controls and MDM patients. In biopsies from normal subjects, SLURP-1
mRNA was found to be expressed in epidermis, foreskin, scalp skin and fetal bladder, but not in
the other tissues tested. Interestingly, in one MDM patient with a homozygous splice site mutation
we found two RT-PCR products of different sizes compared to controls indicating that no normal
SLURP-1 mRNA is formed in this patient. These results indicate that SLURP-1 is mainly
expressed in plantar, and most likely, in palmar skin which corresponds to the predominant sites of
MDM lesions.
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Candidate Genes for Alopecia Areata: Signi®cant Association with HLA-Class II and
Exclusion of CGRP, CD8, TNF-a and IL1-RN
M. de Andrade, N. Barahmani,* R. McMillen,* Q. Zhang,² and M. Duvic*
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; * Dermatology, U.T. M.D.
Anderson Cancer Center, Houston, Texas; ² Epidemiology, U.T. Maryland. Anderson Cancer Center,
Houston, Texas
Alopecia Areata (AA), patchy hair loss, may progress to total scalp or body hair loss, and affects 1±
2% of the population. AA is a T cell mediated immune response directed at hair follicles, and may
be another organ speci®c autoimmune disease, like diabetes, in which there is failure of self-
tolerance. The study cohort consists of families identi®ed through several Dermatology Clinics at
Texas Medical Center, Houston, TX and through a web-site. Presently, a total of 118
multigeneration families with at least one affected member have been collected. We selected 5
candidate genes (CG) for this analysis: HLA Class II DR and DQB, TNF-a (tumor necrosis factor
alpha), T-cell differentiation antigen CD8, CGRP (calcitonin gene-related peptide), and IL1-RN
(interleukin 1 receptor antagonist). These CG are located on 6p21.3, 2p12, 11p15.1-p15.2, and
2q14.2, respectively. We used the transmission disequilibrium test (TDT) to test for association
between alleles at speci®c candidate loci and risk of AA in 204 nuclear families. The results showed
an association between the alleles of HLA DQB (p = 0.00033) and DR (p = 0.00025) but not for
TNF-a (p = 0.33), CD8 (p = 0.2), CGRP (p = 0.80) and IL1-RN (p = 0.48). As with other organ-
speci®c autoimmune diseases, the HLA locus appears to be a major determinant contributing to the
pathogenesis of AA.
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A Nonsense Mutation in MSX1 Causes Tooth and Nail (Witkop) Syndrome
D. Jumlongras, M. Bei,² S. DePalma,§ U. Felbor, R. Maas,² C. Seidman, J. Seidman, and B.
Olsen
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts; *Harvard-Forsyth Department
of Oral Biology, Harvard School of Dental Medicine, Boston, Massachusetts; ²Division of Genetics, Brigham
and Women's Hospital, Boston, Massachusetts; ³Department of Genetics, Harvard Medical School, Boston,
Massachusetts; §Howard Hughes Medical Institute, Boston, Massachusetts
Tooth and Nail Syndrome (TNS) is a rare autosomal dominant disorder. It can be distinguished
from other types of ectodermal dysplasias (EDs) in that individuals with TNS have congenitally
missing permanent and/or primary teeth and nail dysplasia, but sweat glands and hair are normal.
To identify a mutation that is responsible for TNS, we used candidate gene linkage analysis and
sequencing in a three-generation family affected by the disorder. We considered the transcription
factor MSX1 an excellent candidate gene because Msx1 is highly expressed in developing murine
tooth buds and forming nail beds of mouse digits. Furthermore, tooth development is arrested in
Msx1 knockout mice, and mutations in MSX1 have been shown to be associated with congenitally
missing teeth in two unrelated families. We established strong linkage between the TNS phenotype
and polymorphic microsatellite markers surrounding the MSX1 gene, and we sequenced exons 1
and 2. We found a C-A transversion at nucleotide position 2143 in exon 2. This results in an
S202X nonsense mutation and creates an NheI restriction site. Using restriction fragment length
analysis, we found that the mutation is present in all affected members, but not in unaffected
members, and 132 normal control chromosomes. This nonsense mutation is located in the
homeodomain of MSX1 and is predicted to cause a truncated protein that cannot bind target
DNA. We hypothesize that haploinsuf®ciency is the most likely mechanism by which the
mutation causes TNS. In addition, we have found that Msx1 knockout mouse embryos have a
delayed development of proximal nail fold, and nail plates in Msx1 knockout mice are much
shorter and thinner than that of their wild-type littermates. The striking resemblance between
tooth and nail phenotype in our family and that of Msx1 knockout mice strongly supports the
conclusions that S202X MSX1 causes Tooth and Nail Syndrome and Msx1 is necessary for normal
tooth and nail development.
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Characterisation of the Upstream Regulatory Region of Type II Hair-Speci®c Keratin
Genes
E. Pearce and P. Bowden
Dermatology, University of Wales (UWCM), Cardiff, United Kingdom
Several hair-speci®c keratin genes have been characterised and they exist, together with the other
keratin genes, in two separate clusters on chromosomes 12 (type II) and 17 (Type I). The hair-
keratin genes are speci®cally expressed in the growing hair shaft and nail plate. They are also
modulated during the hair-growth cycle being down regulated during catagen, no expression
during telogen and up regulated during early anagen. The elements that regulate both the tissue
speci®c and temporal expression and unknown but must reside in the noncoding region up-stream,
within or down-stream of the structural gene. In order to investigate the regulation of these genes,
we have isolated PAC and cosmid clones, which make up a 120-kb contig of chromosome 12q13.
This contains three complete functional type II hair-speci®c keratin genes (KRT-Hb1, KRT-Hb3
and KRT-Hb6) and we have sequenced the upstream regulatory regions of these genes. The PAC
and cosmid clones were isolated by screening genomic libraries with a PCR generated 1 kb
fragment of KRT-Hb3 and KRT-Hb1 genes. Clones were characterised by Southern blotting,
long-range PCR, subcloning and sequencing. A 120-kb contig was assembled and subclones
containing up to 4 kb of the regulatory regions of KRT-Hb1, KRT-Hb3 and KRT-Hb6 were
made and sequenced. The sequences were analysed using the Transfac database (release 5.0) and
prospective regulatory elements identi®ed. Portions of the regulatory region (1 kb, 2 kb and 3 kb)
of Hb3 and Hb6 were subcloned into a luciferase reporter gene vector (Promega pGL3) and
transfected into Cos cells. The genes are about 10 kb apart and we have identi®ed possible
regulatory elements (AP1, CEBP, cRel, CHOP, AP2 and NF?B) up to 4 kb from the
transcriptional start site. Preliminary reporter gene assays suggest some of these elements are
functional in regulating the expression of these type II hair-speci®c keratin genes.
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Evidence for Extensive Locus Heterogeneity in Naxos Disease
A. Kljuic, K. Djabali, A. Martinez-Mir, L. Horev,* L. Klapholtz,* B. Glaser, J. Mc Grath, A.
Zlotogorski, and A. Christiano
Dermatology and Genetics & Development, Columbia University, New York, New York; *Dermatology and
Endocrinology, Hadassah Medical Center, Jerusalem, Israel; ²Dermatology, Saint Johnes Institut of
Dermatology, London, United Kingdom
Naxos disease is a rare inherited defect of the hair shaft resulting in sparse and dystrophic hair. The
clinical picture is associated with a triad of woolly hair, thickened palms and soles (keratoderma)
and heart involvement. The hair involvement is unique, and is characterized by woolly, curly,
rough and light colored scalp hair and sparse eyebrows. Affected individuals suffer at young age
from severe psychological and social disability and later also develop a severe heart disease that may
end with arrhythmia and premature sudden death. This autosomal recessive associated triad was
originally described in patients from the Greek island of Naxos by Protonotarios et al in 1986 and
by Barker et al in 1998. in 1998, Luis Carvajal-Huerta described 18 patients from Ecuador with a
similar autosomal recessive triad, combined of epidermolytic palmoplantar keratoderma with
woolly hair, dilated cardiomyopathy and detailed the skin manifestations. Recently, the gene for
the Greek families was mapped to 17q21, and mutations in two different genes, plakoglobin and
desmoplakin, have been identi®ed as responsible for the disease in the Greek and Ecuadorian
families, respectively. We have identi®ed two additional large consanguineous families from Israel
and obtained DNA from most members of these families. First, we excluded a mutation in the
desmoplakin and plakoglobin genes by sequence analysis, suggesting that at least one additional
gene underlies Naxos disease in these families. We then performed cosegregation studies using
microsatellite markers covering the keratin clusters on chromosomes 12 and 17, the desmoyokin
locus (11q13.1), and the desmocollin/desmoglein cluster (18q12.1). We excluded these as
candidate genes, since none of these regions showed cosegregation with the disease trait using
homozygosity mapping in these inbred families. We have now initiated a whole genome search to
identify the gene(s) causing Naxos disease in our families.
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Proliferation Status of Nevi in Utah Kindred Members with and without CDKN2A
Mutations
S. Florell, J. Holden,* L. Meyer, W. Samlowski,² L. Cannon-Albright,³ S. Neuhausen, J. Zone,
and S. Leachman
Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah; *Pathology, University of
Utah Health Sciences Center, Salt Lake City, Utah; ²Huntsman Cancer Institute, University of Utah
Health Sciences Center, Salt Lake City, Utah; ³Genetic Epidemiology, University of Utah Health Sciences
Center, Salt Lake City, Utah
Approximately 40% of familial melanoma is caused by a mutation in cyclin dependent kinase
inhibitor 2 A (CDKN2A, p16), a tumor suppressor that acts by regulating the cell cycle via the
retinoblastoma (Rb) tumor suppressor pathway. One of several melanoma-prone families studied
more than 10 years ago at the University of Utah was instrumental in establishing the melanoma
susceptibility locus on chromosome 9p21 and later con®rming the relevance of the mutation in
CDKN2A. This family carries a coding mutation of CDKN2A, V126D, that cosegregates with
disease. The mutated protein product is temperature sensitive, showing approximately 33% of
normal CDK4 binding at 30 degrees and dropping to less than 10% at 42 degrees. Defective
binding to CDK4 results in hyperphosphorylation of Rb, and E2F-mediated re-entry into the cell
cycle. DNA topoisomerases are enzymes that control DNA topology. Topoisomerase II-a (topo
II) is required for DNA replication, is cell cycle speci®c, and is a well-established marker of cellular
proliferation. We hypothesized that family members carrying the CDKN2A mutation would have
nevi in a higher proliferative state than family members that did not harbor the mutation. One
hundred four nevi from 54 kindred members were immunostained for topo II. The slides were
evaluated in blinded fashion by two pathologists who performed topo II index counts on each
nevus. Results were evaluated in conjunction with the kindred members' mutation status.
Preliminary results suggest that the cellular proliferation index of nevi as determined by topo II
immunostaining cannot be used to predict CDKN2A mutation status. Future studies with a more
sensitive marker of proliferation are warranted.
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Loss of Heterozygosity at 1p36 and 9p22±21 Regions in the Human Melanocytic Skin
Lesions
M, R. Hussein,* E. Tuthill,² L. Roggero, C. Sudilovsky,³ G. O. Wood, and Sudilovsky
Department of Medicine(Dermatology), University of Wisconsin and the Middlleton VA Medical Center,
Madison, Wisconsin; *Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio;
²Department of Pathology, Instituto de HistopatologõÂa, Rosario 2000, Prov. de Santa FeÂ, Argentina;
³Department of Pathology, Case Western Reserve University, Cleveland, Ohio
Analysis of loss of heterozygosity (LOH) in tumors is a powerful tool for mapping the sites of
tumor suppressor genes (TSGs). We used PCR-based microsatellite assay to analyze 30 benign
melanocytic nevi (BN), 60 melanocytic dysplastic nevi (MDN), and 22 vertical growth phase
melanomas (CMM) for the presence of LOH at 1p and 9p regions. LOH was found at 1p and 9p in
CMM and MDN but not in BN. At 1p36 region, LOH was found in 8/22 (36%) CMM and 9/60
(15%) MDN. 1p36 deletion mapping de®ned 2 deletion regions centered at D1S214 and D1S228
loci. At 9p22±21 regions, LOH was detected in 7/22 (32%) CMM and 9/60 (15%) MDN. The 9p
deletion pattern revealed LOH hot spots at D9S171 and D9S169. Our study suggests the
inactivation of TSGs at 1p and 9p regions during melanoma tumorigenesis.
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A New Locus for Hermansky±Pudlak Syndrome in Puerto Rico
S. Bale, J. Toro, and W. Gahl
National Institutes of Health, Bethesda, Maryland
Hermansky±Pudlak Syndrome (HPS) is an autosomal recessive disorder characterized by
oculocutaneous albinism, a bleeding diathesis due to platelet storage pool de®ciency, and
lysosomal accumulation of ceroid lipofuscin. HPS occurs with a high frequency in north-west
Puerto Rico (PR), where 1 in 21 individuals is a carrier. HPS patients from north-west PR are
homozygous for a 16-bp duplication in exon 15 of the HPS1 gene; this mutation is associated with
signi®cant risk of pulmonary ®brosis. The objective of this study is to determine the phenotype and
genotype of HPS patients from several parst of the island and map the gene for a new subtype of
HPS. Sixty-one of 76 patients displayed the 16-pb duplication in the HPS1 gene; all from North-
west Puerto Rico. However, we found 15 patients from 8 families, all from central Puerto Rico,
who lacked the 16-bp duplication or any other mutation on HPS1 as determined by cDNA
sequencing. All patients studied lacked platelet dense bodies on electron microscopy, con®rming
the diagnosis of HPS. The patients from cental Puerto Rico exhibited only mild visual defects and
mild pigment dilution of hair, eyes and skin, with no pulmonary ®brosis. These ®ndings differed
signi®cantly from HPS individuals with the 16-bp duplication in HPS1. Using homozygosity
mapping on pooled DNA from 8 families from central PR, we mapped the putative new HPS
susceptibility gene to a region of less than 2-cM in an area of the human genome homologous to a
murine locus for a model of HPS. These results indicate the chromosomal location for a new HPS-
causing gene and allow for physical mapping, gene identi®cation, and mutation analysis of human
HPS patients with currently unknown molecular defects.
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CpG Island-Speci®c Hypermethylation in Peripheral Blood Lymphocytes of Systemic
Lupus Erythematosus
H. Fujiwara and M. Ito
Dermatology, Niigata University School of Medicine, Niigata, Japan
DNA methylation, especially methylation in CpG island of genome, is one of the most important
mechanisms in epigenetic regulation of gene expression. We developed highly sensitive method of
evaluating CpG island-speci®c methylation of whole genome, nonisotopic cytosine extension assay
(NICEA), and reported previously. We analyzed CpG island methylation status of peripheral blood
lymphocytes of systemic lupus erythematosus (SLE) and compared with cutaneous LE (discoid LE
and LE profundus). Genomic DNA of peripheral blood lymphocytes of SLE (n = 15), CLE
(n = 10), and control (n = 10) was extracted. The genomic DNA was digested with BssHII, HpaII,
or MspI, and subjected for NICEA study. BssHII/MspI, represents nonmethylated potion of CpG
island vs. whole CpG, and BssHII/HpaII, represents nonmethylated potion of CpG island vs.
nonmethylated potion of whole CpG, were calculated. BssHII/MspI was decreased signi®cantly,
compared with CLE; BssHII/HpaII was decreased signi®cantly, compared with the control. The
difference between CLE and the control was not signi®cant, statistically. In conclusion, CpG island
of peripheral blood lymphocyte was hypermethylated in SLE, but not in CLE. The
hypermethylation of CpG island can be a mechanism of dysregulation in lymphocyte function
of SLE.
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Altered Asian Skin Blanching Responses to Dermatologic Corticosteroids Containing
Alcohol is Associated with an Alcohol Dehydrogenase 2 Polymorphism
H. Rausch, L. Pershing, and M. Hobbs*
Dermatology, University of Utah, Salt Lake City, Utah; *Internal Medicine, University of Utah, Salt Lake
City, Utah
Previous research in our laboratory demonstrated that Asians required 3±10X the dose as
Caucasians to produce the same maximal skin blanching response (SBR) with dermatologic
corticosteroid (DC) products containing alcohols. The ethnic SBR differences were independent
of DC uptake into skin. A possible genetic basis for the SBR differences was investigated with
three candidate genes that encode for (1) 11b hydroxy steroid dehydrogenase 1 (11bHSD-1) and 2
(11bHSD-2): enzymes involved in corticosteroid metabolism that regulate the amount of DC
available to the corticosteroid receptor and (2) alcohol dehydrogenase 2 (ADH-2): an enzyme
responsible for alcohol metabolism and associated with the ¯ushing response. The sequences of
these genes were determined from extracted peripheral blood DNA in 9 Caucasian and 7 Asian
subjects previously evaluated for SBR to seven 0.05% betamethasone dipropionate products with
and without alcohol(s) in their vehicles. Comparisons of the DNA sequences revealed no
differences in exons 1±5 of 11bHSD-1 and no differences in exons 2±5 of 11bHSD-2 between the
two ethnic groups. However, the documented arginine to histidine polymorphism of amino acid
47 in ADH-2 was observed in 100% of the Asian subjects evaluated. These data suggest the
differential SBR to DC between Asians and Caucasians may re¯ect the effect of metabolism of
alcohols contained in the products rather than differences in DC metabolism itself.
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Gene Expression of MMP-1 and MMP-13 is Up-Regulated with Worsening Venous
Re¯ux in Patients with Venous Insuf®ciency
D. Gillespie, A. Patel,* B. Fileta,* S. Barnes,* A. Flagg,* S. O'Donnell, J. Goff, J. Villavicencio, N.
Rich, and A. Chang
Division of Vascular Surgery, Uniformed Services University, Bethesda, Maryland; *Section of Vascular
Surgery & Department of Clinical Investigations Sections of Molecular Biology and Statistics, Walter Reed
Army Medical Center, Washington, District of Colombia
Venous insuf®ciency is a spectrum of disease that varies from varicose veins to chronic venous
ulceration. Worsening venous re¯ux and elevated ambulatory venous pressure are characteristic of
this state. We were interested in investigating if elevations in venous pressure correlated with
changes at the molecular level in the vein walls of these patients. One centimeter segments of
greater saphenous vein (GSV) were obtained from patients undergoing ligation and stripping for
venous insuf®ciency (n = 15). All patients had incompetence of the GSV by color ¯ow duplex and
elevated venous ®lling index (VFI) by air plethysmography. Vein specimens were analyzed for
MMP-l, 3, 13, tryptase and GADPH mRNA using RT-PCR. Quanti®cation of MMP-1, 13
(active/latent forms) and tryptase was performed using Western blot analysis. Gelatin zymography
was performed looking for MMP-1 or MMP-13 activity. Western blots were analyzed using
scanning densitometry and values expressed as the median densitometric index. Spearman's rank
correlation was used for statistical analysis. MMP-l, MMP-13 and tryptase mRNA was expressed in
all segments of GSV. MMP-3 mRNA however, was not found in any segment. We found a direct
correlation between elevated MMP-1 (latent form) gene expression and worsening venous re¯ux
(rs = 0.547) (p = 0.043). Similarly we found a signi®cant difference in the quantity of MMP-13
protein (active form) (rs = 0.618) (p = 0.019) and MMP-13 protein (latent form) (rs = 0.618)
(p = 0.027) and elevated VFI. We found no such correlation however, in the quantity of tryptase in
segments of GSV. This study shows a direct correlation exists between worsening venous re¯ux
and the up regulation of the matrix remodeling proteins MMP-l and MMP-13. We believe this is
the ®rst example connecting physiologic observations with induced molecular changes, ultimately
leading to venous pathology.
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Birt-Hogg±Dube Syndrome has an Increase Risk for Renal Neoplasms and Spontaneous
Pneumothrorax
B. Zbar, J. Toro, M. Turner, G. Glenn, p. Duray, P. Choyke, and M. Linehan
National Cancer Institute, Bethesda and Frederick, Maryland
The Birt-Hogg±DubeÂ syndrome, a genodermatosis characterized by hamartomas of the hair
follicle, has been associated with renal and colonic neoplasms, and spontaneous pneumothorax, but
the risk of developing these disorders is unknown. To determine risk, we recruited families on the
basis of a diagnosis of the Birt-Hogg±DubeÂ syndrome and compared the frequency of renal and
colonic tumors, and of spontaneous pneumothorax in patients affected with the Birt-Hogg±DubeÂ
syndrome, to the frequency of these manifestations in their unaffected siblings (controls). To
determine the number of individuals affected with renal or colon tumors, we added the number of
individuals with a history of renal or colon neoplasia to the number of individuals found to have
tumors by screening procedures. We studied 222 subjects from 26 families affected with the Birt-
Hogg±DubeÂ syndrome; there were 110 affected and 112 unaffected individuals. 15/110 (14%)
patients affected with the Birt-Hogg±DubeÂ syndrome had renal tumors. In comparison, 2/112
(2%) control subjects had renal tumors (p = 0.0009). The risk of developing renal tumors in patients
affected with the Birt-Hogg±DubeÂ syndrome as measured by the odds ratio was: 8.7 (95%
con®dence limits: 1.9±39.0). Renal tumors in patients with the Birt-Hogg±DubeÂ syndrome were
predominantly chromophobe or clear cell renal carcinomas. 25 of 110 (23%) patients with the Birt-
Hogg±DubeÂ syndrome gave a history of spontaneous pneumothorax; 0/112 (0%) of unaffected
members of Birt-Hogg-DubeÂ families gave a history of spontaneous pneumothorax. The risk of
developing spontaneous pneumothorax in patients affected with the Birt-Hogg±DubeÂ syndrome
was: 67.1 (95% con®dence limits: 4.0±1118). Pulmonary cysts were detected by high resolution
thoracic CT scans in 83% of patients affected with the Birt-Hogg±DubeÂ syndrome, and in 10% of
controls. There was no signi®cant difference in the frequency of colon polyps (22% vs. 19%,
p = 0.75) or colon carcinomas in Birt-Hogg-DubeÂ affected compared to non affected individuals.
Birt-Hogg±DubeÂ syndrome confers an increased risk for the development of renal tumors, lung
cyst and spontaneous pneumothorax. We found no increase in risk for colon polyps or colon
carcinomas.
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Mutations in p63 and Genotype-Phenotype Correlation in AEC and EEC Syndromes
J. McGrath and H. van Bokhoven*
Cell and Molecular Pathology, St John's Institute of Dermatology, London, United Kingdom; *Department
of Human Genetics 417, University Medical Centre Nijmegen, Nijmegen, Netherlands
Linkage and mutation analyses have identi®ed heterozygous missense mutations in the DNA-
binding domain of the p63 gene as the major cause of EEC (ectrodactyly, ectodermal dysplasia,
clefting) syndrome. Other autosomal dominant ectodermal dysplasia syndromes have also mapped
to the p63 locus at 3q27 suggesting allelic heterogeneity. In this study, we assessed whether AEC
(ankyloblepharon, ectodermal dysplasia, clefting) syndrome also results from mutations in p63.
Genomic DNA from 2 patients with EEC syndrome and 8 patients with AEC syndrome was
analyzed by PCR ampli®cation of the 15 exons of p63 using primers sited in ¯anking introns. PCR
products were sequenced directly and sequence variants were veri®ed by restriction digestion and
exclusion in 100 control chromosomes. In the EEC patients, we identi®ed heterozygous R279H
and R304W substitutions in exons 7 and 8, respectively. In the AEC patients we detected the
heterozygous mutations L518V, L518F, C526G, C526W, G534V, T537P, Q540L and I541T, all
in exon 13. Eight of the 10 p63 mutations occurred de novo. The amino acid changes in the EEC
patients are located in the core DNA-binding domain of p63 and have been recorded in two other
unrelated patients. Indeed, these two residues correspond to the amino acids in p53 (R248 and
R273) that are most frequently mutated in human tumors. The amino acid substitutions in the
AEC patients establish the molecular basis of this genodermatosis, and con®rm allelic heterogeneity
for p63 mutations in EEC and AEC syndromes. All AEC mutations occurred within the SAM
(steric-alpha-motif) domain, part of p63 which is important in protein±protein interactions, but for
which an equivalent domain in p53 is lacking. In summary, these data provide evidence for a
speci®c genotype-phenotype correlation in this group of inherited ectodermal dysplasia syndromes.
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Identi®cation of a Novel D132H Missense Mutation in the Flavin-containing
Monooxygenase 3 Gene in Trimethylaminuria
S. Kobayashi, J. Kim,* H. Lawley,* S. Tjoa,² P. Fennessey,² G. Preti, and S. Fakharzadeh
Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania; *Monell Chemical Senses Center,
Philadelphia, Pennsylvania; ²Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado
Trimethylaminuria (TMAU) is a metabolic disorder that results from de®ciency of the ¯avin-
containing monooxygenase 3 (FMO3) enzyme. This leads to an inability to metabolize
trimethylamine (TMA), which accumulates and may sporadically impart a ®shy or foul smell.
Affected individuals frequently present to dermatologists complaining of skin malodor. An
autosomal recessive inheritance pattern for this disorder has been observed and mutations within
the FMO3 gene that reduce or ablate its product's function have been identi®ed. However, milder
forms of the disease that result from mutation of one FMO3 allele or even homozygosity for
certain polymorphisms that may reduce FMO3 activity have been described. Also, factors such as
diet, gut ¯ora content, and time in the menstrual cycle may in¯uence the expression of milder
forms. We have performed mutation screenings on subjects that presented with malodor and
displayed reduced capacity to generate trimethylaminoxide (TMAO) after choline challenge. Each
coding exon of the FMO3 gene (exons 2±9) was ampli®ed from genomic DNA and subjected to
direct sequencing. We have identi®ed a female African-American proband who displays 47% of
normal FMO3 activity and carries a novel D132H alteration in exon 4. We detected only the ``g''
to ``c'' change responsible for this amino acid substitution at nucleotide 73 of exon 4 and we
observed no variation at polymorphic sites elsewhere in the FMO3 gene. This suggested that either
she may carry two identical FMO3 alleles or she may have a deletion of one FMO3 allelle.
Southern blot analysis revealed no evidence for allele deletion compared to controls. Taken
together, these observations indicate that the D132H mutation likely accounts for reduced FMO3
activity in this individual. The nucleotide substitution introduces a new NLAIII restriction site into
exon 4 coding sequences. Forty control subjects, of which 16 are African-American, lack this
NLAIII site, indicating that this alteration unlikely represents a polymorphism. In sum, we have
identi®ed a novel D132H missense mutation in the FM03 gene in an individual with TMAU. To
our knowledge, this represents the ®rst report of mutation in FMO3 associated with TMAU in an
African-American individual.
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Mechanism of S-Phase Arrest by Telomere 3¢ Overhang Speci®c DNA
M. Eller, N. Puri, G. Li, and B. Gilchrest
Derm, Boston University, Boston, Massachusetts
Telomeres, repeats of TTAGGG at chromosome ends, are proposed to act as a biological clock and
cancer prevention mechanism. The telomere 3¢ end is a single-stranded overhang, normally
concealed in a loop structure. Telomere disruption triggers apoptosis and other DNA damage
responses, as does treatment of cells with DNA oligonucleotides that share homology with the
telomere overhang. In normal cells, the S-phase arrest induced by ionizing radiation (IR) requires
phosphorylation of p95/Nbs1, the protein mutated in Nijmegen Breakage Syndrome. We
therefore examined the role of p95/Nbs1 in the telomere overhang oligonucleotide-induced S-
phase arrest. A human T cell line (Jurkat), a squamous cell carcinoma line (SCC12F), an
osteosarcoma cell line (Saos-2), normal neonatal human ®broblasts, NBS ®broblasts and age-
matched control ®broblasts were treated with 11-base oligonucleotides either homologous,
complementary, or unrelated to the telomere overhang (11mer-1, ±2, ±3, respectively). After 48 h,
cells were collected for FACS analysis. Cells treated with 11mer-2 or-3 had similar pro®les
compared to diluent-treated controls. However, cells receiving 11mer-1 showed increases of 100%
(Jurkat), 355% (neonatal ®broblasts), 120% (SCC12F) and 68% (Saos-2) in S-phase cells (p < 0.01).
NBS cells showed only a 23% (p < 0.07) increase while the control ®broblasts increased by 85%
(p < 0.01). As previously shown for IR, p95/Nbs1 in cells treated with the 11mer-1 demonstrated
a shift to a higher molecular weight concomitant with the S-phase arrest and this shift was
eliminated by treatment with a serine/threonine phosphatase, implicating phosphorylation of p95/
Nbs1. Because Jurkat cells have a nonfunctional p53 pathway and Saos-2 cells are p53-null, the S-
phase arrest induced by 11mer-1 is independent of p53. These data suggest that p95/Nbs1 mediates
inhibition of DNA replication induced by telomere 3¢ overhang DNA and support the hypothesis
that exposure of this sequence is a physiologic signal for DNA damage responses.
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Induction of Apoptosis by Telomere 3¢ Overhang Speci®c Oligonucleotides in Human
Melanoma Cells
N. Puri, M. Eller, H. Byers, and B. Gilchrest
Derm, Boston University, Boston, Massachusetts
The 3¢ end of each telomere is a single-stranded overhang of repeats of TTAGGG and is proposed
to form a loop structure at the chromosome ends. Considerable evidence suggests that exposure of
the telomere overhang by experimental disruption, DNA damage, progressive telomere shortening
or provision of homologous DNA fragments is a signal for DNA damage response such as
apoptosis. To explore the mechanism and possible therapeutic utility of these responses, we
designed 11-base oligonucleotides homologous, complementary and unrelated to the telomere
overhang (11mer-1, ±2, ±3, respectively) and added them separately to cultures of 5 human
melanoma cell lines. By FACS, 3 of these cell lines showed an increase in apoptotic cells after
treatment with 11mer-1, compared to diluent, 11mer-2 or ±3. In the most responsive cell line,
after 72 h of treatment with 11mer-1, up to 32% of the cells were apoptotic, compared to 2% of the
diluent- or 11mer-2- or 11mer-3-treated cells (p = 0.01) and by 96 h, up to 64% of cells were
apoptotic, compared to 5% of the controls (p = 0.01). Apoptosis was also detected by TUNEL assay
in 11mer-1-treated melanoma cells. In contrast, the 11mer-1 did not induce apoptosis in normal
human melanocytes. To study the mechanism of apoptosis, a responsive line (MM-AN) and a
resistant line (r.p.m.-EP) were treated with the oligonucleotides, proteins were collected and
analyzed by Western blot. An increase in the E2F1 transcription factor was seen after 24 h of
treatment with 11mer-1 but not ±2 or ±3 in the MM-AN cells, followed by an increase in the level
of the p53-related protein p73, known to cooperate with E2F1 in apoptosis. No change in p53
level was detected. No induction of E2F1 or p73 was detected in r.p.m.-EP cells. These data show
that DNA oligonucleotides homologous to the telomere overhang induce apoptosis in a subset of
melanoma cells, likely by the induction of E2F1 and p73, but not in normal melanocytes and also
suggest that these DNAs may have therapeutic potential.
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Induction of Replicative Senescence Markers by Telomere 3¢ Overhang Speci®c DNA
G. Li, M. Eller, and B. Gilchrest
Derm, Boston University, Boston, Massachusetts
Mammalian cells have a tightly regulated program of replicative senescence, suggested to be a
fundamental defense against cancer and controlled largely by telomere length. Telomeres, tandem
repeats of TTAGGG, cap the ends of chromosomes and shorten with cell division. Disruption of
the telomere loop structure exposes the telomere 3¢ overhang and mimics cellular responses to
DNA damage. Treatment of cells with single-stranded oligonucleotides homologous to the
telomere 3¢ overhang also induces DNA damage-like responses. To determine if replicative
senescence is among these responses, normal human ®broblasts were treated with 11-base
oligonucleotides either homologous to or complementary to the telomere 3¢ overhang or with
diluent alone and were stained for senescence-associated b-galactosidase (SA-b-Gal) activity. Cells
treated with the telomere 3¢ overhang homolog showed 6-fold more SA-b-Gal positive cells
compared to cells teated with diluent or the complementary sequence (61 6 10%, 7 6 2% and
10 6 2%, respectively; p = 0.01). Homolog-treated cells also manifested a senescent morphology,
with many large spread cells. To look for other markers of senescence, paired ®broblast cultures
were treated for 3 days as described above or serum-starved to induce quiescence and then serum-
stimulated for 24 h, collected and analyzed by Western blot. Cells treated with the overhang
homolog, compared to diluent- or complement-treated cells or to previously quiescent cells,
overexpressed p53 and the senescent cell-derived inhibitor of pRb phosphorylation, p21 (SDI-1)
and failed to phosphorylate pRb in response to serum stimulation. Furthermore, these cells
expressed higher levels of the promyelocytic leukemia protein (PML) known to be up-regulated
during ras-induced senescence of these cells. The data strongly suggest that telomere shortening
during aging induces senescence by destabilizing the telomere loop and hence exposing the 3¢
overhang and that this physiologic signal can be mimicked by homologous DNA fragments.
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p33ING1 Role in DNA Repair
K. Cheung, P. Lin, V. Ho, and G. Li
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
ING1 is a new tumor suppressor that has no signi®cant homology with other genes. However, it
shares many biological functions with those of p53. Some of its functions include G1-phase growth
arrest and apoptosis in cooperation with p53, replicative senescence, chemosensitivity, and
anchorage-dependent growth. We have recently shown that the regulation of ING1 expression is
not dependent on p53 in vivo and that ING1 expression is induced by UV irradiation in a dose-/
time-dependent and tissue-speci®c manner. To investigate if ING1 plays a role in DNA repair, we
performed the CAT assay where a UV-damaged plasmid containing the chloramphenicol
acetyltransferase reporter gene (pCMV-cat) was cotransfected with either vector, ING1, or
antisense ING1 expression vector into mammalian cells. The activity levels of the reporter gene
were then used as an indicator of the extent of repair. Our data demonstrates that cells transfected
with the ING1 gene have 2±3 fold increase in the rate of repair of the UV-damaged plasmid
compared to the vector and antisense controls. In addition, results from the radioimmunoassay
show that global genomic DNA repair is enhanced by approximately 50% in ING1-transfected
cells compared to the vector-transfected control cells. It is interesting to note that this repair
capability of ING1 is, to a large extent, dependent on the status of p53, as enhancement in ING1-
mediated repair is reduced signi®cantly when p53 is knocked out by transfection with a dominant-
negative p53 construct. Finally, results from immunoprecipitation suggest that there is a weak
physical association between ING1 and GADD45, a DNA-damage-inducible gene involved in
excision repair. These results strongly indicate that ING1 participates in nucleotide excision repair
of UV-damaged DNA.
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The Role of Nucleotide Excision Repair Genes XPA and XPC in Melanoma
Pathogenesis
R. Edwards and S. Lessin
Medical Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Host response to ultraviolet (UV) exposures is a critical factor in cutaneous melanoma pathogenesis
and defects in DNA repair pathways are associated with skin cancer development. Xeroderma
pigmentosum (XP) is a genetic, skin cancer-prone, DNA repair-de®cient disorder resulting from
the inherited loss of function of one of seven XP nucleotide excision repair (NER) genes. A
limited number of studies have suggested that the development of melanoma in XP is most
frequently associated with XPA and XPC gene defects. The goal of this study was to explore the
role of XPA and XPC in sporadic melanoma by screening for the frequency of loss of
heterozogosity (LOH) detected at XPA (9q22.3) and XPC (3p25.1) gene loci. DNA from
microdissected vertical growth phase, tumorigenic cutaneous melanomas (n = 6) was PCR
ampli®ed with primers for microsatellite markers D9S287 (within 1.5 cM of XPA), and with
D3S1597, D3S1263, D3S1585, D3S3726, D3S1293 (spanning a 12.8-cM region around XPC)
and compared to DNA from normal tissue within the same specimens. PCR products were
analyzed by capillary electrophoresis (ABI system 3100). A LOH index was calculated (peak height
tumor allele 1/peak height tumor allele 2 4 peak height normal allele 1/peak height normal allele
2) and LOH was de®ned by an LOH index of 1.5 or < 0.5, indicating a 50% loss in the relative
peak height of allele 2 or allele 1, respectively. For XPA, 3 of 6 cases were informative for D9S287,
and 1 of the 3 informative cases demonstrated LOH at this marker. For XPC, 2 of 6 cases
demonstrated LOH involving a 12.8-cM region ¯anking the XPC gene. The case demonstrating
LOH for XPA also demonstrated LOH for XPC. Our preliminary results demonstrate that LOH
involving XPA and XPC gene loci may be detected within a subset of cutaneous melanomas. This
suggests that an acquired loss of function of XPA and/or XPC genes, resulting in DNA repair
defects may contribute to sporadic melanoma development and progression. Further studies to
con®rm the mutation status of XPA, XPC and other XP NER genes are required to con®rm and
delineate the role of XP NER genes in the pathogenesis of cutaneous melanoma.
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Transcriptional Fine-Tuning: The Nuclear Receptor's Hierarchy in the Regulation of
Keratin Gene Expression
E. Robinson, B. Lee, H. Bender, and M. Tomic-Canic
Dermatology, NYU School of Medicine, New York, New York
We have shown previously that the glucocorticoids (GCs), thyroid hormone (T3) and retinoic acid
(RA) suppress the expression of the disease-associated keratin genes (K5, K14, K6, K16 and K17)
through a unique molecular mechanism that involves particular nuclear receptor con®gurations
and keratin response elements (KREs). One of the remaining questions is how these three
hormone receptors maintain such transcriptional regulation in their natural environment, i.e. when
they are all simultaneously present? To determine how the simultaneous presence of multiple
receptors changes the binding pattern to keratin REs and regulation of keratin gene expression, we
have performed footprinting, gel-shift and cotransfection experiments with the combinations of
T3R, GR and RAR. We have found that T3R and GR can simultaneously bind the KRE using
gel-shift and footprinting experiments. Furthermore, when both T3R and dexamethasone (DEX)
are simultaneously present T3R blocks keratin gene regulation by DEX. Conversely, DEX does
not affect the induction of keratin gene expression mediated by unliganded T3R. We conclude
that T3R dominates over GR in regulating keratin gene transcription. Furthermore, RAR blocks
the regulation by T3R when both are simultaneously present. We conclude that there is the
hierarchy in receptor regulation of keratin genes in which RAR dominates over T3R and T3R
dominates over GR. The role of the KREs is to allow interplay of multiple nuclear receptors, thus
creating a gradient of hormonal action. Such receptor interactions provide ®ne-tuning of
transcriptional regulation of keratin genes. The sequences of KREs dictate the hierarchy of nuclear
receptors responding to a large variety of physiological conditions under which the suppression of
these genes is required. This hierarchy is extremely important in epidermis, a target tissue that is
exposed to and depends on regulation by multiple hormones.
796
An AP2 Site in the Mouse Trichohyalin Gene Promoter May Confer Tissue Speci®c
Expression
G.L.I. Jang and S.P. Steinert
Laboratory of Skin Biology, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National
Institutes of Health, Bethesda, Maryland
Trichohyalin (THH) is a major structural protein in the inner root sheath of hair follicle, and also is
involved in late stage of differentiation in the epidermis. To elucidate factors controlling its
transcription, a series of CAT constructs containing several different size of inserts between ±478 bp
upstream from the transcription start site and the ®rst exon (+36) of mouse THH (mTHH) gene
were transfected into mouse hair follicle cells as well as epidermal keratinocytes. The results
showed that as few as 250 bp are suf®cient to confer strong promoter activity. Within this region,
we found eight elements including three Sp1-like motifs (±234, ±135 & ±104), an AP1 site (±115),
an AP2 site (±69), three unidenti®ed motifs named E1 (±191), E2 (±160), and R1 (±126).
Supershift assays revealed that Sp1, Sp3, c-Jun, AP2-a, AP2-g antibodies each bind to its
corresponding motif. Separate mutations on E2 (±160), Sp1 (±135) and AP1 in the context of the
pCAT (±250/+36) construct reduced CAT activity to basal level in both hair follicle cells and
keratinocytes indicating these three elements are essential for promoter activity. E1 (±191) and the
other Sp1 motifs (±234 & ±104) are necessary but not suf®cient to confer mTHH promoter
activity. Furthermore, mutation of either R1 (±126) or AP2 showed 40% and 60% CAT activity
increase over the wild type construct, respectively, in cultured hair follicle cells. However,
mutation of AP-2 decreased CAT activity to basal level in keratinocytes implicating that AP-2 is a
positive element. Therefore, AP2 site is necessary for mTHH expression in keratinocytes in
addition to the E2 (±160), Sp1 (±135) and AP1 motifs. Thus, it is suggested that AP2 play opposite
roles in mTHH transcription regulation in cultured hair follicle cells vs. keratinocytes. We suggest
it may be involved in THH cell-type speci®c expression.
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Transcriptional Regulation of Mouse Col7a1 Gene in Keratinocytes
M. Naso, J. Uitto, and J. Klement
Dermatology and Cutaneouos Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
The transcriptional control of the mouse Col7a1 gene that codes for the constitutive subunit
polypeptide of type VII collagen, 1 pro a1(VII), was studied in a mouse keratinocyte cell line. This
keratinocyte cell line that biosynthetically resembles basal keratinocytes, was established by
spontaneous immortalization of a primary keratinocyte cell culture from a 129Sv mouse epidermis.
Analysis of Col7a1 promoter/CAT constructs in this cell line revealed the presence of a region
between ±340 and ±560 that was required for high level expression in this cell system. There was
also a region between ±560 and ±1590 that possessed down-regulatory elements. Mutagenesis
identi®ed regions in the proximal promoter between the transcription start site and ±130, and distal
promoter between ±340 and ±560 that are required for high levels of promoter activity.
Electrophoretic mobility shift assays determined that factors similar to Sp1, Sp3, AP1, and AP2
bind to discrete cis-elements in these regions. Such factors have been implicated in the expression
of other epidermal genes, as well. It has been shown by others (Gardella R et al, Hum Mut #364,
2000) that mutation of a single Sp1 site at position ±96 was associated with development of
dystrophic EB. We show that a similar mutation in the mouse Col7a1 promoter results in
decreased promoter function, demonstrating the requirement of Sp1 for basal Col7a1 gene
regulation.
798
Thapsigargin Suppresses Differentiation-Dependent Human Involucrin Promoter
Activity by Reducing CCAAT/Enhancer Binding Protein-A DNA Binding
S. Balasubramanian, C. Agarwal, T. E®mova, G. Dubyak, E. Banks, J. Welter, and R. Eckert
Physiology and Biophysics, and Dermatology, and Dermatology, Case Western Reserve Univeristy School of
Medicine, Cleveland, Ohio
Human involucrin (hINV) is a keratinocyte differentiation marker expressed in the suprabasal
epidermal layers. In cultured keratinocytes, hINV expression is increased by phorbol ester, an agent
that promotes keratinocyte differentiation. Previous studies show that thapsigargin (TGN), an
agent that depletes intracellular calcium stores, inhibits keratinocyte differentiation. We show that
TGN inhibits the phorbol ester-dependent increase in hINV mRNA level and promoter activity.
Inhibition is half-maximal at 10 nM and maximally at 100 nM, but basal hINV promoter activity is
not regulated. Mutation of a functionally important CAATT-enhancer-binding protein (C/EBP)
site within the hINV promoter proximal regulatory region eliminates the regulation, suggesting
that TGN may effect C/EBP-dependent promoter activation. Consistent with this suggestion,
TGN inhibits C/EBPa-dependent promoter activation via a mechanism that involves inhibition
of C/EBPa binding to DNA. This reduction is observed without an accompanying change in C/
EBPa protein level. As C/EBPa is activity is absolutely required for optimal hINV promoter
activity and gene expression (Agarwal et al, JBC 274:6190, 1999), this result suggests that TGN
interferes with hINV expression by interfering with C/EBP transcription-factor function.
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Green Tea Polyphenol Increases Ap1 Factor-Dependent Human Involucrin (HINV)
Gene Expression in Normal Human Keratinocytes
S. Balasubramanian, H. Mukhtar, and R. Eckert
Physiology and Biophysics, and Dermatologys, and Dermatology, Case Western Reserve Univeristy School of
Medicine, Cleveland, Ohio
(±)-Epigallocatechin-3-gallate (EGCG) is an important bioactive constituent of green tea that
ef®ciently reduces epidermal cancer cell proliferation. This inhibition is associated with a reduction
in activator protein 1 (AP 1) transcription factor level and activity. However, the effect of this
candidate therapeutic agent on normal keratinocyte function has not been extensively explored.
Our present studies suggest that EGCG is a potent regulator of normal keratinocyte function. To
understand the mechanism of action, we studied the effects of EGCG on AP1 factor activity, and
expression of the AP1-factor regulated human involucrin (hINV) gene. hINV is an established,
well-studied marker of human epidermal keratinocyte terminal differentiation (Welter et al, JBC
270:12614, 1995; Crish et al, JBC 273:30460, 1998; E®mova et al, JBC 275:1601, 2000). hINV
promoter activity is induced in a concentration-dependent manner at 5, 10, 15 and 20 mg per ml of
EGCG. An 8-fold increase in activity is observed at 20 mg per ml. This response appears to be
physiologic, as a parallel increase in endogenous hINV gene expression is observed. The activation
is comparable to that observed for phorbol ester, a known keratinocyte differentiating agent.
Mutation of a functionally important AP1 site, AP1-1, located within the hINV gene promoter
proximal regulatory region (PRR), eliminates this regulation, suggesting that the response is
mediated via an AP1 transcription factor-dependent mechanism. Fra-1, Fra-2, fosB, junB, junD, c-
jun and c-fos levels are increased by EGCG treatment. Moreover, AP1 factor binding to the AP1-1
site is increased by EGCG and this complex contains Fra-1 and junD. Thus, our results indicate
that EGCG markedly increases AP1 signaling, and differentiation-associated gene expression in
normal keratinocytes. This is in sharp contrast to previous reports in transformed keratinocytes, and
indicate that the mechanism of EGCG action is markedly different in normal vs. immortalized/
transformed keratinocytes.
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The Human Involucrin Gene Contains Spatially Distinct Regulatory Elements that
Regulate Expression During Early Versus Late Epidermal Differentiation
J. Crish, F. Bone, E. Banks, and R. Eckert
Physiology and Biophysics, and Dermatology, Case Western Reserve Univeristy School of Medicine,
Cleveland, Ohio
Human involucrin (hINV) is a keratinocyte protein that is expressed in the suprabasal compartment
of the epidermis and other stratifying surface epithelia. Involucrin gene expression is initiated early
in the differentiation process and is maintained until just prior to terminal cell death. The distal
regulatory region (DRR) is a segment of the hINV promoter (nucleotides ±2473/±1953) that
accurately recapitulates the normal pattern of suprabasal (spinous and granular layer) expression in
transgenic mouse epithelia. To identify sequences that mediate expression at speci®c stages of
differentiation, we divided the DRR into two segments, a 376 nucleotide upstream region (DRR-
2473/±2100) and a 147 nucleotide downstream region (DRR-2100/±1953), and evaluated the
ability of these sequences to drive expression in transgenic mice. The DRR-2473/±2100 segment
drives expression at a level comparable to that observed for the DRR, but expression is restricted to
the upper granular layers (i.e. no spinous layer expression). In contrast, the DRR-2100/±1953
segment does not drive expression. However, reassembling the DRR restores the complete range
of expression. These results suggest that two distinct, spatially separate elements are required to
specify the complete differentiation-dependent program of involucrin gene expression. To identify
speci®c transcription factor binding sites involved in this region, we mutated an activator protein-1
binding site, AP1-5, located within DRR-2473/±2100 segment. This site binds AP1 transcription
factors present in mouse epidermal extracts, and its mutation eliminates appropriate hINV
expression. This result suggests that a multiprotein complex that forms over multiple, spatially
separate, regulatory elements is required for appropriate expression of the hINV gene, and that AP1
factors participate as components of this complex.
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Regulation of Human Involucrin Gene Expression by Serine/Threonine Protein
Phosphatase Inhibitor Okadaic Acid
T. E®mova and R. Eckert
Physiology and Biophysics, and Dermatology and Dermatology, Case Western Reserve Univeristy School of
Medicine, Cleveland, Ohio
Involucrin is a component of the keratinocyte corni®ed envelope that is an important marker of
keratinocyte terminal differentiation. Okadaic acid (OA) is a potent and speci®c inhibitor of
serine/threonine protein phosphatases PP2A and PP1. The role of okadaic acid-sensitive
phosphatases in epidermal differentiation has not been elucidated. In the present study, we examine
the effect of this agent on involucrin gene expression. We show that OA enhances human
involucrin (hINV) promoter activity in cultured human epidermal keratinocytes, and potentiates
phorbol ester-dependent activation of the promoter. The endogenous hINV protein level is also
increased by OA treatment, suggesting that inhibition of OA-sensitive phosphatases induces
keratinocyte differentiation. Regulation of hINV promoter activity by OA requires the AP1-1 and
C/EBP binding sites within the hINV promoter proximal regulatory region (PRR), and activation
of hINV gene expression is associated with an OA-dependent increase in both AP1 and C/EBP
DNA binding activity, respectively, at the hINV promoter AP1-1 and C/EBP sites. In addition,
OA increases the expression of the AP1 transcription family members c-Jun, JunB, JunD, Fra-1
and Fra-2, and alters their phosphorylation state. This increase does not require protein kinase c, as
pretreatment with PKC-speci®c inhibitor, bis-indolylmaleimide, does not block the OA-associated
increase in AP1 protein level. C/EBPa and C/EBPb level are also increased, and their
phosphorylation state is altered by OA in a time- and a concentration-dependent manner. These
changes are associated with an OA-dependent increase in p38 and JNK activity. Thus, OA appears
to increase hINV gene expression via a mechanism whereby the p38 and JNK MAPKs increase
AP1 and C/EBP factor levels and DNA binding.
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AP-1 and Sp1 Cooperatively Regulate Differentiation-Speci®c Expression of the Mouse
Loricrin Gene Via Direct Association
Y. Kawachi and D. Roop
Molecular and Cellular Biology and Dermatology, Baylor College of Medicine, Houston, Texas
We have previously shown that an AP-1 element in the proximal promoter of the mouse loricrin
gene is necessary but not suf®cient for expression in vivo in transgenic mice. To identify additional
regulatory elements required for expression of the loricrin gene, we performed deletion and
mutation analysis of the promoter region. Deletion or mutation of a 8-bp sequence
(GGGAGGAG), which is located 14 bp upstream of the AP-1 element, resulted in a signi®cant
decrease in promoter activity to a level similar to that observed by disruption of the AP-1 element.
Electrophoretic mobility shift assays and supershift assays with speci®c antibodies showed that Sp1
and Sp3 speci®cally bound to this sequence. Overexpression of Sp1 in cultured keratinocytes
resulted in a 12-fold enhancement of the promoter activity, however, Sp3 did not increase
promoter activity. Immunoblotting studies using nuclear and whole cell extracts from
undifferentiated or differentiated keratinocytes indicated that Sp1 translocated to nucleus in
differentiated keratinocytes, potentially inducing differentiation-speci®c expression of the loricrin
gene. Further support for this hypothesis was obtained by cotransfection experiments which
demonstrated that c-fos and Sp1 synergistically activated loricrin promoter activity. Interestingly,
jun family members (c-jun, JunB, JunD) suppressed the positive effect of c-fos on the loricrin
promoter. Site-speci®c mutagenesis of either the AP-1 and/or the Sp1 element indicated that both
elements were essential and acted synergistically for differenciation-speci®c expression of the
loricrin gene. These data suggested functional cooperation between AP-1 and Sp1, therefore we
examined the physical interaction between thees two factors. In vitro binding by means of a
glutathione S-transferase pull down assay showed that both c-jun and c-fos could directly associate
with both Sp1 and Sp3. Taken together, these data provide evidence for both physical and
functional interactions between AP-1 and Sp1 during differentiation-speci®c expression of the
loricrin gene.
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Different Properties of Three Isoforms of Transcription Factor AP-2 in Human
Keratinocytes
N. Oyama, K. Iwatsuki, Y. Homma,* and F. Kaneko
Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan; *Biomolecular Sciences,
Fukushima Medical University School of Medicine, Fukushima, Japan
Transcription factor AP-2/promoter system is essential for the complex keratinocyte biology
mediated by in¯ammatory cytokines, as we demonstrated previously (JID 113 : 600±6, 1999).
Three isoforms, AP-2a, b, and g, share a high homologous structure, but their functions are
considered to be different. We therefore studied the implication of each AP-2 isoform in the
keratinocyte proliferation, differentiation, and carcinogenesis. Serial skin sections from different
sources, normal, psoriasis, and squamous cell carcinoma (SCC), were examined for AP-2
immunoreactivty. AP-2a was present only in the nuclei of normal basal keratinocytes, but
signi®cantly increased in the lesional keratinocytes of both diseases. AP-2b was completely absent
in all samples, whereas AP-2g was homogeneously observed throughout the epidermis in normal
and psoriatic skin as well as the SCC lesion. There was a strong correlation in the expression
pattern between AP-2 isoforms and major keratinocyte markers such as keratin K1, K14,
transglutaminase (TGase) I, and epidermal growth factor receptor (EGFR). Furthermore, in vitro
DNA binding assay revealed the isoform-speci®c gene activation. AP-2a was highly accessible
with the promoter fragments of K14 and EGFR rather than those of K1 and TGase I, all of which
are critical regions for the AP-2-dependent gene activation. In contrast, AP-2g bound to these four
promoter fragments with similar af®nities, but AP-2b did not despite the binding with AP2
consensus oligonucleotide. These results suggest that three AP-2 isoforms perform unique
properties in the spatial and temporal expression of keratinocyte-related genes, thereby maintaining
the epidermal homeostasis. Disruption of the epidermal AP-2 balance may lead to the
establishment of hyperproliferative and neoplastic phenotypes, such as psoriasis and SCC.
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Transcriptional Regulation of Human Papillomaviruses by Interferon Regulatory
Factor-1
S. Tyring,* I. Arany, W. Whitehead, K. Grattendick, and L. Hoskins
Microbiology and Immunology, UTMB, Galveston, Texas; *Dermatology, UTMB, Galveston, Texas
Human papillomaviruses (HPVs) are frequently associated with various lesions of the squamous
epithelium. Cell-mediated immune responses against HPV infection result in release of various
cytokines that in turn could regulate HPV transcription. Interferon regulatory factor-1 (IRF-1) is
induced by several cytokines, and it activates transcription of target genes by binding to a speci®c
sequence in their promoter region. Here we describe the properties of an Interferon Responsive
Element (HIRE) in close proximity to the TATA box of HPV type 16. This site resembles the
consensus IRF-binding element (IRF-E) or interferon-stimulated response element (ISRE) and
overlaps viral E2 binding sites. HPV16 HIRE-1 binds IRF-1 protein in an inducible manner.
Mutational analyses revealed the importance of crucial nucleotides in this binding. In a reporter
system we demonstrated that HIRE-1 stimulates transcription in response to IRF-1 from both
homologous and heterologous promoters in a dose-dependent manner. We also analyzed HIREs
of some known mucosal HPV types by gel-shift assay and showed that some high-risk, but not
low-risk, mucosal types also bind IRF-1. We can assume that transcription of those HPV types is
regulated via HIRE in a fashion similar to that of HPV16. These results might provide important
insights regarding the immune responses against HPVs.
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